Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:monocarboxylic acid anion
go back to main search page
Accession:CHEBI:35757 term browser browse the term
Definition:A carboxylic acid anion formed when the carboxy group of a monocarboxylic acid is deprotonated.
Synonyms:related_synonym: Carboxylate;   Formula=CO2R;   Monocarboxylate;   SMILES=[O-]C([*])=O;   a monocarboxylate;   monocarboxylates;   monocarboxylic acid anions
 alt_id: CHEBI:13657;   CHEBI:25382;   CHEBI:3407
 xref: KEGG:C00060
 cyclic_relationship: is_conjugate_base_of CHEBI:25384


show annotations for term's descendants           Sort by:
(R)-carnitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acaca acetyl-CoA carboxylase alpha decreases expression EXP Carnitine results in decreased expression of ACACA protein CTD PMID:25669660 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457 		JBrowse link
G Acacb acetyl-CoA carboxylase beta decreases expression EXP Carnitine results in decreased expression of ACACB protein CTD PMID:25669660 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:42,366,548...42,457,655 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing increases expression EXP Carnitine results in increased expression of ADIPOQ protein CTD PMID:30256492 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases phosphorylation 		EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carnitine results in increased phosphorylation of AKT1 protein] CTD PMID:29186614 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO Carnitine promotes the reaction [Paraquat deficiency inhibits the reaction [Paraquat promotes the reaction [APP protein binds to APP protein]]] CTD PMID:33290254 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator decreases expression
multiple interactions 		EXP Carnitine results in decreased expression of BAX protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carnitine results in decreased expression of BAX protein]; Carnitine inhibits the reaction [Atrazine results in increased expression of BAX mRNA]; Carnitine inhibits the reaction [Methotrexate results in increased expression of BAX protein] 		CTD PMID:29186614 PMID:36282381 PMID:37312617 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bbox1 gamma-butyrobetaine hydroxylase 1 multiple interactions
increases chemical synthesis 		ISO Aluminum inhibits the reaction [BBOX1 protein results in increased chemical synthesis of Carnitine]; Hydrogen Peroxide inhibits the reaction [BBOX1 protein results in increased chemical synthesis of Carnitine]; Ketoglutaric Acids inhibits the reaction [Aluminum inhibits the reaction [BBOX1 protein results in increased chemical synthesis of Carnitine]]; Ketoglutaric Acids inhibits the reaction [Hydrogen Peroxide inhibits the reaction [BBOX1 protein results in increased chemical synthesis of Carnitine]] CTD PMID:21439360 NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases phosphorylation 		EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carnitine results in increased phosphorylation of BCL2 protein]; Carnitine inhibits the reaction [Atrazine results in decreased expression of BCL2 mRNA]; Carnitine inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA]; Carnitine inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:23213347 PMID:29186614 PMID:36282381 PMID:37312617 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions EXP Carnitine inhibits the reaction [Gentamicins results in decreased expression of BCL2L1 protein] CTD PMID:19491382 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression 		EXP
ISO 		Carnitine inhibits the reaction [Atrazine results in increased expression of CASP3 mRNA]; Carnitine inhibits the reaction [Gentamicins results in increased cleavage of CASP3 protein]; Carnitine inhibits the reaction [Ifosfamide results in increased expression of CASP3 mRNA]; Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of CASP3 mRNA]]; Carnitine inhibits the reaction [Methotrexate results in increased expression of CASP3 protein]
Carnitine results in increased expression of CASP3 protein
Carnitine inhibits the reaction [quinone results in increased activity of CASP3 protein] 		CTD PMID:19491382 PMID:23213347 PMID:25669660 PMID:26562095 PMID:32478940 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8 caspase 8 multiple interactions ISO Carnitine inhibits the reaction [quinone results in increased activity of CASP8 protein] CTD PMID:32478940 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP
ISO 		Carnitine inhibits the reaction [Ifosfamide results in increased expression of CASP9 mRNA]
Carnitine inhibits the reaction [quinone results in increased activity of CASP9 protein] 		CTD PMID:23213347 PMID:32478940 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Cat catalase multiple interactions EXP Carnitine inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Carnitine inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Carnitine inhibits the reaction [Ifosfamide results in decreased expression of CAT mRNA] CTD PMID:16889571 PMID:19294768 PMID:23213347 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions EXP Carnitine inhibits the reaction [Sunitinib results in increased expression of CCN2 mRNA] CTD PMID:26581635 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734 		JBrowse link
G Cdh1 cadherin 1 multiple interactions EXP Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of CDH1 protein] CTD PMID:28973641 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions EXP Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of COL1A1 mRNA]; Carnitine inhibits the reaction [Sunitinib results in increased expression of COL1A1 mRNA] CTD PMID:26581635 PMID:28973641 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Col2a1 collagen type II alpha 1 chain multiple interactions EXP [COL2A1 protein co-treated with Freund's Adjuvant] affects the abundance of Carnitine; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Carnitine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Carnitine]; huang-lien-chieh-tu-tang inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Carnitine] CTD PMID:24709313 NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions EXP
ISO 		valproyl-coenzyme A inhibits the reaction [CPT1A protein results in increased metabolism of Carnitine]
[Doxorubicin co-treated with Carnitine] results in increased expression of CPT1A mRNA; [Genistein co-treated with Carnitine] results in increased expression of CPT1A protein; Carnitine inhibits the reaction [quinone results in decreased expression of CPT1A protein] 		CTD PMID:16283381 PMID:16362726 PMID:19854160 PMID:32478940 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions
increases expression 		ISO
EXP 		Carnitine promotes the reaction [[Bezafibrate results in increased activity of CPT2 protein] which results in increased abundance of Adenosine Triphosphate]
Carnitine results in increased expression of CPT2 protein 		CTD PMID:21816645 PMID:25669660 NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:122,664,677...122,682,095 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions EXP Carnitine inhibits the reaction [Sunitinib results in increased expression of CYBB mRNA]; Carnitine inhibits the reaction [Sunitinib results in increased expression of CYBB protein] CTD PMID:26581635 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:13,359,430...13,392,586 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions EXP Carnitine inhibits the reaction [Atrazine results in decreased expression of CYP17A1 mRNA] CTD PMID:29710542 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP Carnitine promotes the reaction [Ethanol results in increased expression of CYP2E1 protein] CTD PMID:8130774 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Fabp3 fatty acid binding protein 3 multiple interactions EXP Carnitine inhibits the reaction [Doxorubicin results in decreased expression of FABP3 mRNA] CTD PMID:20470772 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:142,651,956...142,658,718 		JBrowse link
G Fabp9 fatty acid binding protein 9 multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in decreased expression of FABP9 mRNA]; Carnitine inhibits the reaction [carbendazim results in decreased expression of FABP9 protein] CTD PMID:33965443 NCBI chr 2:91,591,842...91,595,873
Ensembl chr 2:91,592,298...91,595,873 		JBrowse link
G Fasn fatty acid synthase decreases expression EXP Carnitine results in decreased expression of FASN protein CTD PMID:25669660 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261 		JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in decreased expression of FSHB protein] CTD PMID:33965443 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370 		JBrowse link
G Gdf9 growth differentiation factor 9 multiple interactions
increases expression 		ISO Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of GDF9 mRNA]
Carnitine results in increased expression of GDF9 mRNA 		CTD PMID:37863343 NCBI chr10:37,589,200...37,599,970
Ensembl chr10:37,595,679...37,599,672 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions EXP Carnitine inhibits the reaction [Atrazine results in increased expression of GFAP protein] CTD PMID:36282381 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589 		JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions
increases expression 		ISO Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of GJA1 mRNA]
Carnitine results in increased expression of GJA1 mRNA 		CTD PMID:37863343 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582 		JBrowse link
G Gja4 gap junction protein, alpha 4 increases expression
multiple interactions 		ISO Carnitine results in increased expression of GJA4 mRNA
Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of GJA4 mRNA] 		CTD PMID:37863343 NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:139,633,287...139,635,925 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions EXP Carnitine inhibits the reaction [Atrazine results in increased activity of GPT protein] CTD PMID:36282381 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions EXP Carnitine inhibits the reaction [Ifosfamide results in decreased expression of GPX1 mRNA] CTD PMID:23213347 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024 		JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions ISO Carnitine inhibits the reaction [quinone results in decreased expression of HADHA protein] CTD PMID:32478940 NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:26,187,956...26,227,869 		JBrowse link
G Has2 hyaluronan synthase 2 multiple interactions
increases expression 		ISO Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of HAS2 mRNA]
Carnitine results in increased expression of HAS2 mRNA 		CTD PMID:37863343 NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP Carnitine inhibits the reaction [Methotrexate results in decreased expression of HMOX1 protein] CTD PMID:37312617 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hrk harakiri, BCL2 interacting protein multiple interactions ISO Carnitine inhibits the reaction [Gentamicins results in increased expression of HRK mRNA]; Carnitine inhibits the reaction [Gentamicins results in increased expression of HRK protein] CTD PMID:16239342 NCBI chr12:44,048,402...44,070,561 JBrowse link
G Hspa2 heat shock protein family A (Hsp70) member 2 multiple interactions EXP Carnitine inhibits the reaction [Cadmium Chloride results in increased expression of HSPA2 protein] CTD PMID:22359436 NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:95,128,350...95,131,287 		JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 multiple interactions
increases abundance 		ISO Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Carnitine] CTD PMID:27469509 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025 		JBrowse link
G Il10 interleukin 10 multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in decreased expression of IL10 protein]; Carnitine inhibits the reaction [Sunitinib results in decreased expression of IL10 mRNA] CTD PMID:26581635 PMID:33965443 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il18 interleukin 18 increases expression EXP Carnitine results in increased expression of IL18 protein CTD PMID:25669660 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression 		EXP Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of IL1B mRNA]]; Carnitine inhibits the reaction [sunitinib results in increased expression of IL1B mRNA]
Carnitine results in increased expression of IL1B protein 		CTD PMID:25669660 PMID:26562095 PMID:26581635 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in increased expression of IL6 protein]; Carnitine inhibits the reaction [Methotrexate results in increased expression of IL6 protein]; Carnitine inhibits the reaction [Sunitinib results in increased expression of IL6 mRNA] CTD PMID:26581635 PMID:33965443 PMID:37312617 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ins1 insulin 1 decreases uptake
multiple interactions 		ISO
EXP 		INS1 protein results in decreased uptake of Carnitine
Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased secretion of INS1 protein] 		CTD PMID:28298333 PMID:30256492 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536 		JBrowse link
G Ldha lactate dehydrogenase A multiple interactions ISO Carnitine inhibits the reaction [Doxorubicin results in increased activity of LDHA protein] CTD PMID:37453608 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472 		JBrowse link
G Lepr leptin receptor affects abundance ISO LEPR affects the abundance of Carnitine CTD PMID:20567778 NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908 		JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in decreased expression of LHB protein] CTD PMID:33965443 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP Carnitine inhibits the reaction [sunitinib results in decreased expression of MMP9 mRNA] CTD PMID:26581635 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Mpo myeloperoxidase multiple interactions
increases activity 		EXP [Carboplatin co-treated with Carnitine deficiency] results in increased expression of MPO protein; Acetaminophen promotes the reaction [Carnitine deficiency results in increased activity of MPO protein] CTD PMID:18597074 PMID:18852009 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819 		JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I multiple interactions ISO Carnitine inhibits the reaction [nickel chloride results in decreased expression of COX1 mRNA] CTD PMID:21419151 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867 		JBrowse link
G Mt-nd6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 multiple interactions ISO Carnitine inhibits the reaction [nickel chloride results in decreased expression of ND6 mRNA] CTD PMID:21419151 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061 		JBrowse link
G Mttp microsomal triglyceride transfer protein multiple interactions EXP Carnitine inhibits the reaction [Stavudine results in decreased expression of MTTP mRNA] CTD PMID:18299183 NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions EXP Carnitine inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] CTD PMID:37312617 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 increases expression EXP Carnitine results in increased expression of NLRP3 protein CTD PMID:25669660 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in increased expression of NOS2 protein]; Carnitine inhibits the reaction [Ifosfamide results in increased expression of NOS2 mRNA] CTD PMID:23213347 PMID:33965443 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Nos3 nitric oxide synthase 3 increases expression EXP Carnitine results in increased expression of NOS3 CTD PMID:20123095 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166 		JBrowse link
G Ocln occludin multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in decreased expression of OCLN protein] CTD PMID:33965443 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions
increases expression
increases activity 		EXP [pirinixic acid results in increased activity of PPARA protein] promotes the reaction [SLC22A21 protein results in increased uptake of Carnitine]; PPARA protein promotes the reaction [Carnitine results in decreased susceptibility to Gentamicins]
Carnitine results in increased expression of PPARA protein
Carnitine results in increased activity of PPARA protein 		CTD PMID:19491382 PMID:19735737 PMID:25669660 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma increases expression
multiple interactions 		EXP Carnitine results in increased expression of PPARG protein
Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein] 		CTD PMID:30256492 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions EXP Carnitine inhibits the reaction [Methotrexate results in decreased expression of PPARGC1A protein] CTD PMID:37312617 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Ptgis prostaglandin I2 synthase increases expression
increases response to substance
multiple interactions 		EXP Carnitine results in increased expression of PTGIS mRNA
PTGIS protein results in increased susceptibility to Carnitine
[Carnitine results in increased expression of PTGIS mRNA] which results in increased chemical synthesis of 6-Ketoprostaglandin F1 alpha 		CTD PMID:19491382 NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451 		JBrowse link
G Pycard PYD and CARD domain containing increases expression EXP Carnitine results in increased expression of PYCARD protein CTD PMID:25669660 NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in increased expression of RELA protein] CTD PMID:33965443 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Scd stearoyl-CoA desaturase decreases expression EXP Carnitine results in decreased expression of SCD protein CTD PMID:25669660 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions EXP Carnitine inhibits the reaction [Methotrexate results in decreased expression of SIRT1 protein] CTD PMID:37312617 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Sirt3 sirtuin 3 multiple interactions ISO Carnitine inhibits the reaction [Cyclophosphamide results in increased expression of SIRT3 mRNA] CTD PMID:37863343 NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808 		JBrowse link
G Slc22a1 solute carrier family 22 member 1 decreases expression EXP Carnitine results in decreased expression of SLC22A1 protein CTD PMID:25669660 NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases expression EXP Carnitine results in decreased expression of SLC22A2 protein CTD PMID:25669660 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268 		JBrowse link
G Slc22a21 solute carrier family 22 (organic cation transporter), member 21 multiple interactions
increases uptake 		EXP [pirinixic acid results in increased activity of PPARA protein] promotes the reaction [SLC22A21 protein results in increased uptake of Carnitine] CTD PMID:19735737 NCBI chr10:38,104,114...38,133,106
Ensembl chr10:38,104,122...38,130,671 		JBrowse link
G Slc22a4 solute carrier family 22 member 4 increases uptake
decreases expression 		ISO
EXP 		SLC22A4 protein results in increased uptake of Carnitine
Carnitine results in decreased expression of SLC22A4 protein 		CTD PMID:21256917 PMID:25669660 PMID:33007874 NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720 		JBrowse link
G Slc22a5 solute carrier family 22 member 5 multiple interactions
affects expression
decreases expression
increases transport
increases uptake
increases expression
affects uptake
affects binding 		ISO
EXP 		[Doxorubicin co-treated with Carnitine] results in increased expression of SLC22A5 mRNA; Amiodarone inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Atorvastatin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Betaine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Carnitine inhibits the reaction [SLC22A5 protein results in increased abundance of Doxorubicin]; Carnitine inhibits the reaction [SLC22A5 protein results in increased transport of pivaloylcarnitine]; Choline inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Clozapine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; grepafloxacin affects the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Ipratropium inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Lidocaine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Nifedipine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Ofloxacin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Olanzapine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine analog]; pivaloylcarnitine inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]; Propranolol inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Quetiapine Fumarate inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Spironolactone inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; talinolol inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; ziprasidone inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
Carnitine affects the expression of SLC22A5 protein
Carnitine inhibits the reaction [SLC22A5 protein results in increased abundance of and results in increased localization of Doxorubicin]
Carnitine results in decreased expression of SLC22A5 mRNA; Carnitine results in decreased expression of SLC22A5 protein
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of SLC22A5 mRNA]; Carnitine inhibits the reaction [Cyclophosphamide results in decreased expression of SLC22A5 protein]; Carnitine inhibits the reaction [Doxorubicin results in decreased expression of SLC22A5 mRNA]; Carnitine inhibits the reaction [SLC22A5 protein results in increased uptake of Tetraethylammonium]; Dithioerythritol inhibits the reaction [Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]]; Ofloxacin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]; Omeprazole inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine]; Tetraethylammonium inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
Carnitine deficiency results in increased expression of SLC22A5 mRNA
SLC22A5 protein results in increased uptake of Carnitine; SLC22A5 protein results in increased uptake of Carnitine analog
SLC22A5 protein affects the uptake of Carnitine
Carnitine binds to SLC22A5 protein 		CTD PMID:12644265 PMID:15486076 PMID:16283381 PMID:16928358 PMID:18762717 More... NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases transport ISO SLC22A8 protein results in increased transport of Carnitine CTD PMID:15100168 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450 		JBrowse link
G Slc25a20 solute carrier family 25 member 20 multiple interactions
increases transport 		EXP Ampicillin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]; Carnitine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SLC25A20 protein]; Cefazolin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]; Cefonicid inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]; Piperacillin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine] CTD PMID:18452908 PMID:23402788 NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:109,365,002...109,386,512 		JBrowse link
G Slc2a4 solute carrier family 2 member 4 increases expression
multiple interactions 		EXP Carnitine results in increased expression of SLC2A4 protein
Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of SLC2A4 protein] 		CTD PMID:30256492 NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565 		JBrowse link
G Snai1 snail family transcriptional repressor 1 multiple interactions EXP Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of SNAI1 protein] CTD PMID:28973641 NCBI chr 3:176,667,476...176,671,965
Ensembl chr 3:156,248,485...156,252,969 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions
decreases expression 		EXP Carnitine inhibits the reaction [Stavudine results in increased expression of SREBF1 mRNA]
Carnitine results in decreased expression of SREBF1 protein 		CTD PMID:18299183 PMID:25669660 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650 		JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions EXP Carnitine inhibits the reaction [carbendazim results in decreased expression of STAR mRNA]; Carnitine inhibits the reaction [carbendazim results in decreased expression of STAR protein] CTD PMID:33965443 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of TGFB1 mRNA]]; Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of TGFB1 mRNA]; Carnitine inhibits the reaction [sunitinib results in increased expression of TGFB1 mRNA] CTD PMID:26562095 PMID:26581635 PMID:28973641 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions EXP Carnitine inhibits the reaction [sunitinib results in increased expression of TIMP1 mRNA] CTD PMID:26581635 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:1,212,972...1,217,664 		JBrowse link
G Tjp1 tight junction protein 1 multiple interactions EXP Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of TJP1 protein] CTD PMID:28973641 NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432 		JBrowse link
G Tnf tumor necrosis factor increases expression
multiple interactions
decreases expression 		EXP Carnitine deficiency results in increased expression of TNF mRNA
[Carboplatin co-treated with Carnitine deficiency] results in increased expression of TNF protein; Acetaminophen promotes the reaction [Carnitine deficiency results in increased expression of TNF mRNA]; Carnitine inhibits the reaction [carbendazim results in increased expression of TNF protein]; Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of TNF mRNA]]; Carnitine inhibits the reaction [Iohexol promotes the reaction [Glycerol results in increased expression of TNF protein]]; Carnitine inhibits the reaction [Methotrexate results in increased expression of TNF protein]
Carnitine results in decreased expression of TNF protein 		CTD PMID:18597074 PMID:18629605 PMID:18852009 PMID:26562095 PMID:33965443 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Vim vimentin multiple interactions EXP Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of VIM protein] CTD PMID:28973641 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187 		JBrowse link
3,4-dihydroxybenzoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Epas1 endothelial PAS domain protein 1 increases expression
multiple interactions 		ISO 3,4-dihydroxybenzoate results in increased expression of EPAS1 mRNA
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of EPAS1 mRNA 		CTD PMID:19679656 NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases expression
affects localization
multiple interactions 		ISO
EXP 		3,4-dihydroxybenzoate results in increased expression of HIF1A mRNA
3,4-dihydroxybenzoate affects the localization of HIF1A protein
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolite] affects the localization of HIF1A protein
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HIF1A mRNA 		CTD PMID:19679656 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression 		ISO [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 mRNA; [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 protein
3,4-dihydroxybenzoate results in increased expression of HMOX1 mRNA; 3,4-dihydroxybenzoate results in increased expression of HMOX1 protein 		CTD PMID:19679656 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Slc40a1 solute carrier family 40 member 1 multiple interactions ISO 3,4-dihydroxybenzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC40A1 protein] CTD PMID:19679656 NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:48,033,526...48,051,481 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
increases expression 		ISO [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SOD2 protein
3,4-dihydroxybenzoate results in increased expression of SOD2 protein 		CTD PMID:19679656 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
4-(trimethylammonio)butanoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bbox1 gamma-butyrobetaine hydroxylase 1 multiple interactions ISO [BBOX1 protein co-treated with Ketoglutaric Acids] results in increased metabolism of gamma-butyrobetaine CTD PMID:21439360 NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458 		JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 multiple interactions
increases abundance 		ISO Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of gamma-butyrobetaine] CTD PMID:27469509 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025 		JBrowse link
6-aminohexanoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin decreases expression ISO Aminocaproic Acid results in decreased expression of A2M protein CTD PMID:11304663 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:154,897,877...154,947,786 		JBrowse link
G Folh1 folate hydrolase 1 multiple interactions ISO [2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [isospaglumic acid binds to FOLH1 protein] CTD PMID:24508213 NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379 		JBrowse link
G Grpr gastrin releasing peptide receptor multiple interactions ISO [2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [bombesin, Tyr(4)- binds to GRPR protein] CTD PMID:24508213 NCBI chr  X:30,998,425...31,038,442
Ensembl chr  X:30,998,416...31,038,442 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] CTD PMID:17482686 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK3 protein] CTD PMID:17482686 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Plg plasminogen multiple interactions ISO Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein]; Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK3 protein] CTD PMID:17482686 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:48,325,185...48,367,786 		JBrowse link
G Serpinc1 serpin family C member 1 increases expression ISO Aminocaproic Acid results in increased expression of SERPINC1 protein CTD PMID:11304663 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293 		JBrowse link
acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Tnf tumor necrosis factor increases secretion EXP Acetate increases secretion of Tnf protein from Kupffer cells RGD PMID:19299582 RGD:9585771 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
Augmentin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of ABCB11 mRNA CTD PMID:34767876 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA CTD PMID:34767876 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852 		JBrowse link
G Casp3 caspase 3 increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP3 protein CTD PMID:30273099 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp9 caspase 9 increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP9 protein CTD PMID:30273099 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Cycs cytochrome c, somatic increases secretion EXP Amoxicillin-Potassium Clavulanate Combination results in increased secretion of CYCS protein CTD PMID:30273099 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054
Ensembl chr18:79,651,378...79,654,054 		JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:76,264,860...76,294,551 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688 		JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP8B1 mRNA CTD PMID:34767876 NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166 		JBrowse link
G Fgf19 fibroblast growth factor 19 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA CTD PMID:34767876 NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:200,056,644...200,060,287 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of G6PD mRNA CTD PMID:34767876 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:152,201,098...152,220,801 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA CTD PMID:34767876 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA CTD PMID:34767876 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GGT1 protein CTD PMID:34767876 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of GOT1 protein CTD PMID:30273099 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633 		JBrowse link
G Gpt glutamic--pyruvic transaminase increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of GPT protein CTD PMID:30273099 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA CTD PMID:34767876 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GSR mRNA CTD PMID:34767876 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661 		JBrowse link
G Me1 malic enzyme 1 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of ME1 mRNA CTD PMID:34767876 NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of NR0B2 mRNA CTD PMID:34767876 NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609 		JBrowse link
G Slc10a1 solute carrier family 10 member 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC10A1 mRNA CTD PMID:34767876 NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670 		JBrowse link
G Slc51a solute carrier family 51 member A decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA CTD PMID:34767876 NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA CTD PMID:34767876 NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536 		JBrowse link
G Tkt transketolase increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of TKT mRNA CTD PMID:34767876 NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698 		JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of TXNRD1 mRNA CTD PMID:34767876 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863 		JBrowse link
benzoates term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahcy adenosylhomocysteinase decreases expression ISO Benzoates analog results in decreased expression of AHCY mRNA CTD PMID:29472718 NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393 		JBrowse link
G Ahr aryl hydrocarbon receptor decreases expression ISO Benzoates analog results in decreased expression of AHR mRNA CTD PMID:29472718 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule decreases expression ISO Benzoates analog results in decreased expression of ALCAM mRNA CTD PMID:29472718 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:48,336,169...48,537,954 		JBrowse link
G Anxa4 annexin A4 decreases expression ISO Benzoates analog results in decreased expression of ANXA4 mRNA CTD PMID:29472718 NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:119,184,374...119,241,161 		JBrowse link
G Batf3 basic leucine zipper ATF-like transcription factor 3 increases expression ISO Benzoates analog results in increased expression of BATF3 mRNA CTD PMID:29472718 NCBI chr13:105,220,782...105,232,365
Ensembl chr13:102,689,657...102,701,139 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Benzoates analog results in decreased expression of BCL2 mRNA CTD PMID:29472718 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bmp2 bone morphogenetic protein 2 decreases expression ISO Benzoates analog results in decreased expression of BMP2 mRNA CTD PMID:29472718 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397 		JBrowse link
G Capg capping actin protein, gelsolin like decreases expression ISO Benzoates analog results in decreased expression of CAPG mRNA CTD PMID:29472718 NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856 		JBrowse link
G Casp3 caspase 3 increases expression
decreases expression 		ISO Benzoates analog results in increased expression of CASP3 protein modified form
Benzoates analog results in decreased expression of CASP3 mRNA 		CTD PMID:29472718 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Ccnd2 cyclin D2 decreases expression ISO Benzoates analog results in decreased expression of CCND2 mRNA CTD PMID:29472718 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495 		JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO Benzoates analog results in decreased expression of CCND3 mRNA CTD PMID:29472718 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:13,394,169...13,489,371 		JBrowse link
G Ccne1 cyclin E1 decreases expression ISO Benzoates analog results in decreased expression of CCNE1 mRNA CTD PMID:29472718 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101 		JBrowse link
G Cd44 CD44 molecule affects expression ISO Benzoates analog affects the expression of CD44 mRNA CTD PMID:29472718 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620 		JBrowse link
G Cd48 Cd48 molecule increases expression ISO Benzoates analog results in increased expression of CD48 mRNA CTD PMID:29472718 NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142 		JBrowse link
G Cd81 Cd81 molecule decreases expression ISO Benzoates analog results in decreased expression of CD81 mRNA CTD PMID:29472718 NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:198,241,484...198,251,660 		JBrowse link
G Cdc42se2 CDC42 small effector 2 decreases expression ISO Benzoates analog results in decreased expression of CDC42SE2 mRNA CTD PMID:29472718 NCBI chr10:38,836,549...38,905,056
Ensembl chr10:38,836,555...38,905,059
Ensembl chr 1:38,836,555...38,905,059 		JBrowse link
G Cdc6 cell division cycle 6 decreases expression ISO Benzoates analog results in decreased expression of CDC6 mRNA CTD PMID:29472718 NCBI chr10:84,360,361...84,374,239
Ensembl chr10:83,864,638...83,878,011 		JBrowse link
G Cish cytokine inducible SH2-containing protein increases expression ISO Benzoates analog results in increased expression of CISH mRNA CTD PMID:29472718 NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:107,972,306...107,977,250 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 increases expression ISO Benzoates analog results in increased expression of CKAP4 mRNA CTD PMID:29472718 NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914 		JBrowse link
G Csf1 colony stimulating factor 1 increases expression ISO Benzoates analog results in increased expression of CSF1 mRNA CTD PMID:29472718 NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704 		JBrowse link
G Cst7 cystatin F increases expression ISO Benzoates analog results in increased expression of CST7 mRNA CTD PMID:29472718 NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557 		JBrowse link
G Ctsz cathepsin Z increases expression ISO Benzoates analog results in increased expression of CTSZ mRNA CTD PMID:29472718 NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression ISO Benzoates analog results in increased expression of CXCL10 mRNA CTD PMID:29472718 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression
decreases expression 		ISO Benzoates results in increased expression of CXCL2 protein
Benzoates results in decreased expression of CXCL2 protein 		CTD PMID:23178550 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075 		JBrowse link
G Cyfip1 cytoplasmic FMR1 interacting protein 1 decreases expression ISO Benzoates analog results in decreased expression of CYFIP1 mRNA CTD PMID:29472718 NCBI chr 1:106,710,924...106,799,393
Ensembl chr 1:106,711,016...106,799,386 		JBrowse link
G Dcps decapping enzyme, scavenger decreases expression ISO Benzoates analog results in decreased expression of DCPS mRNA CTD PMID:29472718 NCBI chr 8:33,468,669...33,524,407
Ensembl chr 8:33,415,671...33,524,389 		JBrowse link
G Dennd5a DENN domain containing 5A increases expression ISO Benzoates analog results in increased expression of DENND5A mRNA CTD PMID:29472718 NCBI chr 1:163,928,183...163,994,207
Ensembl chr 1:163,928,183...163,994,316 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 decreases expression ISO Benzoates analog results in decreased expression of DHRS3 mRNA CTD PMID:29472718 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:156,747,962...156,782,417 		JBrowse link
G Ecm1 extracellular matrix protein 1 decreases expression ISO Benzoates analog results in decreased expression of ECM1 mRNA CTD PMID:29472718 NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671 		JBrowse link
G Eef1akmt1 EEF1A lysine methyltransferase 1 decreases expression ISO Benzoates analog results in decreased expression of EEF1AKMT1 mRNA CTD PMID:29472718 NCBI chr15:31,694,284...31,711,367
Ensembl chr15:31,694,292...31,711,336 		JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO Benzoates analog results in increased expression of EMP1 mRNA CTD PMID:29472718 NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904 		JBrowse link
G Esr1 estrogen receptor 1 increases activity ISO Benzoates results in increased activity of ESR1 protein CTD PMID:16756374 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Etv4 ETS variant transcription factor 4 decreases expression ISO Benzoates analog results in decreased expression of ETV4 mRNA CTD PMID:29472718 NCBI chr10:87,206,977...87,222,202
Ensembl chr10:86,706,749...86,721,974 		JBrowse link
G Fah fumarylacetoacetate hydrolase increases expression ISO Benzoates analog results in increased expression of FAH mRNA CTD PMID:29472718 NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:138,548,834...138,571,505 		JBrowse link
G Fgl2 fibrinogen-like 2 decreases expression ISO Benzoates analog results in decreased expression of FGL2 mRNA CTD PMID:29472718 NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:13,710,575...13,716,207 		JBrowse link
G Flt3 Fms related receptor tyrosine kinase 3 increases response to substance ISO FLT3 protein mutant form results in increased susceptibility to Benzoates analog CTD PMID:29472718 NCBI chr12:12,660,035...12,735,584
Ensembl chr12:7,623,930...7,699,474 		JBrowse link
G Gabarapl1 GABA type A receptor associated protein like 1 increases expression ISO Benzoates analog results in increased expression of GABARAPL1 mRNA CTD PMID:29472718 NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:162,980,249...162,989,450 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression ISO Benzoates analog results in increased expression of GADD45B mRNA CTD PMID:29472718 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:8,778,007...8,780,046 		JBrowse link
G Galm galactose mutarotase decreases expression ISO Benzoates analog results in decreased expression of GALM mRNA CTD PMID:29472718 NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310 		JBrowse link
G Gbp4 guanylate binding protein 4 decreases expression ISO Benzoates analog results in decreased expression of GBP4 mRNA CTD PMID:29472718 NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879 		JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO Benzoates analog inhibits the reaction [GH protein promotes the reaction [STAT5A protein binds to STAT5A protein]]; Benzoates analog inhibits the reaction [GH protein results in increased phosphorylation of STAT5A protein] CTD PMID:29472718 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,228,103...91,230,078 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 multiple interactions ISO [INS1 protein co-treated with Benzoates] results in increased activity of GPD1 protein CTD PMID:2523799 NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529 		JBrowse link
G Gpx4 glutathione peroxidase 4 decreases expression ISO Benzoates analog results in decreased expression of GPX4 mRNA CTD PMID:29472718 NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions EXP Benzoates analog binds to and results in decreased activity of GRIA1 protein CTD PMID:14667236 NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP Benzoates analog binds to and results in decreased activity of GRIA2 protein CTD PMID:14667236 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510 		JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 multiple interactions EXP Benzoates analog binds to and results in decreased activity of GRIA3 protein CTD PMID:14667236 NCBI chr  X:125,103,975...125,369,690
Ensembl chr  X:120,238,534...120,504,096 		JBrowse link
G Gria4 glutamate ionotropic receptor AMPA type subunit 4 multiple interactions EXP Benzoates analog binds to and results in decreased activity of GRIA4 protein CTD PMID:14667236 NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:1,562,119...2,034,979 		JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 multiple interactions ISO Benzoates analog binds to and results in decreased activity of GRIK1 protein CTD PMID:14667236 NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645 		JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 multiple interactions ISO Benzoates analog binds to and results in decreased activity of GRIK2 protein CTD PMID:14667236 NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 decreases expression ISO Benzoates analog results in decreased expression of GSTO1 mRNA CTD PMID:29472718 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:246,721,221...246,731,468 		JBrowse link
G Hk2 hexokinase 2 decreases expression ISO Benzoates analog results in decreased expression of HK2 mRNA CTD PMID:29472718 NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:115,234,509...115,283,530 		JBrowse link
G Ifitm3 interferon induced transmembrane protein 3 decreases expression ISO Benzoates analog results in decreased expression of IFITM3 mRNA CTD PMID:29472718 NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203 		JBrowse link
G Ifngr1 interferon gamma receptor 1 increases expression ISO Benzoates analog results in increased expression of IFNGR1 mRNA CTD PMID:29472718 NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:14,333,187...14,351,785 		JBrowse link
G Il10ra interleukin 10 receptor subunit alpha decreases expression ISO Benzoates analog results in decreased expression of IL10RA mRNA CTD PMID:29472718 NCBI chr 8:54,459,754...54,474,786
Ensembl chr 8:45,563,137...45,578,061 		JBrowse link
G Il1a interleukin 1 alpha increases expression ISO Benzoates results in increased expression of IL1A protein CTD PMID:23178550 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822 		JBrowse link
G Il2rb interleukin 2 receptor subunit beta increases expression ISO Benzoates analog results in increased expression of IL2RB mRNA CTD PMID:29472718 NCBI chr 7:111,913,828...111,928,537
Ensembl chr 7:110,033,341...110,048,054 		JBrowse link
G Il3 interleukin 3 multiple interactions ISO Benzoates analog inhibits the reaction [IL3 protein results in increased activity of STAT5A protein] CTD PMID:29472718 NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,405,716...38,408,066 		JBrowse link
G Il4r interleukin 4 receptor decreases expression ISO Benzoates analog results in decreased expression of IL4R mRNA CTD PMID:29472718 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO Benzoates analog inhibits the reaction [IL6 protein results in increased activity of STAT3 protein] CTD PMID:29472718 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ins1 insulin 1 multiple interactions ISO [INS1 protein co-treated with Benzoates] results in increased activity of GPD1 protein CTD PMID:2523799 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536 		JBrowse link
G Irf4 interferon regulatory factor 4 decreases expression ISO Benzoates analog results in decreased expression of IRF4 mRNA CTD PMID:29472718 NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,721,811...33,740,070 		JBrowse link
G Irf8 interferon regulatory factor 8 decreases expression ISO Benzoates analog results in decreased expression of IRF8 mRNA CTD PMID:29472718 NCBI chr19:65,699,284...65,721,066
Ensembl chr19:48,790,588...48,811,829 		JBrowse link
G Itga6 integrin subunit alpha 6 decreases expression ISO Benzoates analog results in decreased expression of ITGA6 mRNA CTD PMID:29472718 NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428 		JBrowse link
G Klf6 KLF transcription factor 6 increases expression ISO Benzoates analog results in increased expression of KLF6 mRNA CTD PMID:29472718 NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570 		JBrowse link
G Lif LIF, interleukin 6 family cytokine decreases expression ISO Benzoates analog results in decreased expression of LIF mRNA CTD PMID:29472718 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:79,134,574...79,140,482 		JBrowse link
G Map3k8 mitogen-activated protein kinase kinase kinase 8 increases expression ISO Benzoates analog results in increased expression of MAP3K8 mRNA CTD PMID:29472718 NCBI chr17:58,078,175...58,098,455
Ensembl chr17:53,383,131...53,403,216 		JBrowse link
G Mapkapk2 MAPK activated protein kinase 2 decreases expression ISO Benzoates analog results in decreased expression of MAPKAPK2 mRNA CTD PMID:29472718 NCBI chr13:45,066,027...45,112,326
Ensembl chr13:42,513,762...42,560,457 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Benzoates analog results in decreased expression of MKI67 protein CTD PMID:29472718 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762 		JBrowse link
G Mxd1 max dimerization protein 1 increases expression ISO Benzoates analog results in increased expression of MXD1 mRNA CTD PMID:29472718 NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression ISO Benzoates analog results in decreased expression of MYC mRNA CTD PMID:29472718 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630 		JBrowse link
G Myo1c myosin 1C affects expression ISO Benzoates analog affects the expression of MYO1C mRNA CTD PMID:29472718 NCBI chr10:60,996,642...61,019,022
Ensembl chr10:60,498,280...60,520,752 		JBrowse link
G Ncoa3 nuclear receptor coactivator 3 increases expression ISO Benzoates analog results in increased expression of NCOA3 mRNA CTD PMID:29472718 NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594 		JBrowse link
G Ncs1 neuronal calcium sensor 1 decreases expression ISO Benzoates analog results in decreased expression of NCS1 mRNA CTD PMID:29472718 NCBI chr 3:34,920,949...34,966,554
Ensembl chr 3:14,523,220...14,568,829 		JBrowse link
G Ndrg1 N-myc downstream regulated 1 increases expression ISO Benzoates analog results in increased expression of NDRG1 mRNA CTD PMID:29472718 NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880 		JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated increases expression ISO Benzoates analog results in increased expression of NFIL3 mRNA CTD PMID:29472718 NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,280,484...12,295,858 		JBrowse link
G Nfkbiz NFKB inhibitor zeta increases expression ISO Benzoates analog results in increased expression of NFKBIZ mRNA CTD PMID:29472718 NCBI chr11:58,251,720...58,279,767
Ensembl chr11:44,782,676...44,810,723 		JBrowse link
G Nop2 NOP2 nucleolar protein decreases expression ISO Benzoates analog results in decreased expression of NOP2 mRNA CTD PMID:29472718 NCBI chr 4:157,932,731...157,944,462
Ensembl chr 4:157,932,716...157,944,459 		JBrowse link
G Odc1 ornithine decarboxylase 1 decreases expression ISO Benzoates analog results in decreased expression of ODC1 mRNA CTD PMID:29472718 NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440 		JBrowse link
G P2rx4 purinergic receptor P2X 4 increases expression ISO Benzoates analog results in increased expression of P2RX4 mRNA CTD PMID:29472718 NCBI chr12:33,844,609...33,862,265
Ensembl chr12:33,844,396...33,862,253 		JBrowse link
G P4ha1 prolyl 4-hydroxylase subunit alpha 1 increases expression ISO Benzoates analog results in increased expression of P4HA1 mRNA CTD PMID:29472718 NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,302,141...27,352,786 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO Benzoates analog results in increased cleavage of PARP1 protein CTD PMID:29472718 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Pdgfrb platelet derived growth factor receptor beta decreases expression ISO Benzoates analog results in decreased expression of PDGFRB protein CTD PMID:29472718 NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 decreases expression ISO Benzoates analog results in decreased expression of PHLDA1 mRNA CTD PMID:29472718 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:46,967,409...46,969,861 		JBrowse link
G Phtf2 putative homeodomain transcription factor 2 decreases expression ISO Benzoates analog results in decreased expression of PHTF2 mRNA CTD PMID:29472718 NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513 		JBrowse link
G Pim1 Pim-1 proto-oncogene, serine/threonine kinase decreases expression ISO Benzoates analog results in decreased expression of PIM1 mRNA CTD PMID:29472718 NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,554,921...7,559,174 		JBrowse link
G Plin2 perilipin 2 increases expression ISO Benzoates analog results in increased expression of PLIN2 mRNA CTD PMID:29472718 NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319 		JBrowse link
G Plscr1 phospholipid scramblase 1 increases expression ISO Benzoates analog results in increased expression of PLSCR1 mRNA CTD PMID:29472718 NCBI chr 8:101,662,512...101,684,474
Ensembl chr 8:92,784,356...92,804,692 		JBrowse link
G Pnp purine nucleoside phosphorylase decreases expression ISO Benzoates analog results in decreased expression of PNP mRNA CTD PMID:29472718 NCBI chr15:26,644,147...26,651,808
Ensembl chr15:24,170,602...24,203,986 		JBrowse link
G Prnp prion protein increases expression ISO Benzoates analog results in increased expression of PRNP mRNA CTD PMID:29472718 NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:119,177,485...119,203,937 		JBrowse link
G Ptch1 patched 1 increases expression ISO Benzoates analog results in increased expression of PTCH1 mRNA CTD PMID:29472718 NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,542,877...1,607,333 		JBrowse link
G Ptrh2 peptidyl-tRNA hydrolase 2 decreases expression ISO Benzoates analog results in decreased expression of PTRH2 mRNA CTD PMID:29472718 NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398 		JBrowse link
G Pus1 pseudouridine synthase 1 decreases expression ISO Benzoates analog results in decreased expression of PUS1 mRNA CTD PMID:29472718 NCBI chr12:45,880,364...45,889,196
Ensembl chr12:45,880,440...45,889,196 		JBrowse link
G Rabgap1l RAB GTPase activating protein 1-like increases expression ISO Benzoates analog results in increased expression of RABGAP1L mRNA CTD PMID:29472718 NCBI chr13:72,464,114...73,059,845
Ensembl chr13:72,468,110...73,059,984 		JBrowse link
G Rgs16 regulator of G-protein signaling 16 affects expression ISO Benzoates analog affects the expression of RGS16 mRNA CTD PMID:29472718 NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857 		JBrowse link
G Rhoh ras homolog family member H increases expression ISO Benzoates analog results in increased expression of RHOH mRNA CTD PMID:29472718 NCBI chr14:42,694,860...42,725,690
Ensembl chr14:42,337,751...42,386,369 		JBrowse link
G Rragd Ras-related GTP binding D increases expression ISO Benzoates analog results in increased expression of RRAGD mRNA CTD PMID:29472718 NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356 		JBrowse link
G Sh3bgrl2 SH3 domain binding glutamate-rich protein like 2 increases expression ISO Benzoates analog results in increased expression of SH3BGRL2 mRNA CTD PMID:29472718 NCBI chr 8:84,461,019...84,553,124
Ensembl chr 8:84,461,121...84,551,564 		JBrowse link
G Slc1a5 solute carrier family 1 member 5 increases expression ISO Benzoates analog results in increased expression of SLC1A5 mRNA CTD PMID:29472718 NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:77,456,694...77,470,952 		JBrowse link
G Slc2a3 solute carrier family 2 member 3 increases expression ISO Benzoates analog results in increased expression of SLC2A3 mRNA CTD PMID:29472718 NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472 		JBrowse link
G Slc39a8 solute carrier family 39 member 8 decreases expression ISO Benzoates analog results in decreased expression of SLC39A8 mRNA CTD PMID:29472718 NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:224,256,654...224,319,129 		JBrowse link
G Smpdl3a sphingomyelin phosphodiesterase, acid-like 3A increases expression ISO Benzoates analog results in increased expression of SMPDL3A mRNA CTD PMID:29472718 NCBI chr20:37,132,592...37,155,567
Ensembl chr20:37,132,592...37,155,567 		JBrowse link
G Snx9 sorting nexin 9 increases expression ISO Benzoates analog results in increased expression of SNX9 mRNA CTD PMID:29472718 NCBI chr 1:46,424,897...46,510,096
Ensembl chr 1:46,423,553...46,509,036 		JBrowse link
G Socs2 suppressor of cytokine signaling 2 increases expression ISO Benzoates analog results in increased expression of SOCS2 mRNA CTD PMID:29472718 NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:30,008,578...30,043,548 		JBrowse link
G Spred2 sprouty-related, EVH1 domain containing 2 decreases expression ISO Benzoates analog results in decreased expression of SPRED2 mRNA CTD PMID:29472718 NCBI chr14:98,350,577...98,452,143
Ensembl chr14:94,148,837...94,249,162 		JBrowse link
G St3gal4 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 affects expression ISO Benzoates analog affects the expression of ST3GAL4 mRNA CTD PMID:29472718 NCBI chr 8:41,673,510...41,723,158
Ensembl chr 8:33,415,671...33,524,389 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions ISO Benzoates analog inhibits the reaction [IL6 protein results in increased activity of STAT3 protein] CTD PMID:29472718 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057 		JBrowse link
G Stat5a signal transducer and activator of transcription 5A decreases phosphorylation
multiple interactions 		ISO Benzoates analog results in decreased phosphorylation of STAT5A protein
Benzoates analog inhibits the reaction [GH protein promotes the reaction [STAT5A protein binds to STAT5A protein]]; Benzoates analog inhibits the reaction [GH protein results in increased phosphorylation of STAT5A protein]; Benzoates analog inhibits the reaction [IL3 protein results in increased activity of STAT5A protein] 		CTD PMID:29472718 NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866 		JBrowse link
G Stat5b signal transducer and activator of transcription 5B multiple interactions ISO Benzoates analog binds to and results in decreased phosphorylation of STAT5B protein CTD PMID:29472718 NCBI chr10:86,205,148...86,276,178
Ensembl chr10:85,705,670...85,775,668 		JBrowse link
G Swap70 switching B-cell complex subunit SWAP70 increases expression ISO Benzoates analog results in increased expression of SWAP70 mRNA CTD PMID:29472718 NCBI chr 1:164,267,588...164,328,796
Ensembl chr 1:164,267,609...164,328,794 		JBrowse link
G Syt11 synaptotagmin 11 increases expression ISO Benzoates analog results in increased expression of SYT11 mRNA CTD PMID:29472718 NCBI chr 2:174,206,032...174,232,540
Ensembl chr 2:174,206,191...174,231,964 		JBrowse link
G Tgm2 transglutaminase 2 decreases expression ISO Benzoates analog results in decreased expression of TGM2 mRNA CTD PMID:29472718 NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981 		JBrowse link
G Tiam1 TIAM Rac1 associated GEF 1 decreases expression ISO Benzoates analog results in decreased expression of TIAM1 mRNA CTD PMID:29472718 NCBI chr11:29,031,347...29,380,153
Ensembl chr11:29,031,348...29,159,901 		JBrowse link
G Tnfrsf1b TNF receptor superfamily member 1B decreases expression ISO Benzoates analog results in decreased expression of TNFRSF1B mRNA CTD PMID:29472718 NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206 		JBrowse link
G Tnfrsf21 TNF receptor superfamily member 21 decreases expression ISO Benzoates analog results in decreased expression of TNFRSF21 mRNA CTD PMID:29472718 NCBI chr 9:25,376,400...25,451,323
Ensembl chr 9:17,879,156...17,954,085 		JBrowse link
G Traf1 TNF receptor-associated factor 1 increases expression ISO Benzoates analog results in increased expression of TRAF1 mRNA CTD PMID:29472718 NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807 		JBrowse link
G Ttc39b tetratricopeptide repeat domain 39B increases expression ISO Benzoates analog results in increased expression of TTC39B mRNA CTD PMID:29472718 NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270 		JBrowse link
G Uck2 uridine-cytidine kinase 2 decreases expression ISO Benzoates analog results in decreased expression of UCK2 mRNA CTD PMID:29472718 NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352 		JBrowse link
G Umps uridine monophosphate synthetase decreases expression ISO Benzoates analog results in decreased expression of UMPS mRNA CTD PMID:29472718 NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903 		JBrowse link
G Xbp1 X-box binding protein 1 increases expression ISO Benzoates analog results in increased expression of XBP1 mRNA CTD PMID:29472718 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693 		JBrowse link
CAR(3:0(Me2)) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc22a5 solute carrier family 22 member 5 affects binding
increases uptake
multiple interactions
increases transport 		ISO
EXP 		pivaloylcarnitine binds to SLC22A5 protein
SLC22A5 protein results in increased uptake of pivaloylcarnitine
Carnitine inhibits the reaction [SLC22A5 protein results in increased transport of pivaloylcarnitine]; pivaloylcarnitine inhibits the reaction [SLC22A5 protein results in increased transport of Carnitine] 		CTD PMID:18762717 PMID:19539806 NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309 		JBrowse link
carnitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acacb acetyl-CoA carboxylase beta decreases expression EXP L-carnitine decreases expression of Acacb mRNA and protein in rat heart RGD PMID:30644033 RGD:329955369 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:42,366,548...42,457,655 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A increases expression
multiple interactions 		EXP L-carnitine increases expression of Cpt1a mRNA and protein in rat heart
L-carnitine inhibits the reaction [sunitinib decreases expression of Cpt1a mRNA and protein in rat heart] 		RGD PMID:30644033 PMID:30644033 RGD:329955369, RGD:329955369 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Mlycd malonyl-CoA decarboxylase increases expression
multiple interactions 		EXP L-carnitine increases expression of Mlycd protein in rat heart
L-carnitine inhibits the reaction [sunitinib increases expression of Mlycd protein in rat heart] 		RGD PMID:30644033 PMID:30644033 RGD:329955369, RGD:329955369 NCBI chr19:64,356,582...64,372,447
Ensembl chr19:47,447,970...47,463,793 		JBrowse link
G Prkaa2 protein kinase AMP-activated catalytic subunit alpha 2 increases expression
multiple interactions 		EXP L-carnitine increases expression of Ampka2 protein in rat serum and heart
L-carnitine inhibits the reaction [sunitinib decreases expression of Ampka2 protein in rat serum and heart] 		RGD PMID:30644033 PMID:30644033 RGD:329955369, RGD:329955369 NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:119,813,226...119,879,543 		JBrowse link
chlorhexidine gluconate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gpt glutamic--pyruvic transaminase increases secretion EXP chlorhexidine gluconate results in increased secretion of GPT protein CTD PMID:145039 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
cholate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions EXP [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of A2M mRNA; [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of A2M protein CTD PMID:25814186 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:154,897,877...154,947,786 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 increases expression
decreases activity
multiple interactions 		ISO Cholates results in increased expression of ABCB11 mRNA
Cholates results in decreased activity of ABCB11 protein
Cholates inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] 		CTD PMID:14684751 PMID:24014644 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases activity ISO Cholates results in increased activity of ABCC3 protein CTD PMID:17569508 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions
increases expression 		ISO Cholates promotes the reaction [ABCG5 protein results in increased secretion of Cholesterol]
Cholates results in increased expression of ABCG5 mRNA; Cholates results in increased expression of ABCG5 protein 		CTD PMID:15611112 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:9,965,118...9,990,563 		JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 multiple interactions
increases expression 		ISO Cholates promotes the reaction [ABCG8 protein results in increased secretion of Cholesterol]
Cholates results in increased expression of ABCG8 mRNA; Cholates results in increased expression of ABCG8 protein 		CTD PMID:15611112 NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:9,945,629...9,964,912 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions EXP [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of COL1A1 mRNA; resveratrol inhibits the reaction [[cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of COL1A1 mRNA] CTD PMID:25814186 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO Cholates results in decreased expression of CYP7A1 mRNA CTD PMID:10809780 PMID:14684751 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation ISO Cholates results in increased phosphorylation of MAPK8 protein CTD PMID:15750181 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 increases activity
increases expression 		ISO Cholates results in increased activity of NR1H4 protein
Cholates results in increased expression of NR1H4 protein 		CTD PMID:14684751 NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions EXP [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of PPARGC1A mRNA CTD PMID:25814186 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Slc19a1 solute carrier family 19 member 1 decreases activity
multiple interactions 		EXP Cholates results in decreased activity of SLC19A1 protein
Cholates inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] 		CTD PMID:14612385 NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions ISO Cholates inhibits the reaction [SLC22A8 protein affects the transport of estrone sulfate] CTD PMID:11306713 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions EXP [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of SREBF1 mRNA CTD PMID:25814186 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of TGFB1 mRNA CTD PMID:25814186 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of TNF mRNA CTD PMID:25814186 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfaip3 TNF alpha induced protein 3 multiple interactions EXP [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of TNFAIP3 protein; resveratrol inhibits the reaction [[cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of TNFAIP3 protein] CTD PMID:25814186 NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282 		JBrowse link
eosin YS dye term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Iyd iodotyrosine deiodinase multiple interactions ISO Eosine Yellowish-(YS) inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] CTD PMID:33352258 NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319 		JBrowse link
erythrosin B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A decreases activity ISO Erythrosine results in decreased activity of ABCB1 protein CTD PMID:20041016 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP [Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA CTD PMID:32981412 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Ccnd1 cyclin D1 increases expression ISO Erythrosine results in increased expression of CCND1 protein CTD PMID:8927716 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Cdk2 cyclin dependent kinase 2 increases activity ISO Erythrosine results in increased activity of CDK2 protein CTD PMID:8927716 PMID:9168006 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 decreases activity EXP Erythrosine results in decreased activity of CYP19A1 protein CTD PMID:18310892 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases activity ISO Erythrosine results in decreased activity of CYP3A4 protein CTD PMID:20041016 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Erythrosine results in increased expression of FOSL1 protein CTD PMID:20025956 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO Erythrosine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions EXP [Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA CTD PMID:32981412 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698 		JBrowse link
G Hpgds hematopoietic prostaglandin D synthase decreases activity ISO Erythrosine results in decreased activity of HPGDS protein CTD PMID:25603235 NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:94,373,342...94,397,883 		JBrowse link
G Iyd iodotyrosine deiodinase decreases activity ISO Erythrosine results in decreased activity of IYD protein CTD PMID:24012475 NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO Erythrosine results in increased expression of JUN protein CTD PMID:20025956 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656 		JBrowse link
G Orm1 orosomucoid 1 increases expression ISO Erythrosine results in increased expression of ORM1 protein CTD PMID:20025956 NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154 		JBrowse link
G Phex phosphate regulating endopeptidase X-linked increases expression ISO Erythrosine results in increased expression of PHEX protein CTD PMID:20025956 NCBI chr  X:37,607,553...37,856,183
Ensembl chr  X:37,610,760...37,854,469 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP [Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA CTD PMID:32981412 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tp53 tumor protein p53 increases activity ISO Erythrosine results in increased activity of TP53 protein CTD PMID:9168006 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Trh thyrotropin releasing hormone multiple interactions EXP Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein] CTD PMID:2160137 NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637 		JBrowse link
G Tshb thyroid stimulating hormone subunit beta multiple interactions EXP Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein] CTD PMID:2160137 NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559 		JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 decreases activity ISO Erythrosine results in decreased activity of UGT1A6 protein CTD PMID:20041016 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 decreases activity ISO Erythrosine results in decreased activity of UGT2B7 protein CTD PMID:20041016 NCBI chr14:21,251,535...21,274,451
Ensembl chr14:20,896,682...20,919,604 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO Erythrosine results in increased expression of VEGFA protein CTD PMID:20025956 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
GGTI-2133 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions EXP GGTI-2133 inhibits the reaction [Smoke analog results in increased phosphorylation of AKT1 protein] CTD PMID:19299917 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions EXP GGTI-2133 inhibits the reaction [Smoke analog results in increased phosphorylation of MAPK1 protein] CTD PMID:19299917 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions EXP GGTI-2133 inhibits the reaction [Smoke analog results in increased phosphorylation of MAPK3 protein] CTD PMID:19299917 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP GGTI-2133 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]; GGTI-2133 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein] CTD PMID:19299917 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Rap1a RAP1A, member of RAS oncogene family decreases geranoylation ISO GGTI-2133 results in decreased geranoylation of RAP1A protein CTD PMID:25578243 NCBI chr 2:195,896,967...195,974,851
Ensembl chr 2:193,208,635...193,286,501 		JBrowse link
glycyrrhetinate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB11 mRNA] CTD PMID:28549656 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]; [Glycyrrhetinic Acid affects the activity of ABCB1 protein] which affects the susceptibility to Vinblastine; [Glycyrrhetinic Acid affects the activity of ABCB1 protein] which results in increased abundance of Daunorubicin; Glycyrrhetinic Acid inhibits the reaction [ABCB1 protein results in increased uptake of Digoxin]; Glycyrrhetinic Acid inhibits the reaction [Verapamil results in increased activity of ABCB1 protein] CTD PMID:16904803 PMID:18204840 PMID:24380838 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCB4 mRNA] CTD PMID:28549656 NCBI chr 4:26,106,895...26,164,440
Ensembl chr 4:25,151,953...25,209,202 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions
increases activity 		ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCC1 mRNA]
Glycyrrhetinic Acid results in increased activity of ABCC1 protein
[Glycyrrhetinic Acid affects the activity of ABCC1 protein] which affects the susceptibility to Doxorubicin; [Glycyrrhetinic Acid affects the activity of ABCC1 protein] which results in increased abundance of fluorexon 		CTD PMID:18204840 PMID:28549656 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions EXP Glycyrrhetinic Acid inhibits the reaction [ABCC2 protein results in increased transport of estradiol-17 beta-glucuronide] CTD PMID:18436619 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions ISO 18alpha-glycyrrhetinic acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ABCC3 mRNA] CTD PMID:28549656 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [ABCG2 protein results in increased transport of estradiol-17 beta-glucuronide] CTD PMID:18436619 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCG5 mRNA] CTD PMID:28549656 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:9,965,118...9,990,563 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions ISO 18alpha-glycyrrhetinic acid affects the reaction [1-Naphthylisothiocyanate affects the expression of ACAT2 mRNA] CTD PMID:28549656 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [Monocrotaline results in increased expression of ACTA2 protein] CTD PMID:31325423 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases activity ISO Glycyrrhetinic Acid results in decreased activity of AKR1C1 protein CTD PMID:12604236 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 decreases activity ISO Glycyrrhetinic Acid results in decreased activity of AKR1C2 protein CTD PMID:12604236 NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 affects activity
decreases activity 		ISO 18alpha-glycyrrhetinic acid affects the activity of AKR1C3 protein
Glycyrrhetinic Acid results in decreased activity of AKR1C3 protein 		CTD PMID:11165023 PMID:12604236 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873 		JBrowse link
G Alb albumin multiple interactions ISO ALB protein binds to and affects the transport of Glycyrrhetinic Acid CTD PMID:8831264 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of ALPL protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of ALPL mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [Ethinyl Estradiol results in increased expression of ALPL protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [RUNX2 protein results in increased expression of ALPL mRNA] CTD PMID:21910061 PMID:38244730 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446 		JBrowse link
G Atf6 activating transcription factor 6 multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ATF6 mRNA] CTD PMID:35699857 NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ATP8B1 mRNA] CTD PMID:28549656 NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
decreases expression 		EXP
ISO 		18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of BAX]; 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in increased expression of BAX protein]; Glycyrrhetinic Acid promotes the reaction [bisphenol A results in increased expression of BAX protein]
Glycyrrhetinic Acid results in decreased expression of BAX protein
18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of BAX protein] 		CTD PMID:28414158 PMID:31325423 PMID:35699857 PMID:38348715 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression 		EXP
ISO 		18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in decreased expression of BCL2]; 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]; Glycyrrhetinic Acid inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]
Glycyrrhetinic Acid results in decreased expression of BCL2 protein
18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of BCL2 protein] 		CTD PMID:28414158 PMID:31325423 PMID:35699857 PMID:38348715 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of BGLAP protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of BGLAP mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [RUNX2 protein results in increased expression of BGLAP mRNA] CTD PMID:21910061 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:173,838,518...173,839,495 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of ALPL protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of BGLAP protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of RUNX2 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of ALPL mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of BGLAP mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of COL1A1 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of SP7 mRNA] CTD PMID:21910061 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of CASP3] CTD PMID:35699857 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Cat catalase multiple interactions ISO
EXP 		Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of CAT mRNA]
Glycyrrhetinic Acid inhibits the reaction [bisphenol A results in decreased activity of CAT protein] 		CTD PMID:23341968 PMID:38348715 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of CDKN1B protein] CTD PMID:31325423 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of COL1A1 mRNA] CTD PMID:21910061 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions ISO Glycyrrhetinic Acid promotes the reaction [Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]] CTD PMID:10460758 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199 		JBrowse link
G Cxcr3 C-X-C motif chemokine receptor 3 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [Ethinyl Estradiol results in increased expression of CXCR3 mRNA] CTD PMID:38244730 NCBI chr  X:66,844,318...66,846,969
Ensembl chr  X:66,844,318...66,846,969 		JBrowse link
G Cycs cytochrome c, somatic decreases expression
multiple interactions 		EXP Glycyrrhetinic Acid results in decreased expression of CYCS protein
Glycyrrhetinic Acid inhibits the reaction [bisphenol A results in increased expression of CYCS protein] 		CTD PMID:38348715 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054
Ensembl chr18:79,651,378...79,654,054 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions EXP [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein CTD PMID:21800547 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP2E1 protein CTD PMID:21800547 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] CTD PMID:28549656 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of EIF2AK3 mRNA] CTD PMID:35699857 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 multiple interactions ISO
EXP 		18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of ERN1 protein]
18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ERN1 mRNA] 		CTD PMID:29444456 PMID:35699857 NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in increased activity of GGT1 protein] CTD PMID:28414158 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [Ethinyl Estradiol results in increased expression of GOT1 protein] CTD PMID:38244730 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO
EXP 		18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of GPT protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [Ethinyl Estradiol results in increased expression of GPT protein]; Glycyrrhetinic Acid inhibits the reaction [diosbulbin B results in increased activity of GPT protein]
18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in increased activity of GPT protein] 		CTD PMID:28414158 PMID:28549656 PMID:36807597 PMID:38244730 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX2 mRNA] CTD PMID:23341968 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of HMOX1 mRNA] CTD PMID:28414158 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hras HRas proto-oncogene, GTPase decreases expression ISO Glycyrrhetinic Acid results in decreased expression of HRAS protein CTD PMID:19958823 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 decreases activity ISO 18alpha-glycyrrhetinic acid results in decreased activity of HSD11B1 protein CTD PMID:24135201 NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 decreases activity
multiple interactions 		ISO 18alpha-glycyrrhetinic acid results in decreased activity of HSD11B2 protein
Glycyrrhetinic Acid inhibits the reaction [tributyltin results in increased activity of HSD11B2 protein]; Glycyrrhetinic Acid inhibits the reaction [triphenyltin chloride results in increased activity of HSD11B2 protein] 		CTD PMID:24135201 PMID:31927052 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions ISO [Glycyrrhetinic Acid co-treated with NADP] binds to HSD3B1 protein CTD PMID:25526675 NCBI chr 2:188,858,574...188,864,694
Ensembl chr 2:186,169,863...186,175,999 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of HSPA5 mRNA] CTD PMID:35699857 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP
ISO 		18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in increased expression of IL1B protein]
Glycyrrhetinic Acid promotes the reaction [Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]]
Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA] 		CTD PMID:10460758 PMID:23373965 PMID:28414158 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA] CTD PMID:21644799 PMID:23373965 PMID:24849676 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactosamine] promotes the reaction [TRAF6 protein binds to IRAK1 protein]] CTD PMID:28213090 NCBI chr  X:151,768,621...151,778,521
Ensembl chr  X:151,768,777...151,778,521 		JBrowse link
G Irak3 interleukin-1 receptor-associated kinase 3 increases expression
multiple interactions 		ISO Glycyrrhetinic Acid results in increased expression of IRAK3 protein
[Glycyrrhetinic Acid co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IRAK3 mRNA; IRAK3 protein promotes the reaction [Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]] 		CTD PMID:28213090 NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121 		JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]] CTD PMID:28213090 NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] CTD PMID:29444456 NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK1 protein] CTD PMID:23373965 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK3 protein] CTD PMID:23373965 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased activity of MMP9 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] CTD PMID:24613819 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Mpo myeloperoxidase multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [diosbulbin B results in increased activity of MPO protein] CTD PMID:36807597 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819 		JBrowse link
G Mttp microsomal triglyceride transfer protein multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of MTTP mRNA] CTD PMID:28549656 NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
increases expression 		EXP
ISO 		18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein]
[Glycyrrhetinic Acid results in increased expression of NFE2L2] which results in decreased susceptibility to Carbon Tetrachloride; Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] 		CTD PMID:23341968 PMID:28414158 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in decreased expression of NFKB1 protein] CTD PMID:24613819 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
Glycyrrhetinic Acid inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactosamine] results in increased phosphorylation of NFKBIA protein]; Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of and affects the localization of NFKBIA protein] 		CTD PMID:23373965 PMID:24613819 PMID:28213090 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein] CTD PMID:21644799 PMID:23373965 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Npc1l1 NPC1 like intracellular cholesterol transporter 1 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of NPC1L1 mRNA] CTD PMID:28549656 NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113 		JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of BAX protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of CDKN1B protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of BCL2 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RHOA mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RHOA protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK1 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK1 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK2 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK2 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PPP1R12A protein] CTD PMID:31325423 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984 		JBrowse link
G Pik3cd phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta decreases activity ISO 18alpha-glycyrrhetinic acid results in decreased activity of PIK3CD protein CTD PMID:21644799 NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:160,094,952...160,120,930 		JBrowse link
G Pik3cg phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma decreases activity ISO 18alpha-glycyrrhetinic acid results in decreased activity of PIK3CG protein CTD PMID:21644799 NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:48,766,864...48,802,043 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions EXP 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Ppp1r12a protein phosphatase 1, regulatory subunit 12A multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased phosphorylation of PPP1R12A protein] CTD PMID:31325423 NCBI chr 7:45,368,922...45,480,158
Ensembl chr 7:43,482,803...43,593,425 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein] CTD PMID:21644799 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in decreased expression of RELA protein]
Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of RELA protein] 		CTD PMID:23373965 PMID:24613819 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Ren renin decreases activity ISO Glycyrrhetinic Acid results in decreased activity of REN protein CTD PMID:20460744 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489 		JBrowse link
G Rhoa ras homolog family member A multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RHOA mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RHOA protein] CTD PMID:31325423 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746 		JBrowse link
G Rock1 Rho-associated coiled-coil containing protein kinase 1 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK1 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK1 protein] CTD PMID:31325423 NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,115,905...1,235,571 		JBrowse link
G Rock2 Rho-associated coiled-coil containing protein kinase 2 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK2 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of ROCK2 protein] CTD PMID:31325423 NCBI chr 6:45,407,823...45,502,773
Ensembl chr 6:39,679,082...39,774,031 		JBrowse link
G Rorc RAR-related orphan receptor C multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [Ethinyl Estradiol results in increased expression of RORC mRNA] CTD PMID:38244730 NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:182,009,286...182,034,907 		JBrowse link
G Runx2 RUNX family transcription factor 2 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of RUNX2 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [RUNX2 protein results in increased expression of ALPL mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [RUNX2 protein results in increased expression of BGLAP mRNA] CTD PMID:21910061 NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167 		JBrowse link
G Slc51b SLC51 subunit beta multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLC51B mRNA] CTD PMID:28549656 NCBI chr 8:74,827,047...74,835,109
Ensembl chr 8:65,931,890...65,940,145 		JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of SLCO1A4 mRNA] CTD PMID:28549656 NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573 		JBrowse link
G Sod3 superoxide dismutase 3 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of SOD3 mRNA] CTD PMID:23341968 NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990 		JBrowse link
G Sp7 Sp7 transcription factor multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased expression of SP7 mRNA] CTD PMID:21910061 NCBI chr 7:135,363,193...135,373,376
Ensembl chr 7:133,484,609...133,494,847 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]] CTD PMID:28213090 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO
EXP 		18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; Glycyrrhetinic Acid inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactosamine] results in increased expression of and results in increased secretion of TNF protein]; Glycyrrhetinic Acid inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactosamine] results in increased expression of TNF mRNA]; Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; IRAK3 protein promotes the reaction [Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]]
18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in increased expression of TNF protein]
18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in decreased expression of NFKB1 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in decreased expression of RELA protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased activity of MMP9 protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of VEGFA protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] 		CTD PMID:21644799 PMID:24613819 PMID:28213090 PMID:28414158 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tp53 tumor protein p53 decreases expression EXP Glycyrrhetinic Acid results in decreased expression of TP53 protein CTD PMID:38348715 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Traf6 TNF receptor associated factor 6 multiple interactions ISO Glycyrrhetinic Acid inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactosamine] promotes the reaction [TRAF6 protein binds to IRAK1 protein]] CTD PMID:28213090 NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:87,963,514...87,983,507 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of VEGFA protein]; 18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA] CTD PMID:24613819 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Xbp1 X-box binding protein 1 multiple interactions ISO 18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form] CTD PMID:29444456 NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693 		JBrowse link
ketorolac tromethamine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aanat aralkylamine N-acetyltransferase multiple interactions EXP Ketorolac Tromethamine results in decreased localization of and results in decreased activity of AANAT protein CTD PMID:37348669 NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801 		JBrowse link
G Cat catalase multiple interactions
increases activity 		EXP Melatonin inhibits the reaction [Ketorolac Tromethamine results in increased activity of CAT protein] CTD PMID:37348669 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Ereg epiregulin increases expression ISO Ketorolac Tromethamine results in increased expression of EREG mRNA CTD PMID:32816093 NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,027,287...17,041,062 		JBrowse link
G Gpx1 glutathione peroxidase 1 decreases activity EXP Ketorolac Tromethamine results in decreased activity of GPX1 protein CTD PMID:37348669 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024 		JBrowse link
G Gsr glutathione-disulfide reductase increases activity EXP Ketorolac Tromethamine results in increased activity of GSR protein CTD PMID:37348669 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661 		JBrowse link
G Il24 interleukin 24 increases expression ISO Ketorolac Tromethamine results in increased expression of IL24 mRNA CTD PMID:32816093 NCBI chr13:44,905,362...44,910,760
Ensembl chr13:42,353,090...42,358,487 		JBrowse link
G Maoa monoamine oxidase A multiple interactions
increases activity 		EXP Melatonin inhibits the reaction [Ketorolac Tromethamine results in increased activity of MAOA protein] CTD PMID:37348669 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:6,030,795...6,099,593 		JBrowse link
G Mtnr1a melatonin receptor 1A increases localization EXP Ketorolac Tromethamine results in increased localization of MTNR1A protein CTD PMID:37348669 NCBI chr16:47,144,461...47,163,919
Ensembl chr16:47,144,461...47,163,919 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression ISO Ketorolac Tromethamine results in increased expression of PTGS2 mRNA CTD PMID:32816093 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Slpi secretory leukocyte peptidase inhibitor increases expression ISO Ketorolac Tromethamine results in increased expression of SLPI mRNA CTD PMID:32816093 NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453 		JBrowse link
G Sod1 superoxide dismutase 1 decreases activity EXP Ketorolac Tromethamine results in decreased activity of SOD1 protein CTD PMID:37348669 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249 		JBrowse link
G Sod2 superoxide dismutase 2 decreases activity EXP Ketorolac Tromethamine results in decreased activity of SOD2 protein CTD PMID:37348669 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
lead tetraacetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G App amyloid beta precursor protein decreases expression ISO lead tetraacetate results in decreased expression of APP mRNA CTD PMID:20865013 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Mapt microtubule-associated protein tau decreases expression ISO lead tetraacetate results in decreased expression of MAPT mRNA CTD PMID:20865013 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129 		JBrowse link
G Nrxn1 neurexin 1 decreases expression ISO lead tetraacetate results in decreased expression of NRXN1 mRNA CTD PMID:20865013 NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:3,177,897...4,322,710 		JBrowse link
G Prnp prion protein decreases expression ISO lead tetraacetate results in decreased expression of PRNP mRNA CTD PMID:20865013 NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:119,177,485...119,203,937 		JBrowse link
G Syp synaptophysin decreases expression ISO lead tetraacetate results in decreased expression of SYP mRNA CTD PMID:20865013 NCBI chr  X:17,521,348...17,536,449
Ensembl chr  X:14,849,444...14,864,745 		JBrowse link
G Tubb3 tubulin, beta 3 class III decreases expression ISO lead tetraacetate results in decreased expression of TUBB3 mRNA CTD PMID:20865013 NCBI chr19:68,365,687...68,374,741
Ensembl chr19:51,457,184...51,466,243 		JBrowse link
lobaplatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Birc2 baculoviral IAP repeat-containing 2 increases degradation ISO Lobaplatin increases degradation of BIRC2 protein in human nasopharyngeal carcinoma cells RGD PMID:32413426 RGD:155226873 NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 increases degradation ISO Lobaplatin increases degradation of BIRC3 protein in human nasopharyngeal carcinoma cells RGD PMID:32413426 RGD:155226873 NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802 		JBrowse link
meglumine amidotrizoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Diatrizoate Meglumine results in increased expression of BAX protein CTD PMID:17173243 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression
decreases expression
multiple interactions 		ISO
EXP 		Diatrizoate Meglumine results in increased expression of BCL2 protein
Diatrizoate Meglumine results in decreased expression of BCL2 mRNA
Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in decreased expression of BCL2 mRNA] 		CTD PMID:17173243 PMID:28412091 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Casp12 caspase 12 increases cleavage EXP Diatrizoate Meglumine results in increased cleavage of CASP12 protein CTD PMID:20071420 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037 		JBrowse link
G Casp3 caspase 3 increases activity
increases expression
multiple interactions 		ISO
EXP 		Diatrizoate Meglumine results in increased activity of CASP3 protein
Diatrizoate Meglumine results in increased expression of CASP3 mRNA
[Diatrizoate Meglumine co-treated with Gentamicins] results in increased cleavage of CASP3 protein; [sulforaphane co-treated with Diatrizoate Meglumine] results in increased activity of CASP3 protein; CTF1 protein inhibits the reaction [[Diatrizoate Meglumine co-treated with Gentamicins] results in increased cleavage of CASP3 protein]; Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of CASP3 mRNA]; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Diatrizoate Meglumine] results in increased activity of CASP3 protein] 		CTD PMID:17173243 PMID:23335628 PMID:28412091 PMID:31173751 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Ctf1 cardiotrophin 1 multiple interactions EXP CTF1 protein inhibits the reaction [[Diatrizoate Meglumine co-treated with Gentamicins] results in increased cleavage of CASP3 protein]; CTF1 protein inhibits the reaction [[Diatrizoate Meglumine co-treated with Gentamicins] results in increased expression of HAVCR1 protein]; CTF1 protein inhibits the reaction [[Diatrizoate Meglumine co-treated with Gentamicins] results in increased expression of SERPINE1 protein] CTD PMID:23335628 NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:182,328,090...182,333,335 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A increases phosphorylation EXP Diatrizoate Meglumine results in increased phosphorylation of EIF2A protein CTD PMID:20071420 NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:142,761,416...142,795,068 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases phosphorylation EXP Diatrizoate Meglumine results in increased phosphorylation of EIF2AK3 protein CTD PMID:20071420 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression EXP Diatrizoate Meglumine results in increased expression of GSTA2 mRNA CTD PMID:28412091 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions EXP [Diatrizoate Meglumine co-treated with Gentamicins] results in increased expression of HAVCR1 protein; CTF1 protein inhibits the reaction [[Diatrizoate Meglumine co-treated with Gentamicins] results in increased expression of HAVCR1 protein] CTD PMID:23335628 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression
decreases expression
multiple interactions 		EXP Diatrizoate Meglumine results in increased expression of HMOX1 mRNA
Diatrizoate Meglumine results in decreased expression of HMOX1 protein
Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of HMOX1 mRNA] 		CTD PMID:28412091 PMID:31173751 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 increases expression EXP Diatrizoate Meglumine results in increased expression of HSP90B1 protein CTD PMID:20071420 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:21,110,457...21,124,788 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression EXP Diatrizoate Meglumine results in increased expression of HSPA5 protein CTD PMID:20071420 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression 		EXP Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Diatrizoate Meglumine results in increased expression of IL6 protein]]; sulforaphane inhibits the reaction [Diatrizoate Meglumine results in increased expression of IL6 protein]
Diatrizoate Meglumine results in increased expression of IL6 mRNA; Diatrizoate Meglumine results in increased expression of IL6 protein 		CTD PMID:28412091 PMID:31173751 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
decreases expression
increases expression 		EXP Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Diatrizoate Meglumine] results in increased activity of CASP3 protein]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Diatrizoate Meglumine results in increased expression of IL6 protein]]
Diatrizoate Meglumine results in decreased expression of NFE2L2 protein 		CTD PMID:28412091 PMID:31173751 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions EXP [Diatrizoate Meglumine co-treated with Gentamicins] results in increased expression of SERPINE1 protein; CTF1 protein inhibits the reaction [[Diatrizoate Meglumine co-treated with Gentamicins] results in increased expression of SERPINE1 protein] CTD PMID:23335628 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657 		JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions 		EXP Diatrizoate Meglumine results in increased expression of TP53 mRNA
Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of TP53 mRNA] 		CTD PMID:28412091 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
merbromin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Car2 carbonic anhydrase 2 decreases activity ISO Merbromin results in decreased activity of CA2 protein CTD PMID:16858005 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO Merbromin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
N-methylnicotinate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace angiotensin I converting enzyme multiple interactions ISO
EXP 		oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE protein]]; trigonelline affects the reaction [INS2 protein affects the expression of ACE mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of ACE protein]
oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]]; trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA] 		CTD PMID:29211853 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions ISO
EXP 		oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE2 mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE2 protein]]; trigonelline affects the reaction [INS2 protein affects the expression of ACE2 mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of ACE2 protein]
oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA] 		CTD PMID:29211853 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:30,293,589...30,340,977 		JBrowse link
G Agt angiotensinogen multiple interactions ISO
EXP 		oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of AGT mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of AGT protein]]; trigonelline affects the reaction [INS2 protein affects the expression of AGT mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of AGT protein]
oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]]; trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA] 		CTD PMID:29211853 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977 		JBrowse link
G Atg7 autophagy related 7 multiple interactions ISO trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]
ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein] 		CTD PMID:30208301 NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP
ISO 		trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]
[trigonelline co-treated with Cisplatin] results in increased expression of BAX protein; [trigonelline co-treated with Etoposide] results in increased expression of BAX protein 		CTD PMID:31935362 PMID:33148531 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP
ISO 		trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
[trigonelline co-treated with Cisplatin] results in decreased expression of BCL2 protein; [trigonelline co-treated with Etoposide] results in decreased expression of BCL2 protein 		CTD PMID:31935362 PMID:33148531 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Becn1 beclin 1 multiple interactions ISO trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of BECN1 protein]
trigonelline inhibits the reaction [[Cholesterol, Dietary co-treated with Dietary Fats] results in decreased expression of BECN1 protein]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of BECN1 protein] 		CTD PMID:30208301 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742 		JBrowse link
G Casp3 caspase 3 increases activity
multiple interactions 		ISO
EXP 		trigonelline results in increased activity of CASP3 protein
[trigonelline co-treated with Cisplatin] results in increased cleavage of CASP3 protein; [trigonelline co-treated with Etoposide] results in increased cleavage of CASP3 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein] 		CTD PMID:26593444 PMID:31935362 PMID:33148531 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Cd36 CD36 molecule multiple interactions ISO trigonelline inhibits the reaction [[Cholesterol, Dietary co-treated with Dietary Fats] results in increased expression of CD36 protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of CD36 protein] CTD PMID:30208301 NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions ISO [trigonelline co-treated with ferric citrate] results in increased expression of DDIT3 mRNA CTD PMID:29959986 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of NFE2L2 protein] CTD PMID:33148531 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions
decreases phosphorylation 		ISO trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
trigonelline results in decreased phosphorylation of EGFR protein 		CTD PMID:33148531 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions ISO trigonelline inhibits the reaction [Palmitic Acid results in increased phosphorylation of EIF2S1 protein] CTD PMID:30208301 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions ISO [trigonelline co-treated with ferric citrate] results in increased expression of FTH1 mRNA CTD PMID:29959986 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424 		JBrowse link
G Ftl1 ferritin light chain 1 multiple interactions ISO [trigonelline co-treated with ferric citrate] results in increased expression of FTL mRNA CTD PMID:29959986 NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725
Ensembl chr10:95,936,387...95,939,725
Ensembl chr 2:95,936,387...95,939,725 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO trigonelline inhibits the reaction [Pyocyanine results in increased expression of GCLC mRNA] CTD PMID:24015256 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544 		JBrowse link
G Hexb hexosaminidase subunit beta multiple interactions ISO trigonelline inhibits the reaction [iodixanol results in increased secretion of HEXB protein] CTD PMID:34774977 NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223 		JBrowse link
G Hmox1 heme oxygenase 1 decreases expression ISO trigonelline results in decreased expression of HMOX1 mRNA; trigonelline results in decreased expression of HMOX1 protein CTD PMID:33148531 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions ISO trigonelline inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein] CTD PMID:30208301 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein] CTD PMID:31935362 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein] CTD PMID:31935362 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ins1 insulin 1 multiple interactions ISO trigonelline inhibits the reaction [[Cholesterol, Dietary co-treated with Dietary Fats] results in increased expression of INS1 protein] CTD PMID:30208301 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536 		JBrowse link
G Ins2 insulin 2 multiple interactions ISO oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE protein]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE2 mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of ACE2 protein]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of AGT mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of AGT protein]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of MAS1 mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of MAS1 protein]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 protein]]; oltipraz inhibits the reaction [trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 mRNA]]; trigonelline affects the reaction [INS2 protein affects the expression of ACE mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of ACE protein]; trigonelline affects the reaction [INS2 protein affects the expression of ACE2 mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of ACE2 protein]; trigonelline affects the reaction [INS2 protein affects the expression of AGT mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of AGT protein]; trigonelline affects the reaction [INS2 protein affects the expression of MAS1 mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of MAS1 protein]; trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 protein]; trigonelline inhibits the reaction [INS2 protein affects the abundance of angiotensin I (1-7)] CTD PMID:29211853 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 multiple interactions ISO [trigonelline co-treated with ferric citrate] results in decreased expression of KEAP1 mRNA CTD PMID:29959986 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862 		JBrowse link
G Lepr leptin receptor affects abundance ISO LEPR affects the abundance of trigonelline CTD PMID:20567778 NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
decreases phosphorylation 		ISO trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]
trigonelline results in decreased phosphorylation of MAPK1 protein 		CTD PMID:33148531 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
decreases phosphorylation 		ISO trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
trigonelline results in decreased phosphorylation of MAPK3 protein 		CTD PMID:33148531 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mas1 MAS1 proto-oncogene, G protein-coupled receptor multiple interactions EXP
ISO 		oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of MAS1 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of MAS1 mRNA]
oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of MAS1 mRNA]]; oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of MAS1 protein]]; trigonelline affects the reaction [INS2 protein affects the expression of MAS1 mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of MAS1 protein] 		CTD PMID:29211853 NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions ISO trigonelline inhibits the reaction [Palmitic Acid results in increased phosphorylation of MTOR protein] CTD PMID:30208301 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor decreases expression ISO trigonelline results in decreased expression of MYC mRNA CTD PMID:26593444 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
decreases phosphorylation 		ISO
EXP 		trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of NFE2L2 protein]; trigonelline inhibits the reaction [ferric citrate affects the localization of NFE2L2 protein]; trigonelline inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Cisplatin]; trigonelline inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Etoposide]; trigonelline inhibits the reaction [Pyocyanine results in increased expression of and affects the localization of NFE2L2 protein]
oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 protein]]; oltipraz inhibits the reaction [trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 mRNA]]; trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 mRNA]; trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 protein]
oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]]; trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]
trigonelline results in decreased phosphorylation of NFE2L2 protein 		CTD PMID:24015256 PMID:29211853 PMID:29959986 PMID:33148531 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
decreases expression 		ISO trigonelline inhibits the reaction [ferric citrate results in increased expression of NQO1 protein]; trigonelline inhibits the reaction [Pyocyanine results in increased expression of NQO1 mRNA]
trigonelline results in decreased expression of NQO1 mRNA; trigonelline results in decreased expression of NQO1 protein 		CTD PMID:24015256 PMID:29959986 PMID:33148531 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO trigonelline inhibits the reaction [Palmitic Acid results in increased cleavage of PARP1 protein]
[trigonelline co-treated with Cisplatin] results in increased cleavage of PARP1 protein; [trigonelline co-treated with Etoposide] results in increased cleavage of PARP1 protein 		CTD PMID:30208301 PMID:33148531 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Plcg1 phospholipase C, gamma 1 multiple interactions ISO trigonelline inhibits the reaction [iodixanol results in increased phosphorylation of PLCG1 protein] CTD PMID:34774977 NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330 		JBrowse link
G Plin1 perilipin 1 multiple interactions ISO trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PLIN1 protein] CTD PMID:30208301 NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:133,664,892...133,676,828 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]
trigonelline inhibits the reaction [[Cholesterol, Dietary co-treated with Dietary Fats] results in increased expression of PPARG protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] 		CTD PMID:30208301 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions ISO trigonelline inhibits the reaction [[Cholesterol, Dietary co-treated with Dietary Fats] results in increased expression of SQSTM1 protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SQSTM1 protein] CTD PMID:30208301 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions ISO trigonelline inhibits the reaction [[Cholesterol, Dietary co-treated with Dietary Fats] results in increased expression of SREBF1 protein]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]
ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein] 		CTD PMID:30208301 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein]]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TNF protein] CTD PMID:31935362 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
O-acetyl-L-carnitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase multiple interactions EXP Acetylcarnitine inhibits the reaction [Dexamethasone results in decreased activity of ACHE protein]; Acetylcarnitine inhibits the reaction [Dexamethasone results in increased activity of ACHE protein] CTD PMID:21986892 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases expression EXP Acetylcarnitine results in increased expression of APEX1 mRNA CTD PMID:14654561 NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785 		JBrowse link
G Atp6v1f ATPase H+ transporting V1 subunit F increases expression EXP Acetylcarnitine results in increased expression of ATP6V1F mRNA CTD PMID:14654561 NCBI chr 4:59,033,020...59,035,980 JBrowse link
G C1qa complement C1q A chain decreases expression ISO Acetylcarnitine results in decreased expression of C1QA mRNA CTD PMID:19555370 NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:149,133,636...149,136,534 		JBrowse link
G C4b complement C4B decreases expression ISO Acetylcarnitine results in decreased expression of C4B mRNA CTD PMID:19555370 NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,197,366...4,211,681 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP Acetylcarnitine inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]; Acetylcarnitine inhibits the reaction [Sodium Selenite results in increased expression of CASP3 mRNA] CTD PMID:20067779 PMID:29278859 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP Acetylcarnitine inhibits the reaction [sodium arsenite results in increased activity of CASP9 protein] CTD PMID:29278859 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Cat catalase multiple interactions EXP Acetylcarnitine inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Acetylcarnitine inhibits the reaction [Sodium Selenite results in decreased expression of CAT mRNA] CTD PMID:20067779 PMID:26349760 PMID:29278859 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Col2a1 collagen type II alpha 1 chain multiple interactions EXP [COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of Acetylcarnitine CTD PMID:24709313 NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546 		JBrowse link
G Cs citrate synthase decreases activity EXP Acetylcarnitine results in decreased activity of CS protein CTD PMID:9821151 NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421 		JBrowse link
G Ctss cathepsin S decreases expression ISO Acetylcarnitine results in decreased expression of CTSS mRNA CTD PMID:19555370 NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:183,086,437...183,114,483 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 decreases expression ISO Acetylcarnitine results in decreased expression of CXCL14 mRNA CTD PMID:19555370 NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839 		JBrowse link
G Egr1 early growth response 1 multiple interactions EXP Acetylcarnitine inhibits the reaction [Sodium Selenite results in increased expression of EGR1 mRNA] CTD PMID:20067779 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766 		JBrowse link
G Gfap glial fibrillary acidic protein decreases expression ISO Acetylcarnitine results in decreased expression of GFAP mRNA CTD PMID:19555370 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions ISO Acetylcarnitine inhibits the reaction [Acetaminophen results in decreased expression of GSR protein] CTD PMID:26265018 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions EXP Acetylcarnitine affects the reaction [Dexamethasone results in decreased expression of GSTP1 mRNA] CTD PMID:21986892 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP Acetylcarnitine affects the reaction [Dexamethasone results in increased expression of HMOX1 mRNA] CTD PMID:21986892 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hmox2 heme oxygenase 2 multiple interactions EXP Acetylcarnitine affects the reaction [Dexamethasone results in increased expression of HMOX2 mRNA] CTD PMID:21986892 NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 decreases expression EXP Acetylcarnitine results in decreased expression of HSPB1 mRNA CTD PMID:14654561 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743 		JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 increases abundance
multiple interactions 		ISO IDH2 protein mutant form results in increased abundance of Acetylcarnitine
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Acetylcarnitine] 		CTD PMID:27469509 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP Acetylcarnitine inhibits the reaction [sodium arsenite results in increased expression of IL1B protein] CTD PMID:29278859 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP Acetylcarnitine inhibits the reaction [sodium arsenite results in increased expression of IL6 protein] CTD PMID:29278859 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 increases expression EXP Acetylcarnitine results in increased expression of MGST1 mRNA CTD PMID:14654561 NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892 		JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I multiple interactions EXP Acetylcarnitine inhibits the reaction [Sodium Selenite results in decreased expression of COX1 mRNA] CTD PMID:20067779 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867 		JBrowse link
G Ngf nerve growth factor multiple interactions EXP Acetylcarnitine inhibits the reaction [Cisplatin results in decreased expression of NGF protein] CTD PMID:14654561 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452 		JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions EXP Acetylcarnitine affects the reaction [Dexamethasone results in increased expression of NOS1 mRNA] CTD PMID:21986892 NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions EXP Acetylcarnitine affects the reaction [Dexamethasone results in increased expression of NOS2 mRNA] CTD PMID:21986892 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Pah phenylalanine hydroxylase decreases expression ISO Acetylcarnitine results in decreased expression of PAH mRNA CTD PMID:19555370 NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130 		JBrowse link
G Pink1 PTEN induced kinase 1 multiple interactions ISO Acetylcarnitine inhibits the reaction [Cadmium results in increased expression of PINK1] CTD PMID:25464205 NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:150,530,523...150,542,635 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha increases expression
multiple interactions 		ISO Acetylcarnitine results in increased expression of PPARGC1A protein
[Acetylcarnitine co-treated with Thioctic Acid] results in increased expression of PPARGC1A protein 		CTD PMID:20414966 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions ISO Acetylcarnitine inhibits the reaction [Cadmium results in increased expression of PRKN] CTD PMID:25464205 NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555 		JBrowse link
G Psmb6 proteasome 20S subunit beta 6 increases expression EXP Acetylcarnitine results in increased expression of PSMB6 mRNA CTD PMID:14654561 NCBI chr10:55,239,256...55,241,586
Ensembl chr10:55,239,241...55,241,586 		JBrowse link
G Ptma prothymosin alpha increases expression EXP Acetylcarnitine results in increased expression of PTMA mRNA CTD PMID:14654561 NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP Acetylcarnitine inhibits the reaction [sodium arsenite results in increased expression of RELA protein] CTD PMID:29278859 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Rps17 ribosomal protein S17 increases expression EXP Acetylcarnitine results in increased expression of RPS17 mRNA CTD PMID:14654561 NCBI chr 1:135,295,920...135,298,506
Ensembl chr 1:135,295,919...135,298,535
Ensembl chr 8:135,295,919...135,298,535 		JBrowse link
G Skap2 src kinase associated phosphoprotein 2 decreases expression ISO Acetylcarnitine results in decreased expression of SKAP2 mRNA CTD PMID:19555370 NCBI chr 4:80,948,832...81,100,900
Ensembl chr 4:80,950,580...81,100,891 		JBrowse link
G Slc25a20 solute carrier family 25 member 20 multiple interactions EXP Acetylcarnitine inhibits the reaction [Hydrogen Peroxide results in decreased activity of SLC25A20 protein] CTD PMID:23402788 NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:109,365,002...109,386,512 		JBrowse link
G Snca synuclein alpha multiple interactions ISO [Acetylcarnitine co-treated with Thioctic Acid] inhibits the reaction [Rotenone results in increased expression of SNCA protein]; Acetylcarnitine inhibits the reaction [Rotenone results in increased expression of SNCA protein] CTD PMID:20414966 NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262 		JBrowse link
G Tnni3 troponin I3, cardiac type multiple interactions EXP Acetylcarnitine inhibits the reaction [Cisplatin results in increased expression of TNNI3 protein] CTD PMID:21034734 NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580 		JBrowse link
O-butanoyl-L-carnitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 multiple interactions
increases abundance 		ISO Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of butyrylcarnitine] CTD PMID:27469509 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025 		JBrowse link
O-octanoylcarnitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Crot carnitine O-octanoyltransferase increases chemical synthesis ISO CROT protein results in increased chemical synthesis of octanoylcarnitine CTD PMID:6838215 NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:25,080,587...25,133,109 		JBrowse link
O-palmitoylcarnitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Col2a1 collagen type II alpha 1 chain multiple interactions EXP [COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of Palmitoylcarnitine CTD PMID:24709313 NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546 		JBrowse link
G Gls glutaminase increases chemical synthesis ISO GLS protein results in increased chemical synthesis of Palmitoylcarnitine CTD PMID:31040181 NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:49,344,781...49,416,900 		JBrowse link
G Ppp3r1 protein phosphatase 3, regulatory subunit B, alpha decreases metabolic processing ISO PPP3R1 gene mutant form results in decreased metabolism of Palmitoylcarnitine CTD PMID:19700627 NCBI chr14:95,758,333...95,808,015
Ensembl chr14:91,604,121...91,606,907 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 increases chemical synthesis ISO PRKAA1 protein results in increased chemical synthesis of Palmitoylcarnitine CTD PMID:31040181 NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:54,240,137...54,275,978 		JBrowse link
O-propanoyl-L-carnitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G App amyloid beta precursor protein increases abundance
multiple interactions 		ISO APP protein mutant form results in increased abundance of propionylcarnitine
PF-06840003 inhibits the reaction [APP protein mutant form results in increased abundance of propionylcarnitine]
[APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with PF-06840003] results in decreased abundance of propionylcarnitine 		CTD PMID:39172838 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Mapt microtubule-associated protein tau decreases abundance
multiple interactions 		ISO MAPT protein mutant form results in decreased abundance of propionylcarnitine
PF-06840003 inhibits the reaction [MAPT protein mutant form results in decreased abundance of propionylcarnitine] 		CTD PMID:39172838 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129 		JBrowse link
G Psen1 presenilin 1 multiple interactions ISO [APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with PF-06840003] results in decreased abundance of propionylcarnitine CTD PMID:39172838 NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:103,323,120...103,371,650 		JBrowse link
phosphoenolpyruvate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G App amyloid beta precursor protein multiple interactions
increases secretion 		ISO Phosphoenolpyruvate inhibits the reaction [Rotenone results in decreased secretion of APP protein modified form]
Phosphoenolpyruvate results in increased secretion of APP protein modified form 		CTD PMID:22906069 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Mapt microtubule-associated protein tau multiple interactions ISO [amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Phosphoenolpyruvate; PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Phosphoenolpyruvate] CTD PMID:39172838 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129 		JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions
increases metabolic processing 		ISO 3-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]; 5-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]; 6-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]; 7-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]; Apigenin inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]; flavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]; wogonin inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate] CTD PMID:25388478 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:60,057,402...60,079,599 		JBrowse link
physostigmine salicylate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase decreases activity ISO physostigmine salicylate results in decreased activity of ACHE protein CTD PMID:623676 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
pitavastatin(1-) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca1 ATP binding cassette subfamily A member 1 multiple interactions
increases expression 		EXP
ISO 		GW 6471 inhibits the reaction [pitavastatin results in increased expression of ABCA1 mRNA]
pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased expression of ABCA1 protein]
GW 6471 inhibits the reaction [pitavastatin results in increased expression of ABCA1 mRNA]; PPARA protein affects the reaction [pitavastatin results in increased expression of ABCA1 mRNA] 		CTD PMID:16415093 PMID:21554872 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases activity 		ISO pitavastatin inhibits the reaction [ABCB11 protein affects the import of Taurocholic Acid]; pitavastatin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
pitavastatin results in decreased activity of ABCB11 protein 		CTD PMID:15901796 PMID:24014644 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A affects transport ISO ABCB1 protein affects the transport of pitavastatin CTD PMID:15955871 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions
affects transport 		EXP
ISO 		ABCC2 protein binds to and results in increased uptake of pitavastatin analog; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]
ABCC2 protein affects the transport of pitavastatin 		CTD PMID:15955871 PMID:23562342 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 affects transport ISO ABCG2 protein affects the transport of pitavastatin CTD PMID:15955871 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions
increases expression 		ISO EIF2AK3 protein affects the reaction [pitavastatin results in increased expression of ATF4 protein] CTD PMID:37956312 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446 		JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions
increases expression
affects response to substance 		ISO BBC3 protein affects the susceptibility to [S63845 co-treated with pitavastatin]; BBC3 protein affects the susceptibility to [venetoclax co-treated with pitavastatin]
pitavastatin results in increased expression of BBC3 mRNA; pitavastatin results in increased expression of BBC3 protein
BBC3 protein affects the susceptibility to pitavastatin 		CTD PMID:37956312 NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509 		JBrowse link
G Casp3 caspase 3 increases activity ISO pitavastatin results in increased activity of CASP3 protein CTD PMID:38053498 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8 caspase 8 multiple interactions ISO [pitavastatin co-treated with Cisplatin] results in decreased activity of CASP8 protein CTD PMID:38053498 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Casp9 caspase 9 increases activity ISO pitavastatin results in increased activity of CASP9 protein CTD PMID:38053498 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] CTD PMID:18323514 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions ISO EIF2AK3 protein affects the reaction [pitavastatin results in increased expression of ATF4 protein] CTD PMID:37956312 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911 		JBrowse link
G Foxo1 forkhead box O1 decreases phosphorylation ISO pitavastatin results in decreased phosphorylation of FOXO1 protein CTD PMID:33034787 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790 		JBrowse link
G Ifnb1 interferon beta 1 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of IFNB1 mRNA]; pitavastatin inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA] CTD PMID:18323514 NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [Poly I-C results in increased expression of IL6 mRNA] CTD PMID:18323514 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Irf3 interferon regulatory factor 3 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRF3 protein]; pitavastatin inhibits the reaction [Palmitic Acid results in increased phosphorylation of IRF3 protein] CTD PMID:18323514 NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935 		JBrowse link
G Irf4 interferon regulatory factor 4 decreases expression ISO pitavastatin results in decreased expression of IRF4 protein CTD PMID:33034787 NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,721,811...33,740,070 		JBrowse link
G Lep leptin multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA]; pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of TNF mRNA] CTD PMID:18323514 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262 		JBrowse link
G Mstn myostatin increases expression ISO pitavastatin results in increased expression of MSTN protein CTD PMID:33034787 NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; pitavastatin inhibits the reaction [Poly I-C results in increased expression of NOS2 mRNA] CTD PMID:18323514 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Nr1h2 nuclear receptor subfamily 1, group H, member 2 multiple interactions ISO NR1H2 gene mutant form inhibits the reaction [pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased export of Cholesterol]]; NR1H2 gene mutant form inhibits the reaction [pitavastatin results in decreased export of Cholesterol] CTD PMID:16415093 NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377 		JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 multiple interactions ISO NR1H3 gene mutant form inhibits the reaction [pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased export of Cholesterol]]; NR1H3 gene mutant form inhibits the reaction [pitavastatin results in decreased export of Cholesterol] CTD PMID:16415093 NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO pitavastatin results in increased cleavage of PARP1 protein CTD PMID:37956312 PMID:38053498 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions
increases expression 		ISO 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [pitavastatin results in increased expression of PMAIP1 protein] CTD PMID:37956312 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429 		JBrowse link
G Pon1 paraoxonase 1 multiple interactions
increases expression 		ISO farnesyl pyrophosphate inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA]; Mevalonic Acid inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA]; Plicamycin inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA] CTD PMID:15690306 NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions
increases expression 		ISO pitavastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; PPARA protein affects the reaction [pitavastatin results in increased expression of ABCA1 mRNA]
pitavastatin results in increased expression of PPARA mRNA 		CTD PMID:11779144 PMID:21554872 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Ppard peroxisome proliferator-activated receptor delta increases expression ISO pitavastatin results in increased expression of PPARD mRNA CTD PMID:21554872 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968 		JBrowse link
G Rap1a RAP1A, member of RAS oncogene family decreases prenylation
decreases expression 		ISO pitavastatin results in decreased prenylation of RAP1A protein
pitavastatin results in decreased expression of RAP1A protein alternative form 		CTD PMID:37956312 NCBI chr 2:195,896,967...195,974,851
Ensembl chr 2:193,208,635...193,286,501 		JBrowse link
G Rxra retinoid X receptor alpha multiple interactions ISO pitavastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]] CTD PMID:11779144 NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712 		JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 affects transport ISO SLCO1A4 protein affects the transport of pitavastatin CTD PMID:19833843 NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein] CTD PMID:18323514 NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of TNF mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] CTD PMID:18323514 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
rose bengal term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A decreases activity ISO Rose Bengal results in decreased activity of ABCB1 protein CTD PMID:20041016 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 decreases activity EXP Rose Bengal results in decreased activity of CYP19A1 protein CTD PMID:18310892 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases activity ISO Rose Bengal results in decreased activity of CYP3A4 protein CTD PMID:20041016 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Gsta3 glutathione S-transferase alpha 3 decreases response to substance EXP GSTA3 protein results in decreased susceptibility to Rose Bengal CTD PMID:1740415 NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240 		JBrowse link
G Iyd iodotyrosine deiodinase decreases activity ISO Rose Bengal results in decreased activity of IYD protein CTD PMID:24012475 NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases activity ISO Rose Bengal results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
G Klkb1 kallikrein B1 multiple interactions
decreases response to substance 		ISO 7-Ala-angiotensin (1-7) inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; nimesulide inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; splitomicin inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal] CTD PMID:25339356 NCBI chr16:53,690,180...53,714,570
Ensembl chr16:46,958,707...46,982,053 		JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 decreases activity ISO Rose Bengal results in decreased activity of UGT1A6 protein CTD PMID:20041016 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
rosuvastatin calcium term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca1 ATP binding cassette subfamily A member 1 decreases expression
multiple interactions 		ISO Rosuvastatin Calcium results in decreased expression of ABCA1 mRNA
Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in decreased expression of ABCA1 mRNA] 		CTD PMID:18192897 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions ISO
EXP 		Rosuvastatin Calcium inhibits the reaction [ABCB11 protein affects the import of Taurocholic Acid]
[Cyclosporine results in decreased activity of ABCB11 protein] which results in decreased secretion of Rosuvastatin Calcium; [Glyburide results in decreased activity of ABCB11 protein] which results in decreased secretion of Rosuvastatin Calcium; [troglitazone results in decreased activity of ABCB11 protein] which results in decreased secretion of Rosuvastatin Calcium 		CTD PMID:15901796 PMID:19853032 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions
increases expression
affects secretion 		ISO
EXP 		ABCC2 protein binds to and results in increased uptake of Rosuvastatin Calcium analog; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]
Rosuvastatin Calcium results in increased expression of ABCC2 protein
[Benzbromarone results in decreased activity of ABCC2 protein] which results in decreased secretion of Rosuvastatin Calcium; [Probenecid results in decreased activity of ABCC2 protein] which results in decreased secretion of Rosuvastatin Calcium; [Sulfasalazine results in decreased activity of ABCC2 protein] which results in decreased secretion of Rosuvastatin Calcium; ABCC2 protein binds to and results in increased uptake of Rosuvastatin Calcium analog; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]
ABCC2 protein affects the secretion of Rosuvastatin Calcium 		CTD PMID:19853032 PMID:23562342 PMID:24909372 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression EXP Rosuvastatin Calcium results in increased expression of ABCC3 protein CTD PMID:24909372 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression ISO Rosuvastatin Calcium results in decreased expression of ABCG1 mRNA CTD PMID:18192897 NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,126,687...9,182,948 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions
increases activity 		EXP
ISO 		[Novobiocin results in decreased activity of ABCG2 protein] which results in decreased secretion of Rosuvastatin Calcium
Rosuvastatin Calcium results in increased activity of ABCG2 protein 		CTD PMID:19853032 PMID:30083819 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409 		JBrowse link
G Ache acetylcholinesterase multiple interactions EXP [Piracetam co-treated with Rosuvastatin Calcium] inhibits the reaction [[Sodium Chloride, Dietary co-treated with Cholesterol, Dietary co-treated with Coconut Oil] results in increased activity of ACHE protein]; Rosuvastatin Calcium inhibits the reaction [[Sodium Chloride, Dietary co-treated with Cholesterol, Dietary co-treated with Coconut Oil] results in increased activity of ACHE protein] CTD PMID:28441890 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 affects phosphorylation EXP Rosuvastatin Calcium affects the phosphorylation of AKT1 protein CTD PMID:27815113 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Apoa1 apolipoprotein A1 multiple interactions
increases expression 		ISO Niacin promotes the reaction [Rosuvastatin Calcium results in increased expression of APOA1 protein] CTD PMID:12767421 PMID:15539964 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035 		JBrowse link
G Apob apolipoprotein B decreases expression ISO Rosuvastatin Calcium results in decreased expression of APOB protein CTD PMID:15539964 PMID:18702965 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA] CTD PMID:32007421 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Rosuvastatin Calcium results in decreased expression of BCL2 protein CTD PMID:20852871 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G C3 complement C3 decreases expression ISO Rosuvastatin Calcium results in decreased expression of C3 mRNA CTD PMID:32771489 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429 		JBrowse link
G Casp3 caspase 3 increases activity
increases expression 		ISO Rosuvastatin Calcium results in increased activity of CASP3 protein
Rosuvastatin Calcium results in increased expression of CASP3 protein 		CTD PMID:21478229 PMID:32771489 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Cat catalase increases activity
multiple interactions 		EXP Rosuvastatin Calcium results in increased activity of CAT protein
[Rosuvastatin Calcium co-treated with Isoproterenol] inhibits the reaction [Interleukin-6 results in increased expression of CAT protein]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in decreased activity of CAT protein] 		CTD PMID:20146376 PMID:32007421 PMID:35130744 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression EXP Rosuvastatin Calcium results in decreased expression of CCL2 mRNA CTD PMID:15681303 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Creb5 cAMP responsive element binding protein 5 decreases expression ISO Rosuvastatin Calcium results in decreased expression of CREB5 mRNA CTD PMID:18192897 NCBI chr 4:82,393,091...82,794,320
Ensembl chr 4:82,393,730...82,790,325 		JBrowse link
G Crp C-reactive protein multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [CRP protein results in decreased expression of NOS3] CTD PMID:21562509 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178 		JBrowse link
G Cyba cytochrome b-245 alpha chain multiple interactions
decreases expression 		EXP [[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species CTD PMID:21562509 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions
decreases expression 		ISO
EXP 		Rosuvastatin Calcium inhibits the reaction [Nitroglycerin results in increased expression of CYBB mRNA]
[[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species 		CTD PMID:16633368 PMID:21562509 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:13,359,430...13,392,586 		JBrowse link
G Esr1 estrogen receptor 1 decreases expression ISO Rosuvastatin Calcium results in decreased expression of ESR1 protein CTD PMID:32771489 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression
multiple interactions 		ISO Rosuvastatin Calcium results in increased expression of GCLC mRNA
[Tetradecanoylphorbol Acetate co-treated with Rosuvastatin Calcium] results in increased expression of GCLC mRNA 		CTD PMID:18154958 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544 		JBrowse link
G Gpr183 G protein-coupled receptor 183 multiple interactions
increases expression 		ISO Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in increased expression of GPR183 mRNA] CTD PMID:18192897 NCBI chr15:105,445,129...105,457,192
Ensembl chr15:99,036,367...99,050,559 		JBrowse link
G Gzmk granzyme K multiple interactions
increases expression 		ISO Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in increased expression of GZMK mRNA] CTD PMID:18192897 NCBI chr 2:44,840,811...44,848,829
Ensembl chr 2:44,840,811...44,848,894 		JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha increases secretion ISO HNF4A protein results in increased secretion of Rosuvastatin Calcium CTD PMID:27160211 NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320 		JBrowse link
G Il18rap interleukin 18 receptor accessory protein decreases expression
multiple interactions 		ISO Rosuvastatin Calcium results in decreased expression of IL18RAP mRNA
Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in decreased expression of IL18RAP mRNA] 		CTD PMID:18192897 NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959 		JBrowse link
G Il1b interleukin 1 beta decreases expression EXP Rosuvastatin Calcium results in decreased expression of IL1B mRNA CTD PMID:15681303 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases activity ISO Rosuvastatin Calcium results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008 		JBrowse link
G Kcnj15 potassium inwardly-rectifying channel, subfamily J, member 15 decreases expression ISO Rosuvastatin Calcium results in decreased expression of KCNJ15 mRNA CTD PMID:18192897 NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952 		JBrowse link
G Kdr kinase insert domain receptor multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of KDR protein] CTD PMID:27097221 NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018 		JBrowse link
G Mb myoglobin affects expression EXP Rosuvastatin Calcium affects the expression of MB protein CTD PMID:27815113 NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383 		JBrowse link
G Mstn myostatin increases expression ISO Rosuvastatin Calcium results in increased expression of MSTN protein CTD PMID:33034787 NCBI chr 9:48,452,533...48,458,933
Ensembl chr 9:48,452,533...48,458,933 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions EXP Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA] CTD PMID:32007421 PMID:35130744 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions 		EXP Rosuvastatin Calcium results in increased expression of NOS2 mRNA
Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA] 		CTD PMID:21443142 PMID:32007421 PMID:35130744 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Nos3 nitric oxide synthase 3 multiple interactions
increases expression
affects response to substance 		ISO
EXP 		Rosuvastatin Calcium inhibits the reaction [CRP protein results in decreased expression of NOS3]; Rosuvastatin Calcium results in increased phosphorylation of and results in increased activity of NOS3 protein
Rosuvastatin Calcium results in increased expression of NOS3 mRNA
NOS3 protein affects the susceptibility to Rosuvastatin Calcium 		CTD PMID:12354446 PMID:15681303 PMID:18162361 PMID:21562509 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166 		JBrowse link
G Orm1 orosomucoid 1 multiple interactions
decreases expression 		ISO Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in decreased expression of ORM1 mRNA] CTD PMID:18192897 NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154 		JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PECAM1 protein] CTD PMID:27097221 NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116 		JBrowse link
G Selp selectin P decreases expression EXP Rosuvastatin Calcium results in decreased expression of SELP mRNA CTD PMID:15681303 NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845 		JBrowse link
G Serpine2 serpin family E member 2 multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of SERPINE2 protein]; Rosuvastatin Calcium inhibits the reaction [[TGFB1 protein co-treated with Serotonin] results in increased secretion of SERPINE2 protein] CTD PMID:27097221 NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:81,124,804...81,188,826 		JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 multiple interactions
increases uptake
decreases expression
affects transport 		EXP
ISO 		Fusidic Acid inhibits the reaction [SLCO1A4 protein results in increased uptake of Rosuvastatin Calcium]
diosmetin inhibits the reaction [SLCO1A2 protein results in increased uptake of Rosuvastatin Calcium]
Rosuvastatin Calcium results in decreased expression of SLCO1A4 protein
SLCO1A4 protein affects the transport of Rosuvastatin Calcium 		CTD PMID:19833843 PMID:24909372 PMID:26888941 PMID:28867436 NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573 		JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 multiple interactions
increases uptake 		EXP
ISO 		Fusidic Acid inhibits the reaction [SLCO1B2 protein results in increased uptake of Rosuvastatin Calcium]
Fusidic Acid inhibits the reaction [SLCO1B3 protein results in increased uptake of Rosuvastatin Calcium] 		CTD PMID:26888941 PMID:31299240 NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981 		JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 increases uptake
multiple interactions 		ISO SLCO2B1 protein results in increased uptake of Rosuvastatin Calcium
Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Rosuvastatin Calcium] 		CTD PMID:24285294 NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:153,959,293...154,007,353 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
increases expression 		EXP [[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species CTD PMID:21562509 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249 		JBrowse link
G Tff1 trefoil factor 1 decreases expression ISO Rosuvastatin Calcium results in decreased expression of TFF1 mRNA CTD PMID:32771489 NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
decreases expression 		ISO
EXP 		Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of TGFB1 protein]; Rosuvastatin Calcium inhibits the reaction [[TGFB1 protein co-treated with Serotonin] results in increased secretion of SERPINE2 protein]
Rosuvastatin Calcium results in decreased expression of TGFB1 mRNA 		CTD PMID:15681303 PMID:27097221 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tnf tumor necrosis factor decreases expression
multiple interactions 		EXP Rosuvastatin Calcium results in decreased expression of TNF mRNA
Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of TNF protein] 		CTD PMID:15681303 PMID:32007421 PMID:35130744 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnni3 troponin I3, cardiac type multiple interactions EXP Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein] CTD PMID:32007421 PMID:35130744 NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580 		JBrowse link
G Vnn3 vanin 3 decreases expression ISO Rosuvastatin Calcium results in decreased expression of VNN3P mRNA CTD PMID:18192897 NCBI chr 1:21,571,364...21,583,626
Ensembl chr 1:21,571,364...21,583,626 		JBrowse link
G Wt1 WT1 transcription factor increases expression EXP Rosuvastatin Calcium results in increased expression of WT1 mRNA CTD PMID:21443142 NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:91,567,001...91,613,643 		JBrowse link
sodium acetate trihydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acox1 acyl-CoA oxidase 1 increases expression ISO Sodium Acetate results in increased expression of ACOX1 mRNA CTD PMID:36156098 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 increases expression ISO Sodium Acetate results in increased expression of ACSS1 mRNA CTD PMID:36156098 NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:139,450,383...139,500,325 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Sodium Acetate results in increased expression of ACSS2 mRNA CTD PMID:36156098 NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:144,004,336...144,059,675 		JBrowse link
G Ada adenosine deaminase multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased activity of ADA protein] CTD PMID:31857090 NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088 		JBrowse link
G Apob apolipoprotein B multiple interactions ISO [Sodium Acetate co-treated with acetic anhydride] results in increased acetylation of APOB protein CTD PMID:11304478 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP 		Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein] CTD PMID:36372261 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp7 caspase 7 multiple interactions ISO Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP7 protein] CTD PMID:36372261 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729 		JBrowse link
G Cat catalase multiple interactions ISO
EXP 		Sodium Acetate inhibits the reaction [Cisplatin results in decreased expression of CAT protein] CTD PMID:36372261 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1A1 mRNA]; Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] 		CTD PMID:31621310 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA]; Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased activity of GGT1 protein] CTD PMID:31857090 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442 		JBrowse link
G Ifng interferon gamma multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA] CTD PMID:37269894 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB protein] CTD PMID:37269894 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250 		JBrowse link
G Il2 interleukin 2 multiple interactions ISO Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of IL2 protein] CTD PMID:17615583 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA] CTD PMID:37269894 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ins1 insulin 1 multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased expression of INS1 protein] CTD PMID:31857090 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536 		JBrowse link
G Kpnb1 karyopherin subunit beta 1 multiple interactions ISO Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [NFATC2 protein binds to KPNB1 protein]] CTD PMID:17615583 NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA] CTD PMID:37269894 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415 		JBrowse link
G Nat2 N-acetyltransferase 2 increases expression ISO Sodium Acetate results in increased expression of NAT2 mRNA CTD PMID:36156098 NCBI chr16:26,974,874...27,005,191
Ensembl chr16:22,208,194...22,238,520 		JBrowse link
G Nfatc2 nuclear factor of activated T-cells 2 multiple interactions ISO Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of NFATC2 protein]; Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [NFATC2 protein binds to KPNB1 protein]]; Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of NFATC2 protein] CTD PMID:17615583 NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:157,198,872...157,328,325 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in decreased expression of NFKBIA protein] CTD PMID:37269894 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 increases expression ISO Sodium Acetate results in increased expression of PCK1 mRNA CTD PMID:36156098 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of and results in increased phosphorylation of RELA protein]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of RELA mRNA] CTD PMID:37269894 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO
EXP 		Sodium Acetate inhibits the reaction [Cisplatin results in decreased expression of SOD2 protein] CTD PMID:36372261 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA] CTD PMID:37269894 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tlr2 toll-like receptor 2 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 protein] CTD PMID:37269894 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 protein] CTD PMID:37269894 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TNF mRNA] CTD PMID:37269894 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 multiple interactions ISO Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A1 mRNA] CTD PMID:31621310 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Xdh xanthine dehydrogenase multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased activity of XDH protein] CTD PMID:31857090 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268 		JBrowse link
sodium benzoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase multiple interactions
increases activity 		EXP Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased activity of ACHE protein] CTD PMID:35187746 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO Sodium Benzoate inhibits the reaction [arsenite results in increased expression of ACTA2 protein] CTD PMID:38703806 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions ISO Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA] CTD PMID:19860415 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Camk2a calcium/calmodulin-dependent protein kinase II alpha multiple interactions EXP Sodium Benzoate promotes the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein] CTD PMID:17609678 NCBI chr18:56,648,779...56,711,505
Ensembl chr18:54,378,784...54,438,994 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression
increases activity 		ISO
EXP 		Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP3 protein]
Sodium Benzoate results in increased expression of CASP3 protein
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of CASP3 protein]
Sodium Benzoate results in increased activity of CASP3 protein 		CTD PMID:11329530 PMID:32911041 PMID:35187746 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp9 caspase 9 multiple interactions ISO Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein] CTD PMID:12540492 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Cat catalase decreases activity
multiple interactions 		EXP Sodium Benzoate results in decreased activity of CAT protein
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in decreased activity of CAT protein] 		CTD PMID:32911041 PMID:35187746 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO Sodium Benzoate inhibits the reaction [arsenite results in increased expression of COL1A1 protein] CTD PMID:38703806 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions ISO Sodium Benzoate inhibits the reaction [arsenite results in increased expression of COL3A1 protein] CTD PMID:38703806 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547 		JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 multiple interactions ISO Sodium Benzoate inhibits the reaction [arsenite results in increased expression of CPS1 protein] CTD PMID:38703806 NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA] CTD PMID:19860415 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Dao D-amino-acid oxidase multiple interactions
decreases activity 		ISO
EXP 		Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]
Sodium Benzoate results in decreased activity of DAO protein 		CTD PMID:19860415 PMID:20952482 NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741 		JBrowse link
G Esr1 estrogen receptor 1 decreases activity ISO Sodium Benzoate results in decreased activity of ESR1 protein CTD PMID:22562034 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Fshb follicle stimulating hormone subunit beta increases expression EXP Sodium Benzoate results in increased expression of FSHB protein CTD PMID:32911041 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370 		JBrowse link
G Ifng interferon gamma multiple interactions ISO
EXP 		Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IFNG mRNA 		CTD PMID:26706697 PMID:32179172 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Il10 interleukin 10 multiple interactions EXP [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL10 mRNA CTD PMID:32179172 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP [Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL1B mRNA CTD PMID:32179172 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression 		ISO
EXP 		Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL6 mRNA
Sodium Benzoate results in increased expression of IL6 protein 		CTD PMID:26706697 PMID:32179172 PMID:32911041 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Lhb luteinizing hormone subunit beta increases expression EXP Sodium Benzoate results in increased expression of LHB protein CTD PMID:32911041 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form]; Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] CTD PMID:9614211 NCBI chr16:52,717,775...52,803,602
Ensembl chr16:52,717,732...52,799,676 		JBrowse link
G Otc ornithine transcarbamylase multiple interactions ISO Sodium Benzoate affects the reaction [OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Glycine]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Serotonin]; Sodium Benzoate affects the reaction [OTC gene mutant form results in increased abundance of Ammonium Compounds] CTD PMID:3091026 PMID:3374991 NCBI chr  X:12,453,834...12,529,954
Ensembl chr  X:12,453,834...12,566,918 		JBrowse link
G Tfam transcription factor A, mitochondrial increases expression EXP Sodium Benzoate results in increased expression of TFAM protein CTD PMID:32911041 NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		ISO
EXP 		Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of TNF mRNA; Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of TNF protein] 		CTD PMID:26706697 PMID:32179172 PMID:32911041 PMID:35187746 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression 		ISO
EXP 		Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]
Sodium Benzoate results in increased expression of TP53 protein 		CTD PMID:16357363 PMID:32911041 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Ucp2 uncoupling protein 2 increases expression EXP Sodium Benzoate results in increased expression of UCP2 protein CTD PMID:32911041 NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611 		JBrowse link
G Vim vimentin multiple interactions ISO Sodium Benzoate inhibits the reaction [arsenite results in increased expression of VIM protein] CTD PMID:38703806 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187 		JBrowse link
G Xdh xanthine dehydrogenase increases activity EXP Sodium Benzoate results in increased activity of XDH protein CTD PMID:32911041 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268 		JBrowse link
sodium cholate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alb albumin multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of ALB protein CTD PMID:26606054 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of ALPL protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of ALPL protein] CTD PMID:27394961 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of BAX protein CTD PMID:27394961 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of BCL2 protein CTD PMID:27394961 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of CASP3 protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of CASP3 protein] CTD PMID:27394961 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO
EXP 		[eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL2 mRNA
[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CCL2 mRNA 		CTD PMID:23665937 PMID:26606054 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL5 mRNA CTD PMID:23665937 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of CCND1 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of CCND1 protein] CTD PMID:27394961 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ces1d carboxylesterase 1D increases expression ISO Sodium Cholate results in increased expression of CES1 mRNA CTD PMID:9565681 NCBI chr19:30,046,494...30,085,039
Ensembl chr19:13,796,623...13,912,035 		JBrowse link
G Cst3 cystatin C multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CST3 protein CTD PMID:26606054 NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CYBB mRNA CTD PMID:26606054 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:13,359,430...13,392,586 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions EXP
ISO 		[1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity of CYP3A2 protein
[1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity of CYP3A4 protein 		CTD PMID:1627548 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions ISO [Sodium Cholate co-treated with Dietary Fats] results in decreased expression of CYP7A1 mRNA CTD PMID:23665937 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688 		JBrowse link
G Fabp1 fatty acid binding protein 1 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of FABP1 protein CTD PMID:26606054 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:103,191,006...103,194,788 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of GCLC protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of GCLC protein] CTD PMID:27394961 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544 		JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of GPX2 mRNA CTD PMID:26606054 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of HAVCR1 mRNA CTD PMID:26606054 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of HIF1A mRNA CTD PMID:26606054 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions ISO [Sodium Cholate co-treated with Dietary Fats] results in decreased expression of HMGCR mRNA CTD PMID:23665937 NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of HMOX1 mRNA CTD PMID:26606054 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of ICAM1 mRNA CTD PMID:23665937 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO
EXP 		[eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of IL1B mRNA
[cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of IL1B mRNA 		CTD PMID:23665937 PMID:26606054 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK1 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK1 protein] CTD PMID:27394961 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK3 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK3 protein] CTD PMID:27394961 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase multiple interactions ISO MET gene mutant form affects the susceptibility to [Cholesterol, Dietary co-treated with Sodium Cholate]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of TRP53 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of CCND1 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of GCLC protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1I3 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of RARA protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK1 protein]; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased phosphorylation of MAPK3 protein]; MET gene mutant form promotes the reaction [[[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased oxidation of Lipids] which results in increased abundance of Thiobarbituric Acid Reactive Substances]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of PPARA protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased abundance of Triglycerides]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of CASP3 protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of SREBF1 protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1H3 protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased oxidation of Glutathione]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of ALPL protein]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased secretion of Bile Acids and Salts]; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased uptake of and results in increased oxidation of Lipids] CTD PMID:27394961 NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876 		JBrowse link
G Naglu N-acetyl-alpha-glucosaminidase multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of NAGLU protein CTD PMID:26606054 NCBI chr10:86,501,864...86,509,333
Ensembl chr10:86,001,566...86,008,972 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NFE2L2 protein] CTD PMID:27394961 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1H3 protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1H3 protein] CTD PMID:27394961 NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1I3 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of NR1I3 protein] CTD PMID:27394961 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:83,632,899...83,637,906 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of PPARA protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of PPARA protein] CTD PMID:27394961 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Rara retinoic acid receptor, alpha multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of RARA protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased expression of RARA protein] CTD PMID:27394961 NCBI chr10:84,379,780...84,424,371
Ensembl chr10:83,893,384...83,928,142 		JBrowse link
G S100a8 S100 calcium binding protein A8 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of S100A8 mRNA CTD PMID:26606054 NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643 		JBrowse link
G Scd stearoyl-CoA desaturase multiple interactions ISO [Sodium Cholate co-treated with Dietary Fats] results in increased expression of SCD1 mRNA; eicosapentaenoic acid ethyl ester inhibits the reaction [[Sodium Cholate co-treated with Dietary Fats] results in increased expression of SCD1 mRNA] CTD PMID:23665937 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Soat2 sterol O-acyltransferase 2 multiple interactions ISO [Sodium Cholate co-treated with Dietary Fats] results in increased expression of SOAT2 mRNA; eicosapentaenoic acid ethyl ester inhibits the reaction [[Sodium Cholate co-treated with Dietary Fats] results in increased expression of SOAT2 mRNA] CTD PMID:23665937 NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO [Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein; [Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of and results in decreased activity of SOD2 protein; Curcumin analog inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein]; Curcumin analog inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of and results in decreased activity of SOD2 protein]; Curcumin analog promotes the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of SOD2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin promotes the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of SOD2 protein]; Plant Extracts inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in decreased expression of and results in decreased activity of SOD2 protein]; Plant Extracts inhibits the reaction [[Sodium Cholate co-treated with Deoxycholic Acid co-treated with Glycocholic Acid co-treated with Taurocholic Acid] results in increased expression of and results in decreased activity of SOD2 protein] CTD PMID:22316666 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Spmip11 sperm microtubule inner protein 11 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in decreased expression of NPHS1 mRNA CTD PMID:26606054 NCBI chr 7:129,720,950...129,742,485
Ensembl chr 7:129,720,950...129,742,485 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of SREBF1 protein; MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased cleavage of SREBF1 protein] CTD PMID:27394961 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of TGFB1 mRNA CTD PMID:26606054 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of TLR4 mRNA CTD PMID:26606054 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of TNF mRNA CTD PMID:26606054 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO [Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of TRP53 protein; MET gene mutant form inhibits the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of TRP53 protein] CTD PMID:27394961 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions EXP [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of VCAM1 mRNA CTD PMID:26606054 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958 		JBrowse link
sodium propionate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in increased expression of BAX mRNA] CTD PMID:35639301 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in increased expression of and results in increased cleavage of CASP3 mRNA] CTD PMID:35639301 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8 caspase 8 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in increased expression of CASP8 mRNA] CTD PMID:35639301 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Cldn1 claudin 1 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in decreased expression of CLDN1 protein] CTD PMID:35639301 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:74,421,569...74,436,724 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO sodium propionate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] CTD PMID:31621310 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO sodium propionate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA]; sodium propionate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Hdac2 histone deacetylase 2 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 mRNA]; sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 protein] CTD PMID:35639301 NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609 		JBrowse link
G Hdac6 histone deacetylase 6 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC6 mRNA] CTD PMID:35639301 NCBI chr  X:17,222,538...17,244,373
Ensembl chr  X:14,551,044...14,572,441 		JBrowse link
G Ifng interferon gamma multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA] CTD PMID:37269894 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB protein] CTD PMID:37269894 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA] CTD PMID:37269894 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Mt1 metallothionein 1 multiple interactions
increases expression 		EXP [sodium propionate co-treated with Cadmium] results in increased expression of MT1A mRNA; [sodium propionate co-treated with Dexamethasone] results in increased expression of MT1A mRNA
sodium propionate results in increased expression of MT1A mRNA 		CTD PMID:1597404 NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
Ensembl chr  X:10,826,032...10,827,049 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA] CTD PMID:37269894 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in decreased expression of NFKBIA protein] CTD PMID:37269894 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in increased expression of NOS2 mRNA] CTD PMID:35639301 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in increased expression of NOX1 mRNA]; sodium propionate inhibits the reaction [TNF protein affects the acetylation of NOX1 promoter] CTD PMID:35639301 NCBI chr  X:101,572,338...101,625,571
Ensembl chr  X:97,279,056...97,302,236 		JBrowse link
G Ocln occludin multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in decreased expression of OCLN protein] CTD PMID:35639301 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of and results in increased phosphorylation of RELA protein]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of RELA mRNA] CTD PMID:37269894 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA] CTD PMID:37269894 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tjp1 tight junction protein 1 multiple interactions ISO sodium propionate inhibits the reaction [Ethanol results in decreased expression of TJP1 protein] CTD PMID:35639301 NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432 		JBrowse link
G Tlr2 toll-like receptor 2 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 protein] CTD PMID:37269894 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 protein] CTD PMID:37269894 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]; sodium propionate inhibits the reaction [TNF protein affects the acetylation of NOX1 promoter] CTD PMID:35639301 PMID:37269894 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 multiple interactions ISO sodium propionate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A1 mRNA] CTD PMID:31621310 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
sodium stibogluconate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions ISO [Lovastatin results in decreased activity of ABCC1 protein] which results in increased susceptibility to Antimony Sodium Gluconate CTD PMID:18056276 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114 		JBrowse link
G Bcl6 BCL6, transcription repressor decreases expression ISO Antimony Sodium Gluconate results in decreased expression of BCL6 protein CTD PMID:27546522 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:76,854,090...76,877,389 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO Antimony Sodium Gluconate results in decreased expression of CCL2 mRNA CTD PMID:20102417 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Epo erythropoietin decreases expression ISO Antimony Sodium Gluconate results in decreased expression of EPO mRNA; Antimony Sodium Gluconate results in decreased expression of EPO protein CTD PMID:9531339 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946 		JBrowse link
G Icam1 intercellular adhesion molecule 1 affects response to substance ISO ICAM1 protein affects the susceptibility to Antimony Sodium Gluconate CTD PMID:11035738 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438 		JBrowse link
G Ifng interferon gamma decreases expression
multiple interactions
affects response to substance 		ISO Antimony Sodium Gluconate results in decreased expression of IFNG mRNA
[IFNG protein co-treated with Antimony Sodium Gluconate] results in decreased expression of IL10 mRNA; [IFNG protein co-treated with Antimony Sodium Gluconate] results in decreased expression of IL4 mRNA; [IFNG protein co-treated with Antimony Sodium Gluconate] results in increased expression of IL12B mRNA; [IFNG protein co-treated with Antimony Sodium Gluconate] results in increased expression of NOS2 mRNA; IFNG protein affects the reaction [IL10RA protein affects the susceptibility to Antimony Sodium Gluconate]
IFNG protein affects the susceptibility to Antimony Sodium Gluconate
[Antimony Sodium Gluconate co-treated with Amphotericin B] results in increased expression of IFNG protein 		CTD PMID:9234779 PMID:9498473 PMID:10603400 PMID:12870129 PMID:17911647 More... NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Ifngr1 interferon gamma receptor 1 increases expression ISO Antimony Sodium Gluconate results in increased expression of IFNGR1 mRNA; Antimony Sodium Gluconate results in increased expression of IFNGR1 protein CTD PMID:12803856 NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:14,333,187...14,351,785 		JBrowse link
G Il10 interleukin 10 multiple interactions
decreases expression
affects response to substance 		ISO [Antimony Sodium Gluconate co-treated with Amphotericin B] results in decreased expression of IL10 protein
Antimony Sodium Gluconate results in decreased expression of IL10 mRNA
IL10 protein affects the susceptibility to Antimony Sodium Gluconate
[IFNG protein co-treated with Antimony Sodium Gluconate] results in decreased expression of IL10 mRNA 		CTD PMID:9234779 PMID:9498473 PMID:12379707 PMID:17911647 PMID:20102417 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il10ra interleukin 10 receptor subunit alpha multiple interactions
affects response to substance 		ISO IFNG protein affects the reaction [IL10RA protein affects the susceptibility to Antimony Sodium Gluconate] CTD PMID:12379707 PMID:12870129 NCBI chr 8:54,459,754...54,474,786
Ensembl chr 8:45,563,137...45,578,061 		JBrowse link
G Il12b interleukin 12B multiple interactions ISO [IFNG protein co-treated with Antimony Sodium Gluconate] results in increased expression of IL12B mRNA CTD PMID:9234779 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903 		JBrowse link
G Il1b interleukin 1 beta decreases expression ISO Antimony Sodium Gluconate results in decreased expression of IL1B mRNA CTD PMID:20102417 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il4 interleukin 4 decreases expression
multiple interactions
affects response to substance 		ISO Antimony Sodium Gluconate results in decreased expression of IL4 mRNA
[IFNG protein co-treated with Antimony Sodium Gluconate] results in decreased expression of IL4 mRNA
IL4 protein affects the susceptibility to Antimony Sodium Gluconate 		CTD PMID:7960131 PMID:9234779 PMID:11069076 PMID:20102417 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750 		JBrowse link
G Itgam integrin subunit alpha M increases expression ISO Antimony Sodium Gluconate results in increased expression of ITGAM protein CTD PMID:12399974 NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO [IFNG protein co-treated with Antimony Sodium Gluconate] results in increased expression of NOS2 mRNA CTD PMID:9234779 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Ptpn6 protein tyrosine phosphatase, non-receptor type 6 decreases activity ISO Antimony Sodium Gluconate results in decreased activity of PTPN6 protein CTD PMID:12399974 NCBI chr 4:159,212,320...159,237,069
Ensembl chr 4:157,526,035...157,550,984 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO [Antimony Sodium Gluconate co-treated with Amphotericin B] results in decreased expression of TGFB1 protein CTD PMID:17911647 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Tnf tumor necrosis factor decreases expression ISO Antimony Sodium Gluconate results in decreased expression of TNF mRNA CTD PMID:20102417 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfrsf18 TNF receptor superfamily member 18 increases response to substance ISO TNFRSF18 protein results in increased susceptibility to Antimony Sodium Gluconate CTD PMID:20139272 NCBI chr 5:166,618,461...166,622,353
Ensembl chr 5:166,618,969...166,622,353 		JBrowse link
G Tnfrsf1a TNF receptor superfamily member 1A decreases expression ISO Antimony Sodium Gluconate results in decreased expression of TNFRSF1A protein CTD PMID:7844400 NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591 		JBrowse link
G Tnfrsf1b TNF receptor superfamily member 1B decreases expression ISO Antimony Sodium Gluconate results in decreased expression of TNFRSF1B protein CTD PMID:7844400 NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206 		JBrowse link
sodium valproate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Hdac8 histone deacetylase 8 decreases activity EXP Sodium valproate attenuates the reaction [deoxycorticosterone acetate increases activity of Hdac8 protein in the heart] RGD PMID:23868068 RGD:9681716 NCBI chr  X:67,385,288...67,593,014
Ensembl chr  X:67,385,289...67,592,923 		JBrowse link
tartrazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB1 mRNA CTD PMID:33819548 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCB4 mRNA CTD PMID:33819548 NCBI chr 4:26,106,895...26,164,440
Ensembl chr 4:25,151,953...25,209,202 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC1 mRNA CTD PMID:33819548 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC2 mRNA CTD PMID:33819548 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCC3 mRNA CTD PMID:33819548 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ABCC4 mRNA CTD PMID:33819548 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG2 mRNA CTD PMID:33819548 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG5 mRNA CTD PMID:33819548 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:9,965,118...9,990,563 		JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ABCG8 mRNA CTD PMID:33819548 NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:9,945,629...9,964,912 		JBrowse link
G Adgrg1 adhesion G protein-coupled receptor G1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of ADGRG1 mRNA CTD PMID:33819548 NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108 		JBrowse link
G Adh1c alcohol dehydrogenase 1C (class I), gamma polypeptide multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH1C mRNA CTD PMID:33819548 NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892 		JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH4 mRNA CTD PMID:33819548 NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:226,947,466...226,987,591 		JBrowse link
G Adh6 alcohol dehydrogenase 6 (class V) multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA CTD PMID:33819548 NCBI chr 2:229,576,612...229,608,359
Ensembl chr 2:226,903,250...226,934,534 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR1D1 mRNA CTD PMID:33819548 NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372 		JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A2 mRNA CTD PMID:33819548 NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394 		JBrowse link
G Alb albumin multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ALB mRNA CTD PMID:33819548 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of AMPD3 mRNA CTD PMID:33819548 NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887 		JBrowse link
G Apoa1 apolipoprotein A1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of APOA1 mRNA CTD PMID:33819548 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ATP8B1 mRNA CTD PMID:33819548 NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396 		JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of BAAT mRNA CTD PMID:33819548 NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:63,850,705...63,860,685 		JBrowse link
G Bach1 BTB domain and CNC homolog 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BACH1 mRNA CTD PMID:33819548 NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BCL2L1 mRNA CTD PMID:33819548 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP [Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA CTD PMID:32981412 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Cat catalase decreases activity
multiple interactions 		EXP
ISO 		Tartrazine results in decreased activity of CAT protein
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CAT mRNA 		CTD PMID:20678534 PMID:33819548 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions EXP [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of CHRNA4 protein CTD PMID:23429044 NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957 		JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions EXP [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of CHRNB2 protein CTD PMID:23429044 NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619 		JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of CSF1 mRNA CTD PMID:33819548 NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2B6 mRNA CTD PMID:33819548 NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP2C18 mRNA CTD PMID:33819548 NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:236,762,842...236,799,066 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A4 mRNA CTD PMID:33819548 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP3A5 mRNA CTD PMID:33819548 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA CTD PMID:33819548 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7B1 mRNA CTD PMID:33819548 NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698 		JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP8B1 mRNA CTD PMID:33819548 NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJB9 mRNA CTD PMID:33819548 NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:61,269,913...61,275,063 		JBrowse link
G Dnajc10 DnaJ heat shock protein family (Hsp40) member C10 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC10 mRNA CTD PMID:33819548 NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719 		JBrowse link
G Dnajc18 DnaJ heat shock protein family (Hsp40) member C18 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of DNAJC18 mRNA CTD PMID:33819548 NCBI chr18:27,269,350...27,303,453
Ensembl chr18:27,269,355...27,298,344 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA CTD PMID:33819548 NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,923,268...3,928,118 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of EIF2AK3 mRNA CTD PMID:33819548 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911 		JBrowse link
G Esr1 estrogen receptor 1 increases activity
multiple interactions 		ISO Tartrazine results in increased activity of ESR1 protein
fulvestrant inhibits the reaction [Tartrazine results in increased activity of ESR1 protein] 		CTD PMID:22562034 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of FMO1 mRNA CTD PMID:33819548 NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of FTH1 mRNA CTD PMID:33819548 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GCLM mRNA CTD PMID:33819548 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535 		JBrowse link
G Gjb2 gap junction protein, beta 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GJB2 mRNA CTD PMID:33819548 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:31,260,357...31,278,177 		JBrowse link
G Gprc5b G protein-coupled receptor, class C, group 5, member B multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of GPRC5B mRNA CTD PMID:33819548 NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932 		JBrowse link
G Grin2a glutamate ionotropic receptor NMDA type subunit 2A multiple interactions EXP [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in decreased expression of GRIN2A protein; [ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine] results in increased expression of GRIN2A protein CTD PMID:23429044 NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA1 mRNA CTD PMID:33819548 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:23,703,477...23,720,121 		JBrowse link
G Gsta4 glutathione S-transferase alpha 4 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA4 mRNA CTD PMID:33819548 NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:79,066,934...79,084,182 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTT1 mRNA CTD PMID:33819548 NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions EXP [Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA CTD PMID:32981412 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698 		JBrowse link
G Hpx hemopexin multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of HPX mRNA CTD PMID:33819548 NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328 		JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IFI27 mRNA CTD PMID:33819548 NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294 		JBrowse link
G Il1r1 interleukin 1 receptor type 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of IL1R1 mRNA CTD PMID:33819548 NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:42,504,735...42,579,937 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of JUN mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of JUN mRNA CTD PMID:33819548 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656 		JBrowse link
G Lipc lipase C, hepatic type multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of LIPC mRNA CTD PMID:33819548 NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464 		JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA CTD PMID:33819548 NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386 		JBrowse link
G Maf MAF bZIP transcription factor multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAF mRNA CTD PMID:33819548 NCBI chr19:60,259,200...60,622,145
Ensembl chr19:43,360,342...43,712,365 		JBrowse link
G Maff MAF bZIP transcription factor F multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAFF mRNA CTD PMID:33819548 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851 		JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP2K2 mRNA CTD PMID:33819548 NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:8,580,905...8,610,243 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAP2K6 mRNA CTD PMID:33819548 NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,373,204...95,488,293 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA CTD PMID:33819548 NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800 		JBrowse link
G Mapkapk3 MAPK activated protein kinase 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA CTD PMID:33819548 NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:107,929,762...107,963,568 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MGST1 mRNA CTD PMID:33819548 NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892 		JBrowse link
G Mlkl mixed lineage kinase domain like pseudokinase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MLKL mRNA CTD PMID:33819548 NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502 		JBrowse link
G Mmut methylmalonyl-CoA mutase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MMUT mRNA CTD PMID:33819548 NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046 		JBrowse link
G Mttp microsomal triglyceride transfer protein multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MTTP mRNA CTD PMID:33819548 NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR0B2 mRNA CTD PMID:33819548 NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609 		JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1H4 mRNA CTD PMID:33819548 NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I2 mRNA CTD PMID:33819548 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of NR1I3 mRNA CTD PMID:33819548 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:83,632,899...83,637,906 		JBrowse link
G Pah phenylalanine hydroxylase multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PAH mRNA CTD PMID:33819548 NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130 		JBrowse link
G Pik3c2a phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3C2A mRNA CTD PMID:33819548 NCBI chr 1:170,577,942...170,684,353
Ensembl chr 1:170,577,942...170,683,472 		JBrowse link
G Pik3c2g phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PIK3C2G mRNA CTD PMID:33819548 NCBI chr 4:172,483,752...172,851,623
Ensembl chr 4:172,484,345...172,850,544 		JBrowse link
G Pik3r3 phosphoinositide-3-kinase regulatory subunit 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PIK3R3 mRNA CTD PMID:33819548 NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:129,701,229...129,772,583 		JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PPP1R3C mRNA CTD PMID:33819548 NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:234,460,652...234,465,961 		JBrowse link
G Prkd3 protein kinase D3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of PRKD3 mRNA CTD PMID:33819548 NCBI chr 6:16,032,507...16,108,444
Ensembl chr 6:16,032,585...16,108,443 		JBrowse link
G Rara retinoic acid receptor, alpha multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RARA mRNA CTD PMID:33819548 NCBI chr10:84,379,780...84,424,371
Ensembl chr10:83,893,384...83,928,142 		JBrowse link
G Rasd1 ras related dexamethasone induced 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of RASD1 mRNA CTD PMID:33819548 NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186 		JBrowse link
G Rdh16 retinol dehydrogenase 16 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of RDH16 mRNA CTD PMID:33819548 NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SERPINE1 mRNA CTD PMID:33819548 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657 		JBrowse link
G Slc10a1 solute carrier family 10 member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC10A1 mRNA CTD PMID:33819548 NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670 		JBrowse link
G Slc22a1 solute carrier family 22 member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SLC22A1 mRNA CTD PMID:33819548 NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of SOD2 mRNA CTD PMID:33819548 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Sorl1 sortilin related receptor 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SORL1 mRNA CTD PMID:33819548 NCBI chr 8:51,238,713...51,401,458
Ensembl chr 8:42,341,704...42,504,513 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SREBF1 mRNA CTD PMID:33819548 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650 		JBrowse link
G Sult2a1 sulfotransferase family 2A member 1 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of SULT2A1 mRNA CTD PMID:33819548 NCBI chr 1:84,582,011...84,639,001
Ensembl chr 1:74,911,100...75,508,134 		JBrowse link
G Tff1 trefoil factor 1 multiple interactions
increases expression 		ISO fulvestrant inhibits the reaction [Tartrazine results in increased expression of TFF1 mRNA] CTD PMID:22562034 NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597 		JBrowse link
G Tlr3 toll-like receptor 3 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR3 mRNA CTD PMID:33819548 NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TLR4 mRNA CTD PMID:33819548 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP [Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA CTD PMID:32981412 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfrsf9 TNF receptor superfamily member 9 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA CTD PMID:33819548 NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:161,381,662...161,408,000 		JBrowse link
G Tnfsf10 TNF superfamily member 10 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of TNFSF10 mRNA CTD PMID:33819548 NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135 		JBrowse link
G Tnfsf11 TNF superfamily member 11 multiple interactions ISO [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFSF11 mRNA CTD PMID:33819548 NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445 		JBrowse link
thimerosal term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abhd17b abhydrolase domain containing 17B, depalmitoylase increases expression ISO Thimerosal results in increased expression of ABHD17B mRNA CTD PMID:27188386 NCBI chr 1:219,198,294...219,232,733
Ensembl chr 1:219,198,471...219,231,933 		JBrowse link
G Abtb3 ankyrin repeat and BTB domain containing 3 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA CTD PMID:27188386 NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834 		JBrowse link
G Acacb acetyl-CoA carboxylase beta decreases expression ISO Thimerosal results in decreased expression of ACACB mRNA CTD PMID:27188386 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:42,366,548...42,457,655 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 increases expression ISO Thimerosal results in increased expression of ACSL4 mRNA CTD PMID:27188386 NCBI chr  X:110,739,633...110,803,416
Ensembl chr  X:105,942,799...106,006,427 		JBrowse link
G Actmap actin maturation protease decreases expression ISO Thimerosal results in decreased expression of ACTMAP mRNA CTD PMID:27188386 NCBI chr 1:82,490,313...82,499,841
Ensembl chr 1:82,490,363...82,499,841 		JBrowse link
G Actr2 actin related protein 2 decreases expression ISO Thimerosal results in decreased expression of ACTR2 mRNA CTD PMID:27188386 NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524 		JBrowse link
G Adcy7 adenylate cyclase 7 decreases expression ISO Thimerosal results in decreased expression of ADCY7 mRNA CTD PMID:27188386 NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311 		JBrowse link
G Adgrb2 adhesion G protein-coupled receptor B2 decreases expression ISO Thimerosal results in decreased expression of ADGRB2 mRNA CTD PMID:24675092 NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540 		JBrowse link
G Adgrl3 adhesion G protein-coupled receptor L3 increases expression ISO Thimerosal results in increased expression of ADGRL3 mRNA CTD PMID:27188386 NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860 		JBrowse link
G Adgrv1 adhesion G protein-coupled receptor V1 increases expression ISO Thimerosal results in increased expression of ADGRV1 mRNA CTD PMID:27188386 NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688 		JBrowse link
G Adm adrenomedullin decreases expression ISO Thimerosal results in decreased expression of ADM mRNA CTD PMID:27188386 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654 		JBrowse link
G Adss1 adenylosuccinate synthase 1 decreases expression ISO Thimerosal results in decreased expression of ADSS1 mRNA CTD PMID:27188386 NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998 		JBrowse link
G Afap1l1 actin filament associated protein 1-like 1 decreases expression ISO Thimerosal results in decreased expression of AFAP1L1 mRNA CTD PMID:27188386 NCBI chr18:55,183,786...55,244,174
Ensembl chr18:55,183,786...55,244,146 		JBrowse link
G Aff4 ALF transcription elongation factor 4 decreases expression ISO Thimerosal results in decreased expression of AFF4 mRNA CTD PMID:27188386 NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751 		JBrowse link
G Agbl5 AGBL carboxypeptidase 5 decreases expression ISO Thimerosal results in decreased expression of AGBL5 mRNA CTD PMID:27188386 NCBI chr 6:25,472,333...25,492,173
Ensembl chr 6:25,472,333...25,490,738 		JBrowse link
G Agfg1 ArfGAP with FG repeats 1 decreases expression ISO Thimerosal results in decreased expression of AGFG1 mRNA CTD PMID:27188386 NCBI chr 9:84,124,845...84,182,615
Ensembl chr 9:84,125,120...84,178,128 		JBrowse link
G Ago1 argonaute RISC component 1 decreases expression ISO Thimerosal results in decreased expression of AGO1 mRNA CTD PMID:27188386 NCBI chr 5:138,722,111...138,757,118
Ensembl chr 5:138,722,111...138,773,546 		JBrowse link
G Agpat1 1-acylglycerol-3-phosphate O-acyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of AGPAT1 mRNA CTD PMID:27188386 NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278 		JBrowse link
G Ahcy adenosylhomocysteinase decreases expression ISO Thimerosal results in decreased expression of AHCY mRNA CTD PMID:27188386 NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393 		JBrowse link
G Ahnak2 AHNAK nucleoprotein 2 decreases expression ISO Thimerosal results in decreased expression of AHNAK2 mRNA CTD PMID:27188386 NCBI chr 6:131,830,668...131,876,311
Ensembl chr 6:131,831,454...131,854,463 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 increases secretion ISO Thimerosal results in increased secretion of AIFM1 protein CTD PMID:12140745 NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:127,650,226...127,689,256 		JBrowse link
G Ak4 adenylate kinase 4 decreases expression ISO Thimerosal results in decreased expression of AK4 mRNA CTD PMID:27188386 NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618 		JBrowse link
G Akap11 A-kinase anchoring protein 11 increases expression ISO Thimerosal results in increased expression of AKAP11 mRNA CTD PMID:27188386 NCBI chr15:53,911,635...53,956,138
Ensembl chr15:53,911,657...53,941,605 		JBrowse link
G Akap8l A-kinase anchoring protein 8 like increases expression ISO Thimerosal results in increased expression of AKAP8L mRNA CTD PMID:27188386 NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275 		JBrowse link
G Akap9 A-kinase anchoring protein 9 increases expression ISO Thimerosal results in increased expression of AKAP9 mRNA CTD PMID:27188386 NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
decreases phosphorylation 		ISO Thimerosal promotes the reaction [wortmannin results in decreased phosphorylation of AKT1 protein]; wortmannin promotes the reaction [Thimerosal results in decreased phosphorylation of AKT1 protein] CTD PMID:23145070 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Akt3 AKT serine/threonine kinase 3 decreases expression ISO Thimerosal results in decreased expression of AKT3 mRNA CTD PMID:27188386 NCBI chr13:91,475,839...91,758,060
Ensembl chr13:88,946,091...89,225,708 		JBrowse link
G Alas1 5'-aminolevulinate synthase 1 decreases expression ISO Thimerosal results in decreased expression of ALAS1 mRNA CTD PMID:27188386 NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917 		JBrowse link
G Alb albumin affects binding ISO Thimerosal binds to ALB protein CTD PMID:18197631 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 decreases expression ISO Thimerosal results in decreased expression of ALDH3A2 mRNA CTD PMID:27188386 NCBI chr10:46,427,789...46,448,449
Ensembl chr10:45,908,524...45,949,281 		JBrowse link
G Aldh5a1 aldehyde dehydrogenase 5 family, member A1 decreases expression ISO Thimerosal results in decreased expression of ALDH5A1 mRNA CTD PMID:27188386 NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Thimerosal results in decreased expression of ALDH6A1 mRNA CTD PMID:27188386 NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A decreases expression ISO Thimerosal results in decreased expression of ALDOA mRNA CTD PMID:27188386 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:181,402,275...181,406,182 		JBrowse link
G Aldoc aldolase, fructose-bisphosphate C decreases expression ISO Thimerosal results in decreased expression of ALDOC mRNA CTD PMID:27188386 NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,217,451...63,221,066 		JBrowse link
G Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit increases expression ISO Thimerosal results in increased expression of ALG13 mRNA CTD PMID:27188386 NCBI chr  X:107,906,320...107,968,232
Ensembl chr  X:107,885,093...107,942,695 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase decreases expression ISO Thimerosal results in decreased expression of ALOX5 mRNA CTD PMID:27188386 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743 		JBrowse link
G Angpt1 angiopoietin 1 decreases expression ISO Thimerosal results in decreased expression of ANGPT1 mRNA CTD PMID:27188386 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067 		JBrowse link
G Ank2 ankyrin 2 increases expression ISO Thimerosal results in increased expression of ANK2 mRNA CTD PMID:27188386 NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:215,379,680...215,862,923 		JBrowse link
G Ankdd1a ankyrin repeat and death domain containing 1A decreases expression ISO Thimerosal results in decreased expression of ANKDD1A mRNA CTD PMID:27188386 NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651 		JBrowse link
G Ankef1 ankyrin repeat and EF-hand domain containing 1 decreases expression ISO Thimerosal results in decreased expression of ANKEF1 mRNA CTD PMID:27188386 NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059 		JBrowse link
G Ankrd10 ankyrin repeat domain 10 increases expression ISO Thimerosal results in increased expression of ANKRD10 mRNA CTD PMID:27188386 NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745 		JBrowse link
G Ankrd35 ankyrin repeat domain 35 decreases expression ISO Thimerosal results in decreased expression of ANKRD35 mRNA CTD PMID:27188386 NCBI chr 2:184,207,076...184,227,063
Ensembl chr 2:184,207,071...184,227,063 		JBrowse link
G Ankrd37 ankyrin repeat domain 37 decreases expression ISO Thimerosal results in decreased expression of ANKRD37 mRNA CTD PMID:27188386 NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963 		JBrowse link
G Ankrd44 ankyrin repeat domain 44 increases expression ISO Thimerosal results in increased expression of ANKRD44 mRNA CTD PMID:24675092 PMID:27188386 NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508 		JBrowse link
G Ankrd9 ankyrin repeat domain 9 decreases expression ISO Thimerosal results in decreased expression of ANKRD9 mRNA CTD PMID:27188386 NCBI chr 6:130,001,914...130,008,792
Ensembl chr 6:129,998,486...130,008,923 		JBrowse link
G Ano4 anoctamin 4 decreases expression ISO Thimerosal results in decreased expression of ANO4 mRNA CTD PMID:24675092 NCBI chr 7:23,329,015...23,738,423
Ensembl chr 7:23,329,070...23,738,434 		JBrowse link
G Anp32b acidic nuclear phosphoprotein 32 family member B decreases expression ISO Thimerosal results in decreased expression of ANP32B mRNA CTD PMID:27188386 NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:60,743,443...60,765,717 		JBrowse link
G Anpep alanyl aminopeptidase, membrane decreases expression ISO Thimerosal results in decreased expression of ANPEP mRNA CTD PMID:27188386 NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789 		JBrowse link
G Apc APC regulator of WNT signaling pathway increases expression ISO Thimerosal results in increased expression of APC mRNA CTD PMID:27188386 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696 		JBrowse link
G Apoh apolipoprotein H multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA CTD PMID:27188386 NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329 		JBrowse link
G Appl2 adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 decreases expression ISO Thimerosal results in decreased expression of APPL2 mRNA CTD PMID:27188386 NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:20,135,375...20,184,754 		JBrowse link
G Arap3 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 decreases expression ISO Thimerosal results in decreased expression of ARAP3 mRNA CTD PMID:27188386 NCBI chr18:29,806,214...29,834,217
Ensembl chr18:29,807,536...29,833,555 		JBrowse link
G Arb2a ARB2 cotranscriptional regulator A decreases expression ISO Thimerosal results in decreased expression of ARB2A mRNA CTD PMID:27188386 NCBI chr 2:7,553,873...8,018,183
Ensembl chr 2:7,553,891...8,018,162 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein increases expression ISO Thimerosal results in increased expression of ARC mRNA CTD PMID:16870260 NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378 		JBrowse link
G Arfgef3 ARFGEF family member 3 decreases expression ISO Thimerosal results in decreased expression of ARFGEF3 mRNA CTD PMID:27188386 NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084 		JBrowse link
G Arglu1 arginine and glutamate rich 1 decreases expression ISO Thimerosal results in decreased expression of ARGLU1 mRNA CTD PMID:27188386 NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349 		JBrowse link
G Arhgap18 Rho GTPase activating protein 18 decreases expression ISO Thimerosal results in decreased expression of ARHGAP18 mRNA CTD PMID:27188386 NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 increases expression ISO Thimerosal results in increased expression of ARHGAP5 mRNA CTD PMID:27188386 NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660 		JBrowse link
G Arhgef10 Rho guanine nucleotide exchange factor 10 decreases expression ISO Thimerosal results in decreased expression of ARHGEF10 mRNA CTD PMID:27188386 NCBI chr16:74,647,147...74,738,784
Ensembl chr16:74,647,153...74,738,173 		JBrowse link
G Arhgef12 Rho guanine nucleotide exchange factor 12 increases expression ISO Thimerosal results in increased expression of ARHGEF12 mRNA CTD PMID:27188386 NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366 		JBrowse link
G Arhgef4 Rho guanine nucleotide exchange factor 4 decreases expression ISO Thimerosal results in decreased expression of ARHGEF4 mRNA CTD PMID:27188386 NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075 		JBrowse link
G Armc7 armadillo repeat containing 7 decreases expression ISO Thimerosal results in decreased expression of ARMC7 mRNA CTD PMID:27188386 NCBI chr10:100,723,080...100,739,636
Ensembl chr10:100,723,105...100,739,636 		JBrowse link
G Armcx5 armadillo repeat containing, X-linked 5 increases expression ISO Thimerosal results in increased expression of ARMCX5 mRNA CTD PMID:27188386 NCBI chr  X:98,709,921...98,714,347
Ensembl chr  X:98,709,841...98,714,674 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator decreases expression ISO Thimerosal results in decreased expression of ARNT mRNA CTD PMID:27188386 NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B decreases expression ISO Thimerosal results in decreased expression of ARPC1B mRNA CTD PMID:27188386 NCBI chr12:14,595,939...14,609,501
Ensembl chr12:9,480,831...9,495,747 		JBrowse link
G Arrdc3 arrestin domain containing 3 increases expression ISO Thimerosal results in increased expression of ARRDC3 mRNA CTD PMID:27188386 NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978 		JBrowse link
G Arsk arylsulfatase family, member K decreases expression ISO Thimerosal results in decreased expression of ARSK mRNA CTD PMID:27188386 NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467 		JBrowse link
G Asf1a anti-silencing function 1A histone chaperone increases expression ISO Thimerosal results in increased expression of ASF1A mRNA CTD PMID:27188386 NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808 		JBrowse link
G Asmtl acetylserotonin O-methyltransferase-like decreases expression ISO Thimerosal results in decreased expression of ASMTL mRNA CTD PMID:27188386 NCBI chr12:16,315,335...16,318,083
Ensembl chr12:16,315,414...16,318,080 		JBrowse link
G Aspm assembly factor for spindle microtubules decreases expression ISO Thimerosal results in decreased expression of ASPM mRNA CTD PMID:27188386 NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755 		JBrowse link
G Atad2b ATPase family, AAA domain containing 2B increases expression ISO Thimerosal results in increased expression of ATAD2B mRNA CTD PMID:27188386 NCBI chr 6:27,914,546...28,070,103
Ensembl chr 6:27,912,862...28,067,047 		JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Thimerosal results in increased expression of ATF3 mRNA CTD PMID:16870260 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631 		JBrowse link
G Atf7ip activating transcription factor 7 interacting protein increases expression ISO Thimerosal results in increased expression of ATF7IP mRNA CTD PMID:27188386 NCBI chr 4:169,385,872...169,471,652
Ensembl chr 4:169,385,872...169,471,650 		JBrowse link
G Atg10 autophagy related 10 increases expression ISO Thimerosal results in increased expression of ATG10 mRNA CTD PMID:27188386 NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233 		JBrowse link
G Atg13 autophagy related 13 decreases expression ISO Thimerosal results in decreased expression of ATG13 mRNA CTD PMID:27188386 NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043 		JBrowse link
G Atg2b autophagy related 2B decreases expression ISO Thimerosal results in decreased expression of ATG2B mRNA CTD PMID:27188386 NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015 		JBrowse link
G Atm ATM serine/threonine kinase increases expression ISO Thimerosal results in increased expression of ATM mRNA CTD PMID:27188386 NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437 		JBrowse link
G Atp11b ATPase phospholipid transporting 11B (putative) decreases expression ISO Thimerosal results in decreased expression of ATP11B mRNA CTD PMID:27188386 NCBI chr 2:118,585,348...118,691,076
Ensembl chr 2:118,585,342...118,690,232 		JBrowse link
G Atp13a3 ATPase 13A3 decreases expression ISO Thimerosal results in decreased expression of ATP13A3 mRNA CTD PMID:27188386 NCBI chr11:83,860,725...83,946,899
Ensembl chr11:70,365,322...70,441,235 		JBrowse link
G Atp1b2 ATPase Na+/K+ transporting subunit beta 2 decreases expression ISO Thimerosal results in decreased expression of ATP1B2 mRNA CTD PMID:27188386 NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,318,701...54,324,933 		JBrowse link
G Atp5f1d ATP synthase F1 subunit delta decreases expression ISO Thimerosal results in decreased expression of ATP5F1D mRNA CTD PMID:27188386 NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:9,560,608...9,565,929 		JBrowse link
G Atp5f1e ATP synthase F1 subunit epsilon increases expression ISO Thimerosal results in increased expression of ATP5F1E mRNA CTD PMID:27188386 NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:163,260,476...163,261,450 		JBrowse link
G Atp5if1 ATP synthase inhibitory factor subunit 1 decreases expression ISO Thimerosal results in decreased expression of ATP5IF1 mRNA CTD PMID:27188386 NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668 		JBrowse link
G Atp6v1d ATPase H+ transporting V1 subunit D increases expression ISO Thimerosal results in increased expression of ATP6V1D mRNA CTD PMID:27188386 NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:97,656,576...97,672,303 		JBrowse link
G Atp8b3 ATPase phospholipid transporting 8B3 decreases expression ISO Thimerosal results in decreased expression of ATP8B3 mRNA CTD PMID:27188386 NCBI chr 7:9,175,544...9,195,449
Ensembl chr 7:9,175,391...9,195,442 		JBrowse link
G Atrx ATRX, chromatin remodeler decreases expression ISO Thimerosal results in decreased expression of ATRX mRNA CTD PMID:27188386 NCBI chr  X:74,916,548...75,062,880
Ensembl chr  X:70,850,981...70,997,330 		JBrowse link
G Atxn1 ataxin 1 decreases expression ISO Thimerosal results in decreased expression of ATXN1 mRNA CTD PMID:27188386 NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360 		JBrowse link
G Atxn7l3b ataxin 7-like 3B decreases expression ISO Thimerosal results in decreased expression of ATXN7L3B mRNA CTD PMID:27188386 NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878 		JBrowse link
G Azi2 5-azacytidine induced 2 increases expression ISO Thimerosal results in increased expression of AZI2 mRNA CTD PMID:27188386 NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:117,773,279...117,797,847 		JBrowse link
G B3galnt2 beta-1,3-N-acetylgalactosaminyltransferase 2 increases expression ISO Thimerosal results in increased expression of B3GALNT2 mRNA CTD PMID:27188386 NCBI chr17:56,030,409...56,072,952
Ensembl chr17:51,334,921...51,377,469 		JBrowse link
G Bace1 beta-secretase 1 decreases expression ISO Thimerosal results in decreased expression of BACE1 mRNA CTD PMID:27188386 NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876 		JBrowse link
G Bace2 beta-secretase 2 decreases expression ISO Thimerosal results in decreased expression of BACE2 mRNA CTD PMID:27188386 NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546 		JBrowse link
G Bag3 BAG cochaperone 3 increases expression ISO Thimerosal results in increased expression of BAG3 mRNA CTD PMID:16870260 NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858 		JBrowse link
G Bag4 BAG cochaperone 4 decreases expression ISO Thimerosal results in decreased expression of BAG4 mRNA CTD PMID:27188386 NCBI chr16:66,288,678...66,305,893
Ensembl chr16:66,288,678...66,308,663 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Thimerosal results in increased expression of BAX CTD PMID:24942245 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bbip1 BBSome interacting protein 1 increases expression ISO Thimerosal results in increased expression of BBIP1 mRNA CTD PMID:27188386 NCBI chr 1:252,943,589...252,959,512
Ensembl chr 1:252,945,557...252,959,352 		JBrowse link
G Bbln bublin coiled coil protein decreases expression ISO Thimerosal results in decreased expression of BBLN mRNA CTD PMID:27188386 NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374 		JBrowse link
G Bcas3 BCAS3, microtubule associated cell migration factor decreases expression ISO Thimerosal results in decreased expression of BCAS3 mRNA CTD PMID:27188386 NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 decreases expression ISO Thimerosal results in decreased expression of BCAT2 mRNA CTD PMID:27188386 NCBI chr 1:96,040,407...96,060,008
Ensembl chr 1:96,042,625...96,060,007 		JBrowse link
G Bcl6b BCL6B, transcription repressor decreases expression ISO Thimerosal results in decreased expression of BCL6B mRNA CTD PMID:27188386 NCBI chr10:55,439,566...55,444,631
Ensembl chr10:54,940,909...54,945,974 		JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 increases expression ISO Thimerosal results in increased expression of BCLAF1 mRNA CTD PMID:27188386 NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832 		JBrowse link
G Bcor BCL6 co-repressor decreases expression ISO Thimerosal results in decreased expression of BCOR mRNA CTD PMID:27188386 NCBI chr  X:10,609,756...10,729,613
Ensembl chr  X:10,687,732...10,729,613 		JBrowse link
G Bdp1 BDP1 general transcription factor IIIB subunit decreases expression ISO Thimerosal results in decreased expression of BDP1 mRNA CTD PMID:27188386 NCBI chr 2:31,378,407...31,470,140
Ensembl chr 2:31,378,924...31,470,119 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 decreases expression ISO Thimerosal results in decreased expression of BHLHE40 mRNA CTD PMID:27188386 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:141,618,476...141,624,774 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions
decreases expression 		ISO Glutathione inhibits the reaction [Thimerosal results in decreased expression of BIRC3 protein] CTD PMID:12140745 NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
decreases expression 		ISO BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein] CTD PMID:23145070 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380 		JBrowse link
G Bloc1s3 biogenesis of lysosomal organelles complex-1, subunit 3 decreases expression ISO Thimerosal results in decreased expression of BLOC1S3 mRNA CTD PMID:27188386 NCBI chr 1:79,155,873...79,158,247
Ensembl chr 1:79,155,693...79,158,505 		JBrowse link
G Bltp3a bridge-like lipid transfer protein family member 3A decreases expression ISO Thimerosal results in decreased expression of BLTP3A mRNA CTD PMID:24675092 NCBI chr20:5,910,261...5,954,641
Ensembl chr20:5,910,260...5,952,404 		JBrowse link
G Bmp2k BMP-2 inducible kinase increases expression ISO Thimerosal results in increased expression of BMP2K mRNA CTD PMID:27188386 NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,484,729...12,579,134 		JBrowse link
G Bnip3 BCL2 interacting protein 3 decreases expression ISO Thimerosal results in decreased expression of BNIP3 mRNA CTD PMID:27188386 NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359 		JBrowse link
G Bod1l1 biorientation of chromosomes in cell division 1-like 1 decreases expression ISO Thimerosal results in decreased expression of BOD1L1 mRNA CTD PMID:27188386 NCBI chr14:69,108,483...69,163,255
Ensembl chr14:69,108,491...69,162,490 		JBrowse link
G Bok BCL2 family apoptosis regulator BOK decreases expression ISO Thimerosal results in decreased expression of BOK mRNA CTD PMID:27188386 NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:94,223,389...94,234,476 		JBrowse link
G Bola2 bolA family member 2 increases expression ISO Thimerosal results in increased expression of BOLA2 mRNA CTD PMID:27188386 NCBI chr 1:181,291,967...181,292,833
Ensembl chr 1:181,291,398...181,292,676 		JBrowse link
G Brca2 BRCA2, DNA repair associated increases expression ISO Thimerosal results in increased expression of BRCA2 mRNA CTD PMID:27188386 NCBI chr12:4,895,092...4,939,340
Ensembl chr12:59,819...100,567 		JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 increases expression ISO Thimerosal results in increased expression of BRWD1 mRNA CTD PMID:27188386 NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768 		JBrowse link
G Brwd3 bromodomain and WD repeat domain containing 3 decreases expression ISO Thimerosal results in decreased expression of BRWD3 mRNA CTD PMID:27188386 NCBI chr  X:73,768,343...73,861,643
Ensembl chr  X:73,774,340...73,861,622 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 increases expression ISO Thimerosal results in increased expression of BTG3 mRNA CTD PMID:27188386 NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170 		JBrowse link
G C11h3orf38 similar to human chromosome 3 open reading frame 38 increases expression ISO Thimerosal results in increased expression of C3ORF38 mRNA CTD PMID:27188386 NCBI chr11:2,483,983...2,488,631
Ensembl chr11:2,481,189...2,488,660 		JBrowse link
G C13h1orf115 similar to human chromosome 1 open reading frame 115 decreases expression ISO Thimerosal results in decreased expression of C1ORF115 mRNA CTD PMID:27188386 NCBI chr13:96,422,308...96,432,044
Ensembl chr13:96,422,302...96,432,068 		JBrowse link
G C13h1orf53 similar to human chromosome 1 open reading frame 53 increases expression ISO Thimerosal results in increased expression of C1ORF53 mRNA CTD PMID:27188386 NCBI chr13:50,413,785...50,418,974
Ensembl chr13:50,413,785...50,419,120 		JBrowse link
G C13h2orf76 similar to chromosome 2 open reading frame 76 increases expression ISO Thimerosal results in increased expression of C2ORF76 mRNA CTD PMID:27188386 NCBI chr13:31,249,733...31,335,367
Ensembl chr13:31,249,959...31,314,943 		JBrowse link
G C15h8orf58 similar to human chromosome 8 open reading frame 58 decreases expression ISO Thimerosal results in decreased expression of C8ORF58 mRNA CTD PMID:27188386 NCBI chr15:45,228,615...45,235,274
Ensembl chr15:45,228,615...45,233,254 		JBrowse link
G C16h8orf48 similar to human chromosome 8 open reading frame 48 increases expression ISO Thimerosal results in increased expression of C8ORF48 mRNA CTD PMID:27188386 NCBI chr16:61,948,170...61,950,066
Ensembl chr16:55,236,322...55,246,650 		JBrowse link
G C17h5orf24 similar to human chromosome 5 open reading frame 24 decreases expression ISO Thimerosal results in decreased expression of C5ORF24 mRNA CTD PMID:27188386 NCBI chr17:8,923,041...8,932,958
Ensembl chr17:8,922,675...8,933,356 		JBrowse link
G C1qtnf3 C1q and TNF related 3 decreases expression ISO Thimerosal results in decreased expression of C1QTNF3 mRNA CTD PMID:27188386 NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433 		JBrowse link
G C1qtnf4 C1q and TNF related 4 decreases expression ISO Thimerosal results in decreased expression of C1QTNF4 mRNA CTD PMID:27188386 NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139 		JBrowse link
G C1rl complement C1r subcomponent like decreases expression ISO Thimerosal results in decreased expression of C1RL mRNA CTD PMID:27188386 NCBI chr 4:157,394,183...157,410,771
Ensembl chr 4:157,394,200...157,410,134 		JBrowse link
G C20h6orf136 similar to human chromosome 6 open reading frame 136 decreases expression ISO Thimerosal results in decreased expression of C6ORF136 mRNA CTD PMID:27188386 NCBI chr20:2,857,840...2,861,952 JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 decreases expression ISO Thimerosal results in decreased expression of C2CD2 mRNA CTD PMID:27188386 NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739 		JBrowse link
G C5h1orf174 similar to human chromosome 1 open reading frame 174 increases expression ISO Thimerosal results in increased expression of C1ORF174 mRNA CTD PMID:27188386 NCBI chr 5:164,515,578...164,520,022
Ensembl chr 5:164,515,559...164,520,021 		JBrowse link
G C7h8orf82 similar to human chromosome 8 open reading frame 82 decreases expression ISO Thimerosal results in decreased expression of C8ORF82 mRNA CTD PMID:27188386 NCBI chr 7:108,443,772...108,446,116
Ensembl chr 7:108,443,782...108,446,121 		JBrowse link
G Cadm2 cell adhesion molecule 2 increases expression ISO Thimerosal results in increased expression of CADM2 mRNA CTD PMID:27188386 NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400 		JBrowse link
G Cadm3 cell adhesion molecule 3 decreases expression ISO Thimerosal results in decreased expression of CADM3 mRNA CTD PMID:27188386 NCBI chr13:85,784,785...85,817,412
Ensembl chr13:85,786,483...85,817,749 		JBrowse link
G Calm3 calmodulin 3 decreases expression ISO Thimerosal results in decreased expression of CALM3 mRNA CTD PMID:27188386 NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207 		JBrowse link
G Calml4 calmodulin-like 4 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA CTD PMID:27188386 NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234 		JBrowse link
G Capn5 calpain 5 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA CTD PMID:27188386 NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923 		JBrowse link
G Capn9 calpain 9 increases expression ISO Thimerosal results in increased expression of CAPN9 mRNA CTD PMID:27188386 NCBI chr19:52,549,448...52,586,413
Ensembl chr19:52,549,448...52,586,413 		JBrowse link
G Car10 carbonic anhydrase 10 increases expression ISO Thimerosal results in increased expression of CA10 mRNA CTD PMID:27188386 NCBI chr10:78,551,067...79,053,421
Ensembl chr10:78,054,114...78,555,834 		JBrowse link
G Car14 carbonic anhydrase 14 decreases expression ISO Thimerosal results in decreased expression of CA14 mRNA CTD PMID:27188386 NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:183,441,667...183,449,693 		JBrowse link
G Card10 caspase recruitment domain family, member 10 decreases expression ISO Thimerosal results in decreased expression of CARD10 mRNA CTD PMID:27188386 NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:110,330,408...110,359,224 		JBrowse link
G Carm1 coactivator-associated arginine methyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of CARM1 mRNA CTD PMID:27188386 NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689 		JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
increases activity 		ISO
EXP 		Thimerosal results in increased cleavage of CASP3 protein
[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein; [Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; SB 203580 inhibits the reaction [Thimerosal results in increased activity of CASP3 protein]
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [Wortmannin results in increased cleavage of CASP3 protein]; Wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]
MC1568 inhibits the reaction [Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein]; Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein 		CTD PMID:12140745 PMID:15869795 PMID:16649253 PMID:17698513 PMID:17888894 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp9 caspase 9 increases cleavage
multiple interactions
increases activity 		ISO Thimerosal results in increased cleavage of CASP9 protein
Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein]
benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [wortmannin results in increased cleavage of CASP9 protein]; wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein] 		CTD PMID:12140745 PMID:15869795 PMID:23145070 Ensembl chr 5:154,109,046...154,126,626 JBrowse link
G Cat catalase multiple interactions ISO [Thimerosal co-treated with Aluminum Hydroxide] results in increased activity of CAT protein CTD PMID:36411272 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cbl Cbl proto-oncogene decreases expression ISO Thimerosal results in decreased expression of CBL mRNA CTD PMID:27188386 NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:44,489,410...44,571,176 		JBrowse link
G Cbx3 chromobox 3 increases expression ISO Thimerosal results in increased expression of CBX3 mRNA CTD PMID:27188386 NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
Ensembl chr 4:80,546,010...80,559,283 		JBrowse link
G Cbx5 chromobox 5 decreases expression ISO Thimerosal results in decreased expression of CBX5 mRNA CTD PMID:27188386 NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:134,331,335...134,375,022 		JBrowse link
G Cbx7 chromobox 7 decreases expression ISO Thimerosal results in decreased expression of CBX7 mRNA CTD PMID:27188386 NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973 		JBrowse link
G Cc2d2b coiled-coil and C2 domain containing 2B decreases expression ISO Thimerosal results in decreased expression of CC2D2B mRNA CTD PMID:27188386 NCBI chr 1:239,561,506...239,655,771
Ensembl chr 1:239,561,987...239,682,416 		JBrowse link
G Ccdc126 coiled-coil domain containing 126 increases expression ISO Thimerosal results in increased expression of CCDC126 mRNA CTD PMID:27188386 NCBI chr 4:78,297,625...78,318,655
Ensembl chr 4:78,297,551...78,318,655 		JBrowse link
G Ccdc183 coiled-coil domain containing 183 decreases expression ISO Thimerosal results in decreased expression of CCDC183 mRNA CTD PMID:27188386 NCBI chr 3:8,428,784...8,438,948
Ensembl chr 3:8,428,787...8,437,194 		JBrowse link
G Ccdc186 coiled-coil domain containing 186 decreases expression ISO Thimerosal results in decreased expression of CCDC186 mRNA CTD PMID:27188386 NCBI chr 1:255,831,663...255,871,954
Ensembl chr 1:255,839,595...255,871,935 		JBrowse link
G Ccdc66 coiled-coil domain containing 66 increases expression ISO Thimerosal results in increased expression of CCDC66 mRNA CTD PMID:27188386 NCBI chr16:2,662,125...2,694,031
Ensembl chr16:2,662,131...2,694,023 		JBrowse link
G Ccdc71l coiled-coil domain containing 71-like decreases expression ISO Thimerosal results in decreased expression of CCDC71L mRNA CTD PMID:27188386 NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:48,960,191...48,960,841
Ensembl chr 6:48,960,191...48,960,841 		JBrowse link
G Ccdc82 coiled-coil domain containing 82 increases expression ISO Thimerosal results in increased expression of CCDC82 mRNA CTD PMID:27188386 NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963 		JBrowse link
G Ccdc85b coiled-coil domain containing 85B decreases expression ISO Thimerosal results in decreased expression of CCDC85B mRNA CTD PMID:27188386 NCBI chr 1:202,763,645...202,764,660
Ensembl chr 1:202,763,631...202,764,703 		JBrowse link
G Ccm2l CCM2 like scaffold protein decreases expression ISO Thimerosal results in decreased expression of CCM2L mRNA CTD PMID:27188386 NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Thimerosal results in increased expression of CCN1 mRNA CTD PMID:16870260 NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO Thimerosal results in increased expression of and results in increased activity of CCNB1 protein CTD PMID:16649253 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Ccnd1 cyclin D1 decreases expression ISO Thimerosal results in decreased expression of CCND1 mRNA CTD PMID:27188386 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ccnd2 cyclin D2 decreases expression ISO Thimerosal results in decreased expression of CCND2 mRNA CTD PMID:27188386 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495 		JBrowse link
G Ccnt1 cyclin T1 decreases expression ISO Thimerosal results in decreased expression of CCNT1 mRNA CTD PMID:27188386 NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871 		JBrowse link
G Ccnt2 cyclin T2 increases expression ISO Thimerosal results in increased expression of CCNT2 mRNA CTD PMID:27188386 NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019 		JBrowse link
G Ccser1 coiled-coil serine-rich protein 1 increases expression ISO Thimerosal results in increased expression of CCSER1 mRNA CTD PMID:27188386 NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786 		JBrowse link
G Cct6b chaperonin containing TCP1 subunit 6B increases expression ISO Thimerosal results in increased expression of CCT6B mRNA CTD PMID:27188386 NCBI chr10:67,652,461...67,701,385
Ensembl chr10:67,652,546...67,701,284 		JBrowse link
G Cd28 Cd28 molecule affects response to substance ISO CD28 affects the susceptibility to Thimerosal CTD PMID:15808517 NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:62,166,192...62,194,685 		JBrowse link
G Cd40 CD40 molecule decreases expression ISO Thimerosal results in decreased expression of CD40 mRNA CTD PMID:27188386 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534 		JBrowse link
G Cd6 Cd6 molecule decreases expression ISO Thimerosal results in decreased expression of CD6 mRNA CTD PMID:24675092 NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634 		JBrowse link
G Cd79b CD79b molecule increases expression ISO Thimerosal results in increased expression of CD79B mRNA CTD PMID:24675092 NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,239,356...91,242,625 		JBrowse link
G Cd81 Cd81 molecule decreases expression ISO Thimerosal results in decreased expression of CD81 mRNA CTD PMID:27188386 NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:198,241,484...198,251,660 		JBrowse link
G Cd86 CD86 molecule multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Cysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Glutathione inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein] CTD PMID:15737199 PMID:20417223 PMID:20457211 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818 		JBrowse link
G Cd99 CD99 molecule (Xg blood group) decreases expression ISO Thimerosal results in decreased expression of CD99 mRNA CTD PMID:27188386 NCBI chr20:54,418,239...54,422,882 JBrowse link
G Cdc20b cell division cycle 20B increases expression ISO Thimerosal results in increased expression of CDC20B mRNA CTD PMID:27188386 NCBI chr 2:44,688,349...44,738,056 JBrowse link
G Cdc27 cell division cycle 27 decreases expression ISO Thimerosal results in decreased expression of CDC27 mRNA CTD PMID:27188386 NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736 		JBrowse link
G Cdc37l1 cell division cycle 37-like 1 increases expression ISO Thimerosal results in increased expression of CDC37L1 mRNA CTD PMID:27188386 NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175 		JBrowse link
G Cdc42se2 CDC42 small effector 2 increases expression ISO Thimerosal results in increased expression of CDC42SE2 mRNA CTD PMID:27188386 NCBI chr10:38,836,549...38,905,056
Ensembl chr10:38,836,555...38,905,059
Ensembl chr 1:38,836,555...38,905,059 		JBrowse link
G Cdca2 cell division cycle associated 2 decreases expression ISO Thimerosal results in decreased expression of CDCA2 mRNA CTD PMID:27188386 NCBI chr15:46,071,360...46,117,524
Ensembl chr15:41,895,901...41,941,611 		JBrowse link
G Cdh8 cadherin 8 increases expression ISO Thimerosal results in increased expression of CDH8 mRNA CTD PMID:27188386 NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,494,174...5,895,669 		JBrowse link
G Cdhr1 cadherin-related family member 1 increases expression ISO Thimerosal results in increased expression of CDHR1 mRNA CTD PMID:24675092 NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,843,437...12,863,396 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 increases expression ISO Thimerosal results in increased expression of CDK1 mRNA CTD PMID:27188386 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408 		JBrowse link
G Cdk14 cyclin-dependent kinase 14 affects expression ISO Thimerosal affects the expression of CDK14 mRNA CTD PMID:27188386 NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861 		JBrowse link
G Cdk16 cyclin-dependent kinase 16 decreases expression ISO Thimerosal results in decreased expression of CDK16 mRNA CTD PMID:27188386 NCBI chr  X:4,046,330...4,057,825
Ensembl chr  X:1,492,814...1,504,148 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 decreases expression ISO Thimerosal results in decreased expression of CDK4 protein CTD PMID:16649253 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 decreases expression ISO Thimerosal results in decreased expression of CDK6 mRNA CTD PMID:27188386 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C decreases expression ISO Thimerosal results in decreased expression of CDKN1C mRNA CTD PMID:27188386 NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 decreases expression ISO Thimerosal results in decreased expression of CDT1 mRNA CTD PMID:27188386 NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659 		JBrowse link
G Cenpn centromere protein N increases expression ISO Thimerosal results in increased expression of CENPN mRNA CTD PMID:27188386 NCBI chr19:44,971,265...44,994,019
Ensembl chr19:44,968,308...44,994,012 		JBrowse link
G Cenpq centromere protein Q increases expression ISO Thimerosal results in increased expression of CENPQ mRNA CTD PMID:27188386 NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789 		JBrowse link
G Cenpu centromere protein U increases expression ISO Thimerosal results in increased expression of CENPU mRNA CTD PMID:27188386 NCBI chr16:52,448,446...52,471,662
Ensembl chr16:45,714,294...45,738,823 		JBrowse link
G Cep126 centrosomal protein 126 decreases expression ISO Thimerosal results in decreased expression of CEP126 mRNA CTD PMID:27188386 NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467 		JBrowse link
G Cep350 centrosomal protein 350 decreases expression ISO Thimerosal results in decreased expression of CEP350 mRNA CTD PMID:27188386 NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214 		JBrowse link
G Cep89 centrosomal protein 89 decreases expression ISO Thimerosal results in decreased expression of CEP89 mRNA CTD PMID:27188386 NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112 		JBrowse link
G Cfap263 cilia and flagella associated protein 263 decreases expression ISO Thimerosal results in decreased expression of CFAP263 mRNA CTD PMID:27188386 NCBI chr19:9,503,062...9,522,957
Ensembl chr19:9,496,886...9,516,923 		JBrowse link
G Cfap300 cilia and flagella associated protein 300 increases expression ISO Thimerosal results in increased expression of CFAP300 mRNA CTD PMID:27188386 NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807 		JBrowse link
G Cfap44 cilia and flagella associated protein 44 increases expression ISO Thimerosal results in increased expression of CFAP44 mRNA CTD PMID:27188386 NCBI chr11:56,199,772...56,283,964
Ensembl chr11:56,201,049...56,283,986 		JBrowse link
G Cfap96 cilia and flagella associated protein 96 decreases expression ISO Thimerosal results in decreased expression of CFAP96 mRNA CTD PMID:27188386 NCBI chr16:46,291,075...46,315,616
Ensembl chr16:46,291,311...46,315,625 		JBrowse link
G Cfp complement factor properdin decreases expression ISO Thimerosal results in decreased expression of CFP mRNA CTD PMID:24675092 NCBI chr  X:3,715,551...3,721,113
Ensembl chr  X:1,161,979...1,167,573 		JBrowse link
G Cga glycoprotein hormones, alpha polypeptide increases expression ISO Thimerosal results in increased expression of CGA mRNA CTD PMID:24675092 NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:49,487,068...49,499,191 		JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 decreases expression ISO Thimerosal results in decreased expression of CHCHD10 mRNA CTD PMID:27188386 NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763 		JBrowse link
G Chd4 chromodomain helicase DNA binding protein 4 decreases expression ISO Thimerosal results in decreased expression of CHD4 mRNA CTD PMID:27188386 NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541 		JBrowse link
G Chd9 chromodomain helicase DNA binding protein 9 increases expression ISO Thimerosal results in increased expression of CHD9 mRNA CTD PMID:27188386 NCBI chr19:15,941,535...16,146,220
Ensembl chr19:15,942,687...16,164,556 		JBrowse link
G Chmp5 charged multivesicular body protein 5 increases expression ISO Thimerosal results in increased expression of CHMP5 mRNA CTD PMID:27188386 NCBI chr 5:60,877,369...60,894,512
Ensembl chr 5:56,081,343...56,098,529 		JBrowse link
G Chn2 chimerin 2 increases expression ISO Thimerosal results in increased expression of CHN2 mRNA CTD PMID:27188386 NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709 		JBrowse link
G Chpt1 choline phosphotransferase 1 increases expression ISO Thimerosal results in increased expression of CHPT1 mRNA CTD PMID:27188386 NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:22,863,027...22,915,103 		JBrowse link
G Cib2 calcium and integrin binding family member 2 decreases expression ISO Thimerosal results in decreased expression of CIB2 mRNA CTD PMID:27188386 NCBI chr 8:54,930,265...54,947,157 JBrowse link
G Cibar1 CBY1 interacting BAR domain containing 1 decreases expression ISO Thimerosal results in decreased expression of CIBAR1 mRNA CTD PMID:27188386 NCBI chr 5:25,613,993...25,632,440
Ensembl chr 5:25,614,033...25,632,489 		JBrowse link
G Cilp2 cartilage intermediate layer protein 2 decreases expression ISO Thimerosal results in decreased expression of CILP2 mRNA CTD PMID:27188386 NCBI chr16:19,539,755...19,547,191
Ensembl chr16:19,539,706...19,547,191 		JBrowse link
G Cisd2 CDGSH iron sulfur domain 2 increases expression ISO Thimerosal results in increased expression of CISD2 mRNA CTD PMID:27188386 NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 increases expression ISO Thimerosal results in increased expression of CITED2 mRNA CTD PMID:16870260 NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897 		JBrowse link
G Clasp2 cytoplasmic linker associated protein 2 increases expression ISO Thimerosal results in increased expression of CLASP2 mRNA CTD PMID:27188386 NCBI chr 8:122,555,532...122,736,934
Ensembl chr 8:113,677,284...113,858,731 		JBrowse link
G Clk4 CDC-like kinase 4 increases expression ISO Thimerosal results in increased expression of CLK4 mRNA CTD PMID:27188386 NCBI chr10:35,523,382...35,541,387
Ensembl chr10:35,524,755...35,541,352 		JBrowse link
G Clp1 cleavage factor polyribonucleotide kinase subunit 1 increases expression ISO Thimerosal results in increased expression of CLP1 mRNA CTD PMID:27188386 NCBI chr 3:69,806,774...69,818,633
Ensembl chr 3:69,806,778...69,810,421 		JBrowse link
G Clu clusterin increases expression
decreases expression 		ISO Thimerosal results in increased expression of CLU mRNA
Thimerosal results in decreased expression of CLU mRNA 		CTD PMID:16870260 PMID:27188386 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315 		JBrowse link
G Cmip c-Maf-inducing protein decreases expression ISO Thimerosal results in decreased expression of CMIP mRNA CTD PMID:27188386 NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709 		JBrowse link
G Cnfn cornifelin decreases expression ISO Thimerosal results in decreased expression of CNFN mRNA CTD PMID:27188386 NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747 		JBrowse link
G Cnot7 CCR4-NOT transcription complex, subunit 7 increases expression ISO Thimerosal results in increased expression of CNOT7 mRNA CTD PMID:27188386 NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576 		JBrowse link
G Cnot9 CCR4-NOT transcription complex subunit 9 increases expression ISO Thimerosal results in increased expression of CNOT9 mRNA CTD PMID:27188386 NCBI chr 9:76,084,269...76,109,111
Ensembl chr 9:76,084,334...76,109,100 		JBrowse link
G Cnpy2 canopy FGF signaling regulator 2 decreases expression ISO Thimerosal results in decreased expression of CNPY2 mRNA CTD PMID:27188386 NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519 		JBrowse link
G Cntnap2 contactin associated protein 2 decreases expression ISO Thimerosal results in decreased expression of CNTNAP2 mRNA CTD PMID:27188386 NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:74,109,472...76,362,027 		JBrowse link
G Cobll1 cordon-bleu WH2 repeat protein-like 1 increases expression ISO Thimerosal results in increased expression of COBLL1 mRNA CTD PMID:24675092 NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194 		JBrowse link
G Cog3 component of oligomeric golgi complex 3 increases expression ISO Thimerosal results in increased expression of COG3 mRNA CTD PMID:24675092 NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570 		JBrowse link
G Col22a1 collagen type XXII alpha 1 chain decreases expression ISO Thimerosal results in decreased expression of COL22A1 mRNA CTD PMID:27188386 NCBI chr 7:103,730,939...103,968,452
Ensembl chr 7:103,731,037...103,968,462 		JBrowse link
G Col4a6 collagen type IV alpha 6 chain increases expression ISO Thimerosal results in increased expression of COL4A6 mRNA CTD PMID:27188386 NCBI chr  X:104,766,463...105,117,499
Ensembl chr  X:104,766,957...105,117,500 		JBrowse link
G Col9a2 collagen type IX alpha 2 chain decreases expression ISO Thimerosal results in decreased expression of COL9A2 mRNA CTD PMID:27188386 NCBI chr 5:139,892,798...139,910,131
Ensembl chr 5:134,607,616...134,624,677 		JBrowse link
G Cops7b COP9 signalosome subunit 7B increases expression ISO Thimerosal results in increased expression of COPS7B mRNA CTD PMID:27188386 NCBI chr 9:87,238,132...87,263,967
Ensembl chr 9:87,238,375...87,263,967 		JBrowse link
G Cox15 cytochrome c oxidase assembly homolog COX15 decreases expression ISO Thimerosal results in decreased expression of COX15 mRNA CTD PMID:27188386 NCBI chr 1:242,605,588...242,622,279
Ensembl chr 1:242,605,588...242,622,261 		JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases expression ISO Thimerosal results in increased expression of COX4I1 mRNA CTD PMID:27188386 NCBI chr19:65,630,383...65,636,623
Ensembl chr19:48,721,199...48,727,921 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 multiple interactions
increases expression 		ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA
Thimerosal results in increased expression of CPEB2 mRNA 		CTD PMID:27188386 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:67,787,507...67,840,743 		JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 increases expression ISO Thimerosal results in increased expression of CPEB3 mRNA CTD PMID:16870260 NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:234,751,733...234,931,560 		JBrowse link
G Cpne3 copine 3 decreases expression ISO Thimerosal results in decreased expression of CPNE3 mRNA CTD PMID:27188386 NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934 		JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 decreases expression ISO Thimerosal results in decreased expression of CPS1 mRNA CTD PMID:27188386 NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033 		JBrowse link
G Crcp CGRP receptor component decreases expression ISO Thimerosal results in decreased expression of CRCP mRNA CTD PMID:27188386 NCBI chr12:26,623,968...26,659,756
Ensembl chr12:26,623,976...26,768,225 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 decreases expression ISO Thimerosal results in decreased expression of CREB1 mRNA CTD PMID:24675092 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816 		JBrowse link
G Crip3 cysteine-rich protein 3 decreases expression ISO Thimerosal results in decreased expression of CRIP3 mRNA CTD PMID:24675092 NCBI chr 9:14,554,450...14,557,344
Ensembl chr 9:14,554,450...14,557,302 		JBrowse link
G Cryab crystallin, alpha B increases expression ISO Thimerosal results in increased expression of CRYAB mRNA CTD PMID:16870260 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:51,093,441...51,099,157 		JBrowse link
G Cs citrate synthase decreases expression ISO Thimerosal results in decreased expression of CS mRNA CTD PMID:27188386 NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421 		JBrowse link
G Cspp1 centrosome and spindle pole associated protein 1 increases expression ISO Thimerosal results in increased expression of CSPP1 mRNA CTD PMID:27188386 NCBI chr 5:13,860,072...13,975,299
Ensembl chr 5:9,077,161...9,193,377 		JBrowse link
G Ctdspl2 CTD small phosphatase like 2 increases expression ISO Thimerosal results in increased expression of CTDSPL2 mRNA CTD PMID:27188386 NCBI chr 3:108,915,263...108,970,620
Ensembl chr 3:108,915,280...108,967,227 		JBrowse link
G Ctnna1 catenin alpha 1 decreases expression ISO Thimerosal results in decreased expression of CTNNA1 mRNA CTD PMID:27188386 NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,728,485...26,860,910 		JBrowse link
G Ctxn3 cortexin 3 increases expression ISO Thimerosal results in increased expression of CTXN3 mRNA CTD PMID:27188386 NCBI chr18:50,930,244...50,940,642
Ensembl chr18:50,930,235...50,940,641 		JBrowse link
G Cxhxorf38 similar to human chromosome X open reading frame 38 decreases expression ISO Thimerosal results in decreased expression of CXORF38 mRNA CTD PMID:27188386 NCBI chr  X:10,128,070...10,150,904
Ensembl chr  X:10,129,657...10,150,900 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 decreases expression ISO Thimerosal results in decreased expression of CYB5R3 mRNA CTD PMID:27188386 NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298 		JBrowse link
G Cyb5r4 cytochrome b5 reductase 4 increases expression ISO Thimerosal results in increased expression of CYB5R4 mRNA CTD PMID:27188386 NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832 		JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 increases expression ISO Thimerosal results in increased expression of CYP39A1 mRNA CTD PMID:27188386 NCBI chr 9:24,727,817...24,804,060
Ensembl chr 9:17,230,455...17,306,775 		JBrowse link
G Dact3 dishevelled-binding antagonist of beta-catenin 3 decreases expression ISO Thimerosal results in decreased expression of DACT3 mRNA CTD PMID:27188386 NCBI chr 1:86,674,989...86,686,722
Ensembl chr 1:77,546,900...77,558,630 		JBrowse link
G Dbh dopamine beta-hydroxylase multiple interactions ISO [Thimerosal co-treated with Aluminum Hydroxide] results in increased expression of DBH protein CTD PMID:36411272 NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248 		JBrowse link
G Dbn1 drebrin 1 decreases expression ISO Thimerosal results in decreased expression of DBN1 mRNA CTD PMID:27188386 NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984 		JBrowse link
G Dcaf13 DDB1 and CUL4 associated factor 13 increases expression ISO Thimerosal results in increased expression of DCAF13 mRNA CTD PMID:27188386 NCBI chr 7:70,160,983...70,196,142
Ensembl chr 7:70,160,941...70,196,142 		JBrowse link
G Dcaf16 DDB1 and CUL4 associated factor 16 decreases expression ISO Thimerosal results in decreased expression of DCAF16 mRNA CTD PMID:27188386 NCBI chr14:65,449,631...65,450,015 JBrowse link
G Dcaf4 DDB1 and CUL4 associated factor 4 decreases expression ISO Thimerosal results in decreased expression of DCAF4 mRNA CTD PMID:27188386 NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982 		JBrowse link
G Dcaf7 DDB1 and CUL4 associated factor 7 decreases expression ISO Thimerosal results in decreased expression of DCAF7 mRNA CTD PMID:27188386 NCBI chr10:90,974,095...90,996,275
Ensembl chr10:90,974,095...90,996,275 		JBrowse link
G Dcc DCC netrin 1 receptor increases expression ISO Thimerosal results in increased expression of DCC mRNA CTD PMID:27188386 NCBI chr18:67,144,272...68,248,159
Ensembl chr18:64,873,898...65,972,740 		JBrowse link
G Dcun1d1 defective in cullin neddylation 1 domain containing 1 increases expression ISO Thimerosal results in increased expression of DCUN1D1 mRNA CTD PMID:27188386 NCBI chr 2:118,721,275...118,772,606
Ensembl chr 2:118,721,822...118,772,602 		JBrowse link
G Dcx doublecortin increases expression ISO Thimerosal results in increased expression of DCX mRNA CTD PMID:24675092 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:107,430,767...107,507,476 		JBrowse link
G Ddx39b DExD-box helicase 39B decreases expression ISO Thimerosal results in decreased expression of DDX39B mRNA CTD PMID:27188386 NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996 		JBrowse link
G Ddx6 DEAD-box helicase 6 decreases expression ISO Thimerosal results in decreased expression of DDX6 mRNA CTD PMID:27188386 NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
Ensembl chr 8:44,931,974...44,964,405 		JBrowse link
G Dennd1b DENN domain containing 1B increases expression ISO Thimerosal results in increased expression of DENND1B mRNA CTD PMID:27188386 NCBI chr13:50,545,324...50,772,922
Ensembl chr13:50,545,836...50,770,601 		JBrowse link
G Dexi Dexi homolog decreases expression ISO Thimerosal results in decreased expression of DEXI mRNA CTD PMID:27188386 NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738 		JBrowse link
G Dgat1 diacylglycerol O-acyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of DGAT1 mRNA CTD PMID:27188386 NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:108,218,524...108,234,299 		JBrowse link
G Dhcr24 24-dehydrocholesterol reductase decreases expression ISO Thimerosal results in decreased expression of DHCR24 mRNA CTD PMID:27188386 NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:121,344,575...121,371,137 		JBrowse link
G Dhcr7 7-dehydrocholesterol reductase decreases expression ISO Thimerosal results in decreased expression of DHCR7 mRNA CTD PMID:27188386 NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055 		JBrowse link
G Dhrs1 dehydrogenase/reductase 1 decreases expression ISO Thimerosal results in decreased expression of DHRS1 mRNA CTD PMID:27188386 NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838 		JBrowse link
G Dhx36 DEAH-box helicase 36 increases expression ISO Thimerosal results in increased expression of DHX36 mRNA CTD PMID:27188386 NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572 		JBrowse link
G Dhx9 DExH-box helicase 9 decreases expression ISO Thimerosal results in decreased expression of DHX9 mRNA CTD PMID:27188386 NCBI chr13:68,152,813...68,189,580
Ensembl chr13:65,602,323...65,639,069 		JBrowse link
G Dkkl1 dickkopf like acrosomal protein 1 decreases expression ISO Thimerosal results in decreased expression of DKKL1 mRNA CTD PMID:24675092 NCBI chr 1:95,694,010...95,699,259
Ensembl chr 1:95,694,010...95,699,259 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 decreases expression ISO Thimerosal results in decreased expression of DLG1 mRNA CTD PMID:27188386 NCBI chr11:82,416,853...82,607,797
Ensembl chr11:68,911,883...69,102,689 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression ISO Thimerosal results in increased expression of DNAJB1 mRNA CTD PMID:16870260 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:24,522,717...24,526,458 		JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 increases expression ISO Thimerosal results in increased expression of DNAJB4 mRNA CTD PMID:16870260 NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089 		JBrowse link
G Dnajc13 DnaJ heat shock protein family (Hsp40) member C13 decreases expression ISO Thimerosal results in decreased expression of DNAJC13 mRNA CTD PMID:27188386 NCBI chr 8:113,646,573...113,756,104
Ensembl chr 8:104,767,788...104,877,317 		JBrowse link
G Dnajc4 DnaJ heat shock protein family (Hsp40) member C4 decreases expression ISO Thimerosal results in decreased expression of DNAJC4 mRNA CTD PMID:27188386 NCBI chr 1:204,178,189...204,182,412
Ensembl chr 1:204,178,191...204,182,387 		JBrowse link
G Dnase1 deoxyribonuclease 1 decreases expression ISO Thimerosal results in decreased expression of DNASE1 mRNA CTD PMID:27188386 NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha decreases expression ISO Thimerosal results in decreased expression of DNMT3A mRNA CTD PMID:27188386 NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687 		JBrowse link
G Dock11 dedicator of cytokinesis 11 decreases expression ISO Thimerosal results in decreased expression of DOCK11 mRNA CTD PMID:27188386 NCBI chr  X:119,997,523...120,180,643
Ensembl chr  X:115,131,909...115,314,854 		JBrowse link
G Dock4 dedicator of cytokinesis 4 increases expression ISO Thimerosal results in increased expression of DOCK4 mRNA CTD PMID:27188386 NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855 		JBrowse link
G Dock6 dedicator of cytokinesis 6 decreases expression ISO Thimerosal results in decreased expression of DOCK6 mRNA CTD PMID:27188386 NCBI chr 8:28,618,523...28,670,741
Ensembl chr 8:20,342,089...20,394,552 		JBrowse link
G Dst dystonin affects expression ISO Thimerosal affects the expression of DST mRNA CTD PMID:27188386 NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Thimerosal results in increased expression of DUSP1 mRNA CTD PMID:16870260 NCBI chr10:17,184,853...17,187,646 JBrowse link
G Dusp7 dual specificity phosphatase 7 decreases expression ISO Thimerosal results in decreased expression of DUSP7 mRNA CTD PMID:27188386 NCBI chr 8:115,888,091...115,895,126
Ensembl chr 8:107,008,528...107,016,404 		JBrowse link
G Dynlt2b dynein light chain Tctex-type 2B increases expression ISO Thimerosal results in increased expression of DYNLT2B mRNA CTD PMID:27188386 NCBI chr11:68,359,138...68,367,573
Ensembl chr11:68,358,263...68,367,499 		JBrowse link
G Echdc2 enoyl CoA hydratase domain containing 2 decreases expression ISO Thimerosal results in decreased expression of ECHDC2 mRNA CTD PMID:27188386 NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:122,916,134...122,934,859 		JBrowse link
G Ecrg4 ECRG4 augurin precursor decreases expression ISO Thimerosal results in decreased expression of ECRG4 mRNA CTD PMID:27188386 NCBI chr 9:45,992,954...46,012,605
Ensembl chr 9:45,992,954...46,012,595 		JBrowse link
G Ednrb endothelin receptor type B decreases expression ISO Thimerosal results in decreased expression of EDNRB mRNA CTD PMID:27188386 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115 		JBrowse link
G Eea1 early endosome antigen 1 decreases expression ISO Thimerosal results in decreased expression of EEA1 mRNA CTD PMID:27188386 NCBI chr 7:30,554,686...30,722,186
Ensembl chr 7:30,554,552...30,718,487 		JBrowse link
G Eef1a2 eukaryotic translation elongation factor 1 alpha 2 decreases expression ISO Thimerosal results in decreased expression of EEF1A2 mRNA CTD PMID:27188386 NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071 		JBrowse link
G Eef1akmt3 EEF1A lysine methyltransferase 3 decreases expression ISO Thimerosal results in decreased expression of EEF1AKMT3 mRNA CTD PMID:27188386 NCBI chr 7:62,853,304...62,864,558
Ensembl chr 7:62,854,899...62,864,617 		JBrowse link
G Efcab14 EF-hand calcium binding domain 14 decreases expression ISO Thimerosal results in decreased expression of EFCAB14 mRNA CTD PMID:27188386 NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625 		JBrowse link
G Egfl7 EGF-like-domain, multiple 7 decreases expression ISO Thimerosal results in decreased expression of EGFL7 mRNA CTD PMID:24675092 PMID:27188386 NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879 		JBrowse link
G Egln1 egl-9 family hypoxia-inducible factor 1 decreases expression ISO Thimerosal results in decreased expression of EGLN1 mRNA CTD PMID:27188386 NCBI chr19:69,765,276...69,804,681
Ensembl chr19:52,869,486...52,907,777 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 decreases expression ISO Thimerosal results in decreased expression of EGLN3 mRNA CTD PMID:27188386 NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:71,650,297...71,675,766 		JBrowse link
G Ehbp1 EH domain binding protein 1 decreases expression ISO Thimerosal results in decreased expression of EHBP1 mRNA CTD PMID:27188386 NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332 		JBrowse link
G Ehd4 EH-domain containing 4 decreases expression ISO Thimerosal results in decreased expression of EHD4 mRNA CTD PMID:27188386 NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:107,058,958...107,122,002 		JBrowse link
G Ehmt1 euchromatic histone lysine methyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of EHMT1 mRNA CTD PMID:27188386 NCBI chr 3:7,580,680...7,729,046
Ensembl chr 3:7,580,683...7,729,007 		JBrowse link
G Eif3f eukaryotic translation initiation factor 3, subunit F decreases expression ISO Thimerosal results in decreased expression of EIF3F mRNA CTD PMID:27188386 NCBI chr 1:162,934,220...162,943,204
Ensembl chr 1:162,934,212...162,943,204 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B decreases expression ISO Thimerosal results in decreased expression of EIF4B mRNA CTD PMID:27188386 NCBI chr 7:133,206,637...133,228,436 JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 decreases expression ISO Thimerosal results in decreased expression of EIF4G1 mRNA CTD PMID:27188386 NCBI chr11:93,726,322...93,746,387
Ensembl chr11:80,221,919...80,241,941 		JBrowse link
G Eif5a2 eukaryotic translation initiation factor 5A2 decreases expression ISO Thimerosal results in decreased expression of EIF5A2 mRNA CTD PMID:27188386 NCBI chr 2:113,656,748...113,674,598
Ensembl chr 2:111,729,323...111,746,087 		JBrowse link
G Elac1 elaC ribonuclease Z 1 increases expression ISO Thimerosal results in increased expression of ELAC1 mRNA CTD PMID:27188386 NCBI chr18:67,321,231...67,341,358
Ensembl chr18:67,323,583...67,340,936 		JBrowse link
G Elmo1 engulfment and cell motility 1 decreases expression ISO Thimerosal results in decreased expression of ELMO1 mRNA CTD PMID:27188386 NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788 		JBrowse link
G Eloa elongin A decreases expression ISO Thimerosal results in decreased expression of ELOA mRNA CTD PMID:27188386 NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:148,231,596...148,246,765 		JBrowse link
G Eml5 EMAP like 5 increases expression ISO Thimerosal results in increased expression of EML5 mRNA CTD PMID:27188386 NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831 		JBrowse link
G Eno1 enolase 1 decreases expression ISO Thimerosal results in decreased expression of ENO1 mRNA CTD PMID:27188386 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 5:160,719,951...160,731,336
Ensembl chr 3:160,719,951...160,731,336 		JBrowse link
G Eno2 enolase 2 decreases expression ISO Thimerosal results in decreased expression of ENO2 mRNA CTD PMID:27188386 NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:157,572,088...157,580,980 		JBrowse link
G Eno3 enolase 3 decreases expression ISO Thimerosal results in decreased expression of ENO3 mRNA CTD PMID:27188386 NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,366,975...55,375,921 		JBrowse link
G Enpp5 ectonucleotide pyrophosphatase/phosphodiesterase family member 5 decreases expression ISO Thimerosal results in decreased expression of ENPP5 mRNA CTD PMID:27188386 NCBI chr 9:16,910,187...16,917,633
Ensembl chr 9:16,910,831...16,917,480 		JBrowse link
G Ep400 E1A binding protein p400 decreases expression ISO Thimerosal results in decreased expression of EP400 mRNA CTD PMID:27188386 NCBI chr12:51,551,665...51,658,635
Ensembl chr12:45,891,916...45,998,861 		JBrowse link
G Epb41l1 erythrocyte membrane protein band 4.1-like 1 decreases expression ISO Thimerosal results in decreased expression of EPB41L1 mRNA CTD PMID:27188386 NCBI chr 3:144,929,195...145,052,723
Ensembl chr 3:144,984,640...145,052,721 		JBrowse link
G Epb41l4a erythrocyte membrane protein band 4.1 like 4A decreases expression ISO Thimerosal results in decreased expression of EPB41L4A mRNA CTD PMID:27188386 NCBI chr18:25,405,461...25,615,392
Ensembl chr18:25,406,057...25,615,149 		JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 decreases expression ISO Thimerosal results in decreased expression of EPB41L5 mRNA CTD PMID:27188386 NCBI chr13:33,221,705...33,321,400
Ensembl chr13:30,669,764...30,768,360 		JBrowse link
G Epc1 enhancer of polycomb homolog 1 increases expression ISO Thimerosal results in increased expression of EPC1 mRNA CTD PMID:27188386 NCBI chr17:54,503,358...54,594,444
Ensembl chr17:54,503,358...54,594,425 		JBrowse link
G Epcam epithelial cell adhesion molecule increases expression ISO Thimerosal results in increased expression of EPCAM mRNA CTD PMID:24675092 NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127 		JBrowse link
G Epop elongin BC and polycomb repressive complex 2 associated protein decreases expression ISO Thimerosal results in decreased expression of EPOP mRNA CTD PMID:27188386 NCBI chr10:82,624,392...82,625,912
Ensembl chr10:82,624,392...82,625,912 		JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 decreases expression ISO Thimerosal results in decreased expression of EPRS1 mRNA CTD PMID:27188386 NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966 		JBrowse link
G Erc1 ELKS/RAB6-interacting/CAST family member 1 decreases expression ISO Thimerosal results in decreased expression of ERC1 mRNA CTD PMID:27188386 NCBI chr 4:152,763,664...153,055,724
Ensembl chr 4:152,767,419...153,055,639 		JBrowse link
G Ercc2 ERCC excision repair 2, TFIIH core complex helicase subunit decreases expression ISO Thimerosal results in decreased expression of ERCC2 mRNA CTD PMID:27188386 NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102 		JBrowse link
G Ergic1 endoplasmic reticulum-golgi intermediate compartment 1 decreases expression ISO Thimerosal results in decreased expression of ERGIC1 mRNA CTD PMID:27188386 NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957 		JBrowse link
G Ergic2 ERGIC and golgi 2 increases expression ISO Thimerosal results in increased expression of ERGIC2 mRNA CTD PMID:27188386 NCBI chr 4:181,090,808...181,123,074
Ensembl chr 4:181,090,808...181,123,060 		JBrowse link
G Esco1 establishment of sister chromatid cohesion N-acetyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of ESCO1 mRNA CTD PMID:27188386 NCBI chr18:1,630,560...1,686,803
Ensembl chr18:1,631,954...1,686,942 		JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 decreases expression ISO Thimerosal results in decreased expression of ESCO2 mRNA CTD PMID:27188386 NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
Ensembl chr15:40,034,568...40,055,306 		JBrowse link
G Esf1 ESF1 nucleolar pre-rRNA processing protein homolog increases expression ISO Thimerosal results in increased expression of ESF1 mRNA CTD PMID:27188386 NCBI chr 3:127,454,744...127,507,941
Ensembl chr 3:127,454,811...127,507,817 		JBrowse link
G Etnk1 ethanolamine kinase 1 increases expression ISO Thimerosal results in increased expression of ETNK1 mRNA CTD PMID:27188386 NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770 		JBrowse link
G Evc2 EvC ciliary complex subunit 2 decreases expression ISO Thimerosal results in decreased expression of EVC2 mRNA CTD PMID:27188386 NCBI chr14:73,366,832...73,454,539
Ensembl chr14:73,367,963...73,454,516 		JBrowse link
G Evi5 ecotropic viral integration site 5 decreases expression ISO Thimerosal results in decreased expression of EVI5 mRNA CTD PMID:27188386 NCBI chr14:2,020,524...2,166,593
Ensembl chr14:1,875,647...2,021,678 		JBrowse link
G Exoc6 exocyst complex component 6 increases expression ISO Thimerosal results in increased expression of EXOC6 mRNA CTD PMID:27188386 NCBI chr 1:244,727,084...244,870,263
Ensembl chr 1:235,300,369...235,457,015 		JBrowse link
G F12 coagulation factor XII decreases expression ISO Thimerosal results in decreased expression of F12 mRNA CTD PMID:27188386 NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530 		JBrowse link
G Fabp7 fatty acid binding protein 7 increases expression ISO Thimerosal results in increased expression of FABP7 mRNA CTD PMID:24675092 NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880 		JBrowse link
G Fads1 fatty acid desaturase 1 decreases expression ISO Thimerosal results in decreased expression of FADS1 mRNA CTD PMID:27188386 NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:206,827,765...206,842,734 		JBrowse link
G Fads2 fatty acid desaturase 2 decreases expression ISO Thimerosal results in decreased expression of FADS2 mRNA CTD PMID:27188386 NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:206,708,783...206,748,789 		JBrowse link
G Faf2 Fas associated factor family member 2 decreases expression ISO Thimerosal results in decreased expression of FAF2 mRNA CTD PMID:27188386 NCBI chr17:9,952,329...9,994,596
Ensembl chr17:9,947,220...9,989,485 		JBrowse link
G Fah fumarylacetoacetate hydrolase decreases expression ISO Thimerosal results in decreased expression of FAH mRNA CTD PMID:27188386 NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:138,548,834...138,571,505 		JBrowse link
G Fam124b family with sequence similarity 124 member B decreases expression ISO Thimerosal results in decreased expression of FAM124B mRNA CTD PMID:27188386 NCBI chr 9:81,513,018...81,533,621
Ensembl chr 9:81,515,399...81,533,341 		JBrowse link
G Fam135a family with sequence similarity 135, member A affects expression ISO Thimerosal affects the expression of FAM135A mRNA CTD PMID:27188386 NCBI chr 9:26,420,116...26,500,803
Ensembl chr 9:26,420,528...26,500,717 		JBrowse link
G Fam149a family with sequence similarity 149, member A decreases expression ISO Thimerosal results in decreased expression of FAM149A mRNA CTD PMID:27188386 NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066 		JBrowse link
G Fam162a family with sequence similarity 162, member A decreases expression ISO Thimerosal results in decreased expression of FAM162A mRNA CTD PMID:27188386 NCBI chr11:64,680,978...64,709,865
Ensembl chr11:64,680,323...64,711,239 		JBrowse link
G Fam168b family with sequence similarity 168, member B decreases expression ISO Thimerosal results in decreased expression of FAM168B mRNA CTD PMID:27188386 NCBI chr 9:37,005,569...37,038,631
Ensembl chr 9:37,006,689...37,033,723 		JBrowse link
G Fam234b family with sequence similarity 234, member B decreases expression ISO Thimerosal results in decreased expression of FAM234B mRNA CTD PMID:27188386 NCBI chr 4:168,048,313...168,124,017
Ensembl chr 4:168,048,396...168,097,338 		JBrowse link
G Fam3c FAM3 metabolism regulating signaling molecule C increases expression ISO Thimerosal results in increased expression of FAM3C mRNA CTD PMID:27188386 NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078 		JBrowse link
G Fam76b family with sequence similarity 76, member B increases expression ISO Thimerosal results in increased expression of FAM76B mRNA CTD PMID:24675092 NCBI chr 8:10,689,396...10,711,847
Ensembl chr 8:10,688,963...10,711,861 		JBrowse link
G Fam81b family with sequence similarity 81, member B increases expression ISO Thimerosal results in increased expression of FAM81B mRNA CTD PMID:27188386 NCBI chr 2:5,750,678...5,870,580
Ensembl chr 2:5,771,240...5,879,440 		JBrowse link
G Fancf FA complementation group F decreases expression ISO Thimerosal results in decreased expression of FANCF mRNA CTD PMID:16870260 NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923 		JBrowse link
G Fas Fas cell surface death receptor increases expression ISO Thimerosal results in increased expression of FAS mRNA CTD PMID:27188386 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591 		JBrowse link
G Fasn fatty acid synthase decreases expression ISO Thimerosal results in decreased expression of FASN mRNA CTD PMID:27188386 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261 		JBrowse link
G Fastkd2 FAST kinase domains 2 increases expression ISO Thimerosal results in increased expression of FASTKD2 mRNA CTD PMID:27188386 NCBI chr 9:65,166,148...65,188,184
Ensembl chr 9:65,168,228...65,188,174 		JBrowse link
G Fbln2 fibulin 2 decreases expression ISO Thimerosal results in decreased expression of FBLN2 mRNA CTD PMID:27188386 NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948 		JBrowse link
G Fbn1 fibrillin 1 decreases expression ISO Thimerosal results in decreased expression of FBN1 mRNA CTD PMID:27188386 NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:112,554,925...112,750,889 		JBrowse link
G Fbxo3 F-box protein 3 increases expression ISO Thimerosal results in increased expression of FBXO3 mRNA CTD PMID:27188386 NCBI chr 3:90,417,262...90,449,557
Ensembl chr 3:90,417,297...90,449,557 		JBrowse link
G Fbxo7 F-box protein 7 decreases expression ISO Thimerosal results in decreased expression of FBXO7 mRNA CTD PMID:27188386 NCBI chr 7:19,696,951...19,725,180
Ensembl chr 7:17,809,231...17,837,530 		JBrowse link
G Fbxo9 f-box protein 9 increases expression ISO Thimerosal results in increased expression of FBXO9 mRNA CTD PMID:27188386 NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949 		JBrowse link
G Fer FER tyrosine kinase increases expression ISO Thimerosal results in increased expression of FER mRNA CTD PMID:27188386 NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:103,520,493...103,821,451 		JBrowse link
G Fer1l4 fer-1-like family member 4 decreases expression ISO Thimerosal results in decreased expression of FER1L4 mRNA CTD PMID:27188386 NCBI chr 3:144,536,099...144,571,634
Ensembl chr 3:144,536,099...144,571,634 		JBrowse link
G Fgd6 FYVE, RhoGEF and PH domain containing 6 increases expression ISO Thimerosal results in increased expression of FGD6 mRNA CTD PMID:27188386 NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456 		JBrowse link
G Fgf11 fibroblast growth factor 11 decreases expression ISO Thimerosal results in decreased expression of FGF11 mRNA CTD PMID:27188386 NCBI chr10:55,015,232...55,020,773
Ensembl chr10:54,517,077...54,522,062 		JBrowse link
G Fgfbp3 fibroblast growth factor binding protein 3 decreases expression ISO Thimerosal results in decreased expression of FGFBP3 mRNA CTD PMID:27188386 NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:234,644,019...234,646,547 		JBrowse link
G Fgfr1op2 FGFR1 oncogene partner 2 increases expression ISO Thimerosal results in increased expression of FGFR1OP2 mRNA CTD PMID:27188386 NCBI chr 4:179,491,602...179,512,630
Ensembl chr 4:179,491,599...179,512,630 		JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 decreases expression ISO Thimerosal results in decreased expression of FGFR2 mRNA CTD PMID:27188386 NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626 		JBrowse link
G Fkbp10 FKBP prolyl isomerase 10 decreases expression ISO Thimerosal results in decreased expression of FKBP10 mRNA CTD PMID:27188386 NCBI chr10:85,345,434...85,357,998
Ensembl chr10:85,346,126...85,427,330 		JBrowse link
G Flcn folliculin multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA CTD PMID:27188386 NCBI chr10:45,088,164...45,107,581
Ensembl chr10:44,588,624...44,607,769 		JBrowse link
G Fmnl2 formin-like 2 decreases expression ISO Thimerosal results in decreased expression of FMNL2 mRNA CTD PMID:27188386 NCBI chr 3:37,348,791...37,624,746
Ensembl chr 3:37,348,574...37,624,754 		JBrowse link
G Fn1 fibronectin 1 increases secretion ISO Thimerosal results in increased secretion of FN1 protein CTD PMID:24942245 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678 		JBrowse link
G Fnbp4 formin binding protein 4 decreases expression ISO Thimerosal results in decreased expression of FNBP4 mRNA CTD PMID:27188386 NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079 		JBrowse link
G Fndc10 fibronectin type III domain containing 10 decreases expression ISO Thimerosal results in decreased expression of FNDC10 mRNA CTD PMID:27188386 NCBI chr 5:171,581,960...171,584,519
Ensembl chr 5:166,300,122...166,310,326 		JBrowse link
G Fndc11 fibronectin type III domain containing 11 decreases expression ISO Thimerosal results in decreased expression of FNDC11 mRNA CTD PMID:27188386 NCBI chr 3:168,330,607...168,333,111
Ensembl chr 3:168,330,602...168,334,617 		JBrowse link
G Fndc4 fibronectin type III domain containing 4 decreases expression ISO Thimerosal results in decreased expression of FNDC4 mRNA CTD PMID:27188386 NCBI chr 6:30,797,102...30,800,782
Ensembl chr 6:25,077,349...25,080,675 		JBrowse link
G Folr1 folate receptor alpha decreases expression ISO Thimerosal results in decreased expression of FOLR1 mRNA CTD PMID:24675092 NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Thimerosal results in increased expression of FOS mRNA CTD PMID:16870260 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit increases expression ISO Thimerosal results in increased expression of FOSB mRNA CTD PMID:16870260 NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465 		JBrowse link
G Foxc1 forkhead box C1 decreases expression ISO Thimerosal results in decreased expression of FOXC1 mRNA CTD PMID:27188386 NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803 		JBrowse link
G Foxp2 forkhead box P2 increases expression ISO Thimerosal results in increased expression of FOXP2 mRNA CTD PMID:27188386 NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683 		JBrowse link
G Fra10ac1 FRA10A associated CGG repeat 1 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA CTD PMID:27188386 NCBI chr 1:235,969,071...236,001,074
Ensembl chr 1:235,969,112...236,001,210 		JBrowse link
G Frmd7 FERM domain containing 7 increases expression ISO Thimerosal results in increased expression of FRMD7 mRNA CTD PMID:24675092 NCBI chr  X:130,375,925...130,423,836
Ensembl chr  X:130,377,227...130,423,771 		JBrowse link
G Frmpd3 FERM and PDZ domain containing 3 increases expression ISO Thimerosal results in increased expression of FRMPD3 mRNA CTD PMID:24675092 NCBI chr  X:103,964,168...104,113,864
Ensembl chr  X:104,043,194...104,111,968 		JBrowse link
G Frs2 fibroblast growth factor receptor substrate 2 increases expression ISO Thimerosal results in increased expression of FRS2 mRNA CTD PMID:27188386 NCBI chr 7:52,711,255...52,792,738
Ensembl chr 7:52,711,257...52,792,743 		JBrowse link
G Fshb follicle stimulating hormone subunit beta increases expression ISO Thimerosal results in increased expression of FSHB mRNA; Thimerosal results in increased expression of FSHB protein CTD PMID:24675092 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370 		JBrowse link
G Fsip2 fibrous sheath-interacting protein 2 increases expression ISO Thimerosal results in increased expression of FSIP2 mRNA CTD PMID:27188386 NCBI chr 3:67,962,345...68,032,866
Ensembl chr 3:67,962,360...68,032,868 		JBrowse link
G Fut1 fucosyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of FUT1 mRNA CTD PMID:27188386 NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:96,086,635...96,090,616 		JBrowse link
G Fut11 fucosyltransferase 11 decreases expression ISO Thimerosal results in decreased expression of FUT11 mRNA CTD PMID:27188386 NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356 		JBrowse link
G Fxyd6 FXYD domain-containing ion transport regulator 6 decreases expression ISO Thimerosal results in decreased expression of FXYD6 mRNA CTD PMID:27188386 NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958 		JBrowse link
G Fzd2 frizzled class receptor 2 decreases expression ISO Thimerosal results in decreased expression of FZD2 mRNA CTD PMID:27188386 NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334 		JBrowse link
G Fzd7 frizzled class receptor 7 decreases expression ISO Thimerosal results in decreased expression of FZD7 mRNA CTD PMID:27188386 NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:60,930,875...60,935,781 		JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 affects expression ISO Thimerosal affects the expression of G3BP1 mRNA CTD PMID:27188386 NCBI chr10:40,087,533...40,120,931
Ensembl chr10:39,586,864...39,620,268 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase decreases expression ISO Thimerosal results in decreased expression of G6PD mRNA CTD PMID:27188386 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:152,201,098...152,220,801 		JBrowse link
G Gabra1 gamma-aminobutyric acid type A receptor subunit alpha 1 increases expression ISO Thimerosal results in increased expression of GABRA1 mRNA CTD PMID:27188386 NCBI chr10:27,096,731...27,152,563
Ensembl chr10:26,595,160...26,650,864 		JBrowse link
G Gabrr1 gamma-aminobutyric acid type A receptor subunit rho 1 increases expression ISO Thimerosal results in increased expression of GABRR1 mRNA CTD PMID:27188386 NCBI chr 5:47,524,151...47,561,228
Ensembl chr 5:47,524,151...47,561,228 		JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma increases expression ISO Thimerosal results in increased expression of GADD45G mRNA CTD PMID:16870260 NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,376,839...13,378,610 		JBrowse link
G Gapvd1 GTPase activating protein and VPS9 domains 1 decreases expression ISO Thimerosal results in decreased expression of GAPVD1 mRNA CTD PMID:27188386 NCBI chr 3:17,968,345...18,041,888
Ensembl chr 3:17,969,599...18,055,218 		JBrowse link
G Garem1 GRB2 associated regulator of MAPK1 subtype 1 decreases expression ISO Thimerosal results in decreased expression of GAREM1 mRNA CTD PMID:27188386 NCBI chr18:12,420,169...12,585,323
Ensembl chr18:12,423,882...12,585,345 		JBrowse link
G Garem2 GRB2 associated regulator of MAPK1 subtype 2 decreases expression ISO Thimerosal results in decreased expression of GAREM2 mRNA CTD PMID:27188386 NCBI chr 6:26,228,965...26,255,576
Ensembl chr 6:26,230,048...26,241,762 		JBrowse link
G Gas2l1 growth arrest-specific 2 like 1 decreases expression ISO Thimerosal results in decreased expression of GAS2L1 mRNA CTD PMID:27188386 NCBI chr14:84,169,398...84,175,514
Ensembl chr14:79,950,555...79,961,438 		JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression ISO Thimerosal results in decreased expression of GBE1 mRNA CTD PMID:27188386 NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210 		JBrowse link
G Gemin4 gem (nuclear organelle) associated protein 4 decreases expression ISO Thimerosal results in decreased expression of GEMIN4 mRNA CTD PMID:16870260 NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,066,425...61,073,431
Ensembl chr10:61,066,425...61,073,431 		JBrowse link
G Gfm1 G elongation factor, mitochondrial 1 increases expression ISO Thimerosal results in increased expression of GFM1 mRNA CTD PMID:27188386 NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471 		JBrowse link
G Gh1 growth hormone 1 increases expression ISO Thimerosal results in increased expression of GH mRNA CTD PMID:24675092 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,228,103...91,230,078 		JBrowse link
G Ghrhr growth hormone releasing hormone receptor increases expression ISO Thimerosal results in increased expression of GHRHR mRNA CTD PMID:24675092 NCBI chr 4:85,830,345...85,863,127
Ensembl chr 4:84,500,212...84,532,776 		JBrowse link
G Gigyf1 GRB10 interacting GYF protein 1 increases expression ISO Thimerosal results in increased expression of GIGYF1 mRNA CTD PMID:27188386 NCBI chr12:19,166,070...19,181,570
Ensembl chr12:19,166,088...19,175,023 		JBrowse link
G Gin1 gypsy retrotransposon integrase 1 increases expression ISO Thimerosal results in increased expression of GIN1 mRNA CTD PMID:27188386 NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848 		JBrowse link
G Git2 GIT ArfGAP 2 decreases expression ISO Thimerosal results in decreased expression of GIT2 mRNA CTD PMID:27188386 NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097 		JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression ISO Thimerosal results in decreased expression of GJA4 mRNA CTD PMID:27188386 NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:139,633,287...139,635,925 		JBrowse link
G Glmp glycosylated lysosomal membrane protein decreases expression ISO Thimerosal results in decreased expression of GLMP mRNA CTD PMID:27188386 NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960 		JBrowse link
G Gls glutaminase increases expression ISO Thimerosal results in increased expression of GLS mRNA CTD PMID:27188386 NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:49,344,781...49,416,900 		JBrowse link
G Gm2a ganglioside GM2 activator decreases expression ISO Thimerosal results in decreased expression of GM2A mRNA CTD PMID:27188386 NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757 		JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase decreases expression ISO Thimerosal results in decreased expression of GMDS mRNA CTD PMID:27188386 NCBI chr17:32,304,029...32,830,708
Ensembl chr17:32,095,386...32,621,961 		JBrowse link
G Gnal G protein subunit alpha L decreases expression ISO Thimerosal results in decreased expression of GNAL mRNA CTD PMID:27188386 NCBI chr18:60,622,311...60,762,599
Ensembl chr18:60,622,311...60,762,599 		JBrowse link
G Gnb1 G protein subunit beta 1 decreases expression ISO Thimerosal results in decreased expression of GNB1 mRNA CTD PMID:27188386 NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:166,075,629...166,142,124 		JBrowse link
G Gng4 G protein subunit gamma 4 increases expression ISO Thimerosal results in increased expression of GNG4 mRNA CTD PMID:24675092 NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254 		JBrowse link
G Gng7 G protein subunit gamma 7 decreases expression ISO Thimerosal results in decreased expression of GNG7 mRNA CTD PMID:27188386 NCBI chr 7:9,348,148...9,411,924
Ensembl chr 7:8,697,521...8,761,240 		JBrowse link
G Gnrhr gonadotropin releasing hormone receptor increases expression ISO Thimerosal results in increased expression of GNRHR mRNA CTD PMID:24675092 NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861 		JBrowse link
G Gon4l gon-4 like decreases expression ISO Thimerosal results in decreased expression of GON4L mRNA CTD PMID:27188386 NCBI chr 2:176,531,274...176,604,446
Ensembl chr 2:174,233,461...174,306,634 		JBrowse link
G Gpcpd1 glycerophosphocholine phosphodiesterase 1 increases expression ISO Thimerosal results in increased expression of GPCPD1 mRNA CTD PMID:27188386 NCBI chr 3:140,240,574...140,285,469
Ensembl chr 3:119,787,682...119,832,517 		JBrowse link
G Gpi glucose-6-phosphate isomerase decreases expression ISO Thimerosal results in decreased expression of GPI mRNA CTD PMID:27188386 NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086 		JBrowse link
G Gpr135 G protein-coupled receptor 135 decreases expression ISO Thimerosal results in decreased expression of GPR135 mRNA CTD PMID:27188386 NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551 		JBrowse link
G Gpr22 G protein-coupled receptor 22 increases expression ISO Thimerosal results in increased expression of GPR22 mRNA CTD PMID:27188386 NCBI chr 6:48,309,619...48,317,864
Ensembl chr 6:48,310,505...48,317,486 		JBrowse link
G Grem2 gremlin 2, DAN family BMP antagonist decreases expression ISO Thimerosal results in decreased expression of GREM2 mRNA CTD PMID:27188386 NCBI chr13:89,310,897...89,403,856
Ensembl chr13:86,778,500...86,871,615 		JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 increases expression ISO Thimerosal results in increased expression of GRIK2 mRNA CTD PMID:27188386 NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375 		JBrowse link
G Grik5 glutamate ionotropic receptor kainate type subunit 5 affects expression ISO Thimerosal affects the expression of GRIK5 protein CTD PMID:15184908 NCBI chr 1:89,733,736...89,795,769
Ensembl chr 1:80,605,892...80,667,125 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 decreases expression ISO Thimerosal results in decreased expression of GRIN1 protein CTD PMID:15184908 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B decreases expression ISO Thimerosal results in decreased expression of GRIN2B protein CTD PMID:15184908 NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279 		JBrowse link
G Grk3 G protein-coupled receptor kinase 3 decreases expression ISO Thimerosal results in decreased expression of GRK3 mRNA CTD PMID:27188386 NCBI chr12:49,285,228...49,395,803
Ensembl chr12:43,624,897...43,731,262 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 affects response to substance ISO GSTM1 affects the susceptibility to Thimerosal CTD PMID:11007341 NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 decreases expression ISO Thimerosal results in decreased expression of GSTM2 mRNA CTD PMID:27188386 NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 affects response to substance
decreases expression 		ISO GSTT1 affects the susceptibility to Thimerosal
Thimerosal results in decreased expression of GSTT1 mRNA 		CTD PMID:11007341 PMID:27188386 NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585 		JBrowse link
G Gtf2a1 general transcription factor 2A subunit 1 decreases expression ISO Thimerosal results in decreased expression of GTF2A1 mRNA CTD PMID:27188386 NCBI chr 6:110,488,891...110,521,502
Ensembl chr 6:110,488,931...110,521,511 		JBrowse link
G Gtf2b general transcription factor IIB increases expression ISO Thimerosal results in increased expression of GTF2B mRNA CTD PMID:27188386 NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651 		JBrowse link
G Gtf2f1 general transcription factor IIF subunit 1 decreases expression ISO Thimerosal results in decreased expression of GTF2F1 mRNA CTD PMID:27188386 NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423 		JBrowse link
G Guca1a guanylate cyclase activator 1A decreases expression ISO Thimerosal results in decreased expression of GUCA1A mRNA CTD PMID:27188386 NCBI chr 9:13,588,988...13,598,566
Ensembl chr 9:13,588,525...13,598,565 		JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 increases expression ISO Thimerosal results in increased expression of GULP1 mRNA CTD PMID:27188386 NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005 		JBrowse link
G Gxylt1 glucoside xylosyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of GXYLT1 mRNA CTD PMID:27188386 NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699 		JBrowse link
G H1f0 H1.0 linker histone decreases expression ISO Thimerosal results in decreased expression of H1-0 mRNA CTD PMID:27188386 NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:110,592,208...110,594,694 		JBrowse link
G H1f10 H1.10 linker histone decreases expression ISO Thimerosal results in decreased expression of H1-10 mRNA CTD PMID:27188386 NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448 		JBrowse link
G H1f4 H1.4 linker histone, cluster member decreases expression ISO Thimerosal results in decreased expression of H1-4 mRNA CTD PMID:27188386 NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403 		JBrowse link
G H4f3 H1.3 linker histone, cluster member decreases expression ISO Thimerosal results in decreased expression of H1-3 mRNA CTD PMID:27188386 NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334 		JBrowse link
G Hacd2 3-hydroxyacyl-CoA dehydratase 2 decreases expression ISO Thimerosal results in decreased expression of HACD2 mRNA CTD PMID:27188386 NCBI chr11:79,175,470...79,268,975
Ensembl chr11:65,670,281...65,762,889 		JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha decreases expression ISO Thimerosal results in decreased expression of HADHA mRNA CTD PMID:27188386 NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:26,187,956...26,227,869 		JBrowse link
G Hat1 histone acetyltransferase 1 increases expression ISO Thimerosal results in increased expression of HAT1 mRNA CTD PMID:27188386 NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO Thimerosal results in increased expression of HBEGF mRNA CTD PMID:16870260 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,105,760...28,116,441 		JBrowse link
G Hbs1l HBS1-like translational GTPase increases expression ISO Thimerosal results in increased expression of HBS1L mRNA CTD PMID:27188386 NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:16,092,547...16,170,074 		JBrowse link
G Hcfc1r1 host cell factor C1 regulator 1 decreases expression ISO Thimerosal results in decreased expression of HCFC1R1 mRNA CTD PMID:27188386 NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850 		JBrowse link
G Hdac4 histone deacetylase 4 multiple interactions
increases expression 		ISO
EXP 		MC1568 inhibits the reaction [Thimerosal results in increased expression of HDAC4 protein] CTD PMID:27660204 NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164 		JBrowse link
G Hdx highly divergent homeobox increases expression ISO Thimerosal results in increased expression of HDX mRNA CTD PMID:27188386 NCBI chr  X:76,552,539...76,697,177
Ensembl chr  X:76,560,665...76,869,972 		JBrowse link
G Heatr1 HEAT repeat containing 1 decreases expression ISO Thimerosal results in decreased expression of HEATR1 mRNA CTD PMID:27188386 NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948 		JBrowse link
G Hebp1 heme binding protein 1 decreases expression ISO Thimerosal results in decreased expression of HEBP1 mRNA CTD PMID:27188386 NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854 		JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 decreases expression ISO Thimerosal results in decreased expression of HECTD1 mRNA CTD PMID:27188386 NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:69,181,436...69,268,053 		JBrowse link
G Hectd2 HECT domain E3 ubiquitin protein ligase 2 increases expression ISO Thimerosal results in increased expression of HECTD2 mRNA CTD PMID:27188386 NCBI chr 1:234,274,967...234,345,598
Ensembl chr 1:234,275,705...234,343,487 		JBrowse link
G Hecw1 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 increases expression ISO Thimerosal results in increased expression of HECW1 mRNA CTD PMID:27188386 NCBI chr17:50,671,239...51,084,536
Ensembl chr17:50,670,954...51,080,720 		JBrowse link
G Hells helicase, lymphoid specific increases expression ISO Thimerosal results in increased expression of HELLS mRNA CTD PMID:27188386 NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844 		JBrowse link
G Henmt1 HEN methyltransferase 1 increases expression ISO Thimerosal results in increased expression of HENMT1 mRNA CTD PMID:27188386 NCBI chr 2:196,585,732...196,603,700
Ensembl chr 2:196,586,797...196,599,738 		JBrowse link
G Heph hephaestin decreases expression ISO Thimerosal results in decreased expression of HEPH mRNA CTD PMID:27188386 NCBI chr  X:61,151,131...61,402,980
Ensembl chr  X:61,296,345...61,402,980 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 decreases expression ISO Thimerosal results in decreased expression of HES1 mRNA CTD PMID:27188386 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192 		JBrowse link
G Hes3 hes family bHLH transcription factor 3 decreases expression ISO Thimerosal results in decreased expression of HES3 mRNA CTD PMID:24675092 NCBI chr 5:162,793,611...162,799,578
Ensembl chr 5:162,794,367...162,796,261 		JBrowse link
G Hif3a hypoxia inducible factor 3 subunit alpha decreases expression ISO Thimerosal results in decreased expression of HIF3A mRNA CTD PMID:27188386 NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758 		JBrowse link
G Hip1 huntingtin interacting protein 1 decreases expression ISO Thimerosal results in decreased expression of HIP1 mRNA CTD PMID:27188386 NCBI chr12:21,133,364...21,267,796
Ensembl chr12:21,133,406...21,267,725 		JBrowse link
G Hipk2 homeodomain interacting protein kinase 2 decreases expression ISO Thimerosal results in decreased expression of HIPK2 mRNA CTD PMID:27188386 NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:67,440,501...67,619,223 		JBrowse link
G Hk1 hexokinase 1 decreases expression ISO Thimerosal results in decreased expression of HK1 mRNA CTD PMID:27188386 NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,230,486...30,332,131 		JBrowse link
G Hk2 hexokinase 2 decreases expression ISO Thimerosal results in decreased expression of HK2 mRNA CTD PMID:27188386 NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:115,234,509...115,283,530 		JBrowse link
G Hmga1 high mobility group AT-hook 1 decreases expression ISO Thimerosal results in decreased expression of HMGA1 mRNA CTD PMID:27188386 NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,611,694...5,618,752 		JBrowse link
G Hmgb1 high mobility group box 1 increases expression ISO Thimerosal results in increased expression of HMGB1 mRNA CTD PMID:27188386 NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565
Ensembl chr16:5,901,586...5,978,565 		JBrowse link
G Hmgn5 high mobility group nucleosome binding domain 5 increases expression ISO Thimerosal results in increased expression of HMGN5 mRNA CTD PMID:27188386 NCBI chr  X:74,085,871...74,094,488
Ensembl chr  X:74,085,875...74,094,441
Ensembl chr 1:74,085,875...74,094,441 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO Thimerosal results in increased expression of HMOX1 mRNA CTD PMID:16870260 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hnrnpa0 heterogeneous nuclear ribonucleoprotein A0 decreases expression ISO Thimerosal results in decreased expression of HNRNPA0 mRNA CTD PMID:27188386 NCBI chr17:6,507,728...6,510,385
Ensembl chr17:6,507,275...6,509,375 		JBrowse link
G Hnrnpul2 heterogeneous nuclear ribonucleoprotein U-like 2 decreases expression ISO Thimerosal results in decreased expression of HNRNPUL2 mRNA CTD PMID:27188386 NCBI chr 1:205,713,431...205,725,553
Ensembl chr 1:205,711,886...205,725,553 		JBrowse link
G Hsd17b6 hydroxysteroid (17-beta) dehydrogenase 6 decreases expression ISO Thimerosal results in decreased expression of HSD17B6 mRNA CTD PMID:27188386 NCBI chr 7:422,466...442,008
Ensembl chr 7:422,480...442,425 		JBrowse link
G Hsf2 heat shock transcription factor 2 increases expression ISO Thimerosal results in increased expression of HSF2 mRNA CTD PMID:27188386 NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 decreases expression ISO Thimerosal results in decreased expression of HSP90AB1 mRNA CTD PMID:27188386 NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:15,433,691...15,438,488 		JBrowse link
G Hspa13 heat shock protein family A (Hsp70) member 13 increases expression ISO Thimerosal results in increased expression of HSPA13 mRNA CTD PMID:27188386 NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A increases expression
decreases expression 		ISO Thimerosal results in increased expression of HSPA1A mRNA
Thimerosal results in decreased expression of HSPA1A mRNA 		CTD PMID:16870260 PMID:24675092 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression ISO Thimerosal results in increased expression of HSPA1B mRNA CTD PMID:16870260 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240
Ensembl chr20:3,856,006...3,873,240 		JBrowse link
G Hspa1l heat shock protein family A (Hsp70) member 1 like increases expression ISO Thimerosal results in increased expression of HSPA1L mRNA CTD PMID:16870260 NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,848,843...3,855,571 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like increases expression ISO Thimerosal results in increased expression of HSPA4L mRNA CTD PMID:27188386 NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084 		JBrowse link
G Hspa6l-ps1 heat shock protein family A (Hsp70) member 6 like, pseudogene 1 increases expression ISO Thimerosal results in increased expression of HSPA6 mRNA CTD PMID:16870260 NCBI chr13:85,805,911...85,807,052 JBrowse link
G Hspb1 heat shock protein family B (small) member 1 increases expression ISO Thimerosal results in increased expression of HSPB1 mRNA CTD PMID:16870260 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743 		JBrowse link
G Htatsf1 HIV-1 Tat specific factor 1 decreases expression ISO Thimerosal results in decreased expression of HTATSF1 mRNA CTD PMID:27188386 NCBI chr  X:134,935,426...134,949,607
Ensembl chr  X:134,935,426...134,949,607 		JBrowse link
G Htr2c 5-hydroxytryptamine receptor 2C increases expression ISO Thimerosal results in increased expression of HTR2C mRNA CTD PMID:27188386 NCBI chr  X:110,640,777...110,870,288
Ensembl chr  X:110,641,153...110,870,287 		JBrowse link
G Hyls1 HYLS1, centriolar and ciliogenesis associated increases expression ISO Thimerosal results in increased expression of HYLS1 mRNA CTD PMID:27188386 NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760 		JBrowse link
G Ier5l immediate early response 5-like decreases expression ISO Thimerosal results in decreased expression of IER5L mRNA CTD PMID:24675092 PMID:27188386 NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:13,744,078...13,745,647 		JBrowse link
G Ifng interferon gamma affects response to substance
multiple interactions 		ISO IFNG affects the susceptibility to Thimerosal
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein] 		CTD PMID:15808517 PMID:17079650 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Ift80 intraflagellar transport 80 increases expression ISO Thimerosal results in increased expression of IFT80 mRNA CTD PMID:27188386 NCBI chr 2:153,144,707...153,240,024
Ensembl chr 2:153,145,795...153,240,024 		JBrowse link
G Igdcc3 immunoglobulin superfamily, DCC subclass, member 3 decreases expression ISO Thimerosal results in decreased expression of IGDCC3 mRNA CTD PMID:27188386 NCBI chr 8:65,661,165...65,707,961
Ensembl chr 8:65,661,196...65,707,959 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein]
IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein] 		CTD PMID:14745455 PMID:23145070 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296 		JBrowse link
G Igf2bp3 insulin-like growth factor 2 mRNA binding protein 3 decreases expression ISO Thimerosal results in decreased expression of IGF2BP3 mRNA CTD PMID:27188386 NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 decreases expression ISO Thimerosal results in decreased expression of IGFBP2 mRNA CTD PMID:27188386 NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO Thimerosal results in decreased expression of IGFBP5 mRNA CTD PMID:27188386 NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156 		JBrowse link
G Iglon5 IgLON family member 5 decreases expression ISO Thimerosal results in decreased expression of IGLON5 mRNA CTD PMID:27188386 NCBI chr 1:93,880,906...93,898,929
Ensembl chr 1:93,881,991...93,898,754 		JBrowse link
G Ikzf1 IKAROS family zinc finger 1 decreases expression ISO Thimerosal results in decreased expression of IKZF1 mRNA CTD PMID:27188386 NCBI chr14:90,468,696...90,556,522
Ensembl chr14:86,255,065...86,342,416 		JBrowse link
G Il13 interleukin 13 multiple interactions ISO [Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein; Glutathione inhibits the reaction [[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein] CTD PMID:17079650 NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737 		JBrowse link
G Il13ra1 interleukin 13 receptor subunit alpha 1 decreases expression ISO Thimerosal results in decreased expression of IL13RA1 mRNA CTD PMID:27188386 NCBI chr  X:120,213,670...120,294,777
Ensembl chr  X:115,348,860...115,408,681
Ensembl chr11:115,348,860...115,408,681 		JBrowse link
G Il17ra interleukin 17 receptor A decreases expression ISO Thimerosal results in decreased expression of IL17RA mRNA CTD PMID:27188386 NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174 		JBrowse link
G Il27ra interleukin 27 receptor subunit alpha decreases expression ISO Thimerosal results in decreased expression of IL27RA mRNA CTD PMID:27188386 NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938 		JBrowse link
G Il5 interleukin 5 multiple interactions ISO [Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL5 protein CTD PMID:17079650 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213 		JBrowse link
G Il6 interleukin 6 affects response to substance
multiple interactions 		ISO IL6 affects the susceptibility to Thimerosal
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] 		CTD PMID:15808517 PMID:17079650 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ilf3 interleukin enhancer binding factor 3 decreases expression ISO Thimerosal results in decreased expression of ILF3 mRNA CTD PMID:27188386 NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350 		JBrowse link
G Ilrun inflammation and lipid regulator with UBA-like and NBR1-like domains decreases expression ISO Thimerosal results in decreased expression of ILRUN mRNA CTD PMID:27188386 NCBI chr20:5,809,931...5,876,197
Ensembl chr20:5,809,936...5,876,012 		JBrowse link
G Immp1l inner mitochondrial membrane peptidase subunit 1 increases expression ISO Thimerosal results in increased expression of IMMP1L mRNA CTD PMID:27188386 NCBI chr 3:92,385,329...92,449,559
Ensembl chr 3:92,385,379...92,452,313 		JBrowse link
G Inafm1 InaF-motif containing 1 decreases expression ISO Thimerosal results in decreased expression of INAFM1 mRNA CTD PMID:27188386 NCBI chr 1:86,104,970...86,106,454 JBrowse link
G Ing3 inhibitor of growth family, member 3 increases expression ISO Thimerosal results in increased expression of ING3 mRNA CTD PMID:27188386 NCBI chr 4:51,439,218...51,469,502
Ensembl chr 4:50,477,962...50,503,715 		JBrowse link
G Ino80d INO80 complex subunit D increases expression ISO Thimerosal results in increased expression of INO80D mRNA CTD PMID:27188386 NCBI chr 9:64,447,075...64,514,013
Ensembl chr 9:64,457,165...64,515,242 		JBrowse link
G Insig1 insulin induced gene 1 decreases expression ISO Thimerosal results in decreased expression of INSIG1 mRNA CTD PMID:27188386 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952 		JBrowse link
G Ints10 integrator complex subunit 10 increases expression ISO Thimerosal results in increased expression of INTS10 mRNA CTD PMID:27188386 NCBI chr16:20,915,223...20,947,146
Ensembl chr16:20,916,082...20,967,610 		JBrowse link
G Ints14 integrator complex subunit 14 increases expression ISO Thimerosal results in increased expression of INTS14 mRNA CTD PMID:27188386 NCBI chr 8:65,475,788...65,500,807
Ensembl chr 8:65,475,910...65,500,804 		JBrowse link
G Ints6 integrator complex subunit 6 increases expression ISO Thimerosal results in increased expression of INTS6 mRNA CTD PMID:27188386 NCBI chr15:36,908,966...37,048,043
Ensembl chr15:36,933,724...37,021,527 		JBrowse link
G Iqgap1 IQ motif containing GTPase activating protein 1 decreases expression ISO Thimerosal results in decreased expression of IQGAP1 mRNA CTD PMID:27188386 NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755 		JBrowse link
G Irag1 inositol 1,4,5-triphosphate receptor associated 1 decreases expression ISO Thimerosal results in decreased expression of IRAG1 mRNA CTD PMID:27188386 NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176 		JBrowse link
G Irf2bp2 interferon regulatory factor 2 binding protein 2 decreases expression ISO Thimerosal results in decreased expression of IRF2BP2 mRNA CTD PMID:27188386 NCBI chr19:71,456,689...71,462,368
Ensembl chr19:54,560,128...54,566,642 		JBrowse link
G Isyna1 inositol-3-phosphate synthase 1 decreases expression ISO Thimerosal results in decreased expression of ISYNA1 mRNA CTD PMID:27188386 NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979 		JBrowse link
G Itpr3 inositol 1,4,5-trisphosphate receptor, type 3 decreases expression ISO Thimerosal results in decreased expression of ITPR3 mRNA CTD PMID:27188386 NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337 		JBrowse link
G Itprid2 ITPR interacting domain containing 2 decreases expression ISO Thimerosal results in decreased expression of ITPRID2 mRNA CTD PMID:27188386 NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978 		JBrowse link
G Itpripl1 ITPRIP like 1 decreases expression ISO Thimerosal results in decreased expression of ITPRIPL1 mRNA CTD PMID:27188386 NCBI chr 3:134,858,316...134,861,241
Ensembl chr 3:114,402,270...114,414,497 		JBrowse link
G Itpripl2 ITPRIP like 2 decreases expression ISO Thimerosal results in decreased expression of ITPRIPL2 mRNA CTD PMID:27188386 NCBI chr 1:172,801,152...172,803,047
Ensembl chr 1:172,796,849...172,802,950 		JBrowse link
G Itsn2 intersectin 2 decreases expression ISO Thimerosal results in decreased expression of ITSN2 mRNA CTD PMID:27188386 NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124 		JBrowse link
G Iws1 interacts with SUPT6H, CTD assembly factor 1 decreases expression ISO Thimerosal results in decreased expression of IWS1 mRNA CTD PMID:27188386 NCBI chr18:23,695,496...23,737,363
Ensembl chr18:23,695,425...23,736,172 		JBrowse link
G Jmjd1c jumonji domain containing 1C decreases expression ISO Thimerosal results in decreased expression of JMJD1C mRNA CTD PMID:27188386 NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122 		JBrowse link
G Jph3 junctophilin 3 decreases expression ISO Thimerosal results in decreased expression of JPH3 mRNA CTD PMID:27188386 NCBI chr19:66,702,497...66,763,948
Ensembl chr19:49,793,092...49,855,338 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO Thimerosal results in increased expression of JUN mRNA CTD PMID:16870260 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656 		JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Thimerosal results in decreased expression of JUND mRNA CTD PMID:27188386 NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799 		JBrowse link
G Kansl1l KAT8 regulatory NSL complex subunit 1-like increases expression ISO Thimerosal results in increased expression of KANSL1L mRNA CTD PMID:16870260 NCBI chr 9:68,211,151...68,316,992
Ensembl chr 9:68,211,189...68,300,222 		JBrowse link
G Kat2b lysine acetyltransferase 2B increases expression ISO Thimerosal results in increased expression of KAT2B mRNA CTD PMID:27188386 NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,562,288...6,667,064 		JBrowse link
G Kat6a lysine acetyltransferase 6A decreases expression ISO Thimerosal results in decreased expression of KAT6A mRNA CTD PMID:27188386 NCBI chr16:75,787,411...75,868,584
Ensembl chr16:69,084,914...69,163,606 		JBrowse link
G Kat8 lysine acetyltransferase 8 decreases expression ISO Thimerosal results in decreased expression of KAT8 mRNA CTD PMID:27188386 NCBI chr 1:191,954,827...191,967,107
Ensembl chr 1:182,515,327...182,536,633 		JBrowse link
G Kbtbd2 kelch repeat and BTB domain containing 2 decreases expression ISO Thimerosal results in decreased expression of KBTBD2 mRNA CTD PMID:27188386 NCBI chr 4:86,027,947...86,050,266
Ensembl chr 4:86,027,947...86,050,211 		JBrowse link
G Kbtbd8 kelch repeat and BTB domain containing 8 increases expression ISO Thimerosal results in increased expression of KBTBD8 mRNA CTD PMID:27188386 NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697 		JBrowse link
G Kcnb2 potassium voltage-gated channel subfamily B member 2 increases expression ISO Thimerosal results in increased expression of KCNB2 mRNA CTD PMID:24675092 NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599 		JBrowse link
G Kcnip3 potassium voltage-gated channel interacting protein 3 multiple interactions ISO [SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]] CTD PMID:30503815 NCBI chr 3:114,677,027...114,742,923
Ensembl chr 3:114,677,030...114,743,556 		JBrowse link
G Kcnrg potassium channel regulator increases expression ISO Thimerosal results in increased expression of KCNRG mRNA CTD PMID:27188386 NCBI chr15:35,774,456...35,779,409
Ensembl chr15:35,774,326...35,779,415 		JBrowse link
G Kdelr1 KDEL endoplasmic reticulum protein retention receptor 1 decreases expression ISO Thimerosal results in decreased expression of KDELR1 mRNA CTD PMID:27188386 NCBI chr 1:105,483,598...105,494,587
Ensembl chr 1:96,347,150...96,358,157 		JBrowse link
G Kdm4b lysine demethylase 4B decreases expression ISO Thimerosal results in decreased expression of KDM4B mRNA CTD PMID:27188386 NCBI chr 9:1,158,737...1,237,233
Ensembl chr 9:1,158,752...1,236,543 		JBrowse link
G Kdm6a lysine demethylase 6A decreases expression ISO Thimerosal results in decreased expression of KDM6A mRNA CTD PMID:27188386 NCBI chr  X:4,337,466...4,477,100
Ensembl chr  X:4,337,750...4,477,062 		JBrowse link
G Khk ketohexokinase decreases expression ISO Thimerosal results in decreased expression of KHK mRNA CTD PMID:27188386 NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717 		JBrowse link
G Kif1a kinesin family member 1A decreases expression ISO Thimerosal results in decreased expression of KIF1A mRNA CTD PMID:27188386 NCBI chr 9:93,563,033...93,647,412
Ensembl chr 9:93,563,045...93,647,480 		JBrowse link
G Kif21b kinesin family member 21B decreases expression ISO Thimerosal results in decreased expression of KIF21B mRNA CTD PMID:24675092 NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127 		JBrowse link
G Kif22 kinesin family member 22 decreases expression ISO Thimerosal results in decreased expression of KIF22 mRNA CTD PMID:24675092 NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401 		JBrowse link
G Kiss1r KISS1 receptor decreases expression ISO Thimerosal results in decreased expression of KISS1R mRNA CTD PMID:27188386 NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793 		JBrowse link
G Klf12 KLF transcription factor 12 increases expression ISO Thimerosal results in increased expression of KLF12 mRNA CTD PMID:27188386 NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056 		JBrowse link
G Klf13 KLF transcription factor 13 decreases expression ISO Thimerosal results in decreased expression of KLF13 mRNA CTD PMID:27188386 NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:117,503,602...117,551,227 		JBrowse link
G Klf15 KLF transcription factor 15 increases expression ISO Thimerosal results in increased expression of KLF15 mRNA CTD PMID:27188386 NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:122,965,807...122,978,374 		JBrowse link
G Klf4 KLF transcription factor 4 increases expression ISO Thimerosal results in increased expression of KLF4 mRNA CTD PMID:16870260 NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602 		JBrowse link
G Klhdc10 kelch domain containing 10 decreases expression ISO Thimerosal results in decreased expression of KLHDC10 mRNA CTD PMID:27188386 NCBI chr 4:59,021,300...59,079,118
Ensembl chr 4:59,021,310...59,074,941 		JBrowse link
G Klhl24 kelch-like family member 24 decreases expression ISO Thimerosal results in decreased expression of KLHL24 mRNA CTD PMID:27188386 NCBI chr11:94,348,024...94,382,085
Ensembl chr11:80,846,755...80,877,636 		JBrowse link
G Klhl3 kelch-like family member 3 decreases expression ISO Thimerosal results in decreased expression of KLHL3 mRNA CTD PMID:27188386 NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154 		JBrowse link
G Klhl41 kelch-like family member 41 increases expression ISO Thimerosal results in increased expression of KLHL41 mRNA CTD PMID:27188386 NCBI chr 3:54,434,291...54,447,415
Ensembl chr 3:54,434,234...54,449,222 		JBrowse link
G Kmt2a lysine methyltransferase 2A decreases expression ISO Thimerosal results in decreased expression of KMT2A mRNA CTD PMID:27188386 NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:45,118,814...45,193,181 		JBrowse link
G Knl1 kinetochore scaffold 1 decreases expression ISO Thimerosal results in decreased expression of KNL1 mRNA CTD PMID:27188386 NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:106,029,661...106,091,915 		JBrowse link
G Kras KRAS proto-oncogene, GTPase decreases expression ISO Thimerosal results in decreased expression of KRAS mRNA CTD PMID:27188386 NCBI chr 4:179,916,255...179,949,613 JBrowse link
G Krcc1 lysine-rich coiled-coil 1 increases expression ISO Thimerosal results in increased expression of KRCC1 mRNA CTD PMID:27188386 NCBI chr 4:103,261,642...103,274,672
Ensembl chr 4:103,261,536...103,277,156 		JBrowse link
G Krr1 KRR1, small subunit processome component homolog increases expression ISO Thimerosal results in increased expression of KRR1 mRNA CTD PMID:27188386 NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985 		JBrowse link
G Larp1b La ribonucleoprotein 1B increases expression ISO Thimerosal results in increased expression of LARP1B mRNA CTD PMID:27188386 NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896 		JBrowse link
G Larp4 La ribonucleoprotein 4 decreases expression ISO Thimerosal results in decreased expression of LARP4 mRNA CTD PMID:27188386 NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:131,101,564...131,150,811 		JBrowse link
G Larp7 La ribonucleoprotein 7, transcriptional regulator increases expression ISO Thimerosal results in increased expression of LARP7 mRNA CTD PMID:27188386 NCBI chr 2:218,672,145...218,687,332
Ensembl chr 2:215,997,649...216,012,865 		JBrowse link
G Lars1 leucyl-tRNA synthetase 1 decreases expression ISO Thimerosal results in decreased expression of LARS1 mRNA CTD PMID:27188386 NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931 		JBrowse link
G Lcorl ligand dependent nuclear receptor corepressor-like increases expression ISO Thimerosal results in increased expression of LCORL mRNA CTD PMID:27188386 NCBI chr14:69,482,919...69,620,269
Ensembl chr14:65,271,135...65,404,174 		JBrowse link
G Ldha lactate dehydrogenase A decreases expression ISO Thimerosal results in decreased expression of LDHA mRNA CTD PMID:27188386 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472 		JBrowse link
G Lgals3bp galectin 3 binding protein decreases expression ISO Thimerosal results in decreased expression of LGALS3BP mRNA CTD PMID:27188386 NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256 		JBrowse link
G Lgalsl galectin-like decreases expression ISO Thimerosal results in decreased expression of LGALSL mRNA CTD PMID:27188386 NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 increases expression ISO Thimerosal results in increased expression of LGR5 mRNA CTD PMID:24675092 NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446 		JBrowse link
G Lgr6 leucine-rich repeat-containing G protein-coupled receptor 6 increases expression ISO Thimerosal results in increased expression of LGR6 mRNA CTD PMID:24675092 NCBI chr13:46,424,382...46,544,074
Ensembl chr13:46,424,383...46,543,945 		JBrowse link
G Lhb luteinizing hormone subunit beta increases expression ISO Thimerosal results in increased expression of LHB mRNA; Thimerosal results in increased expression of LHB protein CTD PMID:24675092 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Lhx9 LIM homeobox 9 decreases expression ISO Thimerosal results in decreased expression of LHX9 mRNA CTD PMID:27188386 NCBI chr13:50,389,052...50,409,947
Ensembl chr13:50,389,738...50,410,806 		JBrowse link
G Lima1 LIM domain and actin binding 1 decreases expression ISO Thimerosal results in decreased expression of LIMA1 mRNA CTD PMID:27188386 NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473 		JBrowse link
G Lims1 LIM zinc finger domain containing 1 increases expression ISO Thimerosal results in increased expression of LIMS1 mRNA CTD PMID:27188386 NCBI chr20:26,851,364...26,961,607
Ensembl chr20:26,309,895...26,418,500 		JBrowse link
G Lin7c lin-7 homolog C, crumbs cell polarity complex component increases expression ISO Thimerosal results in increased expression of LIN7C mRNA CTD PMID:27188386 NCBI chr 3:96,406,800...96,417,779
Ensembl chr 3:96,406,813...96,417,728 		JBrowse link
G Lin9 lin-9 DREAM MuvB core complex component increases expression ISO Thimerosal results in increased expression of LIN9 mRNA CTD PMID:27188386 NCBI chr13:92,374,612...92,419,664
Ensembl chr13:92,374,593...92,419,654
Ensembl chr14:92,374,593...92,419,654 		JBrowse link
G Litaf lipopolysaccharide-induced TNF factor decreases expression ISO Thimerosal results in decreased expression of LITAF mRNA CTD PMID:27188386 NCBI chr10:5,163,258...5,199,930
Ensembl chr10:4,625,552...4,692,763 		JBrowse link
G Lix1l limb and CNS expressed 1 like decreases expression ISO Thimerosal results in decreased expression of LIX1L mRNA CTD PMID:27188386 NCBI chr 2:184,136,018...184,161,918
Ensembl chr 2:184,136,038...184,161,916 		JBrowse link
G Lmbrd2 LMBR1 domain containing 2 increases expression ISO Thimerosal results in increased expression of LMBRD2 mRNA CTD PMID:27188386 NCBI chr 2:58,189,558...58,251,565
Ensembl chr 2:58,189,558...58,247,076 		JBrowse link
G Lmf1 lipase maturation factor 1 decreases expression ISO Thimerosal results in decreased expression of LMF1 mRNA CTD PMID:27188386 NCBI chr10:14,597,726...14,684,071
Ensembl chr10:14,597,594...14,684,119 		JBrowse link
G Lnpep leucyl and cystinyl aminopeptidase multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA CTD PMID:27188386 NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544 		JBrowse link
G Lpcat1 lysophosphatidylcholine acyltransferase 1 increases expression ISO Thimerosal results in increased expression of LPCAT1 mRNA CTD PMID:24675092 NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:29,766,071...29,816,401 		JBrowse link
G Lpgat1 lysophosphatidylglycerol acyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of LPGAT1 mRNA CTD PMID:27188386 NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333 		JBrowse link
G Lrp6 LDL receptor related protein 6 decreases expression ISO Thimerosal results in decreased expression of LRP6 mRNA CTD PMID:27188386 NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:167,270,353...167,400,497 		JBrowse link
G Lrpprc leucine-rich pentatricopeptide repeat containing increases expression ISO Thimerosal results in increased expression of LRPPRC mRNA CTD PMID:27188386 NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293 		JBrowse link
G Lrrc26 leucine rich repeat containing 26 decreases expression ISO Thimerosal results in decreased expression of LRRC26 mRNA CTD PMID:24675092 NCBI chr 3:8,102,361...8,103,687
Ensembl chr 3:8,102,361...8,103,687 		JBrowse link
G Lrrc7 leucine rich repeat containing 7 increases expression ISO Thimerosal results in increased expression of LRRC7 mRNA CTD PMID:27188386 NCBI chr 2:247,146,616...247,634,945
Ensembl chr 2:247,147,752...247,634,547 		JBrowse link
G Lrrc75b leucine rich repeat containing 75B decreases expression ISO Thimerosal results in decreased expression of LRRC75B mRNA CTD PMID:27188386 NCBI chr20:13,099,741...13,105,942
Ensembl chr20:13,100,302...13,106,503 		JBrowse link
G Lsm12 LSM12 homolog decreases expression ISO Thimerosal results in decreased expression of LSM12 mRNA CTD PMID:27188386 NCBI chr10:87,118,334...87,140,395
Ensembl chr10:87,118,416...87,140,396 		JBrowse link
G Lsm14b LSM family member 14B decreases expression ISO Thimerosal results in decreased expression of LSM14B mRNA CTD PMID:27188386 NCBI chr 3:167,125,633...167,136,417
Ensembl chr 3:167,125,628...167,136,432 		JBrowse link
G Lsm5 LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated increases expression ISO Thimerosal results in increased expression of LSM5 mRNA CTD PMID:27188386 NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165
Ensembl chr 4:104,652,477...104,654,165 		JBrowse link
G Lss lanosterol synthase decreases expression ISO Thimerosal results in decreased expression of LSS mRNA CTD PMID:27188386 NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,092,774...12,118,762 		JBrowse link
G Lta4h leukotriene A4 hydrolase decreases expression ISO Thimerosal results in decreased expression of LTA4H mRNA CTD PMID:27188386 NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:27,969,789...28,001,600 		JBrowse link
G Ltbp2 latent transforming growth factor beta binding protein 2 decreases expression ISO Thimerosal results in decreased expression of LTBP2 mRNA CTD PMID:24675092 NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:104,429,947...104,526,208 		JBrowse link
G Ltn1 listerin E3 ubiquitin protein ligase 1 decreases expression ISO Thimerosal results in decreased expression of LTN1 mRNA CTD PMID:27188386 NCBI chr11:40,090,169...40,147,159
Ensembl chr11:26,603,903...26,660,886 		JBrowse link
G Luzp1 leucine zipper protein 1 decreases expression ISO Thimerosal results in decreased expression of LUZP1 mRNA CTD PMID:24675092 NCBI chr 5:148,706,094...148,781,616
Ensembl chr 5:148,706,138...148,781,609 		JBrowse link
G Lysmd4 LysM domain containing 4 decreases expression ISO Thimerosal results in decreased expression of LYSMD4 mRNA CTD PMID:24675092 NCBI chr 1:120,839,180...120,845,148
Ensembl chr 1:120,839,282...120,845,135 		JBrowse link
G Mafb MAF bZIP transcription factor B increases expression ISO Thimerosal results in increased expression of MAFB mRNA CTD PMID:16870260 NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:148,998,122...149,000,031 		JBrowse link
G Maff MAF bZIP transcription factor F decreases expression ISO Thimerosal results in decreased expression of MAFF mRNA CTD PMID:27188386 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851 		JBrowse link
G Magel2 MAGE family member L2 decreases expression ISO Thimerosal results in decreased expression of MAGEL2 mRNA CTD PMID:27188386 NCBI chr 1:115,880,142...115,884,684
Ensembl chr 1:115,880,474...115,884,250 		JBrowse link
G Magi2 membrane associated guanylate kinase, WW and PDZ domain containing 2 decreases expression ISO Thimerosal results in decreased expression of MAGI2 mRNA CTD PMID:27188386 NCBI chr 4:15,278,518...16,762,427
Ensembl chr 4:14,386,399...15,870,240 		JBrowse link
G Mansc1 MANSC domain containing 1 decreases expression ISO Thimerosal results in decreased expression of MANSC1 mRNA CTD PMID:27188386 NCBI chr 4:167,438,817...167,459,047
Ensembl chr 4:167,439,071...167,479,606 		JBrowse link
G Maoa monoamine oxidase A multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA CTD PMID:27188386 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:6,030,795...6,099,593 		JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 decreases expression ISO Thimerosal results in decreased expression of MAP2K2 mRNA CTD PMID:27188386 NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:8,580,905...8,610,243 		JBrowse link
G Map3k11 mitogen-activated protein kinase kinase kinase 11 decreases expression ISO Thimerosal results in decreased expression of MAP3K11 mRNA CTD PMID:27188386 NCBI chr 1:212,404,685...212,417,986
Ensembl chr 1:202,975,353...202,988,652 		JBrowse link
G Map3k3 mitogen activated protein kinase kinase kinase 3 decreases expression ISO Thimerosal results in decreased expression of MAP3K3 mRNA CTD PMID:27188386 NCBI chr10:91,519,976...91,588,651
Ensembl chr10:91,020,174...91,088,848 		JBrowse link
G Map3k6 mitogen-activated protein kinase kinase kinase 6 decreases expression ISO Thimerosal results in decreased expression of MAP3K6 mRNA CTD PMID:27188386 NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:145,440,346...145,452,212 		JBrowse link
G Map4 microtubule-associated protein 4 decreases expression ISO Thimerosal results in decreased expression of MAP4 mRNA CTD PMID:27188386 NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362 		JBrowse link
G Map4k1 mitogen activated protein kinase kinase kinase kinase 1 decreases expression ISO Thimerosal results in decreased expression of MAP4K1 mRNA CTD PMID:27188386 NCBI chr 1:93,398,460...93,419,996
Ensembl chr 1:84,271,069...84,292,493 		JBrowse link
G Map4k5 mitogen-activated protein kinase kinase kinase kinase 5 decreases expression ISO Thimerosal results in decreased expression of MAP4K5 mRNA CTD PMID:27188386 NCBI chr 6:88,284,087...88,377,118
Ensembl chr 6:88,284,094...88,376,799 		JBrowse link
G Map9 microtubule-associated protein 9 increases expression ISO Thimerosal results in increased expression of MAP9 mRNA CTD PMID:27188386 NCBI chr 2:167,708,661...167,743,927
Ensembl chr 2:167,708,765...167,740,736 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
decreases phosphorylation 		ISO Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein] CTD PMID:18495191 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 increases phosphorylation
decreases expression 		ISO Thimerosal results in increased phosphorylation of MAPK14 protein
Thimerosal results in decreased expression of MAPK14 mRNA 		CTD PMID:15737199 PMID:27188386 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 decreases phosphorylation
multiple interactions
increases phosphorylation 		ISO Thimerosal results in decreased phosphorylation of MAPK3 protein
Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]
Thimerosal results in increased phosphorylation of MAPK3 protein 		CTD PMID:17698513 PMID:18495191 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation
increases expression 		ISO Thimerosal results in increased phosphorylation of MAPK8 protein
Thimerosal results in increased expression of MAPK8 mRNA 		CTD PMID:18495191 PMID:27188386 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases phosphorylation ISO Thimerosal results in increased phosphorylation of MAPK9 protein CTD PMID:17698513 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178 		JBrowse link
G Mapkapk2 MAPK activated protein kinase 2 decreases expression ISO Thimerosal results in decreased expression of MAPKAPK2 mRNA CTD PMID:27188386 NCBI chr13:45,066,027...45,112,326
Ensembl chr13:42,513,762...42,560,457 		JBrowse link
G Marchf1 membrane associated ring-CH-type finger 1 increases expression ISO Thimerosal results in increased expression of MARCHF1 mRNA CTD PMID:27188386 NCBI chr16:23,255,551...24,114,290
Ensembl chr16:23,258,799...24,114,277 		JBrowse link
G Mark4 microtubule affinity regulating kinase 4 decreases expression ISO Thimerosal results in decreased expression of MARK4 mRNA CTD PMID:27188386 NCBI chr 1:79,075,353...79,108,882
Ensembl chr 1:79,068,904...79,108,556 		JBrowse link
G Mbd2 methyl-CpG binding domain protein 2 decreases expression ISO Thimerosal results in decreased expression of MBD2 mRNA CTD PMID:27188386 NCBI chr18:66,449,196...66,516,112
Ensembl chr18:64,174,002...64,240,794 		JBrowse link
G Mbnl2 muscleblind-like splicing regulator 2 decreases expression ISO Thimerosal results in decreased expression of MBNL2 mRNA CTD PMID:27188386 NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937 		JBrowse link
G Mboat7 membrane bound O-acyltransferase domain containing 7 decreases expression ISO Thimerosal results in decreased expression of MBOAT7 mRNA CTD PMID:27188386 NCBI chr 1:74,440,618...74,454,896
Ensembl chr 1:65,525,213...65,539,538 		JBrowse link
G Mcph1 microcephalin 1 increases expression ISO Thimerosal results in increased expression of MCPH1 mRNA CTD PMID:27188386 NCBI chr16:71,021,855...71,224,067
Ensembl chr16:71,024,588...71,224,122 		JBrowse link
G Mdh2 malate dehydrogenase 2 decreases expression ISO Thimerosal results in decreased expression of MDH2 mRNA CTD PMID:27188386 NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271 		JBrowse link
G Meak7 MTOR associated protein, eak-7 homolog decreases expression ISO Thimerosal results in decreased expression of MEAK7 mRNA CTD PMID:27188386 NCBI chr19:47,813,899...47,836,830
Ensembl chr19:47,811,416...47,841,278 		JBrowse link
G Mecom MDS1 and EVI1 complex locus increases expression ISO Thimerosal results in increased expression of MECOM mRNA CTD PMID:27188386 NCBI chr 2:114,837,815...115,393,052
Ensembl chr 2:112,909,321...113,464,590 		JBrowse link
G Med13 mediator complex subunit 13 decreases expression ISO Thimerosal results in decreased expression of MED13 mRNA CTD PMID:27188386 NCBI chr10:71,086,978...71,176,535
Ensembl chr10:71,090,516...71,177,242 		JBrowse link
G Med13l mediator complex subunit 13L increases expression ISO Thimerosal results in increased expression of MED13L mRNA CTD PMID:27188386 NCBI chr12:37,807,596...38,004,886
Ensembl chr12:37,808,285...38,004,473 		JBrowse link
G Med16 mediator complex subunit 16 decreases expression ISO Thimerosal results in decreased expression of MED16 mRNA CTD PMID:27188386 NCBI chr 7:9,798,641...9,811,172
Ensembl chr 7:9,798,668...9,811,172 		JBrowse link
G Med17 mediator complex subunit 17 increases expression ISO Thimerosal results in increased expression of MED17 mRNA CTD PMID:27188386 NCBI chr 8:12,101,594...12,120,592
Ensembl chr 8:12,101,594...12,120,592 		JBrowse link
G Med18 mediator complex subunit 18 decreases expression ISO Thimerosal results in decreased expression of MED18 mRNA CTD PMID:16870260 NCBI chr 5:144,663,316...144,668,652
Ensembl chr 5:144,663,252...144,668,635 		JBrowse link
G Med21 mediator complex subunit 21 increases expression ISO Thimerosal results in increased expression of MED21 mRNA CTD PMID:27188386 NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548 		JBrowse link
G Med25 mediator complex subunit 25 decreases expression ISO Thimerosal results in decreased expression of MED25 mRNA CTD PMID:27188386 NCBI chr 1:95,359,961...95,375,827
Ensembl chr 1:95,360,284...95,375,877 		JBrowse link
G Medag mesenteric estrogen-dependent adipogenesis multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA CTD PMID:27188386 NCBI chr12:5,613,191...5,634,583
Ensembl chr12:5,613,208...5,634,767 		JBrowse link
G Megf6 multiple EGF-like-domains 6 decreases expression ISO Thimerosal results in decreased expression of MEGF6 mRNA CTD PMID:24675092 NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139 		JBrowse link
G Mettl18 methyltransferase 18, RPL3 N3(tau)-histidine increases expression ISO Thimerosal results in increased expression of METTL18 mRNA CTD PMID:27188386 NCBI chr13:76,345,888...76,348,798
Ensembl chr13:76,345,957...76,348,836 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase decreases expression ISO Thimerosal results in decreased expression of MGMT mRNA CTD PMID:27188386 NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756 		JBrowse link
G Mia3 MIA SH3 domain ER export factor 3 increases expression ISO Thimerosal results in increased expression of MIA3 mRNA CTD PMID:27188386 NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972 		JBrowse link
G Mid1 midline 1 decreases expression ISO Thimerosal results in decreased expression of MID1 mRNA CTD PMID:24675092 NCBI chr  X:27,678,248...28,053,049
Ensembl chr  X:24,120,293...24,248,353 		JBrowse link
G Mier3 MIER family member 3 increases expression ISO Thimerosal results in increased expression of MIER3 mRNA CTD PMID:27188386 NCBI chr 2:43,287,546...43,316,422
Ensembl chr 2:43,287,916...43,316,136 		JBrowse link
G Mill1 MHC I like leukocyte 1 decreases expression ISO Thimerosal results in decreased expression of MICA mRNA CTD PMID:27188386 NCBI chr 1:78,372,798...78,398,932
Ensembl chr 1:78,372,802...78,398,930 		JBrowse link
G Mis18bp1 MIS18 binding protein 1 decreases expression ISO Thimerosal results in decreased expression of MIS18BP1 mRNA CTD PMID:27188386 NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383 		JBrowse link
G Mkln1 muskelin 1 increases expression ISO Thimerosal results in increased expression of MKLN1 mRNA CTD PMID:27188386 NCBI chr 4:59,815,912...60,124,047
Ensembl chr 4:60,002,464...60,123,993 		JBrowse link
G Mkrn3 makorin, ring finger protein, 3 decreases expression ISO Thimerosal results in decreased expression of MKRN3 mRNA CTD PMID:27188386 NCBI chr 1:115,926,774...115,929,288
Ensembl chr 1:115,926,776...115,929,283 		JBrowse link
G Mlf2 myeloid leukemia factor 2 decreases expression ISO Thimerosal results in decreased expression of MLF2 mRNA CTD PMID:27188386 NCBI chr 4:157,739,651...157,744,325
Ensembl chr 4:157,728,756...157,744,317 		JBrowse link
G Mmp16 matrix metallopeptidase 16 affects expression ISO Thimerosal affects the expression of MMP16 mRNA CTD PMID:27188386 NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:31,312,280...31,548,388 		JBrowse link
G Mob1a MOB kinase activator 1A decreases expression ISO Thimerosal results in decreased expression of MOB1A mRNA CTD PMID:27188386 NCBI chr 4:115,831,581...115,848,561
Ensembl chr 4:115,831,551...115,848,561
Ensembl chr 1:115,831,551...115,848,561 		JBrowse link
G Mpi mannose phosphate isomerase decreases expression ISO Thimerosal results in decreased expression of MPI mRNA CTD PMID:27188386 NCBI chr 8:57,947,883...57,956,205
Ensembl chr 8:57,947,893...57,956,150 		JBrowse link
G Mrap2 melanocortin 2 receptor accessory protein 2 decreases expression ISO Thimerosal results in decreased expression of MRAP2 mRNA CTD PMID:27188386 NCBI chr 8:96,968,239...97,024,581
Ensembl chr 8:88,088,272...88,143,886 		JBrowse link
G Mroh1 maestro heat-like repeat family member 1 decreases expression ISO Thimerosal results in decreased expression of MROH1 mRNA CTD PMID:27188386 NCBI chr 7:108,098,708...108,172,146
Ensembl chr 7:108,102,734...108,172,146 		JBrowse link
G Mrpl1 mitochondrial ribosomal protein L1 increases expression ISO Thimerosal results in increased expression of MRPL1 mRNA CTD PMID:27188386 NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721 		JBrowse link
G Mrpl10 mitochondrial ribosomal protein L10 decreases expression ISO Thimerosal results in decreased expression of MRPL10 mRNA CTD PMID:27188386 NCBI chr10:82,026,031...82,034,451
Ensembl chr10:82,026,031...82,034,443 		JBrowse link
G Mrpl50 mitochondrial ribosomal protein L50 increases expression ISO Thimerosal results in increased expression of MRPL50 mRNA CTD PMID:27188386 NCBI chr 5:63,867,437...63,872,591 JBrowse link
G Mrps2 mitochondrial ribosomal protein S2 decreases expression ISO Thimerosal results in decreased expression of MRPS2 mRNA CTD PMID:27188386 NCBI chr 3:11,803,044...11,806,341
Ensembl chr 3:11,801,310...11,806,313 		JBrowse link
G Ms4a15 membrane spanning 4-domains A15 increases expression ISO Thimerosal results in increased expression of MS4A15 mRNA CTD PMID:24675092 NCBI chr 1:207,628,305...207,641,799
Ensembl chr 1:207,628,305...207,641,799 		JBrowse link
G Msn moesin decreases expression ISO Thimerosal results in decreased expression of MSN mRNA CTD PMID:27188386 NCBI chr  X:60,996,043...61,064,011
Ensembl chr  X:60,995,951...61,065,628 		JBrowse link
G Mt1 metallothionein 1 affects expression
increases expression 		ISO Thimerosal affects the expression of MT1 mRNA
Thimerosal results in increased expression of MT1 mRNA; Thimerosal results in increased expression of MT1 protein 		CTD PMID:19357975 PMID:19386279 NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
Ensembl chr  X:10,826,032...10,827,049 		JBrowse link
G Mt2 metallothionein 2 increases expression ISO Thimerosal results in increased expression of MT2 mRNA; Thimerosal results in increased expression of MT2 protein CTD PMID:19357975 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784 		JBrowse link
G Mt3 metallothionein 3 increases expression ISO Thimerosal results in increased expression of MT3 mRNA CTD PMID:19357975 NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158 		JBrowse link
G Mta1 metastasis associated 1 decreases expression ISO Thimerosal results in decreased expression of MTA1 mRNA CTD PMID:27188386 NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:132,178,853...132,217,641 		JBrowse link
G Mta2 metastasis associated 1 family, member 2 decreases expression ISO Thimerosal results in decreased expression of MTA2 mRNA CTD PMID:27188386 NCBI chr 1:205,838,181...205,846,903
Ensembl chr 1:205,837,964...205,846,946 		JBrowse link
G Mtarc2 mitochondrial amidoxime reducing component 2 decreases expression ISO Thimerosal results in decreased expression of MTARC2 mRNA CTD PMID:27188386 NCBI chr13:96,362,810...96,397,284 JBrowse link
G Mtcl2 microtubule crosslinking factor 2 increases expression ISO Thimerosal results in increased expression of MTCL2 mRNA CTD PMID:27188386 NCBI chr 3:145,669,102...145,741,578
Ensembl chr 3:145,675,443...145,740,871 		JBrowse link
G Mtcl3 MTCL family member 3 decreases expression ISO Thimerosal results in decreased expression of MTCL3 mRNA CTD PMID:27188386 NCBI chr 1:28,629,036...28,701,416
Ensembl chr 1:28,620,293...28,701,796 		JBrowse link
G Mtfp1 mitochondrial fission process 1 decreases expression ISO Thimerosal results in decreased expression of MTFP1 mRNA CTD PMID:27188386 NCBI chr14:78,968,434...78,972,274
Ensembl chr14:78,968,442...78,972,274 		JBrowse link
G Mthfd2l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like increases expression ISO Thimerosal results in increased expression of MTHFD2L mRNA CTD PMID:27188386 NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112 		JBrowse link
G Mtpap mitochondrial poly(A) polymerase increases expression ISO Thimerosal results in increased expression of MTPAP mRNA CTD PMID:27188386 NCBI chr17:53,320,739...53,341,500
Ensembl chr17:53,320,741...53,341,538 		JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase multiple interactions
decreases expression 		ISO Glutathione inhibits the reaction [Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein]; Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form]
Thimerosal results in decreased expression of MTR mRNA 		CTD PMID:14745455 PMID:26989453 PMID:27188386 NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822 		JBrowse link
G Mvb12a multivesicular body subunit 12A decreases expression ISO Thimerosal results in decreased expression of MVB12A mRNA CTD PMID:27188386 NCBI chr16:18,252,227...18,257,111
Ensembl chr16:18,252,222...18,257,539 		JBrowse link
G Mxd1 max dimerization protein 1 increases expression ISO Thimerosal results in increased expression of MXD1 mRNA CTD PMID:16870260 NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751 		JBrowse link
G Mxra8 matrix remodeling associated 8 decreases expression ISO Thimerosal results in decreased expression of MXRA8 mRNA CTD PMID:27188386 NCBI chr 5:166,448,919...166,453,645
Ensembl chr 5:166,449,154...166,453,636 		JBrowse link
G Mynn myoneurin increases expression ISO Thimerosal results in increased expression of MYNN mRNA CTD PMID:27188386 NCBI chr 2:112,779,654...112,797,188
Ensembl chr 2:112,779,657...112,796,397 		JBrowse link
G Myo1e myosin IE decreases expression ISO Thimerosal results in decreased expression of MYO1E mRNA CTD PMID:27188386 NCBI chr 8:70,887,934...71,080,180
Ensembl chr 8:70,887,870...71,080,169 		JBrowse link
G Myo5a myosin VA decreases expression ISO Thimerosal results in decreased expression of MYO5A mRNA CTD PMID:27188386 NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918 		JBrowse link
G Myo6 myosin VI decreases expression ISO Thimerosal results in decreased expression of MYO6 mRNA CTD PMID:27188386 NCBI chr 8:81,087,157...81,242,022
Ensembl chr 8:81,087,139...81,239,292 		JBrowse link
G Myo9a myosin IXA increases expression ISO Thimerosal results in increased expression of MYO9A mRNA CTD PMID:27188386 NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514 		JBrowse link
G Mzf1 myeloid zinc finger 1 decreases expression ISO Thimerosal results in decreased expression of MZF1 mRNA CTD PMID:24675092 NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635 		JBrowse link
G N4bp2l2 NEDD4 binding protein 2-like 2 increases expression ISO Thimerosal results in increased expression of N4BP2L2 mRNA CTD PMID:27188386 NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784 		JBrowse link
G N4bp3 Nedd4 binding protein 3 decreases expression ISO Thimerosal results in decreased expression of N4BP3 mRNA CTD PMID:27188386 NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001 		JBrowse link
G Naa16 N(alpha)-acetyltransferase 16, NatA auxiliary subunit decreases expression ISO Thimerosal results in decreased expression of NAA16 mRNA CTD PMID:27188386 NCBI chr15:61,120,704...61,179,979
Ensembl chr15:54,711,621...54,770,896 		JBrowse link
G Naaa N-acylethanolamine acid amidase increases expression ISO Thimerosal results in increased expression of NAAA mRNA CTD PMID:27188386 NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410 		JBrowse link
G Naprt nicotinate phosphoribosyltransferase decreases expression ISO Thimerosal results in decreased expression of NAPRT mRNA CTD PMID:27188386 NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102 		JBrowse link
G Nasp nuclear autoantigenic sperm protein decreases expression ISO Thimerosal results in decreased expression of NASP mRNA CTD PMID:27188386 NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928 		JBrowse link
G Natd1 N-acetyltransferase domain containing 1 decreases expression ISO Thimerosal results in decreased expression of NATD1 mRNA CTD PMID:27188386 NCBI chr10:46,079,650...46,089,829 JBrowse link
G Nav3 neuron navigator 3 increases expression ISO Thimerosal results in increased expression of NAV3 mRNA CTD PMID:27188386 NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:45,054,296...45,840,698 		JBrowse link
G Nbas NBAS subunit of NRZ tethering complex decreases expression ISO Thimerosal results in decreased expression of NBAS mRNA CTD PMID:27188386 NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984 		JBrowse link
G Ncam1 neural cell adhesion molecule 1 decreases expression ISO Thimerosal results in decreased expression of NCAM1 mRNA CTD PMID:27188386 NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014 		JBrowse link
G Ndrg1 N-myc downstream regulated 1 decreases expression ISO Thimerosal results in decreased expression of NDRG1 mRNA CTD PMID:27188386 NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880 		JBrowse link
G Ndufa5 NADH:ubiquinone oxidoreductase subunit A5 increases expression ISO Thimerosal results in increased expression of NDUFA5 mRNA CTD PMID:27188386 NCBI chr 4:53,962,877...53,971,235
Ensembl chr 4:52,995,546...53,005,598
Ensembl chr 5:52,995,546...53,005,598 		JBrowse link
G Ndufa9 NADH:ubiquinone oxidoreductase subunit A9 increases expression ISO Thimerosal results in increased expression of NDUFA9 mRNA CTD PMID:27188386 NCBI chr 4:161,345,398...161,374,188
Ensembl chr 4:159,659,242...159,688,018 		JBrowse link
G Ndufaf4 NADH:ubiquinone oxidoreductase complex assembly factor 4 increases expression ISO Thimerosal results in increased expression of NDUFAF4 mRNA CTD PMID:27188386 NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336 		JBrowse link
G Ndufb7 NADH:ubiquinone oxidoreductase subunit B7 decreases expression ISO Thimerosal results in decreased expression of NDUFB7 mRNA CTD PMID:27188386 NCBI chr19:41,472,953...41,477,291
Ensembl chr19:24,568,241...24,572,579 		JBrowse link
G Nefh neurofilament heavy chain decreases expression ISO Thimerosal results in decreased expression of NEFH mRNA CTD PMID:27188386 NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351 		JBrowse link
G Negr1 neuronal growth regulator 1 decreases expression ISO Thimerosal results in decreased expression of NEGR1 mRNA CTD PMID:27188386 NCBI chr 2:245,624,460...246,359,605
Ensembl chr 2:245,624,435...246,356,730 		JBrowse link
G Nes nestin decreases expression ISO Thimerosal results in decreased expression of NES mRNA CTD PMID:27188386 NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777 		JBrowse link
G Nf1 neurofibromin 1 affects expression ISO Thimerosal affects the expression of NF1 mRNA CTD PMID:27188386 NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,306,301...64,536,658 		JBrowse link
G Nfat5 nuclear factor of activated T-cells 5 decreases expression ISO Thimerosal results in decreased expression of NFAT5 mRNA CTD PMID:27188386 NCBI chr19:52,108,982...52,196,418
Ensembl chr19:35,199,016...35,286,675 		JBrowse link
G Nfatc2ip nuclear factor of activated T-cells 2 interacting protein decreases expression ISO Thimerosal results in decreased expression of NFATC2IP mRNA CTD PMID:27188386 NCBI chr 1:190,385,416...190,403,309
Ensembl chr 1:180,955,043...180,971,747 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression
multiple interactions 		ISO Thimerosal results in increased expression of NFE2L2 protein
Aluminum Hydroxide promotes the reaction [Thimerosal results in increased expression of NFE2L2 protein] 		CTD PMID:36411272 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfyb nuclear transcription factor Y subunit beta increases expression ISO Thimerosal results in increased expression of NFYB mRNA CTD PMID:27188386 NCBI chr 7:22,852,543...22,868,116
Ensembl chr 7:20,964,993...20,980,565 		JBrowse link
G Ngf nerve growth factor multiple interactions
decreases response to substance 		ISO [Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein
NGF protein results in decreased susceptibility to Thimerosal 		CTD PMID:15843506 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452 		JBrowse link
G Nipal3 NIPA-like domain containing 3 decreases expression ISO Thimerosal results in decreased expression of NIPAL3 mRNA CTD PMID:27188386 NCBI chr 5:147,687,310...147,725,838
Ensembl chr 5:147,685,288...147,726,351 		JBrowse link
G Nipbl NIPBL, cohesin loading factor decreases expression ISO Thimerosal results in decreased expression of NIPBL mRNA CTD PMID:27188386 NCBI chr 2:57,399,443...57,586,770
Ensembl chr 2:57,399,445...57,565,899 		JBrowse link
G Nipsnap1 nipsnap homolog 1 decreases expression ISO Thimerosal results in decreased expression of NIPSNAP1 mRNA CTD PMID:27188386 NCBI chr14:79,734,234...79,758,101
Ensembl chr14:79,734,209...79,758,098 		JBrowse link
G Nkain2 sodium/potassium transporting ATPase interacting 2 decreases expression ISO Thimerosal results in decreased expression of NKAIN2 mRNA CTD PMID:24675092 NCBI chr 1:24,668,627...25,877,051
Ensembl chr 1:24,669,462...25,877,064 		JBrowse link
G Nlrx1 NLR family member X1 decreases expression ISO Thimerosal results in decreased expression of NLRX1 mRNA CTD PMID:24675092 NCBI chr 8:44,588,476...44,606,678
Ensembl chr 8:44,590,048...44,606,484 		JBrowse link
G Nme4 NME/NM23 nucleoside diphosphate kinase 4 decreases expression ISO Thimerosal results in decreased expression of NME4 mRNA CTD PMID:27188386 NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479 		JBrowse link
G Nog noggin multiple interactions
decreases expression 		ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP1LC3C mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNM2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPSECS mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLCO4A1-AS1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHF2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POP1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAPCD2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A21 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA
Thimerosal results in decreased expression of NOG mRNA 		CTD PMID:27188386 NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,128,712...74,130,339 		JBrowse link
G Nol3 nucleolar protein 3 decreases expression ISO Thimerosal results in decreased expression of NOL3 mRNA CTD PMID:27188386 NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250 		JBrowse link
G Nop53 NOP53 ribosome biogenesis factor decreases expression ISO Thimerosal results in decreased expression of NOP53 mRNA CTD PMID:27188386 NCBI chr 1:85,757,271...85,765,089
Ensembl chr 1:76,629,069...76,636,902 		JBrowse link
G Npas3 neuronal PAS domain protein 3 increases expression ISO Thimerosal results in increased expression of NPAS3 mRNA CTD PMID:24675092 NCBI chr 6:70,702,773...71,527,928
Ensembl chr 6:70,703,170...71,524,884 		JBrowse link
G Npat nuclear protein, co-activator of histone transcription increases expression ISO Thimerosal results in increased expression of NPAT mRNA CTD PMID:16870260 NCBI chr 8:53,932,993...53,970,875
Ensembl chr 8:53,932,993...53,970,875 		JBrowse link
G Nphp1 nephrocystin 1 increases expression ISO Thimerosal results in increased expression of NPHP1 mRNA CTD PMID:27188386 NCBI chr 3:135,413,927...135,469,505
Ensembl chr 3:114,960,650...115,016,234 		JBrowse link
G Nprl3 NPR3-like, GATOR1 complex subunit decreases expression ISO Thimerosal results in decreased expression of NPRL3 mRNA CTD PMID:27188386 NCBI chr10:15,355,361...15,395,812
Ensembl chr10:15,355,355...15,395,810 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression ISO Thimerosal results in increased expression of NQO1 mRNA CTD PMID:27188386 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557 		JBrowse link
G Nr2c2 nuclear receptor subfamily 2, group C, member 2 decreases expression ISO Thimerosal results in decreased expression of NR2C2 mRNA CTD PMID:27188386 NCBI chr 4:124,610,216...124,666,813
Ensembl chr 4:124,608,960...124,661,902 		JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 increases expression ISO Thimerosal results in increased expression of NR4A1 mRNA CTD PMID:16870260 NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297 		JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 increases expression ISO Thimerosal results in increased expression of NR4A2 mRNA CTD PMID:16870260 NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:41,689,851...41,697,877 		JBrowse link
G Nrdc nardilysin convertase increases expression ISO Thimerosal results in increased expression of NRDC mRNA CTD PMID:27188386 NCBI chr 5:128,983,395...129,047,578
Ensembl chr 5:123,755,806...123,818,595 		JBrowse link
G Nrm nurim decreases expression ISO Thimerosal results in decreased expression of NRM mRNA CTD PMID:27188386 NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802 		JBrowse link
G Nt5dc2 5'-nucleotidase domain containing 2 decreases expression ISO Thimerosal results in decreased expression of NT5DC2 mRNA CTD PMID:27188386 NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537 		JBrowse link
G Ntrk1 neurotrophic receptor tyrosine kinase 1 multiple interactions ISO [Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein CTD PMID:15843506 NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:173,236,963...173,253,770 		JBrowse link
G Ntrk3 neurotrophic receptor tyrosine kinase 3 decreases expression ISO Thimerosal results in decreased expression of NTRK3 mRNA CTD PMID:24675092 NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:132,132,849...132,503,286 		JBrowse link
G Nub1 negative regulator of ubiquitin-like proteins 1 decreases expression ISO Thimerosal results in decreased expression of NUB1 mRNA CTD PMID:27188386 NCBI chr 4:11,335,376...11,366,263
Ensembl chr 4:10,442,917...10,473,694 		JBrowse link
G Nynrin NYN domain and retroviral integrase containing decreases expression ISO Thimerosal results in decreased expression of NYNRIN mRNA CTD PMID:27188386 NCBI chr15:29,332,873...29,355,215
Ensembl chr15:29,332,869...29,355,215 		JBrowse link
G Obi1 ORC ubiquitin ligase 1 increases expression ISO Thimerosal results in increased expression of OBI1 mRNA CTD PMID:27188386 NCBI chr15:81,269,413...81,308,734
Ensembl chr15:81,269,416...81,308,734 		JBrowse link
G Obsl1 obscurin like cytoskeletal adaptor 1 decreases expression ISO Thimerosal results in decreased expression of OBSL1 mRNA CTD PMID:27188386 NCBI chr 9:76,967,802...76,993,771
Ensembl chr 9:76,974,253...76,993,560 		JBrowse link
G Ociad1 OCIA domain containing 1 decreases expression ISO Thimerosal results in decreased expression of OCIAD1 mRNA CTD PMID:27188386 NCBI chr14:34,897,851...34,915,291
Ensembl chr14:34,897,847...34,915,286 		JBrowse link
G Omp olfactory marker protein increases expression ISO Thimerosal results in increased expression of OMP mRNA CTD PMID:24675092 NCBI chr 1:152,440,278...152,440,828
Ensembl chr 1:152,433,652...152,441,922 		JBrowse link
G Osbpl8 oxysterol binding protein-like 8 decreases expression ISO Thimerosal results in decreased expression of OSBPL8 mRNA CTD PMID:27188386 NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888 		JBrowse link
G Otub2 OTU deubiquitinase, ubiquitin aldehyde binding 2 decreases expression ISO Thimerosal results in decreased expression of OTUB2 mRNA CTD PMID:27188386 NCBI chr 6:122,545,067...122,563,657
Ensembl chr 6:122,545,061...122,563,644 		JBrowse link
G Otud4 OTU deubiquitinase 4 decreases expression ISO Thimerosal results in decreased expression of OTUD4 mRNA CTD PMID:27188386 NCBI chr19:28,236,713...28,279,815
Ensembl chr19:28,236,713...28,279,815 		JBrowse link
G Otud6b OTU deubiquitinase 6B increases expression ISO Thimerosal results in increased expression of OTUD6B mRNA CTD PMID:27188386 NCBI chr 5:28,181,992...28,214,486
Ensembl chr 5:28,023,594...28,214,334 		JBrowse link
G Otulinl OTU deubiquitinase with linear linkage specificity like multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA CTD PMID:27188386 NCBI chr 2:80,136,411...80,164,290
Ensembl chr 2:78,408,593...78,433,838 		JBrowse link
G P4ha1 prolyl 4-hydroxylase subunit alpha 1 decreases expression ISO Thimerosal results in decreased expression of P4HA1 mRNA CTD PMID:27188386 NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,302,141...27,352,786 		JBrowse link
G Pacsin1 protein kinase C and casein kinase substrate in neurons 1 decreases expression ISO Thimerosal results in decreased expression of PACSIN1 mRNA CTD PMID:27188386 NCBI chr20:5,718,134...5,768,064
Ensembl chr20:5,719,857...5,765,313 		JBrowse link
G Paip2b poly(A) binding protein interacting protein 2B decreases expression ISO Thimerosal results in decreased expression of PAIP2B mRNA CTD PMID:27188386 NCBI chr 4:117,849,625...117,881,021
Ensembl chr 4:116,292,020...116,323,379 		JBrowse link
G Pald1 phosphatase domain containing, paladin 1 decreases expression ISO Thimerosal results in decreased expression of PALD1 mRNA CTD PMID:27188386 NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858 		JBrowse link
G Pank2 pantothenate kinase 2 increases expression ISO Thimerosal results in increased expression of PANK2 mRNA CTD PMID:27188386 NCBI chr 3:138,936,448...138,974,196
Ensembl chr 3:118,483,444...118,518,320 		JBrowse link
G Pard3b par-3 family cell polarity regulator beta increases expression ISO Thimerosal results in increased expression of PARD3B mRNA CTD PMID:24675092 NCBI chr 9:70,532,358...71,561,044
Ensembl chr 9:63,038,436...64,068,053 		JBrowse link
G Parpbp PARP1 binding protein increases expression ISO Thimerosal results in increased expression of PARPBP mRNA CTD PMID:27188386 NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695 		JBrowse link
G Pc pyruvate carboxylase decreases expression ISO Thimerosal results in decreased expression of PC mRNA CTD PMID:27188386 NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:201,804,267...201,898,380 		JBrowse link
G Pcbp2 poly(rC) binding protein 2 decreases expression ISO Thimerosal results in decreased expression of PCBP2 mRNA CTD PMID:27188386 NCBI chr 7:133,605,375...133,631,312
Ensembl chr 7:133,605,573...133,629,863 		JBrowse link
G Pcdha9 protocadherin alpha 9 increases expression ISO Thimerosal results in increased expression of PCDHA9 mRNA CTD PMID:27188386 Ensembl chr18:28,581,225...28,846,211 JBrowse link
G Pclo piccolo (presynaptic cytomatrix protein) increases expression ISO Thimerosal results in increased expression of PCLO mRNA CTD PMID:27188386 NCBI chr 4:19,691,439...20,050,015
Ensembl chr 4:19,695,315...20,049,885 		JBrowse link
G Pcm1 pericentriolar material 1 decreases expression ISO Thimerosal results in decreased expression of PCM1 mRNA CTD PMID:27188386 NCBI chr16:51,008,315...51,105,261
Ensembl chr16:51,008,315...51,105,091 		JBrowse link
G Pcnp PEST proteolytic signal containing nuclear protein decreases expression ISO Thimerosal results in decreased expression of PCNP mRNA CTD PMID:27188386 NCBI chr11:44,592,766...44,607,372
Ensembl chr11:44,592,742...44,607,348 		JBrowse link
G Pcnx1 pecanex 1 increases expression ISO Thimerosal results in increased expression of PCNX1 mRNA CTD PMID:27188386 NCBI chr 6:101,565,461...101,702,339
Ensembl chr 6:101,565,580...101,702,271 		JBrowse link
G Pcp4 Purkinje cell protein 4 increases expression ISO Thimerosal results in increased expression of PCP4 mRNA CTD PMID:27188386 NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725 		JBrowse link
G Pcsk2 proprotein convertase subtilisin/kexin type 2 increases expression ISO Thimerosal results in increased expression of PCSK2 mRNA CTD PMID:27188386 NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 decreases expression ISO Thimerosal results in decreased expression of PDIA3 mRNA CTD PMID:27188386 NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:108,388,245...108,413,236 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 decreases expression ISO Thimerosal results in decreased expression of PDK1 mRNA CTD PMID:27188386 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:56,705,871...56,733,038 		JBrowse link
G Pdlim4 PDZ and LIM domain 4 decreases expression ISO Thimerosal results in decreased expression of PDLIM4 mRNA CTD PMID:27188386 NCBI chr10:38,699,444...38,713,696
Ensembl chr10:38,198,689...38,212,938 		JBrowse link
G Pdss2 decaprenyl diphosphate synthase subunit 2 decreases expression ISO Thimerosal results in decreased expression of PDSS2 mRNA CTD PMID:27188386 NCBI chr20:46,709,631...46,938,704
Ensembl chr20:46,709,649...46,938,708 		JBrowse link
G Pdyn prodynorphin multiple interactions ISO [SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA] CTD PMID:30503815 NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334 		JBrowse link
G Peds1 plasmanylethanolamine desaturase 1 decreases expression ISO Thimerosal results in decreased expression of PEDS1 mRNA CTD PMID:27188386 NCBI chr 3:156,350,135...156,369,309
Ensembl chr 3:156,349,526...156,369,314 		JBrowse link
G Pelp1 proline, glutamate and leucine rich protein 1 decreases expression ISO Thimerosal results in decreased expression of PELP1 mRNA CTD PMID:27188386 NCBI chr10:55,094,798...55,111,833
Ensembl chr10:55,094,796...55,111,994 		JBrowse link
G Pex6 peroxisomal biogenesis factor 6 decreases expression ISO Thimerosal results in decreased expression of PEX6 mRNA CTD PMID:27188386 NCBI chr 9:14,258,145...14,270,335
Ensembl chr 9:14,258,145...14,270,303 		JBrowse link
G Pfdn4 prefoldin subunit 4 increases expression ISO Thimerosal results in increased expression of PFDN4 mRNA CTD PMID:27188386 NCBI chr 3:159,303,173...159,311,221
Ensembl chr 3:159,303,071...159,311,219 		JBrowse link
G Pfkfb2 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 decreases expression ISO Thimerosal results in decreased expression of PFKFB2 mRNA CTD PMID:27188386 NCBI chr13:42,147,473...42,174,699
Ensembl chr13:42,147,478...42,174,699 		JBrowse link
G Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 decreases expression ISO Thimerosal results in decreased expression of PFKFB4 mRNA CTD PMID:27188386 NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634 		JBrowse link
G Pfkp phosphofructokinase, platelet decreases expression ISO Thimerosal results in decreased expression of PFKP mRNA CTD PMID:27188386 NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018 		JBrowse link
G Pfn1 profilin 1 decreases expression ISO Thimerosal results in decreased expression of PFN1 mRNA CTD PMID:27188386 NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631 		JBrowse link
G Pgam1 phosphoglycerate mutase 1 decreases expression ISO Thimerosal results in decreased expression of PGAM1 mRNA CTD PMID:27188386 NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452 		JBrowse link
G Pgap1 post-GPI attachment to proteins inositol deacylase 1 increases expression ISO Thimerosal results in increased expression of PGAP1 mRNA CTD PMID:27188386 NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:55,975,667...56,044,464 		JBrowse link
G Pgap2 post-GPI attachment to proteins 2 decreases expression ISO Thimerosal results in decreased expression of PGAP2 mRNA CTD PMID:27188386 NCBI chr 1:156,591,540...156,618,116
Ensembl chr 1:156,591,615...156,618,114 		JBrowse link
G Pgap4 post-GPI attachment to proteins GalNAc transferase 4 decreases expression ISO Thimerosal results in decreased expression of PGAP4 mRNA CTD PMID:27188386 NCBI chr 5:63,931,916...63,947,004
Ensembl chr 5:63,930,682...63,951,716 		JBrowse link
G Pgap6 post-GPI attachment to proteins 6 decreases expression ISO Thimerosal results in decreased expression of PGAP6 mRNA CTD PMID:27188386 NCBI chr10:15,138,918...15,148,431
Ensembl chr10:15,138,959...15,148,431 		JBrowse link
G Pgf placental growth factor increases expression ISO Thimerosal results in increased expression of PGF mRNA CTD PMID:16870260 NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685 		JBrowse link
G Pgk1 phosphoglycerate kinase 1 decreases expression ISO Thimerosal results in decreased expression of PGK1 mRNA CTD PMID:27188386 NCBI chr  X:75,336,988...75,352,962
Ensembl chr  X:71,271,440...71,287,418 		JBrowse link
G Pgls 6-phosphogluconolactonase decreases expression ISO Thimerosal results in decreased expression of PGLS mRNA CTD PMID:27188386 NCBI chr16:18,300,317...18,305,803
Ensembl chr16:18,300,317...18,305,803 		JBrowse link
G Pgm1 phosphoglucomutase 1 decreases expression ISO Thimerosal results in decreased expression of PGM1 mRNA CTD PMID:27188386 NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728 		JBrowse link
G Pgpep1 pyroglutamyl-peptidase I decreases expression ISO Thimerosal results in decreased expression of PGPEP1 mRNA CTD PMID:27188386 NCBI chr16:18,770,563...18,782,968
Ensembl chr16:18,771,021...18,783,478 		JBrowse link
G Phax phosphorylated adaptor for RNA export increases expression ISO Thimerosal results in increased expression of PHAX mRNA CTD PMID:27188386 NCBI chr18:50,053,133...50,069,823
Ensembl chr18:50,053,023...50,069,823 		JBrowse link
G Phf20 PHD finger protein 20 increases expression ISO Thimerosal results in increased expression of PHF20 mRNA CTD PMID:27188386 NCBI chr 3:144,710,253...144,816,696
Ensembl chr 3:144,710,353...144,814,439 		JBrowse link
G Phf20l1 PHD finger protein 20-like 1 decreases expression ISO Thimerosal results in decreased expression of PHF20L1 mRNA CTD PMID:16870260 NCBI chr 7:98,330,580...98,396,526
Ensembl chr 7:98,330,580...98,396,526 		JBrowse link
G Phf21a PHD finger protein 21A decreases expression ISO Thimerosal results in decreased expression of PHF21A mRNA CTD PMID:27188386 NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865 		JBrowse link
G Phkb phosphorylase kinase regulatory subunit beta decreases expression ISO Thimerosal results in decreased expression of PHKB mRNA CTD PMID:27188386 NCBI chr19:37,179,937...37,383,979
Ensembl chr19:21,025,733...21,210,633 		JBrowse link
G Phldb2 pleckstrin homology-like domain, family B, member 2 decreases expression ISO Thimerosal results in decreased expression of PHLDB2 mRNA CTD PMID:27188386 NCBI chr11:54,859,173...55,078,212
Ensembl chr11:54,859,135...55,078,467 		JBrowse link
G Phldb3 pleckstrin homology-like domain, family B, member 3 decreases expression ISO Thimerosal results in decreased expression of PHLDB3 mRNA CTD PMID:27188386 NCBI chr 1:89,328,991...89,347,446
Ensembl chr 1:80,201,578...80,219,534 		JBrowse link
G Phtf2 putative homeodomain transcription factor 2 increases expression ISO Thimerosal results in increased expression of PHTF2 mRNA CTD PMID:27188386 NCBI chr 4:14,215,190...14,330,549
Ensembl chr 4:14,215,263...14,330,513 		JBrowse link
G Pi4k2a phosphatidylinositol 4-kinase type 2 alpha decreases expression ISO Thimerosal results in decreased expression of PI4K2A mRNA CTD PMID:27188386 NCBI chr 1:240,902,804...240,929,234
Ensembl chr 1:240,902,855...240,929,337 		JBrowse link
G Pias2 protein inhibitor of activated STAT, 2 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA CTD PMID:27188386 NCBI chr18:72,883,008...72,989,486
Ensembl chr18:70,607,665...70,710,033 		JBrowse link
G Pik3c2a phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha increases expression ISO Thimerosal results in increased expression of PIK3C2A mRNA CTD PMID:27188386 NCBI chr 1:170,577,942...170,684,353
Ensembl chr 1:170,577,942...170,683,472 		JBrowse link
G Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha increases expression ISO Thimerosal results in increased expression of PIK3CA mRNA CTD PMID:27188386 NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032 		JBrowse link
G Pin4 peptidylprolyl cis/trans isomerase, NIMA-interacting 4 decreases expression ISO Thimerosal results in decreased expression of PIN4 mRNA CTD PMID:27188386 NCBI chr  X:67,232,066...67,238,709
Ensembl chr  X:67,232,081...67,238,702 		JBrowse link
G Pir pirin increases expression ISO Thimerosal results in increased expression of PIR mRNA CTD PMID:27188386 NCBI chr  X:33,740,428...33,851,049
Ensembl chr  X:30,108,538...30,219,218 		JBrowse link
G Pitpnm2 phosphatidylinositol transfer protein, membrane-associated 2 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNM2 mRNA CTD PMID:27188386 NCBI chr12:32,347,455...32,479,103
Ensembl chr12:32,380,805...32,479,102 		JBrowse link
G Pkn3 protein kinase N3 decreases expression ISO Thimerosal results in decreased expression of PKN3 mRNA CTD PMID:27188386 NCBI chr 3:33,747,610...33,761,405
Ensembl chr 3:13,335,041...13,363,567 		JBrowse link
G Plaat1 phospholipase A and acyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of PLAAT1 mRNA CTD PMID:27188386 NCBI chr11:71,517,492...71,537,142
Ensembl chr11:71,517,493...71,527,020 		JBrowse link
G Plcb4 phospholipase C, beta 4 decreases expression ISO Thimerosal results in decreased expression of PLCB4 mRNA CTD PMID:27188386 NCBI chr 3:122,952,965...123,322,522
Ensembl chr 3:122,953,196...123,322,392 		JBrowse link
G Plcg1 phospholipase C, gamma 1 increases cleavage ISO Thimerosal results in increased cleavage of PLCG1 protein CTD PMID:16649253 NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330 		JBrowse link
G Plekha2 pleckstrin homology domain containing A2 decreases expression ISO Thimerosal results in decreased expression of PLEKHA2 mRNA CTD PMID:27188386 NCBI chr16:73,641,338...73,704,068
Ensembl chr16:66,939,109...66,999,395 		JBrowse link
G Plekha5 pleckstrin homology domain containing A5 decreases expression ISO Thimerosal results in decreased expression of PLEKHA5 mRNA CTD PMID:27188386 NCBI chr 4:173,333,891...173,503,546
Ensembl chr 4:173,334,055...173,503,546 		JBrowse link
G Plekha6 pleckstrin homology domain containing A6 decreases expression ISO Thimerosal results in decreased expression of PLEKHA6 mRNA CTD PMID:24675092 NCBI chr13:44,614,740...44,754,951
Ensembl chr13:44,615,011...44,754,673 		JBrowse link
G Plekhb1 pleckstrin homology domain containing B1 decreases expression ISO Thimerosal results in decreased expression of PLEKHB1 mRNA CTD PMID:27188386 NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142 		JBrowse link
G Plekhf2 pleckstrin homology and FYVE domain containing 2 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHF2 mRNA CTD PMID:27188386 NCBI chr 5:24,091,077...24,106,758
Ensembl chr 5:24,090,688...24,106,601 		JBrowse link
G Plekhg4 pleckstrin homology and RhoGEF domain containing G4 decreases expression ISO Thimerosal results in decreased expression of PLEKHG4 mRNA CTD PMID:27188386 NCBI chr19:50,161,722...50,176,491
Ensembl chr19:33,249,706...33,266,357 		JBrowse link
G Plk2 polo-like kinase 2 increases expression ISO Thimerosal results in increased expression of PLK2 mRNA CTD PMID:16870260 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:41,969,176...41,974,947 		JBrowse link
G Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 decreases expression ISO Thimerosal results in decreased expression of PLOD1 mRNA CTD PMID:27188386 NCBI chr 5:163,623,847...163,650,737
Ensembl chr 5:158,340,490...158,367,620 		JBrowse link
G Plppr3 phospholipid phosphatase related 3 decreases expression ISO Thimerosal results in decreased expression of PLPPR3 mRNA CTD PMID:27188386 NCBI chr 7:9,831,162...9,842,434
Ensembl chr 7:9,831,162...9,845,296 		JBrowse link
G Plxnc1 plexin C1 decreases expression ISO Thimerosal results in decreased expression of PLXNC1 mRNA CTD PMID:27188386 NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779 		JBrowse link
G Pmch pro-melanin-concentrating hormone increases expression ISO Thimerosal results in increased expression of PMCH mRNA CTD PMID:27188386 NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250 		JBrowse link
G Pml PML nuclear body scaffold decreases expression ISO Thimerosal results in decreased expression of PML mRNA CTD PMID:27188386 NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971 		JBrowse link
G Pnpla3 patatin-like phospholipase domain containing 3 decreases expression ISO Thimerosal results in decreased expression of PNPLA3 mRNA CTD PMID:27188386 NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077 		JBrowse link
G Pole4 DNA polymerase epsilon 4, accessory subunit increases expression ISO Thimerosal results in increased expression of POLE4 mRNA CTD PMID:27188386 NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:115,165,285...115,171,097 		JBrowse link
G Polrmt RNA polymerase mitochondrial decreases expression ISO Thimerosal results in decreased expression of POLRMT mRNA CTD PMID:27188386 NCBI chr 7:9,959,532...9,969,791
Ensembl chr 7:9,959,576...9,969,791 		JBrowse link
G Pomc proopiomelanocortin increases expression ISO Thimerosal results in increased expression of POMC mRNA; Thimerosal results in increased expression of POMC protein CTD PMID:24675092 NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664 		JBrowse link
G Pomgnt2 protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) decreases expression ISO Thimerosal results in decreased expression of POMGNT2 mRNA CTD PMID:27188386 NCBI chr 8:130,522,607...130,538,273
Ensembl chr 8:121,644,970...121,660,757 		JBrowse link
G Pop1 POP1 homolog, ribonuclease P/MRP subunit multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POP1 mRNA CTD PMID:27188386 NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141 		JBrowse link
G Pou1f1 POU class 1 homeobox 1 increases expression ISO Thimerosal results in increased expression of POU1F1 mRNA CTD PMID:24675092 NCBI chr11:16,763,312...16,781,295
Ensembl chr11:3,317,058...3,334,801 		JBrowse link
G Ppfia4 PTPRF interacting protein alpha 4 decreases expression ISO Thimerosal results in decreased expression of PPFIA4 mRNA CTD PMID:27188386 NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261 		JBrowse link
G Ppfibp1 PPFIA binding protein 1 decreases expression ISO Thimerosal results in decreased expression of PPFIBP1 mRNA CTD PMID:27188386 NCBI chr 4:179,807,579...179,951,428
Ensembl chr 4:179,808,794...179,951,428 		JBrowse link
G Ppia peptidylprolyl isomerase A decreases expression ISO Thimerosal results in decreased expression of PPIA mRNA CTD PMID:27188386 NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601 		JBrowse link
G Ppil2 peptidylprolyl isomerase like 2 decreases expression ISO Thimerosal results in decreased expression of PPIL2 mRNA CTD PMID:27188386 NCBI chr11:83,897,719...83,920,970
Ensembl chr11:83,897,764...83,922,144 		JBrowse link
G Ppp1r14a protein phosphatase 1, regulatory (inhibitor) subunit 14A decreases expression ISO Thimerosal results in decreased expression of PPP1R14A mRNA CTD PMID:27188386 NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671 		JBrowse link
G Ppp1r3b protein phosphatase 1, regulatory subunit 3B decreases expression ISO Thimerosal results in decreased expression of PPP1R3B mRNA CTD PMID:27188386 NCBI chr16:63,533,318...63,545,683
Ensembl chr16:56,829,660...56,842,406 		JBrowse link
G Ppp1r3e protein phosphatase 1, regulatory subunit 3E decreases expression ISO Thimerosal results in decreased expression of PPP1R3E mRNA CTD PMID:27188386 NCBI chr15:28,348,443...28,349,603
Ensembl chr15:28,347,854...28,349,603 		JBrowse link
G Prdm2 PR/SET domain 2 decreases expression ISO Thimerosal results in decreased expression of PRDM2 mRNA CTD PMID:27188386 NCBI chr 5:155,421,066...155,531,884
Ensembl chr 5:155,422,134...155,531,825 		JBrowse link
G Prelid2 PRELI domain containing 2 decreases expression ISO Thimerosal results in decreased expression of PRELID2 mRNA CTD PMID:27188386 NCBI chr18:33,869,934...33,961,320
Ensembl chr18:33,873,599...33,961,225 		JBrowse link
G Prepl prolyl endopeptidase-like increases expression ISO Thimerosal results in increased expression of PREPL mRNA CTD PMID:27188386 NCBI chr 6:9,580,367...9,609,957
Ensembl chr 6:9,580,217...9,607,772 		JBrowse link
G Prex2 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 increases expression ISO Thimerosal results in increased expression of PREX2 mRNA CTD PMID:27188386 NCBI chr 5:7,937,692...8,253,112
Ensembl chr 5:7,942,573...8,253,068 		JBrowse link
G Prim2 DNA primase subunit 2 increases expression ISO Thimerosal results in increased expression of PRIM2 mRNA CTD PMID:27188386 NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:35,692,376...35,903,030 		JBrowse link
G Prima1 proline rich membrane anchor 1 decreases expression ISO Thimerosal results in decreased expression of PRIMA1 mRNA CTD PMID:27188386 NCBI chr 6:128,094,686...128,155,592
Ensembl chr 6:122,338,370...122,389,921 		JBrowse link
G Prkab2 protein kinase AMP-activated non-catalytic subunit beta 2 decreases expression ISO Thimerosal results in decreased expression of PRKAB2 mRNA CTD PMID:27188386 NCBI chr 2:187,946,008...187,961,615
Ensembl chr 2:185,257,213...185,269,872 		JBrowse link
G Prkd2 protein kinase D2 decreases expression ISO Thimerosal results in decreased expression of PRKD2 mRNA CTD PMID:27188386 NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:77,513,986...77,542,376 		JBrowse link
G Prkd3 protein kinase D3 increases expression ISO Thimerosal results in increased expression of PRKD3 mRNA CTD PMID:27188386 NCBI chr 6:16,032,507...16,108,444
Ensembl chr 6:16,032,585...16,108,443 		JBrowse link
G Prkrip1 PRKR interacting protein 1 decreases expression ISO Thimerosal results in decreased expression of PRKRIP1 mRNA CTD PMID:27188386 NCBI chr12:20,470,802...20,491,789
Ensembl chr12:20,470,820...20,489,115 		JBrowse link
G Prl prolactin increases expression ISO Thimerosal results in increased expression of PRL mRNA; Thimerosal results in increased expression of PRL protein CTD PMID:24675092 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062 		JBrowse link
G Prlr prolactin receptor increases expression ISO Thimerosal results in increased expression of PRLR mRNA CTD PMID:27188386 NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:59,134,588...59,324,718 		JBrowse link
G Prpf6 pre-mRNA processing factor 6 decreases expression ISO Thimerosal results in decreased expression of PRPF6 mRNA CTD PMID:27188386 NCBI chr 3:189,084,465...189,148,705
Ensembl chr 3:168,704,299...168,774,991 		JBrowse link
G Prr14l proline rich 14-like decreases expression ISO Thimerosal results in decreased expression of PRR14L mRNA CTD PMID:27188386 NCBI chr14:77,869,848...77,937,141
Ensembl chr14:77,869,799...77,936,521 		JBrowse link
G Prr5l proline rich 5 like decreases expression ISO Thimerosal results in decreased expression of PRR5L mRNA CTD PMID:27188386 NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:88,003,617...88,082,763 		JBrowse link
G Prrc2c proline-rich coiled-coil 2C decreases expression ISO Thimerosal results in decreased expression of PRRC2C mRNA CTD PMID:27188386 NCBI chr13:75,003,995...75,073,701
Ensembl chr13:75,004,010...75,073,643 		JBrowse link
G Prrt1 proline-rich transmembrane protein 1 decreases expression ISO Thimerosal results in decreased expression of PRRT1 mRNA CTD PMID:27188386 NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600 		JBrowse link
G Psme4 proteasome activator subunit 4 decreases expression ISO Thimerosal results in decreased expression of PSME4 mRNA CTD PMID:27188386 NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408 		JBrowse link
G Psmf1 proteasome inhibitor subunit 1 decreases expression ISO Thimerosal results in decreased expression of PSMF1 mRNA CTD PMID:27188386 NCBI chr 3:140,235,371...140,260,546
Ensembl chr 3:140,235,373...140,260,546 		JBrowse link
G Ptbp2 polypyrimidine tract binding protein 2 increases expression ISO Thimerosal results in increased expression of PTBP2 mRNA CTD PMID:27188386 NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506 		JBrowse link
G Ptchd4 patched domain containing 4 increases expression ISO Thimerosal results in increased expression of PTCHD4 mRNA CTD PMID:27188386 NCBI chr 9:18,462,934...18,666,272
Ensembl chr 9:18,463,737...18,665,705 		JBrowse link
G Ptk2 protein tyrosine kinase 2 multiple interactions
increases response to substance 		ISO [[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]
PTK2 protein results in increased susceptibility to Thimerosal 		CTD PMID:17888894 NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783 		JBrowse link
G Ptms parathymosin decreases expression ISO Thimerosal results in decreased expression of PTMS mRNA CTD PMID:27188386 NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009 		JBrowse link
G Ptov1 PTOV1, extended AT-hook containing adaptor protein decreases expression ISO Thimerosal results in decreased expression of PTOV1 mRNA CTD PMID:27188386 NCBI chr 1:95,347,065...95,354,514
Ensembl chr 1:95,347,068...95,353,613 		JBrowse link
G Ptp4a3 protein tyrosine phosphatase 4A3 decreases expression ISO Thimerosal results in decreased expression of PTP4A3 mRNA CTD PMID:27188386 NCBI chr 7:105,650,640...105,660,921
Ensembl chr 7:105,628,029...105,660,919 		JBrowse link
G Ptpn12 protein tyrosine phosphatase, non-receptor type 12 decreases expression ISO Thimerosal results in decreased expression of PTPN12 mRNA CTD PMID:27188386 NCBI chr 4:14,020,997...14,092,931
Ensembl chr 4:14,021,052...14,092,927 		JBrowse link
G Ptpn4 protein tyrosine phosphatase, non-receptor type 4 increases expression ISO Thimerosal results in increased expression of PTPN4 mRNA CTD PMID:27188386 NCBI chr13:30,772,012...30,952,340
Ensembl chr13:30,776,682...30,952,170 		JBrowse link
G Ptpra protein tyrosine phosphatase, receptor type, A decreases expression ISO Thimerosal results in decreased expression of PTPRA mRNA CTD PMID:27188386 NCBI chr 3:138,103,261...138,212,835
Ensembl chr 3:117,650,183...117,759,728 		JBrowse link
G Ptprk protein tyrosine phosphatase, receptor type, K increases expression ISO Thimerosal results in increased expression of PTPRK mRNA CTD PMID:27188386 NCBI chr 1:18,557,091...19,056,297
Ensembl chr 1:16,850,576...17,103,605 		JBrowse link
G Purb purine rich element binding protein B decreases expression ISO Thimerosal results in decreased expression of PURB mRNA CTD PMID:27188386 NCBI chr14:81,342,374...81,344,857
Ensembl chr14:81,336,448...81,351,432 		JBrowse link
G Pxmp4 peroxisomal membrane protein 4 decreases expression ISO Thimerosal results in decreased expression of PXMP4 mRNA CTD PMID:27188386 NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651 		JBrowse link
G Pygl glycogen phosphorylase L decreases expression ISO Thimerosal results in decreased expression of PYGL mRNA CTD PMID:27188386 NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:88,697,593...88,740,310 		JBrowse link
G Pyroxd1 pyridine nucleotide-disulphide oxidoreductase domain 1 increases expression ISO Thimerosal results in increased expression of PYROXD1 mRNA CTD PMID:27188386 NCBI chr 4:175,292,124...175,311,143
Ensembl chr 4:175,292,177...175,308,689 		JBrowse link
G Qprt quinolinate phosphoribosyltransferase decreases expression ISO Thimerosal results in decreased expression of QPRT mRNA CTD PMID:27188386 NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486 		JBrowse link
G Rab29 RAB29, member RAS oncogene family decreases expression ISO Thimerosal results in decreased expression of RAB29 mRNA CTD PMID:27188386 NCBI chr13:45,859,930...45,865,468
Ensembl chr13:43,307,775...43,313,417 		JBrowse link
G Rab30 RAB30, member RAS oncogene family increases expression ISO Thimerosal results in increased expression of RAB30 mRNA CTD PMID:24675092 NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181 		JBrowse link
G Rab3b RAB3B, member RAS oncogene family affects expression ISO Thimerosal affects the expression of RAB3B mRNA CTD PMID:27188386 NCBI chr 5:123,629,562...123,697,410
Ensembl chr 5:123,644,423...123,697,401 		JBrowse link
G Rab3gap1 RAB3 GTPase activating protein catalytic subunit 1 increases expression ISO Thimerosal results in increased expression of RAB3GAP1 mRNA CTD PMID:24675092 NCBI chr13:41,908,179...41,981,611
Ensembl chr13:39,352,247...39,429,169 		JBrowse link
G Rabl3 RAB, member of RAS oncogene family-like 3 increases expression ISO Thimerosal results in increased expression of RABL3 mRNA CTD PMID:27188386 NCBI chr11:76,658,723...76,687,681
Ensembl chr11:63,152,792...63,182,671 		JBrowse link
G Rad18 RAD18 E3 ubiquitin protein ligase increases expression ISO Thimerosal results in increased expression of RAD18 mRNA CTD PMID:27188386 NCBI chr 4:147,291,463...147,376,904
Ensembl chr 4:145,735,654...145,821,069 		JBrowse link
G Rad23a RAD23 homolog A, nucleotide excision repair protein decreases expression ISO Thimerosal results in decreased expression of RAD23A mRNA CTD PMID:27188386 NCBI chr19:40,219,235...40,225,543
Ensembl chr19:23,314,797...23,320,695 		JBrowse link
G Ralgapa2 Ral GTPase activating protein catalytic subunit alpha 2 increases expression ISO Thimerosal results in increased expression of RALGAPA2 mRNA CTD PMID:27188386 NCBI chr 3:133,658,725...133,938,821
Ensembl chr 3:133,659,761...133,938,916 		JBrowse link
G Rapgef2 Rap guanine nucleotide exchange factor 2 increases expression ISO Thimerosal results in increased expression of RAPGEF2 mRNA CTD PMID:27188386 NCBI chr 2:166,505,868...166,728,139
Ensembl chr 2:164,207,513...164,244,247 		JBrowse link
G Rapgef5 Rap guanine nucleotide exchange factor 5 decreases expression ISO Thimerosal results in decreased expression of RAPGEF5 mRNA CTD PMID:27188386 NCBI chr 6:138,445,184...138,679,943
Ensembl chr 6:138,437,991...138,679,936 		JBrowse link
G Rapgefl1 Rap guanine nucleotide exchange factor like 1 decreases expression ISO Thimerosal results in decreased expression of RAPGEFL1 mRNA CTD PMID:27188386 NCBI chr10:83,793,711...83,810,373
Ensembl chr10:83,793,694...83,810,371 		JBrowse link
G Rarres1 retinoic acid receptor responder 1 increases expression ISO Thimerosal results in increased expression of RARRES1 mRNA CTD PMID:27188386 NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978 		JBrowse link
G Rasa2 RAS p21 protein activator 2 increases expression ISO Thimerosal results in increased expression of RASA2 mRNA CTD PMID:27188386 NCBI chr 8:105,996,797...106,116,285
Ensembl chr 8:97,118,802...97,236,671 		JBrowse link
G Rasgef1a RasGEF domain family, member 1A increases expression
decreases expression 		ISO Thimerosal results in increased expression of RASGEF1A mRNA
Thimerosal results in decreased expression of RASGEF1A mRNA 		CTD PMID:24675092 PMID:27188386 NCBI chr 4:151,187,533...151,267,982
Ensembl chr 4:151,225,856...151,267,995 		JBrowse link
G Rassf4 Ras association domain family member 4 decreases expression ISO Thimerosal results in decreased expression of RASSF4 mRNA CTD PMID:27188386 NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411 		JBrowse link
G Rassf8 Ras association domain family member 8 decreases expression ISO Thimerosal results in decreased expression of RASSF8 mRNA CTD PMID:27188386 NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690 		JBrowse link
G Rbak RB-associated KRAB zinc finger decreases expression ISO Thimerosal results in decreased expression of RBAK mRNA CTD PMID:27188386 NCBI chr12:11,375,314...11,388,937
Ensembl chr12:11,375,318...11,388,934 		JBrowse link
G Rbfox3 RNA binding fox-1 homolog 3 decreases expression ISO Thimerosal results in decreased expression of RBFOX3 mRNA CTD PMID:27188386 NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935 		JBrowse link
G Rbm22 RNA binding motif protein 22 decreases expression ISO Thimerosal results in decreased expression of RBM22 mRNA CTD PMID:27188386 NCBI chr18:54,013,374...54,024,182
Ensembl chr18:54,013,351...54,024,569 		JBrowse link
G Rbm26 RNA binding motif protein 26 decreases expression ISO Thimerosal results in decreased expression of RBM26 mRNA CTD PMID:27188386 NCBI chr15:81,884,783...81,964,245
Ensembl chr15:81,887,219...81,964,118 		JBrowse link
G Rbm7 RNA binding motif protein 7 decreases expression ISO Thimerosal results in decreased expression of RBM7 mRNA CTD PMID:24675092 NCBI chr 8:48,831,894...48,838,399
Ensembl chr 8:48,831,894...48,838,411 		JBrowse link
G Rbm8a RNA binding motif protein 8A decreases expression ISO Thimerosal results in decreased expression of RBM8A mRNA CTD PMID:27188386 NCBI chr 2:184,165,189...184,167,959
Ensembl chr 2:184,165,193...184,167,959 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region decreases expression ISO Thimerosal results in decreased expression of RBPJ mRNA CTD PMID:24675092 NCBI chr14:61,551,366...61,736,220
Ensembl chr14:57,338,507...57,523,353 		JBrowse link
G Rbpms2 RNA binding protein, mRNA processing factor 2 decreases expression ISO Thimerosal results in decreased expression of RBPMS2 mRNA CTD PMID:27188386 NCBI chr 8:66,153,169...66,184,278
Ensembl chr 8:66,153,593...66,184,268 		JBrowse link
G Rcan3 RCAN family member 3 decreases expression ISO Thimerosal results in decreased expression of RCAN3 mRNA CTD PMID:27188386 NCBI chr 5:147,650,935...147,671,881
Ensembl chr 5:147,655,085...147,671,937 		JBrowse link
G Rcor2 REST corepressor 2 decreases expression ISO Thimerosal results in decreased expression of RCOR2 mRNA CTD PMID:27188386 NCBI chr 1:213,882,585...213,890,022
Ensembl chr 1:204,454,360...204,460,838 		JBrowse link
G Reep6 receptor accessory protein 6 decreases expression ISO Thimerosal results in decreased expression of REEP6 mRNA CTD PMID:27188386 NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:9,373,927...9,380,597 		JBrowse link
G Rell1 RELT-like 1 decreases expression ISO Thimerosal results in decreased expression of RELL1 mRNA CTD PMID:24675092 NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500 		JBrowse link
G Reps1 RALBP1 associated Eps domain containing 1 increases expression ISO Thimerosal results in increased expression of REPS1 mRNA CTD PMID:27188386 NCBI chr 1:14,517,589...14,595,404
Ensembl chr 1:12,697,747...12,775,561 		JBrowse link
G Rfc1 replication factor C subunit 1 increases expression ISO Thimerosal results in increased expression of RFC1 mRNA CTD PMID:24675092 NCBI chr14:42,966,279...43,041,372
Ensembl chr14:42,966,324...43,041,370 		JBrowse link
G Rfx7 regulatory factor X, 7 decreases expression ISO Thimerosal results in decreased expression of RFX7 mRNA CTD PMID:27188386 NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209 		JBrowse link
G Rhobtb2 Rho-related BTB domain containing 2 decreases expression ISO Thimerosal results in decreased expression of RHOBTB2 mRNA CTD PMID:27188386 NCBI chr15:44,868,251...44,888,436
Ensembl chr15:44,870,376...44,888,651 		JBrowse link
G Rhobtb3 Rho-related BTB domain containing 3 decreases expression ISO Thimerosal results in decreased expression of RHOBTB3 mRNA CTD PMID:27188386 NCBI chr 2:5,363,388...5,419,164
Ensembl chr 2:5,363,388...5,419,041 		JBrowse link
G Rhou ras homolog family member U decreases expression ISO Thimerosal results in decreased expression of RHOU mRNA CTD PMID:27188386 NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552 		JBrowse link
G Rimkla ribosomal modification protein rimK-like family member A decreases expression ISO Thimerosal results in decreased expression of RIMKLA mRNA CTD PMID:27188386 NCBI chr 5:133,072,179...133,098,840
Ensembl chr 5:133,073,960...133,098,792 		JBrowse link
G Rims1 regulating synaptic membrane exocytosis 1 increases expression ISO Thimerosal results in increased expression of RIMS1 mRNA CTD PMID:27188386 NCBI chr 9:24,696,959...25,196,404
Ensembl chr 9:24,698,854...25,196,631 		JBrowse link
G Rlig1 RNA 5'-phosphate and 3'-OH ligase 1 increases expression ISO Thimerosal results in increased expression of RLIG1 mRNA CTD PMID:27188386 NCBI chr 7:35,396,876...35,408,633
Ensembl chr 7:35,397,995...35,409,600 		JBrowse link
G Rnase4 ribonuclease A family member 4 decreases expression ISO Thimerosal results in decreased expression of RNASE4 mRNA CTD PMID:27188386 NCBI chr15:26,786,287...26,803,634
Ensembl chr15:24,312,464...24,330,117 		JBrowse link
G Rnaset2 ribonuclease T2 decreases expression ISO Thimerosal results in decreased expression of RNASET2 mRNA CTD PMID:27188386 NCBI chr 1:52,576,344...52,603,151
Ensembl chr 1:52,585,929...52,603,147 		JBrowse link
G Rnf130 ring finger protein 130 decreases expression ISO Thimerosal results in decreased expression of RNF130 mRNA CTD PMID:27188386 NCBI chr10:34,342,835...34,456,048
Ensembl chr10:34,342,830...34,456,062 		JBrowse link
G Rnf43 ring finger protein 43 decreases expression ISO Thimerosal results in decreased expression of RNF43 mRNA CTD PMID:27188386 NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977 		JBrowse link
G Rnmt RNA (guanine-7-) methyltransferase increases expression ISO Thimerosal results in increased expression of RNMT mRNA CTD PMID:27188386 NCBI chr18:61,886,230...61,909,775
Ensembl chr18:61,886,292...61,909,775 		JBrowse link
G Rora RAR-related orphan receptor A decreases expression ISO Thimerosal results in decreased expression of RORA mRNA CTD PMID:27188386 NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:69,301,733...70,025,931 		JBrowse link
G Rpl7 ribosomal protein L7 increases expression ISO Thimerosal results in increased expression of RPL7 mRNA CTD PMID:27188386 NCBI chr 5:3,217,184...3,220,192 JBrowse link
G Rps23 ribosomal protein S23 decreases expression ISO Thimerosal results in decreased expression of RPS23 mRNA CTD PMID:27188386 NCBI chr 2:22,079,339...22,080,909
Ensembl chr 2:22,079,302...22,080,918 		JBrowse link
G Rps27l ribosomal protein S27-like increases expression ISO Thimerosal results in increased expression of RPS27L mRNA CTD PMID:27188386 NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
Ensembl chr12:67,562,483...67,567,418
Ensembl chr 2:67,562,483...67,567,418 		JBrowse link
G Rrad RRAD, Ras related glycolysis inhibitor and calcium channel regulator increases expression ISO Thimerosal results in increased expression of RRAD mRNA CTD PMID:16870260 NCBI chr19:360,581...363,874
Ensembl chr19:354,198...357,417 		JBrowse link
G Rsph9 radial spoke head component 9 decreases expression ISO Thimerosal results in decreased expression of RSPH9 mRNA CTD PMID:27188386 NCBI chr 9:14,840,115...14,852,950
Ensembl chr 9:14,840,115...14,860,062 		JBrowse link
G RT1-A2 RT1 class Ia, locus A2 decreases expression ISO Thimerosal results in decreased expression of HLA-E mRNA CTD PMID:27188386 NCBI chr20:4,872,720...4,876,425 JBrowse link
G RT1-CE16 RT1 class I, locus CE16 decreases expression ISO Thimerosal results in decreased expression of HLA-A mRNA CTD PMID:27188386 NCBI chr20:3,261,656...3,265,548
Ensembl chr20:3,257,123...3,279,563 		JBrowse link
G RT1-Hb-ps1 RT1 class II, locus Hb, pseudogene 1 decreases expression ISO Thimerosal results in decreased expression of HLA-DPB1 mRNA CTD PMID:27188386 NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618 		JBrowse link
G Rtl8a retrotransposon Gag like 8A decreases expression ISO Thimerosal results in decreased expression of RTL8A mRNA CTD PMID:27188386 NCBI chr  X:133,414,027...133,415,240
Ensembl chr  X:133,414,030...133,415,240 		JBrowse link
G Rtn4r reticulon 4 receptor decreases expression ISO Thimerosal results in decreased expression of RTN4R mRNA CTD PMID:27188386 NCBI chr11:96,348,613...96,373,554
Ensembl chr11:82,844,309...82,869,466 		JBrowse link
G Rufy2 RUN and FYVE domain containing 2 increases expression ISO Thimerosal results in increased expression of RUFY2 mRNA CTD PMID:27188386 NCBI chr20:25,626,958...25,658,157
Ensembl chr20:25,621,999...25,658,186 		JBrowse link
G Rusc2 RUN and SH3 domain containing 2 decreases expression ISO Thimerosal results in decreased expression of RUSC2 mRNA CTD PMID:24675092 NCBI chr 5:62,424,185...62,471,317
Ensembl chr 5:57,629,904...57,675,524 		JBrowse link
G Ryr3 ryanodine receptor 3 increases expression ISO Thimerosal results in increased expression of RYR3 mRNA CTD PMID:27188386 NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:99,432,505...99,704,961 		JBrowse link
G Sall4 spalt-like transcription factor 4 decreases expression ISO Thimerosal results in decreased expression of SALL4 mRNA CTD PMID:27188386 NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822 		JBrowse link
G Samhd1 SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 decreases expression ISO Thimerosal results in decreased expression of SAMHD1 mRNA CTD PMID:27188386 NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386 		JBrowse link
G Sapcd2 suppressor APC domain containing 2 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAPCD2 mRNA CTD PMID:27188386 NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546 		JBrowse link
G Sar1b secretion associated, Ras related GTPase 1B increases expression ISO Thimerosal results in increased expression of SAR1B mRNA CTD PMID:27188386 NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066 		JBrowse link
G Sav1 salvador family WW domain containing protein 1 decreases expression ISO Thimerosal results in decreased expression of SAV1 mRNA CTD PMID:27188386 NCBI chr 6:88,478,536...88,500,121
Ensembl chr 6:88,478,539...88,499,968 		JBrowse link
G Saxo2 stabilizer of axonemal microtubules 2 increases expression ISO Thimerosal results in increased expression of SAXO2 mRNA CTD PMID:27188386 NCBI chr 1:136,596,445...136,638,444
Ensembl chr 1:136,623,493...136,638,454 		JBrowse link
G Scd stearoyl-CoA desaturase decreases expression ISO Thimerosal results in decreased expression of SCD mRNA CTD PMID:27188386 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Scoc short coiled-coil protein increases expression ISO Thimerosal results in increased expression of SCOC mRNA CTD PMID:27188386 NCBI chr19:24,659,651...24,689,237
Ensembl chr19:24,659,651...24,693,217 		JBrowse link
G Scrn3 secernin 3 decreases expression ISO Thimerosal results in decreased expression of SCRN3 mRNA CTD PMID:27188386 NCBI chr 3:58,188,820...58,213,623
Ensembl chr 3:58,188,889...58,213,623 		JBrowse link
G Scrt1 scratch family transcriptional repressor 1 increases expression ISO Thimerosal results in increased expression of SCRT1 mRNA CTD PMID:27188386 NCBI chr 7:110,121,640...110,125,290
Ensembl chr 7:108,240,986...108,244,636 		JBrowse link
G Scyl2 SCY1 like pseudokinase 2 decreases expression ISO Thimerosal results in decreased expression of SCYL2 mRNA CTD PMID:27188386 NCBI chr 7:24,064,404...24,117,338
Ensembl chr 7:24,064,404...24,117,305 		JBrowse link
G Sdc1 syndecan 1 decreases expression ISO Thimerosal results in decreased expression of SDC1 mRNA CTD PMID:27188386 NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:31,562,739...31,585,264 		JBrowse link
G Secisbp2l SECIS binding protein 2-like decreases expression ISO Thimerosal results in decreased expression of SECISBP2L mRNA CTD PMID:27188386 NCBI chr 3:133,443,023...133,489,467
Ensembl chr 3:112,991,908...113,035,884 		JBrowse link
G Sel1l SEL1L adaptor subunit of SYVN1 ubiquitin ligase decreases expression ISO Thimerosal results in decreased expression of SEL1L mRNA CTD PMID:27188386 NCBI chr 6:116,466,163...116,510,436
Ensembl chr 6:110,735,450...110,779,648 		JBrowse link
G Sema3f semaphorin 3F decreases expression ISO Thimerosal results in decreased expression of SEMA3F mRNA CTD PMID:27188386 NCBI chr 8:117,236,269...117,265,206
Ensembl chr 8:108,357,629...108,387,083 		JBrowse link
G Sema4f semaphorin 4F decreases expression ISO Thimerosal results in decreased expression of SEMA4F mRNA CTD PMID:27188386 NCBI chr 4:115,411,411...115,437,721
Ensembl chr 4:115,411,417...115,437,721 		JBrowse link
G Sema6a semaphorin 6A decreases expression ISO Thimerosal results in decreased expression of SEMA6A mRNA CTD PMID:27188386 NCBI chr18:40,050,623...40,171,954
Ensembl chr18:40,050,624...40,171,954 		JBrowse link
G Senp7 SUMO specific peptidase 7 increases expression ISO Thimerosal results in increased expression of SENP7 mRNA CTD PMID:27188386 NCBI chr11:44,423,733...44,584,129
Ensembl chr11:44,423,735...44,564,711 		JBrowse link
G Sepsecs Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase increases expression
multiple interactions 		ISO Thimerosal results in increased expression of SEPSECS mRNA
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPSECS mRNA 		CTD PMID:27188386 NCBI chr14:58,311,484...58,341,745
Ensembl chr14:58,311,499...58,341,740 		JBrowse link
G Septin9 septin 9 decreases expression ISO Thimerosal results in decreased expression of SEPTIN9 mRNA CTD PMID:27188386 NCBI chr10:102,409,798...102,579,056
Ensembl chr10:102,409,711...102,579,055 		JBrowse link
G Serinc2 serine incorporator 2 decreases expression ISO Thimerosal results in decreased expression of SERINC2 mRNA CTD PMID:27188386 NCBI chr 5:142,592,308...142,614,628
Ensembl chr 5:142,592,309...142,618,364 		JBrowse link
G Serpine1 serpin family E member 1 increases expression ISO Thimerosal results in increased expression of SERPINE1 mRNA CTD PMID:16870260 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657 		JBrowse link
G Serpinh1 serpin family H member 1 increases expression ISO Thimerosal results in increased expression of SERPINH1 mRNA CTD PMID:16870260 NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:153,643,510...153,650,801 		JBrowse link
G Setd2 SET domain containing 2, histone lysine methyltransferase decreases expression ISO Thimerosal results in decreased expression of SETD2 mRNA CTD PMID:27188386 NCBI chr 8:119,390,207...119,475,863
Ensembl chr 8:110,511,772...110,597,489 		JBrowse link
G Setd9-ps1 SET domain containing, pseudogene 1 increases expression ISO Thimerosal results in increased expression of SETD9 mRNA CTD PMID:27188386 NCBI chr 2:43,319,359...43,322,764 JBrowse link
G Setx senataxin decreases expression ISO Thimerosal results in decreased expression of SETX mRNA CTD PMID:27188386 NCBI chr 3:12,428,091...12,480,801
Ensembl chr 3:12,427,635...12,480,803 		JBrowse link
G Sez6l2 seizure related 6 homolog like 2 decreases expression ISO Thimerosal results in decreased expression of SEZ6L2 mRNA CTD PMID:27188386 NCBI chr 1:181,557,109...181,577,456
Ensembl chr 1:181,557,109...181,577,456 		JBrowse link
G Sf3a2 splicing factor 3A subunit 2 decreases expression ISO Thimerosal results in decreased expression of SF3A2 mRNA CTD PMID:27188386 NCBI chr 7:8,909,507...8,916,104
Ensembl chr 7:8,909,507...8,915,530 		JBrowse link
G Sf3b1 splicing factor 3b, subunit 1 decreases expression ISO Thimerosal results in decreased expression of SF3B1 mRNA CTD PMID:27188386 NCBI chr 9:56,492,403...56,532,300
Ensembl chr 9:56,492,403...56,532,300 		JBrowse link
G Sf3b4 splicing factor 3B subunit 4 decreases expression ISO Thimerosal results in decreased expression of SF3B4 mRNA CTD PMID:27188386 NCBI chr 2:183,732,791...183,737,545
Ensembl chr 2:183,732,754...183,737,959 		JBrowse link
G Sfpq splicing factor proline and glutamine rich decreases expression ISO Thimerosal results in decreased expression of SFPQ mRNA CTD PMID:27188386 NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:139,338,075...139,353,472 		JBrowse link
G Sfr1 SWI5-dependent homologous recombination repair protein 1 increases expression ISO Thimerosal results in increased expression of SFR1 mRNA CTD PMID:27188386 NCBI chr 1:246,619,235...246,623,250
Ensembl chr 1:246,597,044...246,623,250 		JBrowse link
G Sfrp1 secreted frizzled-related protein 1 decreases expression ISO Thimerosal results in decreased expression of SFRP1 mRNA CTD PMID:27188386 NCBI chr16:75,278,325...75,316,736
Ensembl chr16:68,575,763...68,614,286 		JBrowse link
G Sgpl1 sphingosine-1-phosphate lyase 1 increases expression ISO Thimerosal results in increased expression of SGPL1 mRNA CTD PMID:24675092 NCBI chr20:29,047,793...29,094,209
Ensembl chr20:29,047,796...29,094,084 		JBrowse link
G Sh3bgrl3 SH3 domain binding glutamate-rich protein like 3 decreases expression ISO Thimerosal results in decreased expression of SH3BGRL3 mRNA CTD PMID:27188386 NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331 		JBrowse link
G Shfl shiftless antiviral inhibitor of ribosomal frameshifting decreases expression ISO Thimerosal results in decreased expression of SHFL mRNA CTD PMID:27188386 NCBI chr 8:27,683,560...27,690,269
Ensembl chr 8:19,408,333...19,413,971 		JBrowse link
G Shisa5 shisa family member 5 decreases expression ISO Thimerosal results in decreased expression of SHISA5 mRNA CTD PMID:27188386 NCBI chr 8:109,691,504...109,706,411
Ensembl chr 8:109,691,522...109,706,408 		JBrowse link
G Shoc2 SHOC2 leucine-rich repeat scaffold protein increases expression ISO Thimerosal results in increased expression of SHOC2 mRNA CTD PMID:27188386 NCBI chr 1:252,958,939...253,048,820
Ensembl chr 1:252,959,723...253,047,337 		JBrowse link
G Siah1 siah E3 ubiquitin protein ligase 1 increases expression ISO Thimerosal results in increased expression of SIAH1 mRNA CTD PMID:27188386 NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808 		JBrowse link
G Sike1 suppressor of IKBKE 1 decreases expression ISO Thimerosal results in decreased expression of SIKE1 mRNA CTD PMID:27188386 NCBI chr 2:190,518,002...190,525,833
Ensembl chr 2:190,518,002...190,525,832 		JBrowse link
G Sipa1 signal-induced proliferation-associated 1 decreases expression ISO Thimerosal results in decreased expression of SIPA1 mRNA CTD PMID:27188386 NCBI chr 1:202,938,532...202,950,672
Ensembl chr 1:202,938,580...202,950,591 		JBrowse link
G Sirpa signal-regulatory protein alpha decreases expression ISO Thimerosal results in decreased expression of SIRPA mRNA CTD PMID:27188386 NCBI chr 3:137,272,932...137,311,279
Ensembl chr 3:116,819,726...116,858,098 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]] CTD PMID:30503815 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Six5 SIX homeobox 5 decreases expression ISO Thimerosal results in decreased expression of SIX5 mRNA CTD PMID:27188386 NCBI chr 1:87,868,859...87,873,929
Ensembl chr 1:78,741,367...78,745,890 		JBrowse link
G Six6 SIX homeobox 6 increases expression ISO Thimerosal results in increased expression of SIX6 mRNA CTD PMID:24675092 NCBI chr 6:91,634,568...91,639,548
Ensembl chr 6:91,634,568...91,639,548 		JBrowse link
G Ska2 spindle and kinetochore associated complex subunit 2 increases expression ISO Thimerosal results in increased expression of SKA2 mRNA CTD PMID:27188386 NCBI chr10:71,921,474...71,939,461
Ensembl chr10:71,921,582...71,939,458 		JBrowse link
G Skic3 SKI3 subunit of superkiller complex decreases expression ISO Thimerosal results in decreased expression of SKIC3 mRNA CTD PMID:27188386 NCBI chr 2:5,631,544...5,783,643
Ensembl chr 2:5,631,635...5,751,626 		JBrowse link
G Slc10a7 solute carrier family 10, member 7 increases expression ISO Thimerosal results in increased expression of SLC10A7 mRNA CTD PMID:27188386 NCBI chr19:29,183,143...29,407,470
Ensembl chr19:29,183,155...29,407,464 		JBrowse link
G Slc12a2 solute carrier family 12 member 2 increases expression ISO Thimerosal results in increased expression of SLC12A2 mRNA CTD PMID:27188386 NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440 		JBrowse link
G Slc16a1 solute carrier family 16 member 1 decreases expression ISO Thimerosal results in decreased expression of SLC16A1 mRNA CTD PMID:27188386 NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:192,124,289...192,144,611 		JBrowse link
G Slc16a14 solute carrier family 16, member 14 increases expression ISO Thimerosal results in increased expression of SLC16A14 mRNA CTD PMID:27188386 NCBI chr 9:93,558,144...93,585,396
Ensembl chr 9:86,112,894...86,137,318 		JBrowse link
G Slc16a6 solute carrier family 16, member 6 increases expression ISO Thimerosal results in increased expression of SLC16A6 mRNA CTD PMID:27188386 NCBI chr10:94,923,888...94,946,990
Ensembl chr10:94,426,244...94,448,779 		JBrowse link
G Slc16a9 solute carrier family 16, member 9 increases expression ISO Thimerosal results in increased expression of SLC16A9 mRNA CTD PMID:27188386 NCBI chr20:18,334,946...18,376,195
Ensembl chr20:18,335,862...18,377,022 		JBrowse link
G Slc18b1 solute carrier family 18 member B1 decreases expression ISO Thimerosal results in decreased expression of SLC18B1 mRNA CTD PMID:27188386 NCBI chr 1:21,628,235...21,670,807
Ensembl chr 1:21,628,237...21,670,684 		JBrowse link
G Slc1a1 solute carrier family 1 member 1 increases expression ISO Thimerosal results in increased expression of SLC1A1 protein CTD PMID:15184908 NCBI chr 1:235,963,455...236,043,572
Ensembl chr 1:226,549,842...226,630,402 		JBrowse link
G Slc22a4 solute carrier family 22 member 4 decreases activity ISO Thimerosal results in decreased activity of SLC22A4 protein CTD PMID:25490951 NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720 		JBrowse link
G Slc25a1 solute carrier family 25 member 1 decreases expression ISO Thimerosal results in decreased expression of SLC25A1 mRNA CTD PMID:27188386 NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781 		JBrowse link
G Slc25a21 solute carrier family 25 member 21 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A21 mRNA CTD PMID:27188386 NCBI chr 6:74,203,439...74,702,902
Ensembl chr 6:74,203,440...74,702,680 		JBrowse link
G Slc25a23 solute carrier family 25 member 23 decreases expression ISO Thimerosal results in decreased expression of SLC25A23 mRNA CTD PMID:27188386 NCBI chr 9:1,882,636...1,898,369
Ensembl chr 9:1,882,621...1,898,561 		JBrowse link
G Slc25a44 solute carrier family 25, member 44 increases expression ISO Thimerosal results in increased expression of SLC25A44 mRNA CTD PMID:27188386 NCBI chr 2:173,868,317...173,883,137
Ensembl chr 2:173,868,320...173,883,020 		JBrowse link
G Slc29a2 solute carrier family 29 member 2 decreases expression ISO Thimerosal results in decreased expression of SLC29A2 mRNA CTD PMID:27188386 NCBI chr 1:211,756,588...211,764,561
Ensembl chr 1:202,327,354...202,335,171 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 decreases expression ISO Thimerosal results in decreased expression of SLC2A1 mRNA CTD PMID:27188386 NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416 		JBrowse link
G Slc2a12 solute carrier family 2 member 12 decreases expression ISO Thimerosal results in decreased expression of SLC2A12 mRNA CTD PMID:27188386 NCBI chr 1:24,623,558...24,683,577
Ensembl chr 1:22,804,418...22,860,971 		JBrowse link
G Slc2a3 solute carrier family 2 member 3 decreases expression ISO Thimerosal results in decreased expression of SLC2A3 mRNA CTD PMID:27188386 NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472 		JBrowse link
G Slc30a5 solute carrier family 30 member 5 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA CTD PMID:27188386 NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934 		JBrowse link
G Slc38a1 solute carrier family 38, member 1 decreases expression ISO Thimerosal results in decreased expression of SLC38A1 mRNA CTD PMID:27188386 NCBI chr 7:129,612,414...129,681,727
Ensembl chr 7:127,738,226...127,802,218 		JBrowse link
G Slc5a3 solute carrier family 5 member 3 increases expression ISO Thimerosal results in increased expression of SLC5A3 mRNA CTD PMID:27188386 NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883 		JBrowse link
G Slc5a7 solute carrier family 5 member 7 decreases expression ISO Thimerosal results in decreased expression of SLC5A7 mRNA CTD PMID:27188386 NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,595,444...7,626,258 		JBrowse link
G Slc6a3 solute carrier family 6 member 3 increases expression
multiple interactions 		ISO Thimerosal results in increased expression of SLC6A3 protein
[Thimerosal co-treated with Aluminum Hydroxide] results in increased expression of SLC6A3 protein 		CTD PMID:36411272 NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413 		JBrowse link
G Slc7a1 solute carrier family 7 member 1 decreases expression ISO Thimerosal results in decreased expression of SLC7A1 mRNA CTD PMID:27188386 NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849 		JBrowse link
G Slc7a3 solute carrier family 7 member 3 decreases expression ISO Thimerosal results in decreased expression of SLC7A3 mRNA CTD PMID:27188386 NCBI chr  X:66,210,071...66,216,482
Ensembl chr  X:66,210,081...66,215,708 		JBrowse link
G Slc8a1 solute carrier family 8 member A1 increases expression ISO Thimerosal results in increased expression of SLC8A1 mRNA CTD PMID:27188386 NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628 		JBrowse link
G Smarcc2 SWI/SNF related BAF chromatin remodeling complex subunit C2 affects expression ISO Thimerosal affects the expression of SMARCC2 mRNA CTD PMID:27188386 NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978 		JBrowse link
G Smc1a structural maintenance of chromosomes 1A decreases expression ISO Thimerosal results in decreased expression of SMC1A mRNA CTD PMID:27188386 NCBI chr  X:21,103,323...21,148,053
Ensembl chr  X:21,103,282...21,148,056 		JBrowse link
G Smchd1 structural maintenance of chromosomes flexible hinge domain containing 1 decreases expression ISO Thimerosal results in decreased expression of SMCHD1 mRNA CTD PMID:27188386 NCBI chr 9:111,243,445...111,387,272
Ensembl chr 9:111,247,702...111,349,665 		JBrowse link
G Smim3 small integral membrane protein 3 decreases expression ISO Thimerosal results in decreased expression of SMIM3 mRNA CTD PMID:27188386 NCBI chr18:53,930,019...53,982,339
Ensembl chr18:53,930,020...53,957,416 		JBrowse link
G Smox spermine oxidase decreases expression ISO Thimerosal results in decreased expression of SMOX mRNA CTD PMID:27188386 NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:118,731,900...118,765,710
Ensembl chr  X:118,731,900...118,765,710 		JBrowse link
G Snap25 synaptosome associated protein 25 decreases expression EXP Thimerosal results in decreased expression of SNAP25 protein CTD PMID:27693314 NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:124,041,898...124,123,760 		JBrowse link
G Sncaip synuclein, alpha interacting protein multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA CTD PMID:27188386 NCBI chr18:48,402,164...48,542,246
Ensembl chr18:46,207,152...46,343,929 		JBrowse link
G Snrpa small nuclear ribonucleoprotein polypeptide A decreases expression ISO Thimerosal results in decreased expression of SNRPA mRNA CTD PMID:27188386 NCBI chr 1:91,609,419...91,618,119
Ensembl chr 1:82,481,770...82,490,538 		JBrowse link
G Snx2 sorting nexin 2 increases expression ISO Thimerosal results in increased expression of SNX2 mRNA CTD PMID:27188386 NCBI chr18:46,602,223...46,643,870
Ensembl chr18:46,602,284...46,643,865 		JBrowse link
G Snx21 sorting nexin family member 21 decreases expression ISO Thimerosal results in decreased expression of SNX21 mRNA CTD PMID:27188386 NCBI chr 3:153,522,474...153,532,235
Ensembl chr 3:153,522,486...153,532,221 		JBrowse link
G Snx4 sorting nexin 4 increases expression ISO Thimerosal results in increased expression of SNX4 mRNA CTD PMID:27188386 NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174 		JBrowse link
G Snx9 sorting nexin 9 decreases expression ISO Thimerosal results in decreased expression of SNX9 mRNA CTD PMID:27188386 NCBI chr 1:46,424,897...46,510,096
Ensembl chr 1:46,423,553...46,509,036 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
increases response to substance 		ISO [SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein; [SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA; [SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]] CTD PMID:30503815 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249 		JBrowse link
G Son SON DNA and RNA binding protein decreases expression ISO Thimerosal results in decreased expression of SON mRNA CTD PMID:27188386 NCBI chr11:30,850,890...30,923,167
Ensembl chr11:30,892,005...30,923,167 		JBrowse link
G Sorbs2 sorbin and SH3 domain containing 2 increases expression ISO Thimerosal results in increased expression of SORBS2 mRNA CTD PMID:27188386 NCBI chr16:46,435,220...46,748,743
Ensembl chr16:46,435,237...46,626,514 		JBrowse link
G Sorbs3 sorbin and SH3 domain containing 3 decreases expression ISO Thimerosal results in decreased expression of SORBS3 mRNA CTD PMID:27188386 NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758 		JBrowse link
G Sorl1 sortilin related receptor 1 decreases expression ISO Thimerosal results in decreased expression of SORL1 mRNA CTD PMID:27188386 NCBI chr 8:51,238,713...51,401,458
Ensembl chr 8:42,341,704...42,504,513 		JBrowse link
G Sox18 SRY-box transcription factor 18 decreases expression ISO Thimerosal results in decreased expression of SOX18 mRNA CTD PMID:24675092 NCBI chr 3:168,785,488...168,787,290
Ensembl chr 3:168,785,490...168,787,290 		JBrowse link
G Sox7 SRY-box transcription factor 7 decreases expression ISO Thimerosal results in decreased expression of SOX7 mRNA CTD PMID:27188386 NCBI chr15:38,180,503...38,187,264
Ensembl chr15:38,180,503...38,187,264 		JBrowse link
G Sox8 SRY-box transcription factor 8 decreases expression ISO Thimerosal results in decreased expression of SOX8 mRNA CTD PMID:27188386 NCBI chr10:15,089,357...15,094,345
Ensembl chr10:14,584,829...14,589,818 		JBrowse link
G Sox9 SRY-box transcription factor 9 increases expression ISO Thimerosal results in increased expression of SOX9 mRNA CTD PMID:24675092 NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994 		JBrowse link
G Sp4 Sp4 transcription factor decreases expression ISO Thimerosal results in decreased expression of SP4 mRNA CTD PMID:27188386 NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126 		JBrowse link
G Sp5 Sp5 transcription factor decreases expression ISO Thimerosal results in decreased expression of SP5 mRNA CTD PMID:27188386 NCBI chr 3:55,274,931...55,277,733
Ensembl chr 3:55,274,931...55,277,733 		JBrowse link
G Sp8 Sp8 transcription factor increases expression ISO Thimerosal results in increased expression of SP8 mRNA CTD PMID:24675092 NCBI chr 6:139,816,258...139,818,865
Ensembl chr 6:139,814,819...139,823,168
Ensembl chr 6:139,814,819...139,823,168 		JBrowse link
G Spag4 sperm associated antigen 4 decreases expression ISO Thimerosal results in decreased expression of SPAG4 mRNA CTD PMID:27188386 NCBI chr 3:144,581,006...144,587,879
Ensembl chr 3:144,581,095...144,585,435 		JBrowse link
G Spag9 sperm associated antigen 9 increases expression ISO Thimerosal results in increased expression of SPAG9 mRNA CTD PMID:27188386 NCBI chr10:79,440,311...79,574,709
Ensembl chr10:78,943,479...79,077,797 		JBrowse link
G Spata18 spermatogenesis associated 18 increases expression ISO Thimerosal results in increased expression of SPATA18 mRNA CTD PMID:27188386 NCBI chr14:34,531,931...34,558,671
Ensembl chr14:34,531,061...34,558,687 		JBrowse link
G Spata2 spermatogenesis associated 2 decreases expression ISO Thimerosal results in decreased expression of SPATA2 mRNA CTD PMID:27188386 NCBI chr 3:156,202,962...156,213,283
Ensembl chr 3:156,202,967...156,211,705 		JBrowse link
G Spatc1l spermatogenesis and centriole associated 1-like decreases expression ISO Thimerosal results in decreased expression of SPATC1L mRNA CTD PMID:27188386 NCBI chr20:12,074,040...12,083,873
Ensembl chr20:12,074,047...12,083,301 		JBrowse link
G Specc1 sperm antigen with calponin homology and coiled-coil domains 1 increases expression ISO Thimerosal results in increased expression of SPECC1 mRNA CTD PMID:27188386 NCBI chr10:46,638,947...46,912,989
Ensembl chr10:46,638,809...46,912,802 		JBrowse link
G Spen spen family transcriptional repressor decreases expression ISO Thimerosal results in decreased expression of SPEN mRNA CTD PMID:27188386 NCBI chr 5:153,775,287...153,848,677
Ensembl chr 5:153,776,234...153,848,811 		JBrowse link
G Spmip4 sperm microtubule inner protein 4 decreases expression ISO Thimerosal results in decreased expression of SPMIP4 mRNA CTD PMID:27188386 NCBI chr 4:79,663,375...79,688,291
Ensembl chr 4:79,663,376...79,689,072 		JBrowse link
G Sppl2b signal peptide peptidase-like 2B decreases expression ISO Thimerosal results in decreased expression of SPPL2B mRNA CTD PMID:27188386 NCBI chr 7:8,843,918...8,856,642
Ensembl chr 7:8,843,918...8,856,608 		JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 decreases expression ISO Thimerosal results in decreased expression of SPTBN1 mRNA CTD PMID:27188386 NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507 		JBrowse link
G Sqle squalene epoxidase decreases expression ISO Thimerosal results in decreased expression of SQLE mRNA CTD PMID:27188386 NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618 		JBrowse link
G Srd5a3 steroid 5 alpha-reductase 3 decreases expression ISO Thimerosal results in decreased expression of SRD5A3 mRNA CTD PMID:27188386 NCBI chr14:32,046,408...32,060,796
Ensembl chr14:32,046,408...32,060,747 		JBrowse link
G Srl sarcalumenin decreases expression ISO Thimerosal results in decreased expression of SRL mRNA CTD PMID:24675092 NCBI chr10:11,033,976...11,078,103
Ensembl chr10:11,034,035...11,078,101 		JBrowse link
G Srpra SRP receptor subunit alpha decreases expression ISO Thimerosal results in decreased expression of SRPRA mRNA CTD PMID:27188386 NCBI chr 8:41,818,199...41,824,292
Ensembl chr 8:33,560,348...33,566,470 		JBrowse link
G Srrm1 serine and arginine repetitive matrix 1 decreases expression ISO Thimerosal results in decreased expression of SRRM1 mRNA CTD PMID:27188386 NCBI chr 5:147,559,515...147,591,895
Ensembl chr 5:147,559,514...147,591,849 		JBrowse link
G Srrm2 serine/arginine repetitive matrix 2 decreases expression ISO Thimerosal results in decreased expression of SRRM2 mRNA CTD PMID:27188386 NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751 		JBrowse link
G Srsf4 serine and arginine rich splicing factor 4 increases expression ISO Thimerosal results in increased expression of SRSF4 mRNA CTD PMID:27188386 NCBI chr 5:144,060,981...144,090,798
Ensembl chr 5:144,061,463...144,089,229 		JBrowse link
G Ssrp1 structure specific recognition protein 1 decreases expression ISO Thimerosal results in decreased expression of SSRP1 mRNA CTD PMID:27188386 NCBI chr 3:70,124,371...70,134,481
Ensembl chr 3:70,118,655...70,134,482 		JBrowse link
G Stag1 STAG1 cohesin complex component increases expression ISO Thimerosal results in increased expression of STAG1 mRNA CTD PMID:27188386 NCBI chr 8:101,179,039...101,564,684
Ensembl chr 8:101,179,039...101,564,677 		JBrowse link
G Stag2 STAG2 cohesin complex component increases expression ISO Thimerosal results in increased expression of STAG2 mRNA CTD PMID:27188386 NCBI chr  X:120,974,687...121,105,677
Ensembl chr  X:120,974,857...121,105,677 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
decreases phosphorylation 		ISO [Thimerosal co-treated with Temozolomide] results in decreased phosphorylation of STAT3 protein
Thimerosal results in decreased phosphorylation of STAT3 protein 		CTD PMID:38325586 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057 		JBrowse link
G Stc1 stanniocalcin 1 decreases expression ISO Thimerosal results in decreased expression of STC1 mRNA CTD PMID:27188386 NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264 		JBrowse link
G Stc2 stanniocalcin 2 decreases expression ISO Thimerosal results in decreased expression of STC2 mRNA CTD PMID:27188386 NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973 		JBrowse link
G Stim2 stromal interaction molecule 2 increases expression ISO Thimerosal results in increased expression of STIM2 mRNA CTD PMID:27188386 NCBI chr14:56,878,428...57,004,405
Ensembl chr14:56,878,645...57,004,179 		JBrowse link
G Stk35 serine/threonine kinase 35 increases expression ISO Thimerosal results in increased expression of STK35 mRNA CTD PMID:27188386 NCBI chr 3:137,465,884...137,498,554
Ensembl chr 3:117,016,950...117,048,066 		JBrowse link
G Ston2 stonin 2 decreases expression ISO Thimerosal results in decreased expression of STON2 mRNA CTD PMID:27188386 NCBI chr 6:110,567,485...110,676,376
Ensembl chr 6:110,567,485...110,676,376 		JBrowse link
G Stpg1 sperm-tail PG-rich repeat containing 1 decreases expression ISO Thimerosal results in decreased expression of STPG1 mRNA CTD PMID:27188386 NCBI chr 5:147,717,084...147,769,792
Ensembl chr 5:147,726,646...147,769,788 		JBrowse link
G Stx2 syntaxin 2 decreases expression ISO Thimerosal results in decreased expression of STX2 mRNA CTD PMID:27188386 NCBI chr12:27,678,744...27,714,751
Ensembl chr12:27,689,819...27,714,751 		JBrowse link
G Stx4 syntaxin 4 increases expression ISO Thimerosal results in increased expression of STX4 mRNA CTD PMID:27188386 NCBI chr 1:182,451,108...182,459,701
Ensembl chr 1:182,451,117...182,459,979 		JBrowse link
G Styx serine/threonine/tyrosine interacting protein decreases expression ISO Thimerosal results in decreased expression of STYX mRNA CTD PMID:27188386 NCBI chr15:18,565,214...18,595,797
Ensembl chr15:18,564,633...18,593,524 		JBrowse link
G Sun2 Sad1 and UNC84 domain containing 2 increases expression ISO Thimerosal results in increased expression of SUN2 mRNA CTD PMID:24675092 NCBI chr 7:113,155,766...113,172,950
Ensembl chr 7:111,275,380...111,292,553 		JBrowse link
G Supt16h SPT16 homolog, facilitates chromatin remodeling subunit decreases expression ISO Thimerosal results in decreased expression of SUPT16H mRNA CTD PMID:27188386 NCBI chr15:24,867,697...24,904,818
Ensembl chr15:24,866,489...24,904,846 		JBrowse link
G Sycp2 synaptonemal complex protein 2 increases expression ISO Thimerosal results in increased expression of SYCP2 mRNA CTD PMID:27188386 NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:165,436,331...165,498,789 		JBrowse link
G Sycp3 synaptonemal complex protein 3 increases expression ISO Thimerosal results in increased expression of SYCP3 mRNA CTD PMID:24675092 NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511 		JBrowse link
G Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein decreases expression ISO Thimerosal results in decreased expression of SYNCRIP mRNA CTD PMID:27188386 NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515 		JBrowse link
G Syne2 spectrin repeat containing nuclear envelope protein 2 decreases expression ISO Thimerosal results in decreased expression of SYNE2 mRNA CTD PMID:27188386 NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064 		JBrowse link
G Syngr3 synaptogyrin 3 decreases expression ISO Thimerosal results in decreased expression of SYNGR3 mRNA CTD PMID:27188386 NCBI chr10:13,710,553...13,715,309
Ensembl chr10:13,704,998...13,715,669 		JBrowse link
G Synj2bp synaptojanin 2 binding protein decreases expression ISO Thimerosal results in decreased expression of SYNJ2BP mRNA CTD PMID:27188386 NCBI chr 6:106,920,970...106,958,653
Ensembl chr 6:101,189,714...101,227,406 		JBrowse link
G Syt6 synaptotagmin 6 decreases expression ISO Thimerosal results in decreased expression of SYT6 mRNA CTD PMID:27188386 NCBI chr 2:191,093,009...191,152,283
Ensembl chr 2:191,093,007...191,149,956 		JBrowse link
G Sytl4 synaptotagmin-like 4 decreases expression ISO Thimerosal results in decreased expression of SYTL4 mRNA CTD PMID:27188386 NCBI chr  X:97,135,496...97,185,867
Ensembl chr  X:97,135,500...97,185,854 		JBrowse link
G Taf9 TATA-box binding protein associated factor 9 increases expression ISO Thimerosal results in increased expression of TAF9 mRNA CTD PMID:27188386 NCBI chr 2:31,794,316...31,798,324
Ensembl chr 2:31,794,142...31,798,769 		JBrowse link
G Taf9b TATA-box binding protein associated factor 9b affects expression ISO Thimerosal affects the expression of TAF9B mRNA CTD PMID:27188386 NCBI chr  X:71,289,290...71,300,142
Ensembl chr  X:71,289,290...71,300,604 		JBrowse link
G Tanc2 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 decreases expression ISO Thimerosal results in decreased expression of TANC2 mRNA CTD PMID:27188386 NCBI chr10:90,553,124...90,873,477
Ensembl chr10:90,553,002...90,868,756 		JBrowse link
G Taok1 TAO kinase 1 decreases expression ISO Thimerosal results in decreased expression of TAOK1 mRNA CTD PMID:27188386 NCBI chr10:62,871,198...62,989,049
Ensembl chr10:62,381,404...62,465,766 		JBrowse link
G Tap2 transporter 2, ATP binding cassette subfamily B member decreases expression ISO Thimerosal results in decreased expression of TAP2 mRNA CTD PMID:27188386 NCBI chr20:4,638,257...4,652,296
Ensembl chr20:4,636,357...4,650,407 		JBrowse link
G Tasor2 transcription activation suppressor family member 2 increases expression ISO Thimerosal results in increased expression of TASOR2 mRNA CTD PMID:27188386 NCBI chr17:66,583,554...66,650,127
Ensembl chr17:66,594,908...66,649,135 		JBrowse link
G Tax1bp1 Tax1 binding protein 1 increases expression ISO Thimerosal results in increased expression of TAX1BP1 mRNA CTD PMID:27188386 NCBI chr 4:81,821,991...81,877,906
Ensembl chr 4:81,821,989...81,879,100 		JBrowse link
G Tbc1d16 TBC1 domain family, member 16 decreases expression ISO Thimerosal results in decreased expression of TBC1D16 mRNA CTD PMID:27188386 NCBI chr10:104,400,963...104,486,698
Ensembl chr10:104,402,398...104,486,670 		JBrowse link
G Tbc1d8b TBC1 domain family member 8B decreases expression ISO Thimerosal results in decreased expression of TBC1D8B mRNA CTD PMID:27188386 NCBI chr  X:103,319,181...103,407,137
Ensembl chr  X:103,319,340...103,407,133 		JBrowse link
G Tbl1x transducin (beta)-like 1 X-linked decreases expression ISO Thimerosal results in decreased expression of TBL1X mRNA CTD PMID:27188386 NCBI chr  X:41,574,558...41,731,117
Ensembl chr  X:41,576,047...41,731,101 		JBrowse link
G Tbl1xr1 TBL1X/Y related 1 increases expression ISO Thimerosal results in increased expression of TBL1XR1 mRNA CTD PMID:27188386 NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055 		JBrowse link
G Tbrg4 transforming growth factor beta regulator 4 decreases expression ISO Thimerosal results in decreased expression of TBRG4 mRNA CTD PMID:24675092 NCBI chr14:81,481,977...81,490,781
Ensembl chr14:81,481,981...81,490,756 		JBrowse link
G Tcf7l1 transcription factor 7 like 1 decreases expression ISO Thimerosal results in decreased expression of TCF7L1 mRNA CTD PMID:27188386 NCBI chr 4:104,680,734...104,846,086
Ensembl chr 4:104,680,739...104,845,287 		JBrowse link
G Tdrd6 tudor domain containing 6 increases expression ISO Thimerosal results in increased expression of TDRD6 mRNA CTD PMID:27188386 NCBI chr 9:17,344,033...17,359,348
Ensembl chr 9:17,344,026...17,359,344 		JBrowse link
G Tdrd7 tudor domain containing 7 decreases expression ISO Thimerosal results in decreased expression of TDRD7 mRNA CTD PMID:27188386 NCBI chr 5:60,238,742...60,312,548
Ensembl chr 5:60,238,678...60,312,544 		JBrowse link
G Tdrkh tudor and KH domain containing decreases expression ISO Thimerosal results in decreased expression of TDRKH mRNA CTD PMID:27188386 NCBI chr 2:182,049,175...182,071,516
Ensembl chr 2:182,049,215...182,070,755 		JBrowse link
G Tead1 TEA domain transcription factor 1 decreases expression ISO Thimerosal results in decreased expression of TEAD1 mRNA CTD PMID:27188386 NCBI chr 1:166,791,900...167,010,591
Ensembl chr 1:166,792,628...167,003,369 		JBrowse link
G Tecr trans-2,3-enoyl-CoA reductase decreases expression ISO Thimerosal results in decreased expression of TECR mRNA CTD PMID:27188386 NCBI chr19:41,431,422...41,472,880
Ensembl chr19:24,541,615...24,568,168 		JBrowse link
G Tet1 tet methylcytosine dioxygenase 1 decreases expression ISO Thimerosal results in decreased expression of TET1 mRNA CTD PMID:27188386 NCBI chr20:25,766,806...25,839,598
Ensembl chr20:25,768,120...25,833,052 		JBrowse link
G Tet2 tet methylcytosine dioxygenase 2 decreases expression ISO Thimerosal results in decreased expression of TET2 mRNA CTD PMID:27188386 NCBI chr 2:224,662,654...224,746,819
Ensembl chr 2:221,988,645...222,072,534 		JBrowse link
G Tet3 tet methylcytosine dioxygenase 3 decreases expression ISO Thimerosal results in decreased expression of TET3 mRNA CTD PMID:24675092 NCBI chr 4:117,425,106...117,525,495
Ensembl chr 4:115,871,265...115,964,193 		JBrowse link
G Tex10 testis expressed 10 decreases expression ISO Thimerosal results in decreased expression of TEX10 mRNA CTD PMID:27188386 NCBI chr 5:62,762,230...62,808,373
Ensembl chr 5:62,762,230...62,808,373 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression ISO Thimerosal results in increased expression of TGFB1 CTD PMID:24942245 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Them4 thioesterase superfamily member 4 increases expression ISO Thimerosal results in increased expression of THEM4 mRNA CTD PMID:27188386 NCBI chr 2:181,953,550...181,974,708
Ensembl chr 2:181,953,550...181,974,708 		JBrowse link
G Themis2 thymocyte selection associated family member 2 decreases expression ISO Thimerosal results in decreased expression of THEMIS2 mRNA CTD PMID:27188386 NCBI chr 5:144,991,110...145,006,362
Ensembl chr 5:144,991,112...145,006,400 		JBrowse link
G Thpo thrombopoietin decreases expression ISO Thimerosal results in decreased expression of THPO mRNA CTD PMID:24675092 Ensembl chr11:80,182,820...80,188,167 JBrowse link
G Thrap3 thyroid hormone receptor associated protein 3 decreases expression ISO Thimerosal results in decreased expression of THRAP3 mRNA CTD PMID:27188386 NCBI chr 5:138,445,284...138,487,544
Ensembl chr 5:138,445,295...138,487,477 		JBrowse link
G Thy1 Thy-1 cell surface antigen decreases expression ISO Thimerosal results in decreased expression of THY1 mRNA CTD PMID:27188386 NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659 		JBrowse link
G Tkt transketolase decreases expression ISO Thimerosal results in decreased expression of TKT mRNA CTD PMID:27188386 NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698 		JBrowse link
G Tle4 TLE family member 4, transcriptional corepressor decreases expression ISO Thimerosal results in decreased expression of TLE4 mRNA CTD PMID:27188386 NCBI chr 1:221,086,250...221,222,826
Ensembl chr 1:211,661,746...211,797,862 		JBrowse link
G Tmc5 transmembrane channel-like 5 multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC5 mRNA CTD PMID:27188386 NCBI chr 1:172,914,915...172,999,478
Ensembl chr 1:172,914,457...172,999,474 		JBrowse link
G Tmc6 transmembrane channel like 6 decreases expression ISO Thimerosal results in decreased expression of TMC6 mRNA CTD PMID:27188386 NCBI chr10:103,480,762...103,498,207
Ensembl chr10:102,971,229...102,998,960 		JBrowse link
G Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 increases expression ISO Thimerosal results in increased expression of TMEFF2 mRNA CTD PMID:27188386 NCBI chr 9:50,445,947...50,733,473
Ensembl chr 9:50,436,079...50,733,475 		JBrowse link
G Tmem240 transmembrane protein 240 decreases expression ISO Thimerosal results in decreased expression of TMEM240 mRNA CTD PMID:24675092 NCBI chr 5:166,344,000...166,350,210
Ensembl chr 5:166,344,386...166,350,636 		JBrowse link
G Tmem33 transmembrane protein 33 decreases expression ISO Thimerosal results in decreased expression of TMEM33 mRNA CTD PMID:27188386 NCBI chr14:40,888,485...40,910,715
Ensembl chr14:40,885,712...40,910,715 		JBrowse link
G Tmem74b transmembrane protein 74B decreases expression ISO Thimerosal results in decreased expression of TMEM74B mRNA CTD PMID:27188386 NCBI chr 3:140,219,592...140,224,208
Ensembl chr 3:140,219,412...140,235,872 		JBrowse link
G Tmem97 transmembrane protein 97 decreases expression ISO Thimerosal results in decreased expression of TMEM97 mRNA CTD PMID:27188386 NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730 		JBrowse link
G Tmod2 tropomodulin 2 increases expression ISO Thimerosal results in increased expression of TMOD2 mRNA CTD PMID:16870260 NCBI chr 8:76,316,736...76,366,003
Ensembl chr 8:76,325,667...76,365,720 		JBrowse link
G Tmtc3 transmembrane O-mannosyltransferase targeting cadherins 3 decreases expression ISO Thimerosal results in decreased expression of TMTC3 mRNA CTD PMID:27188386 NCBI chr 7:35,264,886...35,310,010
Ensembl chr 7:35,264,892...35,310,385 		JBrowse link
G Tnf tumor necrosis factor increases secretion
multiple interactions 		ISO Thimerosal results in increased secretion of TNF protein
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] 		CTD PMID:17079650 PMID:18495191 PMID:20417223 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnfsf13b TNF superfamily member 13b increases expression ISO Thimerosal results in increased expression of TNFSF13B mRNA CTD PMID:27188386 NCBI chr16:86,164,377...86,195,072
Ensembl chr16:79,462,402...79,492,693 		JBrowse link
G Tnip1 TNFAIP3 interacting protein 1 decreases expression ISO Thimerosal results in decreased expression of TNIP1 mRNA CTD PMID:27188386 NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625 		JBrowse link
G Tnni3 troponin I3, cardiac type decreases expression ISO Thimerosal results in decreased expression of TNNI3 mRNA CTD PMID:27188386 NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580 		JBrowse link
G Tob2 transducer of ERBB2, 2 decreases expression ISO Thimerosal results in decreased expression of TOB2 mRNA CTD PMID:27188386 NCBI chr 7:115,242,843...115,251,563
Ensembl chr 7:113,361,148...113,372,688 		JBrowse link
G Top2a DNA topoisomerase II alpha decreases activity ISO Thimerosal results in decreased activity of TOP2A protein CTD PMID:18197631 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874 		JBrowse link
G Tox2 TOX high mobility group box family member 2 decreases expression ISO Thimerosal results in decreased expression of TOX2 mRNA CTD PMID:27188386 NCBI chr 3:151,853,294...151,980,086
Ensembl chr 3:151,853,294...151,980,749 		JBrowse link
G Tp53 tumor protein p53 affects activity ISO Thimerosal affects the activity of TP53 protein CTD PMID:35435491 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Tp53bp1 tumor protein p53 binding protein 1 decreases expression ISO Thimerosal results in decreased expression of TP53BP1 mRNA CTD PMID:27188386 NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822 		JBrowse link
G Tpcn1 two pore segment channel 1 decreases expression ISO Thimerosal results in decreased expression of TPCN1 mRNA CTD PMID:24675092 NCBI chr12:35,972,813...36,029,632
Ensembl chr12:35,972,846...36,029,626 		JBrowse link
G Tpd52 tumor protein D52 decreases expression ISO Thimerosal results in decreased expression of TPD52 mRNA CTD PMID:27188386 NCBI chr 2:94,642,514...94,723,442
Ensembl chr 2:92,735,620...92,816,622 		JBrowse link
G Tpi1 triosephosphate isomerase 1 decreases expression ISO Thimerosal results in decreased expression of TPI1 mRNA CTD PMID:27188386 NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:157,615,386...157,619,541 		JBrowse link
G Tpm4 tropomyosin 4 decreases expression ISO Thimerosal results in decreased expression of TPM4 mRNA CTD PMID:27188386 NCBI chr16:17,718,442...17,732,483
Ensembl chr16:17,683,195...17,705,984 		JBrowse link
G Tpp1 tripeptidyl peptidase 1 decreases expression ISO Thimerosal results in decreased expression of TPP1 mRNA CTD PMID:27188386 NCBI chr 1:160,097,984...160,104,108
Ensembl chr 1:160,096,833...160,104,129 		JBrowse link
G Tpp2 tripeptidyl peptidase 2 decreases expression ISO Thimerosal results in decreased expression of TPP2 mRNA CTD PMID:27188386 NCBI chr 9:46,046,712...46,128,157
Ensembl chr 9:46,046,632...46,128,157 		JBrowse link
G Tpr translocated promoter region, nuclear basket protein decreases expression ISO Thimerosal results in decreased expression of TPR mRNA CTD PMID:27188386 NCBI chr13:64,974,419...65,037,604
Ensembl chr13:62,424,312...62,487,496 		JBrowse link
G Tprkb Tp53rk binding protein increases expression ISO Thimerosal results in increased expression of TPRKB mRNA CTD PMID:27188386 NCBI chr 4:118,342,910...118,357,908
Ensembl chr 4:118,342,945...118,357,901 		JBrowse link
G Traf5 TNF receptor-associated factor 5 decreases expression ISO Thimerosal results in decreased expression of TRAF5 mRNA CTD PMID:27188386 NCBI chr13:103,569,944...103,618,747
Ensembl chr13:103,572,314...103,618,709 		JBrowse link
G Tram1 translocation associated membrane protein 1 increases expression ISO Thimerosal results in increased expression of TRAM1 mRNA CTD PMID:27188386 NCBI chr 5:5,642,579...5,667,666
Ensembl chr 5:5,642,546...5,686,971 		JBrowse link
G Trappc13 trafficking protein particle complex subunit 13 increases expression ISO Thimerosal results in increased expression of TRAPPC13 mRNA CTD PMID:27188386 NCBI chr 2:35,270,495...35,302,049
Ensembl chr 2:35,269,183...35,302,048 		JBrowse link
G Trdmt1 tRNA aspartic acid methyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of TRDMT1 mRNA CTD PMID:27188386 NCBI chr17:81,510,740...81,554,036
Ensembl chr17:76,610,543...76,645,439 		JBrowse link
G Trerf1 transcriptional regulating factor 1 decreases expression ISO Thimerosal results in decreased expression of TRERF1 mRNA CTD PMID:27188386 NCBI chr 9:13,631,619...13,858,326
Ensembl chr 9:13,634,126...13,857,029 		JBrowse link
G Trib3 tribbles pseudokinase 3 decreases expression ISO Thimerosal results in decreased expression of TRIB3 mRNA CTD PMID:27188386 NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:140,809,043...140,814,497 		JBrowse link
G Trim13 tripartite motif-containing 13 increases expression ISO Thimerosal results in increased expression of TRIM13 mRNA CTD PMID:27188386 NCBI chr15:35,733,548...35,772,676
Ensembl chr15:35,734,107...35,772,677 		JBrowse link
G Trim14 tripartite motif-containing 14 decreases expression ISO Thimerosal results in decreased expression of TRIM14 mRNA CTD PMID:27188386 NCBI chr 5:60,800,568...60,824,858
Ensembl chr 5:60,800,032...60,824,858 		JBrowse link
G Trim23 tripartite motif-containing 23 increases expression ISO Thimerosal results in increased expression of TRIM23 mRNA CTD PMID:27188386 NCBI chr 2:35,302,405...35,335,746
Ensembl chr 2:35,302,409...35,335,743 		JBrowse link
G Trim28 tripartite motif-containing 28 decreases expression ISO Thimerosal results in decreased expression of TRIM28 mRNA CTD PMID:27188386 NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380 		JBrowse link
G Trim59 tripartite motif-containing 59 decreases expression ISO Thimerosal results in decreased expression of TRIM59 mRNA CTD PMID:27188386 NCBI chr 2:153,269,210...153,281,185
Ensembl chr 2:153,268,584...153,281,031 		JBrowse link
G Trim9 tripartite motif-containing 9 decreases expression ISO Thimerosal results in decreased expression of TRIM9 mRNA CTD PMID:27188386 NCBI chr 6:88,756,824...88,856,588
Ensembl chr 6:88,757,303...88,856,542 		JBrowse link
G Trmt10a tRNA methyltransferase 10A increases expression ISO Thimerosal results in increased expression of TRMT10A mRNA CTD PMID:27188386 NCBI chr 2:229,342,853...229,357,573
Ensembl chr 2:226,669,832...226,684,151 		JBrowse link
G Trpm3 transient receptor potential cation channel, subfamily M, member 3 increases expression ISO Thimerosal results in increased expression of TRPM3 mRNA CTD PMID:27188386 NCBI chr 1:219,673,200...220,557,610
Ensembl chr 1:219,672,892...220,560,717 		JBrowse link
G Tshb thyroid stimulating hormone subunit beta increases expression ISO Thimerosal results in increased expression of TSHB mRNA; Thimerosal results in increased expression of TSHB protein CTD PMID:24675092 NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559 		JBrowse link
G Tspan33 tetraspanin 33 decreases expression ISO Thimerosal results in decreased expression of TSPAN33 mRNA CTD PMID:27188386 NCBI chr 4:58,305,378...58,330,013
Ensembl chr 4:58,305,437...58,328,940 		JBrowse link
G Ttc39c tetratricopeptide repeat domain 39C multiple interactions ISO [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA CTD PMID:27188386 NCBI chr18:3,768,802...3,887,932
Ensembl chr18:3,805,183...3,887,930 		JBrowse link
G Ttyh2 tweety family member 2 decreases expression ISO Thimerosal results in decreased expression of TTYH2 mRNA CTD PMID:27188386 NCBI chr10:99,709,063...99,753,449
Ensembl chr10:99,709,007...99,753,444 		JBrowse link
G Tubb2a tubulin, beta 2A class IIa decreases expression ISO Thimerosal results in decreased expression of TUBB2A mRNA CTD PMID:27188386 NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714 		JBrowse link
G Tubb4b tubulin, beta 4B class IVb decreases expression ISO Thimerosal results in decreased expression of TUBB4B mRNA CTD PMID:27188386 NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296 		JBrowse link
G Tubgcp3 tubulin gamma complex component 3 increases expression ISO Thimerosal results in increased expression of TUBGCP3 mRNA CTD PMID:27188386 NCBI chr16:76,851,859...76,912,499
Ensembl chr16:76,851,810...76,912,499 		JBrowse link
G Txn1 thioredoxin 1 multiple interactions
decreases activity 		ISO [Thimerosal co-treated with Temozolomide] results in decreased activity of TXN protein
Thimerosal results in decreased activity of TXN protein 		CTD PMID:38325586 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629 		JBrowse link
G Txndc9 thioredoxin domain containing 9 increases expression ISO Thimerosal results in increased expression of TXNDC9 mRNA CTD PMID:27188386 NCBI chr 9:40,211,818...40,221,953
Ensembl chr 9:40,211,412...40,384,279
Ensembl chr 9:40,211,412...40,384,279 		JBrowse link
G Txnip thioredoxin interacting protein decreases expression ISO Thimerosal results in decreased expression of TXNIP mRNA CTD PMID:27188386 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886 		JBrowse link
G Txnrd1 thioredoxin reductase 1 multiple interactions
decreases activity 		ISO [Thimerosal co-treated with Temozolomide] results in decreased activity of TXNRD1 protein
Thimerosal results in decreased activity of TXNRD1 protein 		CTD PMID:38325586 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863 		JBrowse link
G Ube2l3 ubiquitin-conjugating enzyme E2L 3 decreases expression ISO Thimerosal results in decreased expression of UBE2L3 mRNA CTD PMID:27188386 NCBI chr11:97,300,584...97,343,084
Ensembl chr11:83,797,722...83,838,862 		JBrowse link
G Ubn1 ubinuclein 1 decreases expression ISO Thimerosal results in decreased expression of UBN1 mRNA CTD PMID:27188386 NCBI chr10:10,496,576...10,532,010
Ensembl chr10:10,496,576...10,532,010 		JBrowse link
G Ubn2 ubinuclein 2 decreases expression ISO Thimerosal results in decreased expression of UBN2 mRNA CTD PMID:27188386 NCBI chr 4:67,165,278...67,251,562
Ensembl chr 4:67,166,346...67,230,491 		JBrowse link
G Ubr1 ubiquitin protein ligase E3 component n-recognin 1 increases expression ISO Thimerosal results in increased expression of UBR1 mRNA CTD PMID:27188386 NCBI chr 3:107,813,721...107,921,701
Ensembl chr 3:107,811,392...107,922,204 		JBrowse link
G Ucp2 uncoupling protein 2 decreases expression ISO Thimerosal results in decreased expression of UCP2 mRNA CTD PMID:27188386 NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611 		JBrowse link
G Ugcg UDP-glucose ceramide glucosyltransferase decreases expression ISO Thimerosal results in decreased expression of UGCG mRNA CTD PMID:27188386 NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393 		JBrowse link
G Uggt1 UDP-glucose glycoprotein glucosyltransferase 1 decreases expression ISO Thimerosal results in decreased expression of UGGT1 mRNA CTD PMID:27188386 NCBI chr 9:38,355,229...38,468,473
Ensembl chr 9:38,359,089...38,468,467 		JBrowse link
G Ugt8 UDP glycosyltransferase 8 decreases expression ISO Thimerosal results in decreased expression of UGT8 mRNA CTD PMID:27188386 NCBI chr 2:216,938,884...217,007,167
Ensembl chr 2:214,264,483...214,332,660 		JBrowse link
G Uhmk1 U2AF homology motif kinase 1 decreases expression ISO Thimerosal results in decreased expression of UHMK1 mRNA CTD PMID:27188386 NCBI chr13:84,929,418...84,949,194
Ensembl chr13:82,401,187...82,416,292 		JBrowse link
G Upf1 UPF1, RNA helicase and ATPase decreases expression ISO Thimerosal results in decreased expression of UPF1 mRNA CTD PMID:27188386 NCBI chr16:19,076,594...19,097,365
Ensembl chr16:19,076,322...19,096,568 		JBrowse link
G Upp1 uridine phosphorylase 1 increases expression ISO Thimerosal results in increased expression of UPP1 mRNA CTD PMID:16870260 NCBI chr14:88,023,155...88,043,036
Ensembl chr14:83,809,960...83,829,462 		JBrowse link
G Usp1 ubiquitin specific peptidase 1 decreases expression ISO Thimerosal results in decreased expression of USP1 mRNA CTD PMID:27188386 NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932 		JBrowse link
G Usp10 ubiquitin specific peptidase 10 decreases expression ISO Thimerosal results in decreased expression of USP10 mRNA CTD PMID:27188386 NCBI chr19:47,972,858...48,014,900
Ensembl chr19:47,972,611...48,014,897 		JBrowse link
G Usp16 ubiquitin specific peptidase 16 increases expression ISO Thimerosal results in increased expression of USP16 mRNA CTD PMID:27188386 NCBI chr11:40,166,651...40,196,792
Ensembl chr11:26,681,414...26,710,539 		JBrowse link
G Usp25 ubiquitin specific peptidase 25 affects expression ISO Thimerosal affects the expression of USP25 mRNA CTD PMID:27188386 NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348 		JBrowse link
G Usp29 ubiquitin specific peptidase 29 decreases expression ISO Thimerosal results in decreased expression of USP29 mRNA CTD PMID:24675092 NCBI chr 1:66,874,216...67,097,731
Ensembl chr 1:66,874,017...67,097,686 		JBrowse link
G Usp34 ubiquitin specific peptidase 34 affects expression ISO Thimerosal affects the expression of USP34 mRNA CTD PMID:27188386 NCBI chr14:97,285,799...97,476,376
Ensembl chr14:97,286,018...97,476,376 		JBrowse link
G Usp49 ubiquitin specific peptidase 49 decreases expression ISO Thimerosal results in decreased expression of USP49 mRNA CTD PMID:27188386 NCBI chr 9:13,305,640...13,366,132
Ensembl chr 9:13,308,178...13,366,132 		JBrowse link
G Usp51 ubiquitin specific peptidase 51 decreases expression ISO Thimerosal results in decreased expression of USP51 mRNA CTD PMID:27188386 NCBI chr  X:18,374,940...18,381,472
Ensembl chr  X:18,376,930...18,379,888 		JBrowse link
G Vangl1 VANGL planar cell polarity protein 1 decreases expression ISO Thimerosal results in decreased expression of VANGL1 mRNA CTD PMID:27188386 NCBI chr 2:189,586,681...189,637,609
Ensembl chr 2:189,589,229...189,637,619 		JBrowse link
G Vapb VAMP associated protein B and C decreases expression ISO Thimerosal results in decreased expression of VAPB mRNA CTD PMID:27188386 NCBI chr 3:182,954,247...182,997,018
Ensembl chr 3:162,535,905...162,573,763 		JBrowse link
G Vasp vasodilator-stimulated phosphoprotein decreases expression ISO Thimerosal results in decreased expression of VASP mRNA CTD PMID:27188386 NCBI chr 1:88,038,026...88,053,783
Ensembl chr 1:78,910,011...78,925,061 		JBrowse link
G Vat1 vesicle amine transport 1 decreases expression ISO Thimerosal results in decreased expression of VAT1 mRNA CTD PMID:27188386 NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,389,545...86,397,224 		JBrowse link
G Vcp valosin-containing protein decreases expression ISO Thimerosal results in decreased expression of VCP mRNA CTD PMID:27188386 NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:57,210,168...57,229,571 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression
multiple interactions 		ISO Thimerosal results in decreased expression of VEGFA mRNA
[Thimerosal co-treated with Temozolomide] results in decreased expression of VEGFA protein 		CTD PMID:27188386 PMID:38325586 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Vegfb vascular endothelial growth factor B decreases expression ISO Thimerosal results in decreased expression of VEGFB mRNA CTD PMID:27188386 NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944 		JBrowse link
G Vps37b VPS37B subunit of ESCRT-I decreases expression ISO Thimerosal results in decreased expression of VPS37B mRNA CTD PMID:27188386 NCBI chr12:32,560,047...32,589,015
Ensembl chr12:32,560,047...32,589,014 		JBrowse link
G Vps53 VPS53 subunit of GARP complex decreases expression ISO Thimerosal results in decreased expression of VPS53 mRNA CTD PMID:27188386 NCBI chr10:60,919,820...61,038,674
Ensembl chr10:60,919,820...61,038,676 		JBrowse link
G Vsig10l V-set and immunoglobulin domain containing 10 like decreases expression ISO Thimerosal results in decreased expression of VSIG10L mRNA CTD PMID:27188386 NCBI chr 1:103,007,933...103,016,161
Ensembl chr 1:93,851,774...93,879,566 		JBrowse link
G Wapl WAPL cohesin release factor decreases expression ISO Thimerosal results in decreased expression of WAPL mRNA CTD PMID:27188386 NCBI chr16:10,005,520...10,075,270
Ensembl chr16:10,004,941...10,073,510 		JBrowse link
G Wasf2 WASP family member 2 decreases expression ISO Thimerosal results in decreased expression of WASF2 mRNA CTD PMID:27188386 NCBI chr 5:150,620,733...150,685,943
Ensembl chr 5:145,336,842...145,399,242 		JBrowse link
G Wasl WASP like actin nucleation promoting factor decreases expression ISO Thimerosal results in decreased expression of WASL mRNA CTD PMID:27188386 NCBI chr 4:54,049,081...54,097,653
Ensembl chr 4:53,083,536...53,132,022 		JBrowse link
G Wdfy3 WD repeat and FYVE domain containing 3 increases expression ISO Thimerosal results in increased expression of WDFY3 mRNA CTD PMID:27188386 NCBI chr14:7,578,245...7,810,491
Ensembl chr14:7,606,628...7,810,482 		JBrowse link
G Wdr49 WD repeat domain 49 increases expression ISO Thimerosal results in increased expression of WDR49 mRNA CTD PMID:27188386 NCBI chr 2:160,049,478...160,264,581
Ensembl chr 2:160,051,458...160,264,511 		JBrowse link
G Wdr54 WD repeat domain 54 decreases expression ISO Thimerosal results in decreased expression of WDR54 mRNA CTD PMID:27188386 NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:115,654,968...115,661,562 		JBrowse link
G Wdr59 WD repeat domain 59 decreases expression ISO Thimerosal results in decreased expression of WDR59 mRNA CTD PMID:27188386 NCBI chr19:39,416,432...39,483,773
Ensembl chr19:39,416,429...39,483,698 		JBrowse link
G Wdr86 WD repeat domain 86 decreases expression ISO Thimerosal results in decreased expression of WDR86 mRNA CTD PMID:24675092 NCBI chr 4:10,423,496...10,443,473
Ensembl chr 4:10,424,008...10,441,465 		JBrowse link
G Wipf3 WAS/WASL interacting protein family, member 3 decreases expression ISO Thimerosal results in decreased expression of WIPF3 mRNA CTD PMID:27188386 NCBI chr 4:83,550,075...83,629,929
Ensembl chr 4:83,550,468...83,629,386 		JBrowse link
G Wnk1 WNK lysine deficient protein kinase 1 decreases expression ISO Thimerosal results in decreased expression of WNK1 mRNA CTD PMID:27188386 NCBI chr 4:154,800,590...154,926,147
Ensembl chr 4:153,128,334...153,253,905 		JBrowse link
G Wnt3 Wnt family member 3 decreases expression ISO Thimerosal results in decreased expression of WNT3 mRNA CTD PMID:27188386 NCBI chr10:89,180,224...89,224,195
Ensembl chr10:88,680,248...88,724,099 		JBrowse link
G Xiap X-linked inhibitor of apoptosis affects expression
multiple interactions
decreases expression 		ISO Thimerosal affects the expression of XIAP protein
Glutathione inhibits the reaction [Thimerosal results in decreased expression of XIAP protein] 		CTD PMID:12140745 PMID:16649253 NCBI chr  X:125,756,107...125,803,979
Ensembl chr  X:120,897,907...120,934,700 		JBrowse link
G Zc3h12c zinc finger CCCH type containing 12C increases expression ISO Thimerosal results in increased expression of ZC3H12C mRNA CTD PMID:24675092 NCBI chr 8:52,443,791...52,508,643
Ensembl chr 8:52,448,320...52,504,315 		JBrowse link
G Zfp382 zinc finger protein 382 decreases expression ISO Thimerosal results in decreased expression of ZFP382 mRNA CTD PMID:24675092 NCBI chr 1:85,377,614...85,400,832
Ensembl chr 1:85,377,484...85,399,667 		JBrowse link
G Zfp655 zinc finger protein 655 increases expression ISO Thimerosal results in increased expression of ZFP655 mRNA CTD PMID:24675092 NCBI chr12:9,349,985...9,375,449
Ensembl chr12:9,357,639...9,374,569 		JBrowse link
G Zfp958 zinc finger protein 958 decreases expression ISO Thimerosal results in decreased expression of ZFP958 mRNA CTD PMID:24675092 NCBI chr12:3,953,442...3,975,328
Ensembl chr12:3,953,455...3,975,514
Ensembl chr12:3,953,455...3,975,514 		JBrowse link
triarachidonin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Scd stearoyl-CoA desaturase decreases expression
multiple interactions 		ISO Triarachidonin results in decreased expression of SCD1 mRNA
Clofibrate inhibits the reaction [Triarachidonin results in decreased expression of SCD1 mRNA] 		CTD PMID:8729090 PMID:8790349 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20856
    chemical entity 20854
      molecular entity 20853
        ion 17375
          anion 16952
            organic anion 6867
              carboxylic acid anion 2513
                monocarboxylic acid anion 1606
                  (+)-DCA-CL(1-) 0
                  (+)-artemisinate 0
                  (+)-pisiferate 0
                  (-)-DCA-CL(1-) 0
                  (-)-phomoidride B(1-) 0
                  (10aS)-10,10a-dihydrophenazine-1-carboxylate 0
                  (11R)-carlactonoate + 0
                  (1R)-1,4,5,10-tetrahydrophenazine-1-carboxylate 0
                  (1R,10aS)-1,4,10,10a-tetrahydrophenazine-1-carboxylate 0
                  (1S,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 0
                  (2-chloro-5-oxo-2,5-dihydro-2-furyl)acetate + 0
                  (2-hydroxyphenyl)acetate 0
                  (2-methylphenoxy)acetate 0
                  (2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate 0
                  (2R,3R,5S)-2-(S-pantetheinyl)-carbapenam-3-carboxylate 0
                  (2R,3R,5S,6R)-6-(ethyl)-2-(S-pantetheinyl)-carbapenam-3-carboxylate 0
                  (2R,3R,5S,6R)-6-(methyl)-2-(S-pantetheinyl)-carbapenam-3-carboxylate 0
                  (2S)-3-(4-hydroxyphenyl)-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]propanoate 0
                  (2S)-3-methyl-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]butanoate 0
                  (2S)-3-phenyl-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]propanoate 0
                  (2S)-4-methyl-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]pentanoate 0
                  (2S)-N-acetylazetidine-2-carboxylate 0
                  (2Z,4Z)-2-hydroxyhexa-2,4-dienoate 0
                  (2xi)-3-deoxy-7-O-phosphonato-beta-D-threo-hept-6-ulopyranosonate + 0
                  (2xi)-D-gluco-heptonate + 0
                  (3,5-dichlorophenyl)ureidoformate 0
                  (3-nitro-4-oxidophenyl)acetate 0
                  (3R)-7,8-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate 0
                  (3R,5S)-fluvastatin(1-) + 0
                  (3S)-1,2-diazinane-3-carboxylate 0
                  (3S)-3-(\{(2S)-2-[5-tert-butyl-3-\{[(4-methyl-1,2,5-oxadiazol-3-yl)methyl]amino\}-2-oxopyrazin-1(2H)-yl]butanoyl\}amino)-5-[hexyl(methyl)amino]-4-oxopentanoate 0
                  (3S)-7,8-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate 0
                  (3S,5R)-fluvastatin(1-) + 0
                  (3S,5S)-carbapenam-3-carboxylate 0
                  (4-hydroxy-3-nitrophenyl)acetate 0
                  (4-hydroxy-5-iodo-3-nitrophenyl)acetate 0
                  (4-nitrophenyl)acetate 0
                  (4-octa-1-enyl-2,5-dioxo-2,5-dihydro-3-furanyl)acetate 0
                  (4R,5S)-dethiobiotin(1-) 0
                  (4S)-4,16-dihydroxyretinoate 0
                  (5R)-carbapenem-3-carboxylate 0
                  (7R)-6-deoxy-D-manno-oct-7-ulosuronate 0
                  (8E,10S,12Z,15Z)-10-hydroperoxyoctadec-8,12,15-trienoate 0
                  (9E)-12-(phosphonooxy)octadecenoate(3-) 0
                  (9Z)-18-hydroxyoctadec-9-enoate 18-O-beta-D-glucoside 0
                  (9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienoate 0
                  (E)-3-(indol-3-yl)acrylate(1-) 0
                  (E)-4-O-(beta-D-glucuronosyl)-ferulate(2-) 0
                  (R)-2-(4-chloro-2-methylphenoxy)propanoate 0
                  (R)-2-O-sulfonatolactate(2-) 0
                  (R)-3,5-bisphosphonatomevalonate(5-) 0
                  (R)-3-sulfolactate 0
                  (R)-5-diphosphonatomevalonate(4-) 0
                  (R)-dichlorprop(1-) 0
                  (R)-dihydrocamalexate 0
                  (R)-imazamox(1-) + 0
                  (R)-imazapic(1-) + 0
                  (R)-imazapyr(1-) + 0
                  (R)-imazaquin(1-) + 0
                  (R)-lorglumide(1-) + 0
                  (R,R)-chrysanthemate 0
                  (S)-2-(4-chloro-2-methylphenoxy)propanoate 0
                  (S)-2-O-sulfonatolactate(2-) 0
                  (S)-2-chloropropanoate 0
                  (S)-4-amino-5-oxopentanoate 0
                  (S)-5-carboxymethyl-tetronate(1-) 0
                  (S)-alpha-hydroxyglutarate-gamma-lactone 0
                  (S)-dichlorprop(1-) 0
                  (S)-dihydrocamalexate 0
                  (S)-haloxyfop(1-) 0
                  (S)-imazamox(1-) + 0
                  (S)-imazapic(1-) + 0
                  (S)-imazapyr(1-) + 0
                  (S)-imazaquin(1-) + 0
                  (S)-lorglumide(1-) + 0
                  (Z)-2-methylureidoacrylate 0
                  (Z)-3-amino-2-methylacrylate 0
                  (Z)-3-aminoacrylate 0
                  (aminooxy)acetate + 0
                  (methylthio)acetate 0
                  1,2-diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol(1-) 0
                  1,4-dihydroxy-6-naphthoate 0
                  1,6-anhydro-N-acetyl-beta-muramate 0
                  1,6-dihydroxy-2-methylcyclohexa-2,4-diene-1-carboxylate 0
                  1-(2-carboxylatophenylamino)-1-deoxy-D-ribulose 5-phosphate(3-) 0
                  1-O-hexadecyl-2-(8-carboxyoctanoyl)-sn-glycero-3-phosphocholine(1-) 0
                  1-deoxypentalenate 0
                  1-hexadecyl-2-glutaryl-sn-glycero-3-phosphocholine(1-) 0
                  1-hexadecyl-2-succinyl-sn-glycero-3-phosphocholine(1-) 0
                  1-methyl-4-imidazoleacetate 0
                  1-naphthaleneacetate 0
                  1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine(1-) 0
                  1-phosphonato-alpha-D-galacturonate(3-) 0
                  1-phosphonato-alpha-D-glucuronate(3-) 0
                  1-piperideine-6-carboxylate + 0
                  1-pyrrolinecarboxylate + 0
                  12-(octadecanoyloxy)octadecanoate 0
                  12-(phosphonooxy)octadecanoate(3-) 0
                  12-[(9Z)-hexadecenoyloxy]octadecanoate 0
                  12-[(9Z)-octadecenoyloxy]octadecanoate 0
                  12-ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d(1-) 0
                  12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d(1-) 0
                  13-(beta-D-glucosyloxy)docosanoate 0
                  13-(octadecanoyloxy)octadecanoate 0
                  13-[(9Z)-hexadecenoyloxy]octadecanoate 0
                  13-[(9Z)-octadecenoyloxy]octadecanoate 0
                  16-epiestriol 16-O-(beta-D-glucuronide)(1-) 0
                  16-epiestriol 3-O-(beta-D-glucuronide)(1-) 0
                  16-feruloyloxypalmitate 0
                  16-sinapoyloxypalmitate 0
                  17-(4-hydroxyphenyl)heptadecanoate 0
                  17-epiestriol 16-O-(beta-D-glucuronide)(1-) 0
                  17-epiestriol 17-O-(beta-D-glucuronide)(1-) 0
                  17-epiestriol 3-O-(beta-D-glucuronide)(1-) 0
                  17alpha-(N-acetyl-D-glucosaminyl)estradiol 3-glucosiduronate 0
                  17alpha-estradiol 3-glucosiduronate 0
                  17beta-estradiol 17-glucosiduronate + 0
                  19-(4-hydroxyphenyl)nonadecanoate 0
                  2,3,6,8,9-pentahydroxy-1-oxo-3-(2-oxopropyl)-1,2,3,4-tetrahydroanthracene-2-carboxylate 0
                  2,3-bisphosphonato-D-glycerate(5-) 0
                  2,4,5-trihydroxyphenylacetate 0
                  2,4-dichloro-5-oxo-2,5-dihydro-2-furylacetate 0
                  2,4-dihydroxybenzoate 0
                  2,4-divinyl protochlorophyllide a(1-) 0
                  2,6-dihydroxybenzoate 0
                  2,6-dihydroxynicotinate 0
                  2-O-(4-deoxy-beta-L-threo-hex-4-enopyranuronosyl)-alpha-L-rhamnopyranose(1-) 0
                  2-O-(6-phospho-alpha-D-mannosyl)-D-glycerate 0
                  2-O-(alpha-D-glucopyranosyl)-3-O-phosphonato-D-glycerate(3-) 0
                  2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phosphonato-D-glycerate(3-) 0
                  2-O-[alpha-D-mannosyl-(1->2)-alpha-D-glucosyl]-D-glycerate 0
                  2-O-alpha-L-rhamnosyl-alpha-L-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoate 0
                  2-[(1R,8S,14R,15R)-11-hydroxy-14,15-bis[(6E)-oct-6-en-1-yl]-3,5,9-trioxo-4,10-dioxatetracyclo[9.4.0.0(2,6).0(8,12)]pentadeca-2(6),12-dien-8-yl]acetate 0
                  2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]acetate 0
                  2-[1-(\{5-hydroxy-4-oxo-3-[2-(sulfonatooxy)phenyl]-4H-chromen-6-yl\}oxy)-2-oxoethoxy]-3-oxopropanoate 0
                  2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-4-O-sulfonato-D-galactopyranose(2-) + 0
                  2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-6-O-sulfonato-D-galactopyranose(2-) + 0
                  2-amino-2-deoxy-D-gluconate 0
                  2-amino-3-oxo-4-(phosphonatooxy)butanoate 0
                  2-carboxylato-D-arabinitol 1-phosphate(3-) 0
                  2-carboxylato-D-arabinitol(1-) 0
                  2-chloroacrylate 0
                  2-cis-abscisate + 0
                  2-dehydro-3,6-dideoxy-6-sulfo-D-gluconate(2-) 0
                  2-dehydro-3-deoxy-6-phosphonato-D-gluconate(3-) 0
                  2-ethylacrylate 0
                  2-hydroxy-17beta-estradiol 2-O-(beta-D-glucuronide)(1-) 0
                  2-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                  2-hydroxyestrone 2-O-(beta-D-glucuronide)(1-) 0
                  2-hydroxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                  2-imino-3-(7-chloroindol-3-yl)propionate(1-) 0
                  2-imino-3-(indol-3-yl)propanoate 0
                  2-iminopropanoate 0
                  2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                  2-methoxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                  2-methylvalerate 0
                  2-oxindole-3-acetate 0
                  2-oxo-1,2-dihydroquinoline-4-carboxylate 0
                  2-oxo-4-phosphonobutanoate(2-) 0
                  2-phosphonatoglycolate(3-) 0
                  3'-dehydrocarminate(2-) 0
                  3,3',5-triiodo-L-thyroninate + 0
                  3,4,5-trimethoxybenzoate 0
                  3,4,5-trimethoxydihydrocinnamate 0
                  3,4-dehydrothiomorpholine-3-carboxylate 0
                  3,4-dimethylindole-2-carboxylate 0
                  3,5-dibromo-4-oxidobenzoate(2-) 0
                  3-(1-hydroxyethyl)bacteriochlorophyllide a(2-) 0
                  3-(1-hydroxyethyl)chlorophyllide a(2-) 0
                  3-(1-methyl-5-oxo-4,5-dihydro-1H-imidazol-4-yl)propanoate(1-) 0
                  3-(1H-indol-3-yl)propanoate 0
                  3-(2,3-dihydroxyphenyl)propanoate 0
                  3-(2-hydroxyphenyl)propanoate 0
                  3-(3,4-dihydroxyphenyl)propanoate 0
                  3-(3-hydroxyphenyl)propanoate 0
                  3-(3-sulfooxyphenyl)propanoate(2-) 0
                  3-(4-oxo-4,5-dihydro-1H-imidazol-5-yl)propanoate(1-) 0
                  3-(cis-5,6-dihydroxycyclohexa-1,3-dienyl)propanoate + 0
                  3-(dioxido-lambda(5)-azanylidene)propanoate(2-) 0
                  3-(trimethylsilyl)propionate + 0
                  3-ADP-2-phosphoglycerate(5-) 0
                  3-D-glucuronosyl-N(2),6-disulfonato-beta-D-glucosamine(3-) 0
                  3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-D-galactosamine(1-) 0
                  3-acetylchlorophyllide a(2-) 0
                  3-aci-nitropropanoate 0
                  3-butynoate 0
                  3-carboxy-3-hydroxypropanoyl-CoA(5-) + 0
                  3-chloroacrylate 0
                  3-dehydro-L-gulonate 6-phosphate 0
                  3-dehydroshikimate 0
                  3-deoxy-D-glycero-beta-D-galacto-nonulosonate + 0
                  3-deoxy-alpha-D-manno-2-octulosonate-8-phosphate(3-) 0
                  3-deoxy-alpha-D-manno-oct-2-ulosonate 0
                  3-diazoavenalumate 0
                  3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoate 0
                  3-hydroxy-3-(4-O-beta-D-glucosyl-3-methoxyphenyl)propanoate 0
                  3-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoate 0
                  3-hydroxy-3-(4-hydroxyphenyl)propanoate 0
                  3-hydroxy-3-phenylpropionate 0
                  3-mercapto-2-mercaptomethylpropanoate(1-) 0
                  3-methylvalerate 0
                  3-nitroacrylate 0
                  3-nitropropanoate 0
                  3-phenylpropionate + 0
                  3-phosphonatopyruvate(2-) 0
                  3-phosphonatopyruvate(3-) 0
                  3-sulfinatopropionate 0
                  3-ureidoisobutyrate(1-) 0
                  3-vinyl-bacteriochlorophyllide d(1-) 0
                  3-vinylbacteriochlorophyllide a(1-) 0
                  3-vinylbacteriochlorophyllide a(2-) 0
                  3-vinylbacteriochlorophyllide d(1-) 0
                  3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oate(1-) 0
                  4'''-demalonylsalvianin(1-) 0
                  4,4'-diapolycopen-4-oate 0
                  4,4'-diaponeurosporenoate 0
                  4-(2,4-dichlorophenoxy)butanoate 0
                  4-O-beta-D-glucosyl-4-coumarate + 0
                  4-O-beta-D-glucosyl-trans-ferulate 0
                  4-O-beta-D-glucosyl-trans-sinapate 0
                  4-acetamidobutanoate 0
                  4-carboxylato-4'-sulfonatoazobenzene 0
                  4-carboxylatomethyl-3-methylbut-2-en-1,4-olide(1-) 0
                  4-carboxylatomethyl-4-methylbut-2-en-1,4-olide(1-) 0
                  4-carboxylatomethylenebut-2-en-4-olide 0
                  4-chlorophenylacetate 0
                  4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc(2-) 0
                  4-deoxy-L-threo-hex-4-enopyranuronate + 0
                  4-deoxy-beta-L-threo-hex-4-enopyranuronate 0
                  4-guanidinobutanoate 0
                  4-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                  4-hydroxy-17beta-estradiol 4-O-(beta-D-glucuronide)(1-) 0
                  4-hydroxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                  4-hydroxyestrone 4-O-(beta-D-glucuronide)(1-) 0
                  4-hydroxyphenylacetate 0
                  4-methoxy-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate 0
                  4-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                  4-methoxy-4-oxo-3-phenylbutanoate 0
                  4-methoxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                  4-methyl-3-oxopentanoate 0
                  4-methylumbelliferone beta-D-glucuronide(1-) 0
                  4-sulfanylbutanoate 0
                  5(S),8(R)-DiHODE(1-) 0
                  5,10-dihydro-9-dimethylallylphenazine 1-carboxylate 0
                  5,10-dihydrophenazine-1-carboxylate 0
                  5,6,7,8-tetrahydropterin-6-carboxylate 0
                  5,6-epoxyretinoate 0
                  5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl beta-D-glucuronide(1-) 0
                  5-(2,3-dimethoxy-4-methylphenyl)pentanoate 0
                  5-(2-carboxylatoethyl)-4-oxo-4,5-dihydro-1H-imidazol-5-ide 0
                  5-[(9Z)-hexadecenoyloxy]octadecanoate 0
                  5-[(9Z)-octadecenoyloxy]octadecanoate 0
                  5-amino-4-chloro-2-(2-oxidomuconoyl)pyridazin-3(2H)-one(2-) 0
                  5-aminolevulinate 0
                  5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium-3-carbonyl adenylate(3-) 0
                  5-chloromuconolactone(1-) 0
                  5-dehydro-4-deoxy-2-O-sulfo-D-glucuronic acid(2-) 0
                  5-dehydro-D-gluconate 0
                  5-dehydro-L-gluconate 0
                  5-deoxy-D-glucuronate 0
                  5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate 0
                  5-hydroxy-6-methylpyridine-3-carboxylate 0
                  5-hydroxyectoinate 0
                  5-hydroxyferulate + 0
                  5-hydroxyimidazole-4-acetate 0
                  5-oxo-2,5-dihydro-2-furylacetate 0
                  5-oxo-4,5-dihydro-2-furylacetate 0
                  5alpha-androstane-3alpha,17beta-diol 17-glucosiduronate 0
                  5alpha-androstane-3alpha,17beta-diol 3-glucosiduronate(1-) 0
                  5alpha-androstane-3beta,17beta-diol 17-O-(beta-D-glucuronide)(1-) 0
                  5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)(1-) 0
                  6-O-desmethylmycophenolate 0
                  6-[(4-hydroxy-3-nitrophenyl)acetamido]caproate 0
                  6-deoxy-6-sulfo-D-gluconate(2-) 0
                  6-formamidopenicillanate 0
                  6-hydroxynicotinate(1-) 0
                  6-ketopiperidine-2-carboxylate 0
                  6-phospho-D-gluconate 0
                  6-phosphonato-2-dehydro-3-deoxy-D-galactate(3-) 0
                  6-phosphonatooxy-D-gluconate 0
                  6alpha-hydroxygermacra-1(10),4,11(13)-trien-12-oate 0
                  7(1),7(1)-dihydroxybacteriochlorophyllide d(1-) 0
                  7(1)-hydroxybacteriochlorophyllide d(1-) 0
                  7(1)-hydroxychlorophyllide a(2-) 0
                  7,7-dihydroxybacteriochlorophyllide c(1-) 0
                  7-carboxylato-7-deazaguanine 0
                  7-deoxyloganate 0
                  7-deoxyloganetate 0
                  7-hydroxybacteriochlorophyllide c(1-) 0
                  7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate 0
                  8(R)-HPODE(1-) 0
                  8,12-diethyl-3-vinylbacteriochlorophyllide d(1-) 0
                  8-phosphonato-3-deoxy-D-manno-oct-2-ulosonate(3-) 0
                  9(R)-HPODE(1-) 0
                  9(S)-HPODE(1-) 0
                  9-(octadecanoyloxy)octadecanoate 0
                  9-[(10Z)-heptadecenoyloxy]-octadecanoate 0
                  9-[(9Z),(12Z)-octadecadienoyloxy]-octadecanoate 0
                  9-[(9Z)-hexadecenoyloxy]octadecanoate 0
                  9-[(9Z)-octadecenoyloxy]octadecanoate 0
                  9beta-pimara-7,15-dien-19-oate 0
                  ADP-5-ethyl-4-methylthiazole-2-carboxylate(3-) 0
                  CMP-5'-phosphonoformate(3-) 0
                  D-galactopyranuronate + 0
                  D-glucopyranuronate + 0
                  D-glucuronate 1-phosphate 0
                  F420-0(2-) 0
                  L-5-carboxylatomethylhydantoin(1-) 0
                  L-rhamnonate 0
                  L-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoate 0
                  L-thyroxine(1-) + 0
                  N,N-dihydroxy-L-isoleucinate 0
                  N,N-dihydroxy-L-valinate 0
                  N-(11-methyldodecanoyl)-L-phenylalanine(1-) 0
                  N-(1H-1,3-benzodiazol-2-yl)carbamate 0
                  N-(2-furoyl)glycinate 0
                  N-(2-hydroxy,5-methoxyphenyl)malonamate 0
                  N-(2-hydroxyphenyl)malonamate 0
                  N-(3,4-dichlorophenyl)malonamate 0
                  N-(3-carboxypropanoyl)-N-hydroxycadaverine zwitterion 0
                  N-(3-carboxypropanoyl)-N-hydroxyputrescine zwitterion 0
                  N-(indol-3-ylacetyl)glutaminate 0
                  N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]-gamma-aminobutanoate 0
                  N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]-gamma-aminobutyrate 0
                  N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycinate 0
                  N-[(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-icosatetraenoyl]glycinate 0
                  N-[(R)-pantothenoyl]-L-cysteinate 0
                  N-acetyl-1-methyl-L-histidinate 0
                  N-acetyl-3-methyl-L-histidinate 0
                  N-acetyl-D-6-sulfogalactosamine(1-) 0
                  N-acetyl-D-glucosaminate 0
                  N-acetyl-D-muramoyl-L-alanyl-D-isoglutamine(1-) 0
                  N-acetyl-L-alaninate 0
                  N-acetyl-L-alpha-phenylglycinate 0
                  N-acetyl-L-cysteinate + 0
                  N-acetyl-L-isoleucinate 0
                  N-acetyl-L-threoninate 0
                  N-acetyl-L-tryptophanate 0
                  N-acetyl-L-tyrosinate 0
                  N-acetyl-L-valinate 0
                  N-acetyl-alpha-D-muramate 1-phosphate(3-) 0
                  N-acetyl-alpha-neuraminate + 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-6-sulfooxy-glucosaminide(2-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose(1-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose(1-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-6-sulfooxy-glucosaminide(2-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosamine(1-) 0
                  N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-N-acetyl-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminide(1-) 0
                  N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-6-O-sulfo-beta-D-glucosaminide(2-) 0
                  N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminide(1-) 0
                  N-acetyl-beta-D-6-sulfogalactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine(3-) 0
                  N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminyl-(2->3)]-beta-D-galactoside(1-) + 0
                  N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-beta-D-4-sulfogalactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-D-4-sulfogalactosamine(4-) 0
                  N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide anion 0
                  N-acetyl-beta-D-muramoyl-L-alanyl-D-isoglutamine(1-) 0
                  N-acetyl-beta-neuraminate 0
                  N-acetylmethioninate + 0
                  N-acetylmuramate 6-phosphate + 0
                  N-acetylphosphinothricin(2-) + 0
                  N-acetyltryptophanate 0
                  N-acyl-gamma-aminobutyrate + 0
                  N-arachidonoyl-gamma-aminobutyrate 0
                  N-carbamoyl-D-phenylglycine(1-) 0
                  N-carbamoyl-beta-alaninate 0
                  N-carbamoylsarcosinate 0
                  N-cinnamoylglycinate 0
                  N-formylmaleamate 0
                  N-hexadecanoyl-O-(1-octadecanoyl-2-oleoyl-sn-glycero-3-phospho)-L-serine(2-) 0
                  N-hexanoylglycinate 0
                  N-hydroxy-L-isoleucinate 0
                  N-hydroxy-L-valinate 0
                  N-isobutyrylglycinate 0
                  N-isovalerylglycinate 0
                  O-formylcefamandole(1-) + 0
                  Photinus luciferin(1-) 0
                  [1-(5-phosphonatoribosyl)imidazol-4-yl]acetate(3-) 0
                  [2-methoxy-5-(\{[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl\}methyl)anilino]acetate 0
                  a carboxymycobactin(1-) 0
                  abietate 0
                  abscisates + 0
                  acetate + 41
                  acrylate + 3
                  adenin-9-yl riburonosate(1-) 0
                  aldehydic acid anion + 0
                  aldonate + 21
                  all-trans-13,14-dihydroretinoate + 0
                  all-trans-3,4-didehydroretinoate(1-) 0
                  allantoate 0
                  alpha-D-FucNAc4-(1->4)-beta-D-ManNAcA-(1->4)-D-GlcNAc-undecaprenyl diphosphate(3-) 0
                  alpha-D-mannopyranuronate 0
                  alpha-D-talopyranuronate 0
                  alpha-L-iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine(2-) 0
                  alpha-L-iduronyl-(1->3)-N-acetyl-beta-D-4-sulfogalactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-D-4-sulfogalactosamine(4-) 0
                  alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminide(1-) + 0
                  alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide(1-) + 0
                  alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminide(1-) + 0
                  alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine(1-) + 0
                  alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                  alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide(1-) 0
                  alpha-Neu5Ac-(2->3)-beta-D-Gal6S-(1->4)-beta-D-GlcNAc6S(3-) 0
                  alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc(1-) 0
                  alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc(1-) + 0
                  alpha-sulfophenylacetate 0
                  amidotrizoic acid anion + 16
                  aminocyclopyrachlor(1-) + 0
                  arsonoacetic acid anion 0
                  ascr#1(1-) + 0
                  ascr#10(1-) + 0
                  ascr#12(1-) + 0
                  ascr#14(1-) 0
                  ascr#16(1-) 0
                  ascr#9(1-) + 0
                  asnovolin I(1-) 0
                  asparagusate 0
                  asperaculane D(1-) 0
                  asperaculane E(1-) 0
                  asperaculane G(1-) 0
                  bacteriochlorophyllide a(2-) + 0
                  bacteriochlorophyllide c(1-) 0
                  bacteriochlorophyllide d(1-) 0
                  bacteriochlorophyllide e(1-) 0
                  bacteriochlorophyllide f(1-) + 0
                  bacteriochlorophyllide g(2-) 0
                  baicalin(1-) 0
                  benazolin(1-) + 0
                  benzoates + 1285
                  beraprost(1-) + 0
                  beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-D-GlcpNAc(1-) + 0
                  beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc(1-) 0
                  beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GlcpNAc(1-) 0
                  beta-D-ManNAcA-(1->4)-alpha-D-GlcNAc-1-diphospho-ditrans,polycis-undecaprenol(3-) 0
                  beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-alpha-D-galactosaminide(1-) 0
                  bile acid anion + 54
                  biotinate + 0
                  biotinate sulfoxide(1-) 0
                  bisorcic(1-) 0
                  bispyribac(1-) + 0
                  bromfenac(1-) + 0
                  bumadizone(1-) + 0
                  butyrylglycinate 0
                  calcitroate 0
                  candesartan(2-) 0
                  carbocyclic thromboxane A2(1-) + 0
                  carboprost(1-) + 0
                  carminate(2-) 0
                  carnosate 0
                  carumonam(1-) + 0
                  catechol beta-D-glucuronide(1-) 0
                  cefmenoxime(1-) 0
                  ceftizoxime(1-) + 0
                  cefuzonam(1-) + 0
                  chenodeoxycholic acid 24-O-(beta-D-glucuronide)(1-) 0
                  chlorfenac(1-) + 0
                  chlorogenate 0
                  chlorophenoxyacetate anion + 0
                  chlorophyllide a(2-) 0
                  chlorophyllide b(1-) 0
                  chlorophyllide b(2-) 0
                  chlorophyllide(2-) + 0
                  cholic acid 24-O-(beta-D-glucuronide)(1-) 0
                  chromenemonocarboxylate + 0
                  cinnamates + 0
                  cis-2-chloro-4-carboxylatomethylenebut-2-en-1,4-olide 0
                  cis-2-methyl-4-carboxylatomethylenebut-2-en-1,4-olide(1-) 0
                  cis-heme d hydroxychlorin gamma-spirolactone(1-) 0
                  clavaldehyde(1-) 0
                  clavulanate + 24
                  clofencet(1-) + 0
                  clonixin(1-) + 0
                  clorazepic acid anion + 0
                  cochalate 0
                  coenzyme B(3-) 0
                  creatinate 0
                  cremeomycin(1-) 0
                  cuevaene A(1-) 0
                  cyclic 2,3-bisphospho-D-glycerate(3-) 0
                  cyclitol carboxylic acid anion + 0
                  cyclohex-1,4-dienecarboxylate + 0
                  cyclohex-2,5-dienecarboxylate + 0
                  cyclohexadienecarboxylate + 0
                  cyclohexanecarboxylate + 0
                  cyclohexenecarboxylate + 0
                  cyclopropanecarboxylate + 0
                  dTDP-D-galacturonate(3-) 0
                  dehydroabietate 0
                  delphinidin-5-olate 3-O-(6''-O-carboxylatoacetyl)-beta-D-glucoside(1-) 0
                  delphinidin-5-olate 3-O-(6''-O-carboxylatoacetyl)-beta-D-glucoside-3'-O-beta-D-glucoside(1-) 0
                  deoxycholic acid 24-O-(beta-D-glucuronide)(1-) 0
                  deoxylimonoate 0
                  deoxyviolaceinate 0
                  dermatan sulfate polyanion + 0
                  desmethylnaproxen(1-) 0
                  dethiobiotin(1-) 0
                  di-trans,poly-cis-polyprenate(1-) 0
                  dicarboxylic acid monoamide(1-) + 0
                  dichloroacetate 0
                  diclofenac(1-) + 0
                  difluoroacetate 0
                  dihydroartemisinate 0
                  dihydroferulate 0
                  dihydroorotate + 0
                  dihydrourocanate 0
                  ditrans,polycis-dodecaprenyl phosphate-GalA(2-) 0
                  divinyl chlorophyllide a(2-) 0
                  ectoinate 0
                  ent-7alpha-hydroxykaur-16-en-19-oate 0
                  ent-Photinus luciferin(1-) 0
                  ent-glycosmisate 0
                  ent-kaur-16-en-19-oate 0
                  epoxy monocarboxylic acid anion + 0
                  etiocholanolone 3-glucuronide(1-) 0
                  etrasimod(1-) + 0
                  fatty acid anion + 138
                  fenoprofen(1-) + 0
                  firefly D-sulfoluciferin(2-) 0
                  firefly L-sulfoluciferin(2-) 0
                  flavokermesate 7-C-beta-D-glucoside(2-) 0
                  flufenamate 0
                  flunixin(1-) + 0
                  fondaparinux(10-) + 0
                  formate + 0
                  fosinopril(1-) + 0
                  fumagillin(1-) 0
                  fumisoquin C(1-) 0
                  furancarboxylate + 0
                  germacra-1(10),4,11(13)-trien-12-oate + 0
                  glutaramate + 0
                  glycosmisate 0
                  glycyrrhetinate 82
                  guanidinoacetate 0
                  gypsogenate 28-beta-D-glucoside(1-) 0
                  gypsogenin(1-) 0
                  haloacetate(1-) + 0
                  haloxyfop-P(1-) + 0
                  hederagenin(1-) 0
                  heparin disaccharide I-S(4-) 0
                  hydantoin-5-propionate + 0
                  hydrogen phosphonatoacetate(2-) 0
                  hydroxy fatty acid ascaroside anion + 0
                  hydroxy monocarboxylic acid anion + 78
                  hyocholic acid 24-O-(beta-D-glucuronide)(1-) 0
                  hyodeoxycholic acid 24-O-(beta-D-glucuronide)(1-) 0
                  ibuprofen(1-) 0
                  icas#1(1-) 0
                  icas#10(1-) 0
                  icas#12(1-) 0
                  icas#9(1-) 0
                  imidazol-4-ylacetate 0
                  imidazolyl carboxylic acid anion + 0
                  indol-3-yl carboxylic acid anion + 0
                  indole-3-carboxylate 0
                  indolecarboxylate + 0
                  isopimarate 0
                  karetazan(1-) + 0
                  kermesate 0
                  ketorolac(1-) + 12
                  laccaic acid D(1-) 0
                  leukotriene A4(1-) 0
                  lithocholic acid 24-O-(beta-D-glucuronide)(1-) 0
                  loganate 0
                  lonazolac(1-) + 0
                  luteolin 7-O-beta-D-glucosiduronate 0
                  m-hydroxyhippurate 0
                  magnesium 13(1)-hydroxyprotoporphyrin 13-monomethyl ester(1-) 0
                  magnesium 13(1)-oxoprotoporphyrin 13-monomethyl ester(1-) 0
                  magnesium protoporphyrin 13-monomethyl ester(1-) 0
                  maleamate + 0
                  marilonates + 0
                  marinolate C 0
                  meclofenamic acid(1-) + 0
                  meglumine amidotrizoate 16
                  methacrylate 0
                  methoxyacetate + 0
                  methyl 8-\{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl]oxy\}nonanoate(1-) 0
                  methyl 8-\{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl]oxy\}nonanoate(1-) 0
                  montelukast(1-) + 0
                  mupirocin(1-) + 0
                  mycophenolate + 0
                  nalidixic acid anion 0
                  naphthoate + 0
                  naproxen(1-) + 0
                  naptalamate 0
                  neopentalenolactone D(1-) 0
                  neurosporaxanthin(1-) 0
                  nocardicin E(1-) 0
                  nocardicin E(2-) 0
                  ochratoxin A(1-) 0
                  ochratoxin B(1-) 0
                  oleanolate 0
                  oleanolate 3-O-beta-D-glucoside 0
                  olivetolate + 0
                  oroxylin A 7-O-beta-D-glucuronate 0
                  oxamate 0
                  oxo monocarboxylic acid anion + 0
                  p-hydroxyhippurate 0
                  p-tolyl beta-D-glucuronide(1-) 0
                  pantothenate + 0
                  penamcarboxylate + 0
                  penicillinate anion + 0
                  penilactone B(1-) 0
                  penilactone D(2-) 0
                  penta-2,4-dienoate + 0
                  pentalenolactone D(1-) 0
                  pentalenolactone E(1-) 0
                  pentalenolactone F(1-) 0
                  pentalenolactone(1-) 0
                  pepstatin A(1-) 0
                  perillate 0
                  perindopril(1-) + 0
                  phaseic acid anion 0
                  phenazine-1-carboxylate 0
                  phenguignardate 0
                  phenoxyacetate + 0
                  phenylacetate + 0
                  phenylacetylglycine(1-) 0
                  phenylpyruvate + 0
                  phomoidride A(1-) 0
                  phosphoenolpyruvate 3
                  phosphonatoenolpyruvate 0
                  phosphonoformate(2-) 0
                  piperidinecarboxylate + 0
                  piperonylate 0
                  pivalate + 0
                  platencin(1-) 0
                  platensimycin(1-) 0
                  pravastatin(1-) + 0
                  primary fluorescent chlorophyll catabolite(1-) 0
                  primary fluorescent dioxobilin-type chlorophyll catabolite(1-) + 0
                  propionylglycinate 0
                  propynoate 0
                  protochlorophyllide b(1-) 0
                  protochlorophyllide(1-) 0
                  protochlorophyllide(2-) 0
                  protodeoxyviolaceinate 0
                  protoviolaceinate 0
                  pseudaminate + 0
                  pseudomonates + 0
                  pteroates + 0
                  purinecarboxylate + 0
                  pyrazine-2-carboxylate 0
                  pyridinemonocarboxylate + 39
                  pyridinium-3-carboxylate-5-thiocarboxylate mononucleotide(3-) 0
                  pyrimidinecarboxylate anion + 0
                  pyrrolecarboxylate + 0
                  pyruvate oxime 0
                  quiannulatate 0
                  quillate 0
                  quinclorac(1-) + 0
                  quinoline-4-carboxylate 0
                  quinolinemonocarboxylate + 0
                  rebaudioside B(1-) 0
                  retinoate + 0
                  ribavirin carboxylate 0
                  rigosertib(1-) + 0
                  rose bengal(2-) + 8
                  rosmarinate + 0
                  salicylurate 0
                  scutellarin(1-) 0
                  sesterfisherate 0
                  soyasapogenol A 3-O-beta-glucuronate 0
                  soyasapogenol B 3-O-beta-glucuronate 0
                  soyasapogenol E 3-O-beta-glucuronate 0
                  soyasaponin I(1-) 0
                  soyasaponin III(1-) 0
                  stellatate 0
                  steviol(1-) 0
                  steviolbioside(1-) 0
                  steviolmonoside(1-) 0
                  streptothricin D acid (pH 7.3) 0
                  streptothricin F acid (pH 7.3) 0
                  succinamate 0
                  sulbactam(1-) + 0
                  sulfonatoacetate 0
                  tafamidis(1-) + 0
                  tartrazine(3-) + 94
                  ternatin C5(2-) 0
                  thiazolidinemonocarboxylate + 0
                  thioglycolate(1-) + 0
                  thioglycolate(2-) 0
                  thiomorpholine-3-carboxylate 0
                  thiophene-2-carboxylate 0
                  thromboxane A2(1-) + 0
                  tolmetin(1-) + 0
                  trans-2-chloro-4-carboxylatomethylenebut-2-en-1,4-olide(1-) 0
                  trans-2-methyl-4-carboxylatomethylenebut-2-en-1,4-olide(1-) 0
                  trans-ferulate + 0
                  trans-heme d hydroxychlorin gamma-spirolactone(1-) 0
                  trichloroacetate 0
                  trifluoroacetate + 5
                  trihazone A(2-) 0
                  ureidoacrylate 0
                  urocanate + 0
                  uronate + 0
                  valerenate 0
                  violaceinate 0
                  wogonin 7-O-beta-D-glucuronate 0
                  yersiniabactin(1-) + 0
                  zealexin A1(1-) 0
                  zofenopril(1-) + 0
                  zofenoprilat(1-) + 0
                  zolasartan(2-) 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 20856
    subatomic particle 20854
      composite particle 20854
        hadron 20854
          baryon 20854
            nucleon 20854
              atomic nucleus 20854
                atom 20854
                  main group element atom 20777
                    p-block element atom 20777
                      carbon group element atom 20710
                        carbon atom 20704
                          organic molecular entity 20704
                            organic ion 11522
                              organic anion 6867
                                carboxylic acid anion 2513
                                  monocarboxylic acid anion 1606
                                    (+)-DCA-CL(1-) 0
                                    (+)-artemisinate 0
                                    (+)-pisiferate 0
                                    (-)-DCA-CL(1-) 0
                                    (-)-phomoidride B(1-) 0
                                    (10aS)-10,10a-dihydrophenazine-1-carboxylate 0
                                    (11R)-carlactonoate + 0
                                    (1R)-1,4,5,10-tetrahydrophenazine-1-carboxylate 0
                                    (1R,10aS)-1,4,10,10a-tetrahydrophenazine-1-carboxylate 0
                                    (1S,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 0
                                    (2-chloro-5-oxo-2,5-dihydro-2-furyl)acetate + 0
                                    (2-hydroxyphenyl)acetate 0
                                    (2-methylphenoxy)acetate 0
                                    (2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate 0
                                    (2R,3R,5S)-2-(S-pantetheinyl)-carbapenam-3-carboxylate 0
                                    (2R,3R,5S,6R)-6-(ethyl)-2-(S-pantetheinyl)-carbapenam-3-carboxylate 0
                                    (2R,3R,5S,6R)-6-(methyl)-2-(S-pantetheinyl)-carbapenam-3-carboxylate 0
                                    (2S)-3-(4-hydroxyphenyl)-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]propanoate 0
                                    (2S)-3-methyl-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]butanoate 0
                                    (2S)-3-phenyl-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]propanoate 0
                                    (2S)-4-methyl-2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]pentanoate 0
                                    (2S)-N-acetylazetidine-2-carboxylate 0
                                    (2Z,4Z)-2-hydroxyhexa-2,4-dienoate 0
                                    (2xi)-3-deoxy-7-O-phosphonato-beta-D-threo-hept-6-ulopyranosonate + 0
                                    (2xi)-D-gluco-heptonate + 0
                                    (3,5-dichlorophenyl)ureidoformate 0
                                    (3-nitro-4-oxidophenyl)acetate 0
                                    (3R)-7,8-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate 0
                                    (3R,5S)-fluvastatin(1-) + 0
                                    (3S)-1,2-diazinane-3-carboxylate 0
                                    (3S)-3-(\{(2S)-2-[5-tert-butyl-3-\{[(4-methyl-1,2,5-oxadiazol-3-yl)methyl]amino\}-2-oxopyrazin-1(2H)-yl]butanoyl\}amino)-5-[hexyl(methyl)amino]-4-oxopentanoate 0
                                    (3S)-7,8-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate 0
                                    (3S,5R)-fluvastatin(1-) + 0
                                    (3S,5S)-carbapenam-3-carboxylate 0
                                    (4-hydroxy-3-nitrophenyl)acetate 0
                                    (4-hydroxy-5-iodo-3-nitrophenyl)acetate 0
                                    (4-nitrophenyl)acetate 0
                                    (4-octa-1-enyl-2,5-dioxo-2,5-dihydro-3-furanyl)acetate 0
                                    (4R,5S)-dethiobiotin(1-) 0
                                    (4S)-4,16-dihydroxyretinoate 0
                                    (5R)-carbapenem-3-carboxylate 0
                                    (7R)-6-deoxy-D-manno-oct-7-ulosuronate 0
                                    (8E,10S,12Z,15Z)-10-hydroperoxyoctadec-8,12,15-trienoate 0
                                    (9E)-12-(phosphonooxy)octadecenoate(3-) 0
                                    (9Z)-18-hydroxyoctadec-9-enoate 18-O-beta-D-glucoside 0
                                    (9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienoate 0
                                    (E)-3-(indol-3-yl)acrylate(1-) 0
                                    (E)-4-O-(beta-D-glucuronosyl)-ferulate(2-) 0
                                    (R)-2-(4-chloro-2-methylphenoxy)propanoate 0
                                    (R)-2-O-sulfonatolactate(2-) 0
                                    (R)-3,5-bisphosphonatomevalonate(5-) 0
                                    (R)-3-sulfolactate 0
                                    (R)-5-diphosphonatomevalonate(4-) 0
                                    (R)-dichlorprop(1-) 0
                                    (R)-dihydrocamalexate 0
                                    (R)-imazamox(1-) + 0
                                    (R)-imazapic(1-) + 0
                                    (R)-imazapyr(1-) + 0
                                    (R)-imazaquin(1-) + 0
                                    (R)-lorglumide(1-) + 0
                                    (R,R)-chrysanthemate 0
                                    (S)-2-(4-chloro-2-methylphenoxy)propanoate 0
                                    (S)-2-O-sulfonatolactate(2-) 0
                                    (S)-2-chloropropanoate 0
                                    (S)-4-amino-5-oxopentanoate 0
                                    (S)-5-carboxymethyl-tetronate(1-) 0
                                    (S)-alpha-hydroxyglutarate-gamma-lactone 0
                                    (S)-dichlorprop(1-) 0
                                    (S)-dihydrocamalexate 0
                                    (S)-haloxyfop(1-) 0
                                    (S)-imazamox(1-) + 0
                                    (S)-imazapic(1-) + 0
                                    (S)-imazapyr(1-) + 0
                                    (S)-imazaquin(1-) + 0
                                    (S)-lorglumide(1-) + 0
                                    (Z)-2-methylureidoacrylate 0
                                    (Z)-3-amino-2-methylacrylate 0
                                    (Z)-3-aminoacrylate 0
                                    (aminooxy)acetate + 0
                                    (methylthio)acetate 0
                                    1,2-diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol(1-) 0
                                    1,4-dihydroxy-6-naphthoate 0
                                    1,6-anhydro-N-acetyl-beta-muramate 0
                                    1,6-dihydroxy-2-methylcyclohexa-2,4-diene-1-carboxylate 0
                                    1-(2-carboxylatophenylamino)-1-deoxy-D-ribulose 5-phosphate(3-) 0
                                    1-O-hexadecyl-2-(8-carboxyoctanoyl)-sn-glycero-3-phosphocholine(1-) 0
                                    1-deoxypentalenate 0
                                    1-hexadecyl-2-glutaryl-sn-glycero-3-phosphocholine(1-) 0
                                    1-hexadecyl-2-succinyl-sn-glycero-3-phosphocholine(1-) 0
                                    1-methyl-4-imidazoleacetate 0
                                    1-naphthaleneacetate 0
                                    1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine(1-) 0
                                    1-phosphonato-alpha-D-galacturonate(3-) 0
                                    1-phosphonato-alpha-D-glucuronate(3-) 0
                                    1-piperideine-6-carboxylate + 0
                                    1-pyrrolinecarboxylate + 0
                                    12-(octadecanoyloxy)octadecanoate 0
                                    12-(phosphonooxy)octadecanoate(3-) 0
                                    12-[(9Z)-hexadecenoyloxy]octadecanoate 0
                                    12-[(9Z)-octadecenoyloxy]octadecanoate 0
                                    12-ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d(1-) 0
                                    12-ethyl-8-propyl-3-vinylbacteriochlorophyllide d(1-) 0
                                    13-(beta-D-glucosyloxy)docosanoate 0
                                    13-(octadecanoyloxy)octadecanoate 0
                                    13-[(9Z)-hexadecenoyloxy]octadecanoate 0
                                    13-[(9Z)-octadecenoyloxy]octadecanoate 0
                                    16-epiestriol 16-O-(beta-D-glucuronide)(1-) 0
                                    16-epiestriol 3-O-(beta-D-glucuronide)(1-) 0
                                    16-feruloyloxypalmitate 0
                                    16-sinapoyloxypalmitate 0
                                    17-(4-hydroxyphenyl)heptadecanoate 0
                                    17-epiestriol 16-O-(beta-D-glucuronide)(1-) 0
                                    17-epiestriol 17-O-(beta-D-glucuronide)(1-) 0
                                    17-epiestriol 3-O-(beta-D-glucuronide)(1-) 0
                                    17alpha-(N-acetyl-D-glucosaminyl)estradiol 3-glucosiduronate 0
                                    17alpha-estradiol 3-glucosiduronate 0
                                    17beta-estradiol 17-glucosiduronate + 0
                                    19-(4-hydroxyphenyl)nonadecanoate 0
                                    2,3,6,8,9-pentahydroxy-1-oxo-3-(2-oxopropyl)-1,2,3,4-tetrahydroanthracene-2-carboxylate 0
                                    2,3-bisphosphonato-D-glycerate(5-) 0
                                    2,4,5-trihydroxyphenylacetate 0
                                    2,4-dichloro-5-oxo-2,5-dihydro-2-furylacetate 0
                                    2,4-dihydroxybenzoate 0
                                    2,4-divinyl protochlorophyllide a(1-) 0
                                    2,6-dihydroxybenzoate 0
                                    2,6-dihydroxynicotinate 0
                                    2-O-(4-deoxy-beta-L-threo-hex-4-enopyranuronosyl)-alpha-L-rhamnopyranose(1-) 0
                                    2-O-(6-phospho-alpha-D-mannosyl)-D-glycerate 0
                                    2-O-(alpha-D-glucopyranosyl)-3-O-phosphonato-D-glycerate(3-) 0
                                    2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phosphonato-D-glycerate(3-) 0
                                    2-O-[alpha-D-mannosyl-(1->2)-alpha-D-glucosyl]-D-glycerate 0
                                    2-O-alpha-L-rhamnosyl-alpha-L-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoate 0
                                    2-[(1R,8S,14R,15R)-11-hydroxy-14,15-bis[(6E)-oct-6-en-1-yl]-3,5,9-trioxo-4,10-dioxatetracyclo[9.4.0.0(2,6).0(8,12)]pentadeca-2(6),12-dien-8-yl]acetate 0
                                    2-[(E)-\{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene\}amino]acetate 0
                                    2-[1-(\{5-hydroxy-4-oxo-3-[2-(sulfonatooxy)phenyl]-4H-chromen-6-yl\}oxy)-2-oxoethoxy]-3-oxopropanoate 0
                                    2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-4-O-sulfonato-D-galactopyranose(2-) + 0
                                    2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-6-O-sulfonato-D-galactopyranose(2-) + 0
                                    2-amino-2-deoxy-D-gluconate 0
                                    2-amino-3-oxo-4-(phosphonatooxy)butanoate 0
                                    2-carboxylato-D-arabinitol 1-phosphate(3-) 0
                                    2-carboxylato-D-arabinitol(1-) 0
                                    2-chloroacrylate 0
                                    2-cis-abscisate + 0
                                    2-dehydro-3,6-dideoxy-6-sulfo-D-gluconate(2-) 0
                                    2-dehydro-3-deoxy-6-phosphonato-D-gluconate(3-) 0
                                    2-ethylacrylate 0
                                    2-hydroxy-17beta-estradiol 2-O-(beta-D-glucuronide)(1-) 0
                                    2-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                                    2-hydroxyestrone 2-O-(beta-D-glucuronide)(1-) 0
                                    2-hydroxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                                    2-imino-3-(7-chloroindol-3-yl)propionate(1-) 0
                                    2-imino-3-(indol-3-yl)propanoate 0
                                    2-iminopropanoate 0
                                    2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                                    2-methoxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                                    2-methylvalerate 0
                                    2-oxindole-3-acetate 0
                                    2-oxo-1,2-dihydroquinoline-4-carboxylate 0
                                    2-oxo-4-phosphonobutanoate(2-) 0
                                    2-phosphonatoglycolate(3-) 0
                                    3'-dehydrocarminate(2-) 0
                                    3,3',5-triiodo-L-thyroninate + 0
                                    3,4,5-trimethoxybenzoate 0
                                    3,4,5-trimethoxydihydrocinnamate 0
                                    3,4-dehydrothiomorpholine-3-carboxylate 0
                                    3,4-dimethylindole-2-carboxylate 0
                                    3,5-dibromo-4-oxidobenzoate(2-) 0
                                    3-(1-hydroxyethyl)bacteriochlorophyllide a(2-) 0
                                    3-(1-hydroxyethyl)chlorophyllide a(2-) 0
                                    3-(1-methyl-5-oxo-4,5-dihydro-1H-imidazol-4-yl)propanoate(1-) 0
                                    3-(1H-indol-3-yl)propanoate 0
                                    3-(2,3-dihydroxyphenyl)propanoate 0
                                    3-(2-hydroxyphenyl)propanoate 0
                                    3-(3,4-dihydroxyphenyl)propanoate 0
                                    3-(3-hydroxyphenyl)propanoate 0
                                    3-(3-sulfooxyphenyl)propanoate(2-) 0
                                    3-(4-oxo-4,5-dihydro-1H-imidazol-5-yl)propanoate(1-) 0
                                    3-(cis-5,6-dihydroxycyclohexa-1,3-dienyl)propanoate + 0
                                    3-(dioxido-lambda(5)-azanylidene)propanoate(2-) 0
                                    3-(trimethylsilyl)propionate + 0
                                    3-ADP-2-phosphoglycerate(5-) 0
                                    3-D-glucuronosyl-N(2),6-disulfonato-beta-D-glucosamine(3-) 0
                                    3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronate)-D-galactosamine(1-) 0
                                    3-acetylchlorophyllide a(2-) 0
                                    3-aci-nitropropanoate 0
                                    3-butynoate 0
                                    3-carboxy-3-hydroxypropanoyl-CoA(5-) + 0
                                    3-chloroacrylate 0
                                    3-dehydro-L-gulonate 6-phosphate 0
                                    3-dehydroshikimate 0
                                    3-deoxy-D-glycero-beta-D-galacto-nonulosonate + 0
                                    3-deoxy-alpha-D-manno-2-octulosonate-8-phosphate(3-) 0
                                    3-deoxy-alpha-D-manno-oct-2-ulosonate 0
                                    3-diazoavenalumate 0
                                    3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoate 0
                                    3-hydroxy-3-(4-O-beta-D-glucosyl-3-methoxyphenyl)propanoate 0
                                    3-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoate 0
                                    3-hydroxy-3-(4-hydroxyphenyl)propanoate 0
                                    3-hydroxy-3-phenylpropionate 0
                                    3-mercapto-2-mercaptomethylpropanoate(1-) 0
                                    3-methylvalerate 0
                                    3-nitroacrylate 0
                                    3-nitropropanoate 0
                                    3-phenylpropionate + 0
                                    3-phosphonatopyruvate(2-) 0
                                    3-phosphonatopyruvate(3-) 0
                                    3-sulfinatopropionate 0
                                    3-ureidoisobutyrate(1-) 0
                                    3-vinyl-bacteriochlorophyllide d(1-) 0
                                    3-vinylbacteriochlorophyllide a(1-) 0
                                    3-vinylbacteriochlorophyllide a(2-) 0
                                    3-vinylbacteriochlorophyllide d(1-) 0
                                    3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oate(1-) 0
                                    4'''-demalonylsalvianin(1-) 0
                                    4,4'-diapolycopen-4-oate 0
                                    4,4'-diaponeurosporenoate 0
                                    4-(2,4-dichlorophenoxy)butanoate 0
                                    4-O-beta-D-glucosyl-4-coumarate + 0
                                    4-O-beta-D-glucosyl-trans-ferulate 0
                                    4-O-beta-D-glucosyl-trans-sinapate 0
                                    4-acetamidobutanoate 0
                                    4-carboxylato-4'-sulfonatoazobenzene 0
                                    4-carboxylatomethyl-3-methylbut-2-en-1,4-olide(1-) 0
                                    4-carboxylatomethyl-4-methylbut-2-en-1,4-olide(1-) 0
                                    4-carboxylatomethylenebut-2-en-4-olide 0
                                    4-chlorophenylacetate 0
                                    4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc(2-) 0
                                    4-deoxy-L-threo-hex-4-enopyranuronate + 0
                                    4-deoxy-beta-L-threo-hex-4-enopyranuronate 0
                                    4-guanidinobutanoate 0
                                    4-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                                    4-hydroxy-17beta-estradiol 4-O-(beta-D-glucuronide)(1-) 0
                                    4-hydroxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                                    4-hydroxyestrone 4-O-(beta-D-glucuronide)(1-) 0
                                    4-hydroxyphenylacetate 0
                                    4-methoxy-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate 0
                                    4-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide)(1-) 0
                                    4-methoxy-4-oxo-3-phenylbutanoate 0
                                    4-methoxyestrone 3-O-(beta-D-glucuronide)(1-) 0
                                    4-methyl-3-oxopentanoate 0
                                    4-methylumbelliferone beta-D-glucuronide(1-) 0
                                    4-sulfanylbutanoate 0
                                    5(S),8(R)-DiHODE(1-) 0
                                    5,10-dihydro-9-dimethylallylphenazine 1-carboxylate 0
                                    5,10-dihydrophenazine-1-carboxylate 0
                                    5,6,7,8-tetrahydropterin-6-carboxylate 0
                                    5,6-epoxyretinoate 0
                                    5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl beta-D-glucuronide(1-) 0
                                    5-(2,3-dimethoxy-4-methylphenyl)pentanoate 0
                                    5-(2-carboxylatoethyl)-4-oxo-4,5-dihydro-1H-imidazol-5-ide 0
                                    5-[(9Z)-hexadecenoyloxy]octadecanoate 0
                                    5-[(9Z)-octadecenoyloxy]octadecanoate 0
                                    5-amino-4-chloro-2-(2-oxidomuconoyl)pyridazin-3(2H)-one(2-) 0
                                    5-aminolevulinate 0
                                    5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium-3-carbonyl adenylate(3-) 0
                                    5-chloromuconolactone(1-) 0
                                    5-dehydro-4-deoxy-2-O-sulfo-D-glucuronic acid(2-) 0
                                    5-dehydro-D-gluconate 0
                                    5-dehydro-L-gluconate 0
                                    5-deoxy-D-glucuronate 0
                                    5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate 0
                                    5-hydroxy-6-methylpyridine-3-carboxylate 0
                                    5-hydroxyectoinate 0
                                    5-hydroxyferulate + 0
                                    5-hydroxyimidazole-4-acetate 0
                                    5-oxo-2,5-dihydro-2-furylacetate 0
                                    5-oxo-4,5-dihydro-2-furylacetate 0
                                    5alpha-androstane-3alpha,17beta-diol 17-glucosiduronate 0
                                    5alpha-androstane-3alpha,17beta-diol 3-glucosiduronate(1-) 0
                                    5alpha-androstane-3beta,17beta-diol 17-O-(beta-D-glucuronide)(1-) 0
                                    5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)(1-) 0
                                    6-O-desmethylmycophenolate 0
                                    6-[(4-hydroxy-3-nitrophenyl)acetamido]caproate 0
                                    6-deoxy-6-sulfo-D-gluconate(2-) 0
                                    6-formamidopenicillanate 0
                                    6-hydroxynicotinate(1-) 0
                                    6-ketopiperidine-2-carboxylate 0
                                    6-phospho-D-gluconate 0
                                    6-phosphonato-2-dehydro-3-deoxy-D-galactate(3-) 0
                                    6-phosphonatooxy-D-gluconate 0
                                    6alpha-hydroxygermacra-1(10),4,11(13)-trien-12-oate 0
                                    7(1),7(1)-dihydroxybacteriochlorophyllide d(1-) 0
                                    7(1)-hydroxybacteriochlorophyllide d(1-) 0
                                    7(1)-hydroxychlorophyllide a(2-) 0
                                    7,7-dihydroxybacteriochlorophyllide c(1-) 0
                                    7-carboxylato-7-deazaguanine 0
                                    7-deoxyloganate 0
                                    7-deoxyloganetate 0
                                    7-hydroxybacteriochlorophyllide c(1-) 0
                                    7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate 0
                                    8(R)-HPODE(1-) 0
                                    8,12-diethyl-3-vinylbacteriochlorophyllide d(1-) 0
                                    8-phosphonato-3-deoxy-D-manno-oct-2-ulosonate(3-) 0
                                    9(R)-HPODE(1-) 0
                                    9(S)-HPODE(1-) 0
                                    9-(octadecanoyloxy)octadecanoate 0
                                    9-[(10Z)-heptadecenoyloxy]-octadecanoate 0
                                    9-[(9Z),(12Z)-octadecadienoyloxy]-octadecanoate 0
                                    9-[(9Z)-hexadecenoyloxy]octadecanoate 0
                                    9-[(9Z)-octadecenoyloxy]octadecanoate 0
                                    9beta-pimara-7,15-dien-19-oate 0
                                    ADP-5-ethyl-4-methylthiazole-2-carboxylate(3-) 0
                                    CMP-5'-phosphonoformate(3-) 0
                                    D-galactopyranuronate + 0
                                    D-glucopyranuronate + 0
                                    D-glucuronate 1-phosphate 0
                                    F420-0(2-) 0
                                    L-5-carboxylatomethylhydantoin(1-) 0
                                    L-rhamnonate 0
                                    L-rhamnosyl-3-hydroxydecanoyl-3-hydroxydecanoate 0
                                    L-thyroxine(1-) + 0
                                    N,N-dihydroxy-L-isoleucinate 0
                                    N,N-dihydroxy-L-valinate 0
                                    N-(11-methyldodecanoyl)-L-phenylalanine(1-) 0
                                    N-(1H-1,3-benzodiazol-2-yl)carbamate 0
                                    N-(2-furoyl)glycinate 0
                                    N-(2-hydroxy,5-methoxyphenyl)malonamate 0
                                    N-(2-hydroxyphenyl)malonamate 0
                                    N-(3,4-dichlorophenyl)malonamate 0
                                    N-(3-carboxypropanoyl)-N-hydroxycadaverine zwitterion 0
                                    N-(3-carboxypropanoyl)-N-hydroxyputrescine zwitterion 0
                                    N-(indol-3-ylacetyl)glutaminate 0
                                    N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]-gamma-aminobutanoate 0
                                    N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]-gamma-aminobutyrate 0
                                    N-[(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-icosatetraenoyl]glycinate 0
                                    N-[(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-icosatetraenoyl]glycinate 0
                                    N-[(R)-pantothenoyl]-L-cysteinate 0
                                    N-acetyl-1-methyl-L-histidinate 0
                                    N-acetyl-3-methyl-L-histidinate 0
                                    N-acetyl-D-6-sulfogalactosamine(1-) 0
                                    N-acetyl-D-glucosaminate 0
                                    N-acetyl-D-muramoyl-L-alanyl-D-isoglutamine(1-) 0
                                    N-acetyl-L-alaninate 0
                                    N-acetyl-L-alpha-phenylglycinate 0
                                    N-acetyl-L-cysteinate + 0
                                    N-acetyl-L-isoleucinate 0
                                    N-acetyl-L-threoninate 0
                                    N-acetyl-L-tryptophanate 0
                                    N-acetyl-L-tyrosinate 0
                                    N-acetyl-L-valinate 0
                                    N-acetyl-alpha-D-muramate 1-phosphate(3-) 0
                                    N-acetyl-alpha-neuraminate + 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-6-sulfooxy-glucosaminide(2-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose(1-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose(1-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-Fuc-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-6-sulfooxy-glucosaminide(2-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosamine(1-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-N-acetyl-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminide(1-) 0
                                    N-acetyl-alpha-neuraminosyl-(2->6)-beta-D-galactosyl-(1->4)-6-O-sulfo-beta-D-glucosaminide(2-) 0
                                    N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminide(1-) 0
                                    N-acetyl-beta-D-6-sulfogalactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine(3-) 0
                                    N-acetyl-beta-D-galactosaminyl-(1->4)-[N-acetyl-alpha-neuraminyl-(2->3)]-beta-D-galactoside(1-) + 0
                                    N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-beta-D-4-sulfogalactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-D-4-sulfogalactosamine(4-) 0
                                    N-acetyl-beta-D-galactosaminyl-(1->4)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide anion 0
                                    N-acetyl-beta-D-muramoyl-L-alanyl-D-isoglutamine(1-) 0
                                    N-acetyl-beta-neuraminate 0
                                    N-acetylmethioninate + 0
                                    N-acetylmuramate 6-phosphate + 0
                                    N-acetylphosphinothricin(2-) + 0
                                    N-acetyltryptophanate 0
                                    N-acyl-gamma-aminobutyrate + 0
                                    N-arachidonoyl-gamma-aminobutyrate 0
                                    N-carbamoyl-D-phenylglycine(1-) 0
                                    N-carbamoyl-beta-alaninate 0
                                    N-carbamoylsarcosinate 0
                                    N-cinnamoylglycinate 0
                                    N-formylmaleamate 0
                                    N-hexadecanoyl-O-(1-octadecanoyl-2-oleoyl-sn-glycero-3-phospho)-L-serine(2-) 0
                                    N-hexanoylglycinate 0
                                    N-hydroxy-L-isoleucinate 0
                                    N-hydroxy-L-valinate 0
                                    N-isobutyrylglycinate 0
                                    N-isovalerylglycinate 0
                                    O-formylcefamandole(1-) + 0
                                    Photinus luciferin(1-) 0
                                    [1-(5-phosphonatoribosyl)imidazol-4-yl]acetate(3-) 0
                                    [2-methoxy-5-(\{[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl\}methyl)anilino]acetate 0
                                    a carboxymycobactin(1-) 0
                                    abietate 0
                                    abscisates + 0
                                    acetate + 41
                                    acrylate + 3
                                    adenin-9-yl riburonosate(1-) 0
                                    aldehydic acid anion + 0
                                    aldonate + 21
                                    all-trans-13,14-dihydroretinoate + 0
                                    all-trans-3,4-didehydroretinoate(1-) 0
                                    allantoate 0
                                    alpha-D-FucNAc4-(1->4)-beta-D-ManNAcA-(1->4)-D-GlcNAc-undecaprenyl diphosphate(3-) 0
                                    alpha-D-mannopyranuronate 0
                                    alpha-D-talopyranuronate 0
                                    alpha-L-iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine(2-) 0
                                    alpha-L-iduronyl-(1->3)-N-acetyl-beta-D-4-sulfogalactosaminyl-(1->4)-alpha-L-iduronyl-(1->3)-N-acetyl-D-4-sulfogalactosamine(4-) 0
                                    alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminide(1-) + 0
                                    alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide(1-) + 0
                                    alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminide(1-) + 0
                                    alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine(1-) + 0
                                    alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine(1-) 0
                                    alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide(1-) 0
                                    alpha-Neu5Ac-(2->3)-beta-D-Gal6S-(1->4)-beta-D-GlcNAc6S(3-) 0
                                    alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc(1-) 0
                                    alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc(1-) + 0
                                    alpha-sulfophenylacetate 0
                                    amidotrizoic acid anion + 16
                                    aminocyclopyrachlor(1-) + 0
                                    arsonoacetic acid anion 0
                                    ascr#1(1-) + 0
                                    ascr#10(1-) + 0
                                    ascr#12(1-) + 0
                                    ascr#14(1-) 0
                                    ascr#16(1-) 0
                                    ascr#9(1-) + 0
                                    asnovolin I(1-) 0
                                    asparagusate 0
                                    asperaculane D(1-) 0
                                    asperaculane E(1-) 0
                                    asperaculane G(1-) 0
                                    bacteriochlorophyllide a(2-) + 0
                                    bacteriochlorophyllide c(1-) 0
                                    bacteriochlorophyllide d(1-) 0
                                    bacteriochlorophyllide e(1-) 0
                                    bacteriochlorophyllide f(1-) + 0
                                    bacteriochlorophyllide g(2-) 0
                                    baicalin(1-) 0
                                    benazolin(1-) + 0
                                    benzoates + 1285
                                    beraprost(1-) + 0
                                    beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-D-GlcpNAc(1-) + 0
                                    beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc(1-) 0
                                    beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GlcpNAc(1-) 0
                                    beta-D-ManNAcA-(1->4)-alpha-D-GlcNAc-1-diphospho-ditrans,polycis-undecaprenol(3-) 0
                                    beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-alpha-D-galactosaminide(1-) 0
                                    bile acid anion + 54
                                    biotinate + 0
                                    biotinate sulfoxide(1-) 0
                                    bisorcic(1-) 0
                                    bispyribac(1-) + 0
                                    bromfenac(1-) + 0
                                    bumadizone(1-) + 0
                                    butyrylglycinate 0
                                    calcitroate 0
                                    candesartan(2-) 0
                                    carbocyclic thromboxane A2(1-) + 0
                                    carboprost(1-) + 0
                                    carminate(2-) 0
                                    carnosate 0
                                    carumonam(1-) + 0
                                    catechol beta-D-glucuronide(1-) 0
                                    cefmenoxime(1-) 0
                                    ceftizoxime(1-) + 0
                                    cefuzonam(1-) + 0
                                    chenodeoxycholic acid 24-O-(beta-D-glucuronide)(1-) 0
                                    chlorfenac(1-) + 0
                                    chlorogenate 0
                                    chlorophenoxyacetate anion + 0
                                    chlorophyllide a(2-) 0
                                    chlorophyllide b(1-) 0
                                    chlorophyllide b(2-) 0
                                    chlorophyllide(2-) + 0
                                    cholic acid 24-O-(beta-D-glucuronide)(1-) 0
                                    chromenemonocarboxylate + 0
                                    cinnamates + 0
                                    cis-2-chloro-4-carboxylatomethylenebut-2-en-1,4-olide 0
                                    cis-2-methyl-4-carboxylatomethylenebut-2-en-1,4-olide(1-) 0
                                    cis-heme d hydroxychlorin gamma-spirolactone(1-) 0
                                    clavaldehyde(1-) 0
                                    clavulanate + 24
                                    clofencet(1-) + 0
                                    clonixin(1-) + 0
                                    clorazepic acid anion + 0
                                    cochalate 0
                                    coenzyme B(3-) 0
                                    creatinate 0
                                    cremeomycin(1-) 0
                                    cuevaene A(1-) 0
                                    cyclic 2,3-bisphospho-D-glycerate(3-) 0
                                    cyclitol carboxylic acid anion + 0
                                    cyclohex-1,4-dienecarboxylate + 0
                                    cyclohex-2,5-dienecarboxylate + 0
                                    cyclohexadienecarboxylate + 0
                                    cyclohexanecarboxylate + 0
                                    cyclohexenecarboxylate + 0
                                    cyclopropanecarboxylate + 0
                                    dTDP-D-galacturonate(3-) 0
                                    dehydroabietate 0
                                    delphinidin-5-olate 3-O-(6''-O-carboxylatoacetyl)-beta-D-glucoside(1-) 0
                                    delphinidin-5-olate 3-O-(6''-O-carboxylatoacetyl)-beta-D-glucoside-3'-O-beta-D-glucoside(1-) 0
                                    deoxycholic acid 24-O-(beta-D-glucuronide)(1-) 0
                                    deoxylimonoate 0
                                    deoxyviolaceinate 0
                                    dermatan sulfate polyanion + 0
                                    desmethylnaproxen(1-) 0
                                    dethiobiotin(1-) 0
                                    di-trans,poly-cis-polyprenate(1-) 0
                                    dicarboxylic acid monoamide(1-) + 0
                                    dichloroacetate 0
                                    diclofenac(1-) + 0
                                    difluoroacetate 0
                                    dihydroartemisinate 0
                                    dihydroferulate 0
                                    dihydroorotate + 0
                                    dihydrourocanate 0
                                    ditrans,polycis-dodecaprenyl phosphate-GalA(2-) 0
                                    divinyl chlorophyllide a(2-) 0
                                    ectoinate 0
                                    ent-7alpha-hydroxykaur-16-en-19-oate 0
                                    ent-Photinus luciferin(1-) 0
                                    ent-glycosmisate 0
                                    ent-kaur-16-en-19-oate 0
                                    epoxy monocarboxylic acid anion + 0
                                    etiocholanolone 3-glucuronide(1-) 0
                                    etrasimod(1-) + 0
                                    fatty acid anion + 138
                                    fenoprofen(1-) + 0
                                    firefly D-sulfoluciferin(2-) 0
                                    firefly L-sulfoluciferin(2-) 0
                                    flavokermesate 7-C-beta-D-glucoside(2-) 0
                                    flufenamate 0
                                    flunixin(1-) + 0
                                    fondaparinux(10-) + 0
                                    formate + 0
                                    fosinopril(1-) + 0
                                    fumagillin(1-) 0
                                    fumisoquin C(1-) 0
                                    furancarboxylate + 0
                                    germacra-1(10),4,11(13)-trien-12-oate + 0
                                    glutaramate + 0
                                    glycosmisate 0
                                    glycyrrhetinate 82
                                    guanidinoacetate 0
                                    gypsogenate 28-beta-D-glucoside(1-) 0
                                    gypsogenin(1-) 0
                                    haloacetate(1-) + 0
                                    haloxyfop-P(1-) + 0
                                    hederagenin(1-) 0
                                    heparin disaccharide I-S(4-) 0
                                    hydantoin-5-propionate + 0
                                    hydrogen phosphonatoacetate(2-) 0
                                    hydroxy fatty acid ascaroside anion + 0
                                    hydroxy monocarboxylic acid anion + 78
                                    hyocholic acid 24-O-(beta-D-glucuronide)(1-) 0
                                    hyodeoxycholic acid 24-O-(beta-D-glucuronide)(1-) 0
                                    ibuprofen(1-) 0
                                    icas#1(1-) 0
                                    icas#10(1-) 0
                                    icas#12(1-) 0
                                    icas#9(1-) 0
                                    imidazol-4-ylacetate 0
                                    imidazolyl carboxylic acid anion + 0
                                    indol-3-yl carboxylic acid anion + 0
                                    indole-3-carboxylate 0
                                    indolecarboxylate + 0
                                    isopimarate 0
                                    karetazan(1-) + 0
                                    kermesate 0
                                    ketorolac(1-) + 12
                                    laccaic acid D(1-) 0
                                    leukotriene A4(1-) 0
                                    lithocholic acid 24-O-(beta-D-glucuronide)(1-) 0
                                    loganate 0
                                    lonazolac(1-) + 0
                                    luteolin 7-O-beta-D-glucosiduronate 0
                                    m-hydroxyhippurate 0
                                    magnesium 13(1)-hydroxyprotoporphyrin 13-monomethyl ester(1-) 0
                                    magnesium 13(1)-oxoprotoporphyrin 13-monomethyl ester(1-) 0
                                    magnesium protoporphyrin 13-monomethyl ester(1-) 0
                                    maleamate + 0
                                    marilonates + 0
                                    marinolate C 0
                                    meclofenamic acid(1-) + 0
                                    meglumine amidotrizoate 16
                                    methacrylate 0
                                    methoxyacetate + 0
                                    methyl 8-\{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl]oxy\}nonanoate(1-) 0
                                    methyl 8-\{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl]oxy\}nonanoate(1-) 0
                                    montelukast(1-) + 0
                                    mupirocin(1-) + 0
                                    mycophenolate + 0
                                    nalidixic acid anion 0
                                    naphthoate + 0
                                    naproxen(1-) + 0
                                    naptalamate 0
                                    neopentalenolactone D(1-) 0
                                    neurosporaxanthin(1-) 0
                                    nocardicin E(1-) 0
                                    nocardicin E(2-) 0
                                    ochratoxin A(1-) 0
                                    ochratoxin B(1-) 0
                                    oleanolate 0
                                    oleanolate 3-O-beta-D-glucoside 0
                                    olivetolate + 0
                                    oroxylin A 7-O-beta-D-glucuronate 0
                                    oxamate 0
                                    oxo monocarboxylic acid anion + 0
                                    p-hydroxyhippurate 0
                                    p-tolyl beta-D-glucuronide(1-) 0
                                    pantothenate + 0
                                    penamcarboxylate + 0
                                    penicillinate anion + 0
                                    penilactone B(1-) 0
                                    penilactone D(2-) 0
                                    penta-2,4-dienoate + 0
                                    pentalenolactone D(1-) 0
                                    pentalenolactone E(1-) 0
                                    pentalenolactone F(1-) 0
                                    pentalenolactone(1-) 0
                                    pepstatin A(1-) 0
                                    perillate 0
                                    perindopril(1-) + 0
                                    phaseic acid anion 0
                                    phenazine-1-carboxylate 0
                                    phenguignardate 0
                                    phenoxyacetate + 0
                                    phenylacetate + 0
                                    phenylacetylglycine(1-) 0
                                    phenylpyruvate + 0
                                    phomoidride A(1-) 0
                                    phosphoenolpyruvate 3
                                    phosphonatoenolpyruvate 0
                                    phosphonoformate(2-) 0
                                    piperidinecarboxylate + 0
                                    piperonylate 0
                                    pivalate + 0
                                    platencin(1-) 0
                                    platensimycin(1-) 0
                                    pravastatin(1-) + 0
                                    primary fluorescent chlorophyll catabolite(1-) 0
                                    primary fluorescent dioxobilin-type chlorophyll catabolite(1-) + 0
                                    propionylglycinate 0
                                    propynoate 0
                                    protochlorophyllide b(1-) 0
                                    protochlorophyllide(1-) 0
                                    protochlorophyllide(2-) 0
                                    protodeoxyviolaceinate 0
                                    protoviolaceinate 0
                                    pseudaminate + 0
                                    pseudomonates + 0
                                    pteroates + 0
                                    purinecarboxylate + 0
                                    pyrazine-2-carboxylate 0
                                    pyridinemonocarboxylate + 39
                                    pyridinium-3-carboxylate-5-thiocarboxylate mononucleotide(3-) 0
                                    pyrimidinecarboxylate anion + 0
                                    pyrrolecarboxylate + 0
                                    pyruvate oxime 0
                                    quiannulatate 0
                                    quillate 0
                                    quinclorac(1-) + 0
                                    quinoline-4-carboxylate 0
                                    quinolinemonocarboxylate + 0
                                    rebaudioside B(1-) 0
                                    retinoate + 0
                                    ribavirin carboxylate 0
                                    rigosertib(1-) + 0
                                    rose bengal(2-) + 8
                                    rosmarinate + 0
                                    salicylurate 0
                                    scutellarin(1-) 0
                                    sesterfisherate 0
                                    soyasapogenol A 3-O-beta-glucuronate 0
                                    soyasapogenol B 3-O-beta-glucuronate 0
                                    soyasapogenol E 3-O-beta-glucuronate 0
                                    soyasaponin I(1-) 0
                                    soyasaponin III(1-) 0
                                    stellatate 0
                                    steviol(1-) 0
                                    steviolbioside(1-) 0
                                    steviolmonoside(1-) 0
                                    streptothricin D acid (pH 7.3) 0
                                    streptothricin F acid (pH 7.3) 0
                                    succinamate 0
                                    sulbactam(1-) + 0
                                    sulfonatoacetate 0
                                    tafamidis(1-) + 0
                                    tartrazine(3-) + 94
                                    ternatin C5(2-) 0
                                    thiazolidinemonocarboxylate + 0
                                    thioglycolate(1-) + 0
                                    thioglycolate(2-) 0
                                    thiomorpholine-3-carboxylate 0
                                    thiophene-2-carboxylate 0
                                    thromboxane A2(1-) + 0
                                    tolmetin(1-) + 0
                                    trans-2-chloro-4-carboxylatomethylenebut-2-en-1,4-olide(1-) 0
                                    trans-2-methyl-4-carboxylatomethylenebut-2-en-1,4-olide(1-) 0
                                    trans-ferulate + 0
                                    trans-heme d hydroxychlorin gamma-spirolactone(1-) 0
                                    trichloroacetate 0
                                    trifluoroacetate + 5
                                    trihazone A(2-) 0
                                    ureidoacrylate 0
                                    urocanate + 0
                                    uronate + 0
                                    valerenate 0
                                    violaceinate 0
                                    wogonin 7-O-beta-D-glucuronate 0
                                    yersiniabactin(1-) + 0
                                    zealexin A1(1-) 0
                                    zofenopril(1-) + 0
                                    zofenoprilat(1-) + 0
                                    zolasartan(2-) 0
paths to the root